DISTRIBUTOR

U.S. Pharmacopeia 12601 Twinbrook Parkway Rockville, MD 20852

Reference Standards Just Released

>> Citalopram Hydrobromide Related Compound >> Fluvastatin Sodium >> Norgestimate Related Compound A

Headquarters 12601 Twinbrook Parkway Rockville, Maryland 20852, USA

Europe/Middle East/Africa Mnchensteinerstrasse 41 CH-4052 Basel, Switzerland

USPIndia Private Limited ICICI Knowledge Park, Genome Valley Labs 7-10, Phase III Turkapally, Shameerpet Ranga Reddy District Hyderabad 500 078, A.P., India

USPChina Suite 542-550 Shanghai Center 1376 West Nanjing Road Shanghai 200040, China

USP CATALOG September/October 2006

WHATS NEW AT USP

REFERENCE STANDARDS

18 new items
PUBLICATIONS

5th Interim Revision Announcement official October 1, 2006 USP 30NF 25Order Now! Publishing November 1
EDUCATION

Upcoming European courses in Switzerland, Belgium, Italy and India

U.S. PHARMACOPEIA
The Standard of QualitySM
ISO 9001:2000 Certified

MS147CAT

USP 30NF 25Order Now! Publishing November 1

SEPTEMBER/OCTOBER 2006

TABLE OF CONTENTS

New Print Format

Expanded 3-volume set Heavier, more durable paper Convenient storage case*
PRINT AND ELECTRONIC PUBLICATIONS USPNF . . . . . . . . . . . . . . . . . . . . . . . . . 1 Chromatographic Reagents . . . . . . . . . 1 Pharmacopeial Forum . . . . . . . . . . . . . 2 USP Dictionary . . . . . . . . . . . . . . . . . . . 2 PHARMACOPEIAL EDUCATION Course Descriptions and Locations . . . . . . . . . . . . . . . . . . . . 3 USP REFERENCE STANDARDS

New CD and Online Feature

Viewable chemical structures for more than 300 impurities
Available in English (Nov. 2006: print, CD, online) and Spanish (Dec. 2006: print)
*English edition only

Using Reference Standards . . . . . . . . . 19 How to Read Product Listings . . . . . . . 21 New Lots . . . . . . . . . . . . . . . . . . . . . . . . 31 Catalog Listings Alphabetical by Substance . . . . . . . . . . 34 Cross-References . . . . . . . . . . . . . . 93

Attend Pharmacopeial Education Courses Around the World

Upcoming courses are scheduled for October and November in the following locations: India Oct. 4-5, 9-10 Fundamentals of Dissolution Oct. 12 Effectively Using the USPNF Switzerland Oct. 10-11 Oct. 12-13 Belgium Oct. 18 Oct. 19 Fundamentals of Dissolution
(English/German)

Authentic Substances . . . . . . . . . . . 97 Dietary Supplements and Botanicals . . . . . . . . . . . . . . . . . . . . 100 Controlled Substances . . . . . . . . . . 104 USP Authorized Distributors . . . . . . . . 107 ORDER FORMS Pharmacopeial Education Registration Form . . . . . . . . . . . . . . . . . 11 13 15 17

Fundamentals of Dissolution
(English/French)

Effectively Using the USPNF Analytical Method Validation

Italy Nov. 8-9, 14-15 Fundamentals of Dissolution

(English/Italian)

For details and registration, see page 11 in this catalog or contact your USP Authorized Distributor.

The official text is the English version of this catalog. Any discrepancies or differences created in translations are not binding and have no legal effect. USP accepts no responsibility or liability for the accuracy of the translation of this catalog. If any questions arise in regard to the accuracy of information contained in any translated portion of text in this catalog, please refer to the official English version. USP apologizes for any translation that is not correct.

EN GL IS H ES PA O L DE UT SC H FR AN A IS

1 1 2 2

1 1 2 2

1 1 2 2

22 25 28 24 27 30

18

completely NEW Reference Standards this month! (Look for items marked )
For your convenient and quick reference, heres a list of Reference Standards released by USP over the past year. USP continuously releases new Reference Standards. Dont wait until the next catalog to learn about them. Contact your Authorized Distributor to get the latest listing, which is updated daily.
STOCKED & READY TO SHIP

Cat. # Description
1006801 Acetone (1.5 mL/ampule; 3 ampules) 1011007 Acitretin (200 mg) 1011018 Acitretin Related Compound A (20 mg) 1011029 Acitretin Related Compound B (20 mg) 1012076 Acyclovir Related Compound A (50 mg) (AS) 1019712 Amiloride Related Compound A (30 mg) (AS) 1021204 4-Aminophenol (100 mg) 1034909 Anecortave Acetate (200 mg) 1034910 Anecortave Acetate Related Compound A (20 mg) 1042102 L-Arabinitol (500 mg) 1048652 Benazepril Related Compound D (15 mg) 1065210 Berberine Chloride (50 mg) 1071202 Bicalutamide (200 mg) 1071213 Bicalutamide Related Compound A (25 mg) 1076465 Bromazepam CIV (100 mg) (AS) 1078201 Budesonide (200 mg) 1087508 Camphor (1 g) 1134346 Ciprofloxacin Related Compound A (25 mg) (AS) 1134233 Citalopram Hydrobromide (200 mg) 1134277 Citalopram Related Compound D (15 mg) 1162148 Cytosine (100 mg) 1241903 Erythritol (200 mg) 1249202 Escin (350 mg) 1268513 Etidronate Disodium Related Compound A (300 mg) 1270446 Fexofenadine Related Compound C (15 mg) (AS) 1285873 Fluticasone Propionate (100 mg) 1285884 Fluticasone Propionate Resolution Mixture (25 mg) 1285895 Fluticasone Propionate System Suitability Mixture (25 mg) 1285931 Fluvastatin Sodium (350 mg) 1285964 Fluvastatin Related Compound B (15 mg) 1285942 Fluvastatin for System Suitability (25 mg) 1292303 Glimepiride (200 mg) 1292314 Glimepiride Related Compound A (20 mg) 1292325 Glimepiride Related Compound B (20 mg) 1292336 Glimepiride Related Compound C (20 mg) 1292347 Glimepiride Related Compound D (20 mg) 1295516 Glyburide Related Compound A (25 mg) 1305303 Hexacosanol (100 mg)

Lot
F0D028 F0E266 F0E264 F0E265 F0F010 F0E287 F0F099 F0E298 F0E299 F0E311 F0F149 F0E185 F0E321 F0E322 F0F064 F0E302 F0F030 F0E333 F0F157 F0F170 F0E284 F0E313 F0F088 F0E227 F0E291 F0F036 F0E123 F0E122 F0F015 F0F017 F0F016 F0E228 F0E232 F0E233 F0E234 F0E235 F0E224 F0F131

Cat. # Description
1335010 Hyoscyamine Related Compound A (10 mg) 1335541 Ibuprofen Related Compound C (0.2 mL/ampule; 3 ampules) 1349626 Isomalt (200 mg) 1376017 Mecamylamine Related Compound A (10 mg) 1379060 Mefloquine Related Compound A (20 mg) 1396331 Metformin Related Compound B (25 mg) 1396342 Metformin Related Compound C (25 mg) 1424109 Methyl Alcohol (3 x 1.5 mL) 1457491 Naratriptan Resolution Mixture (20 mg) 1457902 Nefazodone Hydrochloride (200 mg) 1460204 Neotame (200 mg) 1460215 Neotame Related Compound A (15 mg) 1471958 Deacetylnorgestimate (25 mg) 1471925 Norgestimate Related Compound A (25 mg) 1478119 Ofloxacin Related Compound A (25 mg) 1478571 Ondansetron (300 mg) 1479010 Orphenadrine Related Compound A (50 mg) (AS) 1482025 Oxandrolone Related Compound B CIII (20 mg) 1491015 Oxytetracycline Hydrochloride (200 mg) (AS) 1492801 Pamidronate Disodium (100 mg) 1524806 Phenol (500 mg) 1546401 Polyethylene Glycol 200 (1 g) 1546423 Polyethylene Glycol 300 (1 g) 1546445 Polyethylene Glycol 400 (1 g) 1546467 Polyethylene Glycol 600 (1 g) 1546489 Polyethylene Glycol 1000 (1 g) 1546503 Polyethylene Glycol 1500 (1 g) 1546525 Polyethylene Glycol 3000 (1 g) 1546547 Polyethylene Glycol 3350 (1 g) 1546569 Polyethylene Glycol 4000 (1 g) 1546580 Polyethylene Glycol 6000 (1 g) 1546605 Polyethylene Glycol 8000 (1 g) 1546627 Polyethylene Glycol 10000 (1 g) 1546649 Polyethylene Glycol 12000 (1 g) 1546650 Polyethylene Glycol 20000 (1 g) 1546660 Polyethylene Glycol 35000 (1 g) 1546966 Polyisobutylene (1 g)

Lot
F0E250 F0F011 F0E263 F0F003 F0E166 F0F019 F0E343 F0D015 F0E346 F0F122 F0F044 F0F045 F0F089 F0F109 F0E276 F0E281 F0F042 F0F136 F0E258 F0F096 F0F029 F0E316 F0E336 F0E344 F0E345 F0F008 F0F009 F0F013 F0F012 F0F040 F0F041 F0F050 F0F051 F0F052 F0F053 F0F054 F0E108

STOCKED & READY TO SHIP

Cat. # Description
1372402 Polyoxyl Lauryl Ether (500 mg) 1557000 Prednisolone Sodium Phosphate (100 mg) 1598323 Ramipril Related Compound B (20 mg) 1598338 Ramipril Related Compound C (20 mg) 1598450 Ranitidine Resolution Mixture (20 mg) 1604803 Ritonavir (200 mg) 1604814 Ritonavir Related Compounds Mixture (50 mg) 1605500 Ropivacaine Hydrochloride (200 mg) 1605512 Ropivacaine Related Compound A (25 mg) 1605523 Ropivacaine Related Compound B (50 mg) 1607040 Saccharin Sodium (100 mg) 1609013 Salicylic Acid Related Compound A (100 mg) 1612404 Sesame Oil (1 mL/ampule; 2 ampules) (AS) 1612415 Sesame Oil Related Compound A (6 mg/vial; 3 vials)

Lot
F0E253 F0E300 F0F151 F0E157 F0E323 F0F049 F0F058 F0E334 F0E315 F0E318 F0F006 F0F108 F0E134 F0E131

Cat. # Description
1612426 Sesame Oil Related Compound B (6 mg/vial; 3 vials) 1614363 Sodium Lauryl Sulfate (1 g) (AS) 1614670 Sodium Starch Glycolate Type B (400 mg) 1619017 Spironolactone Related Compound A (100 mg) (AS) 1642019 Sulindac Related Compound A (20 mg) 1642100 Sulisobenzone (500 mg) 1667355 Tiamulin (100 mg) 1667541 Tinidazole Related Compound B (20 mg) 1682217 Triclosan Related Compounds Mixture A (1.2 mL/ampule; 3 ampules) 1705323 Ubidecarenone Related Compound A (15 mg) 1708718 Valproic Acid Related Compound B (50 mg) (AS) 1709018 Vancomycin B with Monodechlorovancomycin (350 mg) 1711428 Verapamil Related Compound D (50 mg)

Lot
F0E132 F0D381 F0E222 F0E184 F0E314 F0F074 F0E219 F0E274 F0E292 F0E210 F0E201 F0F138 F0E342

MS147CAT

Order Today! Contact your local USP Authorized Distributor.

U.S. Pharmacopeia The Standard of QualitySM

Dear Colleague: USP continues to expand and enhance our product and customer service offerings to meet your quality standards needs. To provide greater convenience and ease of use, we have added several new and enhanced products and services highlighted below. We hope you will find them beneficial in your daily operations. New Reference Standards Since the July/August catalog, USP has introduced 18 new Reference Standards. Please see the opposite page for a listing. USP 30NF 25Available for Pre-order with New Features! Order the latest edition of USPNF today and be prepared for compliance in 2007. USP 30NF 25 contains the important standards information that you need along with beneficial new features. To enhance readability, usability, and comprehension, the new USPNF in print will be published in a 3-volume set on a heavier, more durable paper stock. The CD and online versions will feature viewable chemical structures for more than 300 impurities with special electronic functions that let you zoom in, zoom out, and print. For more information, visit www.usp.org. New Pharmacopeial Education in India and Europe Plan to attend educational courses in locations around the world. Upcoming courses are scheduled for India (Oct. 4-5, 9-10, 12); Switzerland (Oct. 10-11, 12-13); Belgium (Oct. 18-19); and Italy (Nov. 8-9, 14-15). For details and registration, visit www.usp.org/eventsEducation. (This link is case sensitive.) Meet with USP at Upcoming Meetings Throughout the year, USP representatives are available to answer your questions and discuss standards issues at industry meetings and tradeshows held around the world. Look for the USP booth at AAPS, Oct. 29-Nov. 2, San Antonio, Texas; and EAS, Nov. 13-16, Somerset, New Jersey. To order USP Reference Standards and publications, please contact your USP Authorized Distributor. Sincerely,

Headquarters 12601 Twinbrook Parkway Rockville, Maryland 20852 +1-301-881-0666

Europe/Middle East/Africa Mnchensteinerstrasse 41 CH-4052 Basel, Switzerland +41 (0)61 316 30 10

USPIndia Private Limited ICICI Knowledge Park Genome Valley Labs 7-10, Phase III Turkapally, Shameerpet Ranga Reddy District Hyderabad 500 078, A.P., India +91-40-2348-0088

Barbara B. Hubert Director, USP Sales

USPChina Suite 542-550 Shanghai Center 1376 West Nanjing Road Shanghai 200040, China +86-21-6279-7657

www.usp.org

U.S. Pharmacopeia The Standard of QualitySM

Estimado colega: En USP continuamos ampliando y mejorando nuestro producto y nuestras ofertas de servicio al cliente a fin de satisfacer sus necesidades de estndares de calidad. Para ofrecer mayor conveniencia y facilidad de uso, hemos agregado varios productos y servicios tanto nuevos como mejorados, los cuales destacamos abajo. Esperamos que le sean de utilidad en su actividad diaria. Nuevos Estndares de Referencia Desde el catlogo de julio/agosto, USP ha presentado 18 Estndares de Referencia nuevos. Vea un listado de los mismos en la pgina opuesta. USP 30NF 25: Con nuevas caractersticas, disponible desde ya para pedidos! Solicite hoy la edicin ms reciente de USPNF y est preparado para el cumplimiento en 2007. USP 30NF 25 contiene la informacin de estndares importante que usted necesita junto con nuevas caractersticas provechosas. Para mejorar su lectura, uso y comprensin, la nueva versin impresa de USPNF ser publicada en 3 volmenes, en papel ms grueso y duradero. Las versiones en CD y online presentarn estructuras qumicas visualizables de ms de 300 impurezas con funciones electrnicas especiales que le permitirn maximizar, minimizar e imprimir. Para mayor informacin, visite www.usp.org. Nueva educacin farmacopeica en India y Europa Planifique su asistencia a cursos educativos alrededor del mundo. Los prximos cursos programados tendrn lugar en India (Oct. 4-5, 9-10, 12); Suiza (Oct. 10-11, 12-13); Blgica (Oct. 18-19) e Italia (Nov. 8-9, 14-15). Para obtener informacin detallada e inscribirse, visite www.usp.org/eventsEducation. (Este enlace es sensible al uso de maysculas). Encuntrese con USP en las prximas reuniones Durante el ao, los representantes de USP estn a su disposicin para responder a sus preguntas y discutir sobre los estndares en reuniones de la industria y exhibiciones comerciales alrededor del mundo. Visite el stand de USP en AAPS, Oct. 29-Nov. 2, San Antonio, Texas; y EAS, Nov. 13-16, Somerset, Nueva Jersey. Para hacer pedidos de Estndares de Referencia de USP y publicaciones, comunquese con su Distribuidor Autorizado USP. Atentamente,

Headquarters 12601 Twinbrook Parkway Rockville, Maryland 20852 +1-301-881-0666

Europe/Middle East/Africa Mnchensteinerstrasse 41 CH-4052 Basel, Switzerland +41 (0)61 316 30 10

USPIndia Private Limited ICICI Knowledge Park Genome Valley Labs 7-10, Phase III Turkapally, Shameerpet Ranga Reddy District Hyderabad 500 078, A.P., India +91-40-2348-0088

Barbara B. Hubert Directora de Ventas USP

USPChina Suite 542-550 Shanghai Center 1376 West Nanjing Road Shanghai 200040, China +86-21-6279-7657

www.usp.org

Sehr geehrte Kollegin, sehr geehrter Kollege:

U.S. Pharmacopeia The Standard of QualitySM

USP arbeitet fortlaufend an der Erweiterung und Verbesserung seiner Produkt- und Dienstleistungsangebote, um Ihre Anforderungen an Qualittsstandards zu erfllen. Fr eine bequemere und einfachere Anwendung haben wir einige neue und verbesserte Produkte und Dienstleistungen aufgenommen, die nachstehend vorgestellt werden. Wir hoffen, dass sie Ihnen bei Ihrer tglichen Arbeit helfen werden. Neue Referenzstandards Seit der Verffentlichung des Juli/August-Katalogs hat USP 18 neue Referenzstandards eingefhrt, die auf der gegenberliegenden Seite aufgefhrt sind. USP 30NF 25Jetzt mit neuen Merkmalen zur Vorbestellung erhltlich! Bestellen Sie noch heute die neueste Ausgabe des USPNF, um fr die in 2007 geltenden Richtlinien vorbereitet zu sein. Das USP 30NF 25 enthlt die fr Sie wichtigen Standardinformationen sowie hilfreiche neue Merkmale. Die gedruckte Version des neuen USPNF wird in einem 3-bndigen Format auf schwererem und haltbarerem Papier verffentlicht werden, um die Lesbarkeit, die Anwendbarkeit und das Verstndnis zu verbessern. Die CD- und Online-Versionen werden darstellbare chemische Strukturen fr mehr als 300 Unreinheiten mit speziellen elektronischen Funktionen enthalten, mit denen Sie Vergrern, Verkleinern und Ausdrucken knnen. Besuchen Sie www.usp.org fr weitere Informationen. Neue Schulungen zur Pharmakope in Indien und Europa Wir empfehlen die Teilnahme an Schulungskursen, die in verschiedenen Teilen der Welt angeboten werden. Die nchsten Veranstaltungen finden in Indien (4.-5., 9.-10., 12. Oktober), der Schweiz (10.-11., 12.-13. Oktober), Belgien (18.-19. Oktober) und Italien (8.-9., 14.-15. November) statt. Fr weitere Informationen und zur Anmeldung besuchen Sie www.usp.org/eventsEducation (bitte beachten Sie die Gro-/Kleinschreibung des Links). Treffen Sie USP auf demnchst stattfindenden Tagungen Die Berater von USP stehen Ihnen das ganze Jahr hindurch zu Ihrer Verfgung, um auf Fachtagungen und Messen in der ganzen Welt Ihre Fragen zu beantworten und Standards betreffende Themen mit Ihnen zu diskutieren. Besuchen Sie uns vom 29. Oktober bis zum 2. November am USP Stand auf der Tagung der American Association of Pharmaceutical Scientists (AAPS) in San Antonio, Texas, USA, und vom 13. bis zum 16. November auf dem Eastern Analytical Symposium (EAS) in Somerset, New Jersey, USA. Wenn Sie USP Referenzstandards und Verffentlichungen bestellen wollen, wenden Sie sich bitte an Ihren Autorisierten USP Hndler. Mit freundlichen Gren,

Headquarters 12601 Twinbrook Parkway Rockville, Maryland 20852 +1-301-881-0666

Europe/Middle East/Africa Mnchensteinerstrasse 41 CH-4052 Basel, Switzerland +41 (0)61 316 30 10

USPIndia Private Limited ICICI Knowledge Park Genome Valley Labs 7-10, Phase III Turkapally, Shameerpet Ranga Reddy District Hyderabad 500 078, A.P., India +91-40-2348-0088

USPChina Suite 542-550 Shanghai Center 1376 West Nanjing Road Shanghai 200040, China +86-21-6279-7657

Barbara B. Hubert Director, USP Sales

www.usp.org

U.S. Pharmacopeia The Standard of QualitySM

Cher collgue, USP continue de dvelopper et rehausser sa gamme de produits et son service la clientle afin de rpondre vos besoins en matire de normes de qualit. C'est pour vous offrir davantage de commodit et une plus grande simplicit d'emploi que nous avons ajout un certain nombre de produits et services nouveaux et amliors, lesquels sont prsents ci-dessous. Nous esprons que vous pourrez en profiter dans le cadre de votre activit quotidienne. Nouvelles Substances de Rfrence Depuis la parution du catalogue juillet/aot, USP a tabli 18 nouvelles Substances de Rfrence dont la liste figure la page ci-contre. USP 30NF 25Prcommandez-le ds maintenant au nouveau format ! Commandez la toute dernire dition de USPNF ds aujourd'hui et soyez prt rpondre aux normes applicables en 2007. USP 30NF 25 contient l'essentiel de l'information sur les normes et propose de nouveaux lments avantageux. Par souci de lisibilit, de facilit d'utilisation et de comprhension, la nouvelle version imprime de USPNF sortira en trois volumes sur du papier plus pais et plus rsistant. Les versions CD et en ligne comprendront des images de structures chimiques de plus de 300 impurets et s'accompagneront de fonctions lectroniques spciales de zoom avant ou arrire et d'impression. Visitez le site www.usp.org pour tout complment d'information. Nouvelles formations sur la pharmacope en Inde et en Europe Envisagez une formation sur site aux quatre coins du monde. Des stages sont prvus en Inde (4-5, 9-10, 12 oct.), en Suisse (10-11, 12-13 oct.), en Belgique (18-19 oct.) et en Italie (8-9, 14-15 nov.). Visitez www.usp.org/eventsEducation pour tout complment d'information et toute demande d'inscription. (Ce lien fait la distinction entre les minuscules et les majuscules.)

Headquarters 12601 Twinbrook Parkway Rockville, Maryland 20852 +1-301-881-0666

Europe/Middle East/Africa Mnchensteinerstrasse 41 CH-4052 Basel, Switzerland +41 (0)61 316 30 10

Venez la rencontre de USP l'occasion des prochaines confrences Tout au long de l'anne, des reprsentants USP sont votre disposition pour rpondre vos questions et discuter des sujets relatifs aux normes lors de confrences et de salons professionnels tenus dans le monde entier. Rendez-vous au stand USP lors de la confrence AAPS qui se droulera du 29 octobre au 2 novembre San Antonio (Texas, .-U.) et de la confrence EAS du 13 au 16 novembre Somerset (New Jersey, .-U.). Pour commandez les substances de rfrence et les publications USP, contactez votre distributeur USP agr. Avec nos sincres salutations,

USPIndia Private Limited ICICI Knowledge Park Genome Valley Labs 7-10, Phase III Turkapally, Shameerpet Ranga Reddy District Hyderabad 500 078, A.P., India +91-40-2348-0088

USPChina Suite 542-550 Shanghai Center 1376 West Nanjing Road Shanghai 200040, China +86-21-6279-7657

Barbara B. Hubert Director, USP Sales

www.usp.org

USP Publications
USP 30NF 25
The 2007 USPNF features more than 4,000 monographs for drug substances and dosage forms, ingredients, medical devices, and dietary supplements. USPNF standards are enforceable by the U.S. Food and Drug Administration for all drugs manufactured in or exported to the U.S. Annual subscriptions are available in print, online, and CD versions. La USPNF 2007 cuenta con ms de 4.000 monografas de frmacos, formas farmacuticas, ingredientes, dispositivos mdicos, y suplementos dietticos. Las normas establecidas en la USPNF son exigidas por la Administracin de Medicamentos y Alimentos de Estados Unidos (FDA) y rigen para todos los medicamentos fabricados y comercializados en los Estados Unidos. Las suscripciones anuales se ofrecen en versin impresa, online, y en CD. Die USPNF 2007 enthlt ber 4.000 Monographien fr Arzneimittelsubstanzen und Dosierungsformen, Inhaltsstoffe, medizinische Gerte, und Nahrungsmittelergnzungen. USPNF Standards werden von der FDA (U.S. Food and Drug Administration) fr alle in den USA hergestellten oder in die USA importierten Medikamente verlangt. Jahresabonnements sind in Druckversion, online, oder, auf CD erhltlich. Wenn Sie Ihren Wohnsitz in Deutschland, sterreich, oder der Schweiz haben und eine USP Publikation bestellen mchten, wenden Sie sich bitte an unseren Alleinvertreiber, Deutscher Apotheker Verlag, der hinten in diesem Katalog angegeben ist. LUSPNF 2007 recense plus de 4 000 monographies consacres aux substances mdicamenteuses et aux formes posologiques, aux ingrdients, aux appareils mdicaux, et aux complments dittiques. Lapplication des normes USPNF est contrle par la Food and Drug Administration (ladministration amricaine de lalimentation et du mdicament) pour lensemble des mdicaments fabriqus aux tats-Unis ou exports vers ce pays. Des abonnements annuels sont disponibles pour les versions imprimes, en ligne, et sur CD.

Print version available in English and Spanish only Versin impresa disponible en ingls y espaol nicamente Druckversion nur auf Englisch und Spanisch verfgbar Version imprime disponible uniquement en anglais et espagnol

Chromatographic Reagents
2005 Chromatographic Reagents lists the brand names of columns used in developing proposed and official chromatographic procedures in the USPNF and Pharmacopeial Forum. It includes an index of manufacturers. 2005 Chromatographic Reagents enumera las denominaciones comerciales de las columnas utilizadas para desarrollar los procedimientos cromatogrficos propuestos y oficiales en USPNF y en Pharmacopeial Forum. Incluye un ndice de fabricantes. 2005 Chromatographic Reagents listet die Markennamen der Spalten, die in der Entwicklung der vorgeschlagenen und offiziellen chromatografischen Verfahren verwendet werden, in der USPNF und im Pharmacopeial Forum auf. Dazu gehrt auch ein Verzeichnis der Hersteller. Wenn Sie Ihren Wohnsitz in Deutschland, sterreich, oder der Schweiz haben und eine USP Publikation bestellen mchten, wenden Sie sich bitte an unseren Alleinvertreiber, Deutscher Apotheker Verlag, der hinten in diesem Katalog angegeben ist.
Available in English only Disponible nicamente en ingls Nur auf Englisch verfgbar Disponible uniquement en anglais

2005 Chromatographic Reagents : cette publication numre les marques nominales des colonnes utilises pour laborer des propositions et des procdures officielles dans lUSPNF et le Pharmacopeial Forum. Comporte un index des fabricants.

TO ORDER: Contact your USP Authorized Distributor.

Pharmacopeial Forum (33)

The 2007 Pharmacopeial Forum (PF) is an important bimonthly journal that helps pharmaceutical professionals keep up with proposed and approved changes to official USPNF standards and offer comments as changes are processed. It also provides articles by scientific experts on current industry hot topics. Annual subscriptions are available in print and online. Online subscription includes free access to back issues from January 2002. La Pharmacopeial Forum (PF) 2007 es una importante revista bimensual que ayuda a los profesionales farmacuticos a mantenerse al da con los cambios propuestos y aprobados para las normas oficiales de USPNF, adems ofrece comentarios segn se procesan los cambios. Tambin contiene artculos redactados por expertos cientficos sobre temas de actualidad en la industria. Las suscripciones anuales estn disponibles en papel y en lnea. La suscripcin en lnea incluye acceso gratuito a los nmeros anteriores a partir de enero de 2002. Das Pharmacopeial Forum (PF) 2007 ist ein wichtiges Journal, das alle 2 Monate erscheint, und Fachleute auf dem Gebiet der Pharmazie ber vorgeschlagene und angenommene nderungen der offiziellen USPNF Standards informiert und diese nderungen kommentiert. In diesem Journal werden ebenfalls wissenschaftliche Artikel zu aktuellen Themen der Industrie verffentlicht. Jahresabonnements sind in Druckversion und online erhltlich. Bei einem Online-Abonnement kann auf frhere Ausgaben ab Januar 2002 umsonst zugegriffen werden. Wenn Sie Ihren Wohnsitz in Deutschland, sterreich, oder der Schweiz haben und eine USP Publikation bestellen mchten, wenden Sie sich bitte an unseren Alleinvertreiber, Deutscher Apotheker Verlag, der hinten in diesem Katalog angegeben ist. Le Pharmacopeial Forum (PF) 2007 est un priodique bimensuel important qui aide les professionnels du secteur pharmaceutique se tenir au courant des propositions de changement et des modifications approuves des normes officielles de lUSPNF et commenter les changements mis en uvre. Comporte galement des articles dexperts scientifiques consacrs lactualit brlante du secteur. Des abonnements annuels sont disponibles en version imprime et en ligne. Labonnement en ligne permet daccder gratuitement aux anciens numros partir de janvier 2002.

Available in English only Disponible nicamente en ingls Nur auf Englisch verfgbar Disponible uniquement en anglais

USP Dictionary
The 2006 USP Dictionary of USAN and International Drug Names is the most comprehensive and accurate reference for U.S. and international generic names of drugs. In addition, it provides brand names and manufacturers, chemical names and structures, molecular formulas and weights, and pharmacologic and therapeutic categories. Available in print and online. El 2006 USP Dictionary of USAN and International Drug Names es la referencia ms completa y exacta de los nombres genricos de frmacos internacionales y de EE.UU. Adems, incluye denominaciones comerciales y fabricantes, nombres de productos qumicos y estructuras, frmulas y pesos moleculares, y categoras farmacolgicas y teraputicas. Disponible en papel y en lnea. Das 2006 USP Dictionary of USAN and International Drug Names ist das umfassendste und genauste Nachschlagewerk fr die generischen Namen der US-amerikanischen und internationalen Arzneimittel. Darber hinaus gibt dieses Dokument Markennamen und Hersteller, Namen und Struktur der Chemikalien, Formeln und Gewicht des Molekls sowie die pharmakologischen und therapeutischen Kategorien an. In Druckversion und online erhltlich. Wenn Sie Ihren Wohnsitz in Deutschland, sterreich, oder der Schweiz haben und eine USP Publikation bestellen mchten, wenden Sie sich bitte an unseren Alleinvertreiber, Deutscher Apotheker Verlag, der hinten in diesem Katalog angegeben ist. Le 2006 USP Dictionary of USAN and International Drug Names est la rfrence la plus complte et la plus jour en matire de noms gnriques de mdicaments amricains et internationaux. Il comporte en outre les marques nominales et de fabricant, les dnominations et structures chimiques, les formules et poids molculaires, ainsi que les catgories pharmacologiques et thrapeutiques. Disponible en version imprime et en ligne.

Available in English only Disponible nicamente en ingls Nur auf Englisch verfgbar Disponible uniquement en anglais

TO ORDER: Contact your USP Authorized Distributor.

PROFESSIONAL EDUCATION

Pharmacopeial Education Courses Available Worldwide

Learn official standards and methods from the experts

USP education courses offer specialized instruction for chemists, scientists, and professionals in the pharmaceutical and allied industries. USP scientists who play a key role in establishing USP standards teach these courses and provide expert insight on how you can use the USPNF and other official USP standards resources to your best advantage. USP courses equip you with

Registration Information
Use the registration form on page 11 to register, or contact your Authorized Distributor.

Expertise in applying official methods for quality control, product release testing, and regulatory compliance. An understanding of how you can participate in developing standards. Updates on current issues related to standards development.

USP offers courses in analytical method validation, dissolution, microbiological testing, titration, basic statistics, HPLC, and the use of the USPNF. For descriptions and dates, see the following pages.

All courses are conducted at USP Headquarters in Rockville, Maryland, U.S.A., except where indicated otherwise. Talk to your USP Authorized Distributor about course offerings in your area.

Pharmacopeial Education Course Descriptions

Use the registration form on page 11 of this catalog to register, or contact your Authorized Distributor.

Analytical Method Validation

Master the validation of instrumental analytical methods from the USP perspective. Learn when and why specific validation characteristics are required.
TOPICS:

Fundamentals of Dissolution
Gain an overview of the theory, practice, and history of dissolution. Learn the practical aspects of conducting dissolution tests and calibrating apparatus. Gain hands-on laboratory experience in dissolution testing. One-day course includes lecture only. Two-day course includes hands-on laboratory work on day two.
TOPICS:

Validation requirements for pharmaceutical product test methods according to USP General Chapter <1225> Validation of Compendial Methods and ICH Q2A/Q2B Validation characteristics and requirements Theory and practice of efficient analytical method validation and documentation Case studies to evaluate the suitability of validation data sets

Introduction, history, and theory of dissolution USP General Chapter <711> Dissolution Operational qualification of Apparatus 1 and 2 Apparatus suitability test, as done at USP

Effectively Using the USPNF: Session I

Learn about the most efficient and effective way to use the USPNF. Discover how you can apply its trusted official standards to your organizations best advantage.
TOPICS:

Effectively Using the USPNF: Session II

Build on the insights gained in Session I. Enhance your understanding of the USPNF.
TOPICS:

Impact of USPNF general notices and general chapters Development of standards monographs for drug substances and products Participation in the USPNF standards development process Acceptable validation data for monograph revision proposals

Organizational overview USPNF sections and content Pharmacopeial Forum sections and content USPNF standards development process Use of USP chemical Reference Standards for quality control

Fundamentals of Microbiological Testing

Learn the basic principles of microbiological testing. Benefit from the official USPNF perspective, whether you work in the microbiology lab yourself or interact with those who do.
TOPICS:

Fundamentals of Titrations
Become familiar with the fundamental principles of aqueous and nonaqueous titrations and Karl Fischer titrations. Acquire hands-on laboratory experience in performing titrations. One-day course includes lecture only. Two-day course includes hands-on laboratory work on day two.
TOPICS:

Introduction to microbiology Sterility testing Sterility assurance Non-sterile products Environmental monitoring Antimicrobial effectiveness testing Pyrogen and bacterial endotoxin testing

Titration theory and equipment Theory and practice of Karl Fischer direct and residual (back) titrations Common problems encountered in titrimetric analysis Endpoint determination techniques

Basic Statistics and Their Practical Applications to the USPNF

This course is designed for nonstatisticians, with an emphasis on the appropriate use of statistics and the interpretation of their results. The focus is on practical applications (with examples) and not on abstract theory.
TOPICS:

Review of the basics Statistical inference Parametric statistics: student t-tests and analysis of variance tests Survey of additional statistical applications, including chi square, correlation, linear regression, and topics from <1010> Outlier tests

PROFESSIONAL EDUCATION

Cursos de educacin en Farmacopea disponibles en todo el mundo

APRENDA DE LOS EXPERTOS LAS NORMAS Y MTODOS OFICIALES

Los cursos de educacin de USP ofrecen instruccin especializada para qumicos, cientficos, y profesionales de las industrias farmacuticas y relacionadas. Los cientficos de USP que cumplen un papel clave en el establecimiento de las normas USP imparten estos cursos sobre cmo utilizar la USPNF y otros recursos oficiales de la USP de la mejor manera posible. Los cursos de la USP le brindan

Informacin para la inscripcin:

Utilice el formulario de inscripcin en la pgina 13 o comunquese con su Distribuidor Autorizado. Todos los cursos se llevarn a cabo en la sede central de USP en Rockville, Maryland, EE.UU., excepto cuando se indique lo contrario. Hable con su Distribuidor USP Autorizado sobre las ofertas de cursos en su rea.

Experiencia y conocimiento sobre la aplicacin de mtodos oficiales de control de calidad, pruebas para la aprobacin de productos y cumplimiento de la legislacin. Una comprensin de cmo participar en el desarrollo de las normas. Actualizaciones sobre temas actuales relacionados con el desarrollo de normas.

La USP ofrece cursos en validacin de mtodos analticos, disolucin, pruebas microbiolgicas, volumetra, estadstica bsica, HPLC, y el uso de la USPNF. Para mayor informacin sobre los cursos, consulte en las pginas siguientes.

Programa de los cursos de educacin sobre la Farmacopea

Utilice el formulario de inscripcin en la pgina 13 o comunquese con su Distribuidor Autorizado.

Validacin de Mtodos Analticos

Entienda cmo validar mtodos analticos instrumentales desde la perspectiva de USP. Aprenda cundo y porqu se requieren caractersticas especficas de validacin.
TEMAS:

Fundamentos de la Disolucin
Obtenga una visin general de la teora, prctica, e historia de la disolucin. Aprenda los aspectos prcticos para realizar pruebas de disolucin y calibracin de aparatos. Obtenga experiencia de laboratorio prctica en pruebas de disolucin. Los cursos de un da incluyen la conferencia exclusivamente. Los cursos de dos das incluyen el trabajo prctico en el laboratorio en el segundo da.
TEMAS:

Requisitos de validacin para mtodos de prueba de productos farmacuticos de acuerdo con el Captulo General <1225> de la USP Validacin de Mtodos Farmacopeicos e ICH Q2A/Q2B Caractersticas y requisitos de la validacin Teora y prctica de una validacin y documentacin eficientes de un mtodo analtico Estudios de casos para evaluar la adecuacin de los conjuntos de datos de validacin

Introduccin, historia, y teora de la disolucin Disolucin: Captulo General <711> de la USP Calificacin operativa de los Equipos 1 y 2 Prueba de adecuacin del equipo, segn la USP

Uso eficiente de USPNF: Sesin I

Aprenda la manera ms eficaz y eficiente de usar la USPNF. Descubra cmo aplicar sus confiables estndares oficiales en beneficio de su organizacin.
TEMAS:

Uso eficiente de USPNF: Sesin II

En funcin de los conocimientos obtenidos en la Sesin I, aumente su comprensin de la USPNF.
TEMAS:

Impacto de los avisos y captulos generales de la USPNF Desarrollo de monografas de estndares para drogas, sustancias y productos Participacin en el proceso de desarrollo de estndares de la USPNF Datos de validacin aceptables para propuestas de revisin de monografas

Resea de la organizacin Secciones y contenido de la USPNF Secciones y contenido de Pharmacopeial Forum Proceso de desarrollo de estndares de la USPNF Uso de los Estndares de Referencia qumicos USP para control de calidad

Fundamentos de Pruebas Microbiolgicas

Aprenda los principios bsicos de las pruebas microbiolgicas. Benefciese con la perspectiva oficial de USPNF, ya sea que trabaje en el laboratorio de microbiologa o interacte con quienes lo hacen.
TEMAS:

Fundamentos de Valoracin
Familiarcese con los principios fundamentales de las valoraciones acuosas y no acuosas y las valoraciones de Karl Fischer. Obtenga experiencia de laboratorio prctica en la realizacin de valoraciones. Los cursos de un da incluyen la conferencia exclusivamente. Los cursos de dos das incluyen el trabajo prctico en el laboratorio en el segundo da.
TEMAS:

Introduccin a la microbiologa Pruebas de esterilidad Garanta de la esterilidad Productos no estriles Control ambiental Pruebas de eficacia antimicrobiana Pruebas de endotoxinas bacterianas y pirgenos

Teora y equipo de valoracin Teora y prctica de las (retro) valoraciones directas y residuales de Karl Fisher Problemas comunes encontrados en el anlisis titrimtrico Tcnicas para determinacin de los criterios de valoracin

Estadsticas Bsicas y su Aplicacin Prctica al USPNF

El curso est diseado para los que no son expertos en estadstica con nfasis en el uso adecuado de la estadstica y la interpretacin de sus resultados. Se focaliza en las aplicaciones prcticas (con ejemplos) en lugar de la teora abstracta.
TEMAS:

Revisin de los conceptos bsicos Inferencia estadstica Estadstica Paramtrica: Prueba t de Student y anlisis de varianza Estudio de aplicaciones estadsticas adicionales, que incluye chi cuadrado, correlacin, regresin lineal, y temas de <1010> Pruebas de valores extremos

PROFESSIONAL EDUCATION

Pharmakope Schulungskurse Weltweit erhltlich

Lernen Sie offizielle Standards und Methoden vom Experten

Die USP Schulungskurse bieten spezielle Instruktionen fr Chemiker, Wissenschaftler, und Fachleute auf den Gebieten der pharmazeutischen und verwandten Industrien. USP Wissenschaftler, welche eine Schlsselrolle bei der Etablierung der USP-Standards spielen, fhren diese Kurse durch und geben Einblicke, wie Sie USPNF und andere offizielle USP-Standards zu Ihrem Vorteil verwenden knnen. USP-Kurse vermitteln Ihnen

Registrierungsinformation
Verwenden Sie das Registrierungsformular auf Seite 15, um sich anzumelden oder kontaktieren Sie Ihren autorisierten Lieferanten. Alle Kurse finden im USP Hauptsitz in Rockville, Maryland, U.S.A. statt, auer, wenn dies anderweitig angezeigt wird. Sprechen Sie mit Ihrem autorisierten Lieferanten ber Kursangebote in Ihrer Gegend.

Fachkenntnisse bei der Anwendung von offiziellen Methoden zur Qualittskontrolle, zu Produktfreigabe-Tests und zur Einhaltung der behrdlichen Richtlinien. Ein Verstndnis, wie Sie an der Entwicklung der Standards teilnehmen knnen. Updates ber laufende Belange bezglich der Entwicklung von Standards.

USP bietet Kurse an ber Validierung von analytischen Methoden, Auflsung, mikrobiologische Tests, Titration, Grundlagen der Statistik, HPLC, und die Anwendung der USPNF. Beschreibung und Termine finden Sie auf den folgenden Seiten.

Pharmakope Schulungskurse - Beschreibung

Verwenden Sie das Registrierungsformular auf Seite 15 dieses Katalogs, um sich anzumelden oder kontaktieren Sie Ihren autorisierten Lieferanten.

Validierung von analytischen Methoden

Erfahren Sie, wie instrumentelle analytische Methoden aus der Sicht von USP validiert werden. Lernen Sie, wann und warum spezifische Validierungseigenschaften erforderlich sind.
THEMEN:

Grundlagen der Auflsung

Gewinnen Sie einen berblick ber die Theorie, Praxis, und Geschichte der Auflsung. Lernen Sie die praktischen Aspekte der Durchfhrung von Auflsungstests und der Kalibrierungsgerte. Erwerben Sie praktische Erfahrung beim Auflsungstest. Der Eintageskurs umfasst nur die Vorlesung. Der Zweitageskurs enthlt praktische Laborarbeit am zweiten Tag.
THEMEN:

Validierungserfordernisse fr pharmazeutische Produkttestmethoden gem USP Allgemeines Kapitel <1225> Validierung von Methoden in Monographien und ICH Q2A/Q2B Validierungsmerkmale und Erfordernisse Theorie und Praxis der effizienten Validierung von analytischen Methoden und Dokumentation Fallstudien zur Bewertung der Eignung von Validierungsdaten

Einleitung, Geschichte, und Theorie der Auflsung USP Allgemeines Kapitel <711> Auflsung Operative Eignung von Gert 1 und 2 Gert Eignungstest, wie durchgefhrt bei USP

Effektive Nutzung der USPNF: Sitzung I

Lernen Sie die wirksamste und effektivste Weise, die USPNF zu nutzen. Entdecken Sie, wie Sie seine zuverlssigen offiziellen Standards zum Vorteil fr Ihre Organisation anwenden knnen.
THEMEN:

Effektive Nutzung der USPNF: Sitzung II

Bauen Sie auf den Erkenntnissen auf, die Sie in Sitzung I erworben haben. Vertiefen Sie Ihr Verstndnis der USPNF.
THEMEN:

Organisationsmiger berblick USPNF Sektionen und Inhalt Pharmakope Forum Sektionen und Inhalt Entwicklungsprozess der USPNF Standards Verwendung der chemischen Referenz-Standards fr die Qualittskontrolle

Bedeutung der allgemeinen Mitteilungen und allgemeinen Kapitel von USPNF Entwicklung von Standard-Monographien fr ArzneimittelSubstanzen und-produkte Beteiligung am Entwicklungsprozess fr USPNF Standards Akzeptable Validierungsdaten fr Monographie-Revisionsvorschlge

Grundlagen der mikrobiologischen Tests

Lernen Sie die grundlegenden Prinzipien der mikrobiologischen Tests. Profitieren Sie von der offiziellen Sichtweise der USPNF, ganz gleich, ob Sie selbst in einem mikrobiologischen Labor ttig sind oder mit Laborexperten zusammenarbeiten.
THEMEN:

Grundlagen der Titration

Machen Sie sich mit den grundlegenden Prinzipien von wssrigen und nichtwssrigen Titrationen und den Karl Fischer Titrationen vertraut. Erwerben Sie praktische Labor-Erfahrung in der Durchfhrung von Titrationen. Der Eintageskurs umfasst nur die Vorlesung. Der Zweitageskurs enthlt praktische Laborarbeit am zweiten Tag.
THEMEN: Titrationstheorie und Gerte Theorie und Praxis der direkten und Resttitration nach Karl Fischer (Rcktitrationen) Allgemeine Schwierigkeiten, auf die man bei der titrimetrischen Analyse trifft Techniken der Endpunktbestimmung

Einfhrung in die Mikrobiologie Sterilittstests Sterilittssicherheit Unsterile Produkte Umweltberwachung Test der antimikrobiellen Wirksamkeit Test auf Pyrogene und bakterielle Endotoxine

Grundlagen der Statistik und ihre praktischen Anwendungen bei der USPNF
Der Kurs ist fr Personen entworfen, die keine Statistiker sind, mit Schwerpunkt auf die ordnungsgeme Anwendung der Statistik und Interpretation ihrer Ergebnisse. Der Fokus liegt auf praktischen Anwendungen (mit Beispielen) und nicht auf der abstrakten Theorie.
THEMEN:

berblick ber die Grundlagen Statistische Deduktion Parametrische Statistik: Die Student t test und Analyse der Varianztests bersicht ber weitere statistische Anwendungen einschlielich ChiQuadrat-Test, Korrelation, lineare Regression, und Themen von <1010> Outlier Tests

PROFESSIONAL EDUCATION

Cours de formation en pharmacope proposs dans le monde entier

Apprenez d'experts en la matire les normes et mthodes officielles

Les cours ducatifs USP offrent une formation spcialise aux chimistes, scientifiques, et professionnels dans les industries pharmaceutiques et connexes. Les scientifiques d'USP, qui jouent un rle essentiel dans l'tablissement des normes USP, enseignent ces cours et offrent des conseils d'expert sur la faon d'utiliser votre avantage les normes USPNF et autres ressources officielles USP. Les cours USP vous permettent d'acqurir

Renseignements relatifs l'inscription

Utilisez le formulaire d'inscription la page 17 pour vous inscrire ou contactez votre distributeur autoris. Tous les cours ont lieu au sige social d'USP Rockville, dans le Maryland, USA, moins d'indication contraire. Informez-vous auprs de votre distributeur autoris USP pour en apprendre davantage sur les cours offerts dans votre rgion.

une expertise en matire d'application des mthodes officielles dans le contrle de la qualit, d'essai de mise en march de produit et de conformit rglementaire ; une comprhension de la manire dont vous pouvez participer au dveloppement de normes ; des mises jour sur des questions actuelles portant sur le dveloppement de normes.

USP offre des cours en validation de mthode analytique, dissolution, essai microbiologique, titrage, statistiques fondamentales, HPLC, ainsi que des cours portant sur l'utilisation de l'USPNF. Consultez les pages suivantes pour la description et les dates de cours.

Description de cours de formation en pharmacope

Utilisez le formulaire d'inscription la page 17 de ce catalogue pour vous inscrire ou contactez votre distributeur autoris.

Validation de mthode analytique

Comprenez comment valider les mthodes analytiques instrumentales selon le point de vue d'USP. Apprenez dans quelles circonstances et pour quelles raisons des caractristiques de validation sont exiges.
SUJETS :

Principes de dissolution
Obtenez une vue d'ensemble de la thorie, de la pratique, et de l'histoire de la dissolution. Apprenez les aspects pratiques des essais de dissolution et du calibrage d'appareils. Obtenez en laboratoire une exprience pratique en essai de dissolution. Les cours d'une journe ne comprennent que la partie magistrale. Les cours tals sur deux jours comprennent les travaux pratiques en laboratoire la deuxime journe.
SUJETS :

Exigences de validation pour les mthodes d'essai de produits pharmaceutiques selon le chapitre gnral d'USP <1225> Validation des mthodes officinales et ICH Q2A/Q2B Validation des caractristiques et exigences Thorie et pratique de la validation et de la documentation efficaces de mthode analytique tudes de cas pour valuer l'adquation des ensembles de donnes de validation

Introduction, histoire, et thorie de la dissolution Chapitre gnral dUSP <711> sur la dissolution Qualifications oprationnelles des appareils 1 et 2 Test d'adquation des appareils, tel qu'effectu chez USP

Utilisation efficace de l'USPNF : Session I

Apprenez la manire la plus efficace d'utiliser l'USPNF. Dcouvrez de quelle faon vous pouvez appliquer dans votre entreprise ses normes officielles prouves.
SUJETS :

Utilisation efficace de l'USPNF : Session II

Approfondissez vos connaissances partir des acquis de la session I. Amliorez votre comprhension de l'USPNF.
SUJETS :

Impact des avis et chapitres gnraux d'USPNF Dveloppement des monographies de norme pour les substances et les produits pharmaceutiques Participation au processus de dveloppement des normes USP-NF Donnes de validation acceptables pour les propositions de rvision de monographie

Aperu organisationnel Rubriques USPNF et contenu Rubriques de discussions de pharmacope et contenu Processus de dveloppement de normes USPNF Utilisation des normes de rfrence chimiques USP dans le contrle de la qualit

Principes d'essai microbiologique

Apprenez les principes d'essai microbiologique. Tirez profit du point de vue officiel d'USPNF, que vous travailliez vous-mme dans un laboratoire microbiologique, ou interagissiez avec des gens qui y travaillent.
SUJETS :

Principes de titrage
Familiarisez-vous avec les principes de titrages aqueux et non aqueux et de titrages Karl Fischer. Obtenez en laboratoire une exprience pratique en titrage. Les cours d'une journe ne comprennent que la partie magistrale. Les cours tals sur deux jours comprennent les travaux pratiques en laboratoire la deuxime journe.
SUJETS :

Introduction la microbiologie preuve de strilit Assurance de strilit Produits non striles Surveillance de l'environnement preuve d'efficacit antimicrobienne preuve de pyrogne et d'endotoxine bactrienne

Thorie et quipement de titrage Thorie et pratique du titrage direct et rsiduel Karl Fischer (par retour) Problmes courants en analyse titrimtrique Techniques de dtermination du point de virage

Statistiques fondamentales et leur application pratique pour l'USPNF

Le cours est conu pour les non-statisticiens et met l'accent sur l'utilisation approprie des statistiques et l'interprtation de leurs rsultats. Il porte surtout sur les applications pratiques (avec exemples) et non sur la thorie abstraite.
SUJETS :

Examen des principes lmentaires Infrence statistique Statistiques paramtriques : les tests t et l'analyse des tests de variance Prsentation d'applications statistiques supplmentaires, y compris la corrlation du khi-carr, la rgression linaire, et les sujets de la section <1010> Tests d'aberration

10

Course Registration Form

Courses are conducted at USP Headquarters in Rockville, Maryland, and at other regional venues, as noted.
Use this form for one registrant only. Please photocopy the form for additional registrants.

PROFESSIONAL Talk to your USP Authorized Distributor about EDUCATION course offerings in your area.
DATES AND FEES Fundamentals of Dissolution
___ Oct. 34 (North Brunswick, NJ) (Lecture & Laboratory) ..............$1,500 ___ Oct. 45 (Goa, India) (Lecture & Laboratory) ......................................** ___ Oct. 910 (Chandigarh, India) (Lecture & Laboratory).........................** ___ Oct. 1011 (Basel, Switzerland) (Lecture & Laboratory) (German) ......* ___ Oct. 1213 (Basel, Switzerland) (Lecture & Laboratory) (French) ........* ___ Nov. 89 (Milan, Italy) (Lecture & Laboratory) (Italian) ..........................* ___ Nov. 1415 (Rome, Italy) (Lecture & Laboratory) (Italian) .....................*

USP reserves the right to reschedule or cancel courses.

Effectively Using the USPNF, Sessions I & II

___ Sept. 26 (Denver, CO., Annual Scientific Meeting) . . . . . . .$595 condensed Sessions I & II ___ Oct. 12 (Hyderabad, India) condensed Sessions I & II . . . . . .** ___ Oct. 18 (Brussels, Belgium) condensed Sessions I & II .$595***

Basic Statistics and Their Practical Application to USPNF

No additional classes are scheduled to date.

Analytical Method Validation

___ Oct. 19 (Brussels, Belgium) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .$595*** * To register, contact Sotax AG; Tel (+41) 61 487 54 54; Fax: (+41) 61 482 13 31; email: [email protected] ** To register, contact USP office in India; email: [email protected] *** To register, contact USP office in Basel, Switzerland; Tel: +41 (0)61 316 30 10; email: [email protected]

Fundamentals of Microbiological Testing

___ Sept. 26 (Denver, CO., Annual Scientific Meeting) . . . . . . . . . . . . . . . . .$595

CONTACT INFORMATION
Last Name Title Organization Address City Daytime Phone Fax State Email ZIP Country First Name Middle Initial Name for Badge Degree

PAYMENT INFORMATION
Bill me

PLEASE PROVIDE PURCHASE ORDER NUMBER

REGISTER BY MAIL:
Enclosed is my check for $

Charge my credit card:

Credit Card # Cardholders Name

Visa

MasterCard

American Express
Exp. Date

(Checks should be made payable to USP, in U.S. dollars, microcoded, and drawn on a U.S. bank.)

PLEASE PRINT

Cardholders Signature

U.S. Pharmacopeia attn: Maureen Rawson 12601 Twinbrook Parkway Rockville, MD 20852

Please indicate any special needs (dietary, etc.):

Fee (U.S. dollars). Refunds will not be made within two weeks of the class date. Companies may send a replacement. Prior to 14 days, a $50 fee will be charged for cancellations.

For more information, please contact Maureen Rawson at +1-301-816-8237 or via email at [email protected]. To register, fax this form to +1-301-816-8236 (for credit card and purchase order payments).
MS147CAT

11

Formulario de inscripcin en el curso

Todos los cursos se llevarn a cabo en la sede central de USP en Rockville, Maryland, excepto cuando se indique lo contrario.
Utilice slo un formulario por cada inscripto. Haga fotocopias del formulario para inscriptos adicionales.

PROFESSIONAL Hable con su distribuidor USP autorizado sobre las ofertas EDUCATION de cursos en su rea.
FECHAS Y HONORARIOS
USP se reserva el derecho de reprogramar o cancelar cursos.

Fundamentos de la disolucin
___ Oct. 34 (North Brunswick, NJ) (Conferencia y Laboratorio) ..................US$1.500 ___ Oct. 4-5 (Goa, India) (Conferencia y Laboratorio) ................................................** ___ Oct. 9-10 (Chandigarh, India) (Conferencia y Laboratorio) ..................................** ___ Oct. 10-11 (Basel, Suiza) (Conferencia y Laboratorio) (alemn) ...........................* ___ Oct. 12-13 (Basel, Suiza) (Conferencia y Laboratorio) (francs) ...........................* ___ Nov. 8-9 (Miln, Italia) (Conferencia y Laboratorio) (italiano) ................................* ___ Nov. 14-15 (Roma, Italia) (Conferencia y Laboratorio) (italiano) ...........................*

Uso eficiente de la USPNF, Sesiones I y II

___ Sep. 26 (Denver, CO., Encuentro anual de cientficos) ..............US$595 Sesiones I y II resumidas ___ Oct. 12 (Hyderabad, India) Sesiones I y II resumidas..............................** ___ Oct. 18 (Bruselas, Blgica) Sesiones I y II resumidas................US$595***

Estadsticas bsicas y su aplicacin a la USPNF

Hasta la fecha, no hay clases adicionales programadas.

Validacin del mtodo analtico

___ Oct. 19 (Bruselas, Blgica) ...........................................................................US$595***

* Para inscribirse, comunquese con Sotax AG; Tel (+41) 61 487 54 54; Fax (+41) 61 482 13 31; correo electrnico: [email protected] ** Para inscribirse, comunquese con la oficina de USP en India, mediante el correo electrnico: [email protected] *** Para inscribirse, comunquese con la oficina de USP en Basel, Suiza; Tel: +41 (0)61 316 30 10; correo electrnico: [email protected]

Fundamentos de pruebas microbiolgicas

___ Sep. 26 (Denver, CO., Encuentro anual de cientficos ................................S$595

SU INFORMACIN DE CONTACTO
Apellido Cargo Organizacin Direccin Ciudad Telfono (Durante el da) Estado Fax CP Correo electrnico Pas Nombre Inicial segundo nombre Nombre para la credencial Ttulo

INFORMACIN SOBRE EL PAGO

Factura

PROPORCIONE EL NUMERO DE ORDEN DE COMPRA

INSCRIPCIN POR CORREO:

Adjunto cheque por $

Cargo a mi tarjeta de crdito:

No de tarjeta de crdito Nombre del titular

Visa

MasterCard

American Express

Fecha de vencimiento

. (Los cheques deben ser a la orden de USP, en dlares estadounidenses, microcodificados y librados a cargo de un banco de EE.UU.)

EN LETRAS DE IMPRENTA

Firma del titular

U.S. Pharmacopeia attn: Maureen Rawson 12601 Twinbrook Parkway Rockville, MD 20852

Indique cualquier necesidad especial (dieta, etc.):

Tarifas (en dlares estadounidenses). No habr reembolsos dentro de las dos semanas de la fecha de las clases. Las compaas pueden enviar un reemplazante. Antes de los 14 das se cobrar un cargo de $50 por cancelacin.

Para ms informacin comunquese con Maureen Rawson al +1-301-816-8237 o por correo electrnico al: [email protected]. Para inscribirse enve este formulario por fax al +1-301-816-8236 (para pagos con tarjeta de crdito y rdenes de compra).
MS147CAT

13

KURS-ANMELDEFORMULAR
Alle Kurse finden in der Hauptgeschftsstelle der USP in Rockville, Maryland und anderen regionalen Veranstaltungsorten statt, je nach Angabe.

PROFESSIONAL Sprechen Sie mit Ihrem autorisierten Lieferanten ber EDUCATION Kursangebote in Ihrer Gegend.
TERMINE UND GEBHREN Grundlagen der Dissolution
___ 3.-4. Oktober (North Brunswick, NJ, USA) (Vorlesung & Labor) ...........1.500 USD ___ 4.-5. Oktober (Goa, Indien) (Vorlesung & Labor)...................................................** ___ 9.-10. Oktober (Chandigarh, Indien) (Vorlesung & Labor).....................................** ___ 10.-11. Oktober (Basel, Schweiz) (Vorlesung & Labor) (auf Deutsch)....................* ___ 12.-13. Oktober (Basel, Schweiz) (Vorlesung & Labor) (auf Franzsisch)..............* ___ 8.-9. November (Mailand, Italien) (Vorlesung & Labor) (auf Italienisch) .................* ___ 14.-15. November (Rom, Italien) (Vorlesung & Labor) (auf Italienisch) ..................*

Verwenden Sie dieses Formular nur zur Anmeldung einer Person. Fr die Anmeldung von weiteren Personen fotokopieren Sie bitte dieses Formular.

USP behlt sich das Recht vor, einen neuen Termin auszumachen oder Kurse abzusagen.

Effektive Nutzung der USPNF, Sitzung I & II

___ 26. September (Denver, CO., USA, wissenschaftliche.............595 USD Jahrestagung) konzentrierte Sitzungen I & II ___ 12. Oktober (Hyderabad, Indien) konzentrierte Sitzungen I & II...........** ___ 18. Oktober (Brssel, Belgien) konzentrierte .......................595 USD*** Sitzungen I & II

Grundlagen der Statistik und ihre praktische Anwendung auf die USPNF
Zurzeit sind keine weiteren Schulungen geplant.

Analytische Methodenvalidierung
___ 19. Oktober (Brssel, Belgien) ..............................................................595 USD***
* Zur Anmeldung wenden Sie sich bitte an die Sotax AG, Tel (+41) 61 487 54 54; Fax: (+41) 61 482 13 31; E-Mail: [email protected] ** Zur Anmeldung wenden Sie sich bitte an die indische USP-Vertretung; E-Mail: [email protected] *** Zur Anmeldung wenden Sie sich bitte an die USP-Vertretung in Basel (Schweiz); Tel: +41 (0)61 316 30 10; E-Mail: [email protected]

Grundlagen mikrobiologischer Untersuchungen

___ 26. September (Denver, CO., USA, wissenschaftliche Jahrestagung) .....595 USD

IHRE KONTAKTINFORMATION
Zuname Titel Organisation Adresse Stadt Telefon Fax Staat Email Postleitzahl Land Vorname Mittelinitiale Name fr Plakette Akademischer Grad

ZAHLUNGSINFORMATION
Stellen Sie mir in Rechnung Belasten Sie meine Kreditkarte
Kreditkartennummer Karteninhaber
BITTE IN DRUCKSCHRIFT

AUFTRAGSNUMMER BITTE ANGEBEN

ANMELDUNG PER POST

Scheck beiliegend ber $

Visa

MasterCard

American Express

gltig bis

(Schecks sollten zahlbar an USP, in U.S. Dollar und mikrokodiert sein sowie auf eine U.S.Bank lauten.)

Unterschrift Karteninhaber

U.S. Pharmacopeia attn: Maureen Rawson 12601 Twinbrook Parkway Rockville, MD 20852

Bitte geben Sie spezielle Bedrfnisse an (Dit, usw.):

Preis (in US-Dollar) In den zwei Wochen vor Kursbeginn werden keine Kursgebhren mehr erstattet. Firmen knnen eine Ersatzperson schicken. Bei Absagen innerhalb von 14 Tagen vor Kursbeginn wird eine Gebhr von 50 USD berechnet.

Um weitere Informationen zu erhalten, kontaktieren Sie bitte Maureen Rawson unter +1-301-816-8237 oder per E-Mail [email protected].

Fr eine Anmeldung faxen Sie bitte dieses Formular an +1-301-816-8236 (fr Kreditkarten und Zahlungen per Rechnung-Kaufauftrag).
MS147CAT

15

Formulaire dinscription aux cours

Tous les cours ont lieu au sige social d'USP Rockville, dans le Maryland, moins d'indication contraire.
N'utilisez ce formulaire que pour un seul inscrit. Veuillez photocopier ce formulaire pour des inscrits supplmentaires.

PROFESSIONAL Informez-vous auprs de votre distributeur autoris USP pour EDUCATION en apprendre davantage sur les cours offerts dans votre rgion.
DATES ET FRAIS Principes de dissolution
___ 34 oct. (North Brunswick, NJ, .-U.) (confrence et travaux pratiques)........1 500 USD ___ 45 oct. (Goa, Inde) (confrence et travaux pratiques) . ................................................** ___ 910 oct. (Chandigarh, Inde) (confrence et travaux pratiques).....................................** ___ 1011 oct. (Ble, Suisse) (confrence et travaux pratiques) (allemand) ..........................* ___ 1213 oct. (Ble, Suisse) (confrence et travaux pratiques) (franais) ...........................* ___ 89 oct. (Milan, Italie) (confrence et travaux pratiques) (italien) ....................................* ___ 1415 nov. (Rome, Italie) (confrence et travaux pratiques) (italien) ...............................*

USP se rserve le droit de reporter ou d'annuler des cours.

Utilisation efficace de lUSPNF, Sessions I et II

___ 26 sept. (Denver, CO, .-U., Runion scientifique annuelle) ............595 USD sances condenses I et II ___ 12 oct. (Hyderabad, Inde) sances condenses I et II .....................................** ___ 18 oct. (Bruxelles, Belgique) sances condenses I et II..................595 USD***

Statistiques de base et leur application pratique lUSPNF

Aucune formation supplmentaire n'est prvue ce jour.

Validation de la mthode analytique

___ 19 oct. (Bruxelles, Belgique)..................................................................................595 USD*** * Pour toute demande d'inscription, contactez Sotax AG ; tl. : +41 (0)61 487 54 54 ; Fax : +41 (0)61 482 13 31 ; email : [email protected] ** Pour toute demande d'inscription, contactez le bureau USP en Inde ; email : [email protected] *** Pour toute demande d'inscription, contactez le bureau de Ble, en Suisse ; Tl. : +41 (0)61 316 30 10 ; email : [email protected]

Principes dessai microbiologique

___ 26 sept. (Denver, CO, .-U., Runion scientifique annuelle) ................................595 USD

VOS COORDONNES
Nom Titre Entreprise Adresse Ville Tlphone (jour) tat/province Tlcopieur Code postal Courriel Pays Prnom Initiale Nom pour badge Diplme

INFORMATION DE PAIEMENT
Facturez-moi

CRIRE EN CARACTRES D'IMPRIMERIE

INSCRIVEZ-VOUS PAR COURRIER :

Porter au compte de ma carte de crdit : Visa

No de carte de crdit Nom du titulaire

MasterCard

American Express

Ci-joint mon chque au montant

de $
Date d'chance

(Les chques doivent tre faits l'ordre de USP, en devises amricaines, ils doivent tre microcods et dbits au compte d'une banque amricaine.) U.S. Pharmacopeia attn: Maureen Rawson 12601 Twinbrook Parkway Rockville, MD 20852

CRIRE EN CARACTRES D'IMPRIMERIE

Signature du titulaire

Veuillez indiquer tout besoin particulier (dittique, etc.) :

Frais de cours (en dollars amricains). Aucun remboursement ne sera effectu dans les deux semaines prcdant la date de dbut des cours. Les entreprises peuvent envoyer un remplaant. Avant les 14 jours prcdant la date de dbut des cours, des frais de 50 USD s'appliqueront toute annulation.

Pour plus d'information, veuillez contacter Maureen Rawson au +1-301-816-8237 ou par courriel [email protected]. Pour vous inscrire, tlcopiez ce formulaire au +1-301-816-8236 (pour les paiements par carte de crdit et bons de commande).
MS147CAT

17

SeptemberOctober 2006

Distributors Edition Official USP Reference Standards Catalog

19

USING USP REFERENCE STANDARDS

Official Reference Standards USP Reference Standards are required for use in pharmacopeial assays and tests in the official standards publication, the United States PharmacopeiaNational Formulary (USPNF). USP Reference Standards help to ensure compliance with the official, FDA-enforceable quality requirements in the USPNF. The Reference Standards also lend themselves to many other applications, including measurements required to obtain accurate and reproducible results in modern chromatographic and spectrophotometric methods. Rigorous Testing and Quality Control USP Reference Standards are selected for their high purity, critical characteristics, and suitability for the intended purpose. Unless a USP Reference Standard label states a specific potency or content, the USP Reference Standard is taken as being 100.0% pure for the USP purposes for which it is provided. As a service to our customers, labeled purity values for Reference Standards and Authentic Substances released after January 1, 2004, are listed in this catalog. See p. 21 for an explanation of how the values are calculated. Heterogeneous substances, of natural origin, are also designated Reference Standards, where needed. Usually these are the counterparts of international standards. USP Reference Standards are established through a process of rigorous testing, evaluation, and quality control. They are independently tested in three or more laboratoriesUSP, FDA, and academic and industrial laboratories throughout the United States. The Reference Standards are released under the authority of USPs Board of Trustees, on the recommendation of the USP Reference Standards Expert Committee, which approves selection and suitability of each lot. Reference Standards Categories USP offers more than 1,900 Reference Standards for pharmaceuticals, excipients, and dietary supplements. On pages 3492 of this catalog, youll find a full list of available USP and NF Reference Standards, with information updated through June 2006. The list includes Reference Standards required by the current official edition of the USPNF. Reference Standards not required in the current USPNF, but for which sufficient demand remains. Reference Standards specified in the current edition of the Food Chemicals Codex. Authentic Substanceshighly purified samples of chemicals, including substances of abuse, required by analytical, clinical, pharmaceutical, and research laboratories. The distribution of controlled substances is subject to the regulations and licensing provisions of the Drug Enforcement Administration of the U.S. Department of Justice. USP also collaborates with the World Health Organization in its program to provide international biological standards and chemical reference materials for antibiotics, biologicals, and chemotherapeutic agents. Some USP Reference Standards are standardized in terms of the corresponding international standards. Proper Use of USP Reference Standards USP Reference Standards are provided primarily for quality control use in conducting the pharmacopeial assays and tests described in the USPNF. Neither Reference Standards nor Authentic Substances are intended for use as drugs, dietary supplements, or medical devices. To serve its intended purpose, each USP Reference Standard must be properly stored, handled, and used. Users of USP Reference Standards should refer to General Chapter <11> in the USPNF. Listing and directions in the USPNF Refer to the list of revisions, additions, and deletions of individual USP Reference Standards in USP 29NF 24. Individual USP or NF monographs specify the USP Reference Standard(s) required for assay and test procedures. The USP 29NF 24 General Chapter <11> USP Reference Standards provides additional information and instructions for proper use and storage. Note that if specific instructions for use appearing on the label of a USP Reference Standard differ from the instructions in Chapter <11>, the instructions on the label take precedence. Consult the cumulative updates to Reference Standards information provided in USPNF Supplements and also in USPNF Interim Revision Announcements, which are published in USPs bimonthly journal, Pharmacopeial Forum. Suitability for use Users must ascertain that the Reference Standards they are using are from an official lot. Users must determine the suitability of Reference Standards for applications and uses not in the USPNF. Storing Ensure that the USP Reference Standards are stored in their original stoppered containers, according to any special label directions, away from heat and humidity, and protected from light.

20

Distributors Edition Official USP Reference Standards Catalog

SeptemberOctober 2006

USING USP REFERENCE STANDARDS

Weighing Ensure that Reference Standard substances are accurately weighedtaking due account of relatively large errors potentially associated with weighing small masses where it is directed that a standard solution or a standard preparation be prepared for a quantitative determination. See USP 29NF 24 General Chapters <41> Weights and Balances, <31> Volumetric Apparatus, and USPNF General Notices, for information regarding appropriate use of USP Reference Standards. Drying Use a clean and dry vessel, and not the original container, as the drying vessel where a USP Reference Standard is required to be dried before use. Make sure not to dry a specimen repeatedly at temperatures above 25 degrees Celsius. Follow any special drying requirements specified on the Reference Standards label or in specific sections of USP or NF monographs (note that any specific instructions on the label or in the monograph supersede the usual instructions in Procedures under Tests and Assays in USPNF General Notices). Follow Method I under USPNF General Chapter <921> Water Determination where the titrimetric determination of water is required at the time a Reference Standard is to be used. Instrumental or microanalytical methods are acceptable for this purpose. When using typical amounts, about 50 mg of the Reference Standard, titrate with a fourfold dilution of the reagent. Unit of Product USP Reference Standards must be ordered in whole units. Please note that one unit may include several individual containers. No Returns or Exchanges USP Reference Standards may not be returned or exchanged for refund. List Chemicals: List of Reference Standards categorized by the DEA as List Chemicals

Catalog #
1202005 1236007 1240004 1241506 1241550 1430000 1533909 1534005 1581005 1581504

Product Description
Dihydroergotamine Mesylate (250 mg) Ephedrine Sulfate (200 mg) Ergonovine Maleate (100 mg) Ergotamine Tartrate (150 mg) Ergotaminine (100 mg) Methylergonovine Maleate (50 mg) Phenylpropanolamine Bitartrate (100 mg) Phenylpropanolamine Hydrochloride (250 mg) Pseudoephedrine Hydrochloride (125 mg) Pseudoephedrine Sulfate (200 mg)

List Chemicals: A copy of the import permit if the chemical is controlled in the country to which it is being exported. DEA Schedules I, II, III, IV, and V: Original import permit or Letter of No Objection (in English or accompanied by an English translation) valid at least 60 days from the date of its receipt by USP Customer Service. A statement of non-reexport and use exclusively for medical or scientific purposes from the importer (in English or accompanied by an English translation). General Information: Fees Add US$25.00 to all unit prices for all DEA Controlled Substances and List Chemicals shipped outside the United States. The shipping charge for all DEA Controlled Substances shipped outside the United States is US$255.00 per order. Orders for controlled substances to be shipped outside the United States must include a full payment or purchase order for customers with approved net terms from USP. Special Instructions for Import Permits from Mexico: Additional time may be needed to obtain a certificate from the Embassy of Mexico. The customer is responsible for the fee charged by the Embassy of Mexico for the certificate(s). Please contact Julie Smith about the fee, as the price is subject to change without notice. USP cannot ship controlled substances outside the United States without proper authorization from the DEA.

DEA REQUIREMENTS FOR ORDERS SHIPPED OUTSIDE THE UNITED STATES To facilitate efficient and correct ordering, please contact Julie Smith at +1-301-816-8164 or email [email protected].

SeptemberOctober 2006

Distributors Edition Official USP Reference Standards Catalog

21

HOW TO READ PRODUCT LISTINGS

Column 1 (Catalog Number): Catalog number currently assigned to each Reference Standard and Authentic Substance. Please include this number in your order. Column 2 (Description): Product description as designated in USPNF, the product label, and/or the Drug Enforcement Administration Control Schedule, as applicable. The quantity of material per container follows the name in parentheses (all materials are in single containers unless otherwise specified). Column 3 (Current Lot): Current lot designation of each official item being distributed as of the date of this catalog. If the current lot is blank, the item is not in distribution. Column 4 (Purity Value): Assigned purity value as it appears on the Reference Standard or Authentic Substance label. Code interpretations for the basis of purity assignments are as follows: Basis Code (ai) (dr) (an) (fb) (ig) Column 5 (Change Code): Code that identifies any change in USP Reference Standards status or information since the JulyAugust 2006 official catalog. Code interpretations are as follows:

Change Code 1 2 3 4 5 6 7 8 9

Interpretation New Reference Standard New lot Change in package size or description Correction of typographical error New catalog numberuse for all orders Previous lot no longer official; only current lot to be used Valid use date of previous lot extended Change in catalog number and/or name, see cross-reference section Discontinued

Interpretation as is dried anhydrous free base ignited Column 6 (Previous Lot/Valid Use Date): Lot designations for recent lots no longer being distributed. The indicated month and year in parentheses indicate the date (last day of the month) through which that lot was valid as an official USP Reference Standard (e.g., F-1 (06/00) means lot F-1 is no longer being distributed, but was considered official through June 30, 2000). Column 7 (CAS Number*): Chemical Abstracts Service number, when available, for USP Reference Standards and Authentic Substances. For mixtures, typically, the CAS number of the analyte of interest is listed.

* CAS numbers are provided for informational purposes only, and their listing in the USP Reference Standards Catalog does not indicate official designation of any CAS number to a salt, isomer, hydration state, or other chemical form of any specific Reference Standard or Authentic Substance.

22

Edicin del Distribuidor Catlogo de Estndares de Referencia USP Oficiales

Septiembreoctubre 2006

USO DE LOS ESTNDARES DE REFERENCIA USP

Estndares de Referencia Oficiales Es necesario utilizar los Estndares de Referencia USP en anlisis y pruebas de farmacopea en la publicacin de estndares oficiales, la Farmacopea de los Estados UnidosFormulario Nacional (USPNF, por sus siglas en ingls). Los Estndares de Referencia USP ayudan a garantizar el cumplimiento de los requisitos de calidad obligatorios de la Administracin de Alimentos y Frmacos de los Estados Unidos (FDA), en la USPNF. Los Estndares de Referencia tambin se asocian a muchas otras aplicaciones, que incluyen las mediciones necesarias para obtener resultados exactos y reproducibles en los mtodos cromatogrficos y espectofotomtricos modernos. Pruebas Exhaustivas y Control de Calidad Los Estndares de Referencia USP son seleccionados por su elevada pureza, caractersticas esenciales, y adecuacin para un fin en particular. A menos que la etiqueta de un Estndar de Referencia USP establezca una potencia o contenido especficos, se lo considera 100.0% puro para los fines de la USP para los que se lo proporcion. Como servicio para nuestros clientes, se indican en este catlogo los valores de pureza etiquetados de los Estndares de Referencia y Sustancias Autnticas aprobadas despus del 1 de enero de 2004. Consulte p. 24 si desea explicaciones adicionales sobre cmo se calculan los valores. Cuando se requiere, las sustancias heterogneas de origen natural tambin son designadas como Estndares de Referencia. Suelen ser la contrapartida de los estndares internacionales. Los Estndares de Referencia USP se establecen a travs de un proceso de pruebas exhaustivas, evaluacin y control de calidad. Son sometidos a pruebas en forma independiente en tres o ms laboratorios: USP, FDA, y laboratorios acadmicos e industriales a lo largo y ancho de los Estados Unidos. Los Estndares de Referencia son aprobados bajo la autoridad del Consejo de Administracin de la USP, en funcin de las recomendaciones del Comit de Expertos en Estndares de Referencia USP, que aprueba la seleccin y adecuacin de cada lote. Categoras de Estndares de Referencia La USP ofrece ms de 1.900 Estndares de Referencia para productos farmacuticos, excipientes, y suplementos dietticos. En las pginas 3492 de este catlogo, encontrar una lista completa de los Estndares de Referencia USP y NF disponibles, junto con informacin actualizada a junio de 2006. La lista incluye: Estndares de Referencia requeridos por la edicin oficial actual de la USPNF. Estndares de Referencia no requeridos en la USPNF actual, pero para los que an hay suficiente demanda. Estndares de Referencia especificados en la edicin actual del Food Chemicals Codex (FCC o Cdigo de Sustancias Qumicas en Alimentos). Sustancias Autnticas (AS): muestras altamente purificadas de sustancias qumicas incluidas sustancias que causan adiccin requeridas por laboratorios analticos, clnicos, farmacuticos y de investigacin. La distribucin de sustancias controladas est sujeta a los reglamentos y disposiciones que regulan la actividad de la Administracin para Control de Drogas (DEA) del Departamento de Justicia de los EE.UU. La USP tambin colabora con el programa de la Organizacin Mundial de la Salud que tiene como objetivo proporcionar estndares biolgicos internacionales y materiales qumicos de referencia para antibiticos y agentes biolgicos y quimioteraputicos. Algunos Estndares de Referencia USP estn estandarizados de acuerdo con los correspondientes estndares internacionales. Uso Correcto de los Estndares de Referencia USP Los Estndares de Referencia USP son proporcionados fundamentalmente para el control de calidad de las pruebas y anlisis de farmacopea descriptos en la USPNF. Ni los Estndares de Referencia ni las Sustancias Autnticas estn diseados para ser utilizados como frmacos, suplementos dietticos, o dispositivos mdicos. Para cumplir con el propsito para el que fue creado, cada Estndar de Referencia USP debe almacenarse, manipularse y utilizarse en forma correcta. Los usuarios de estos estndares deben consultar el Captulo General <11> en la USPNF: Listado e indicaciones en la USPNF: Consulte la lista de revisiones, agregados y eliminaciones de Estndares de Referencia USP individuales en USP 29NF 24. Las monografas USP o NF individuales especifican el o los Estndar/es de Referencia USP requeridos para los procedimientos de los anlisis y de las pruebas. El Captulo General <11> sobre Pruebas de la USP 29NF 24 de los Estndares de Referencia USP provee informacin adicional e instrucciones para el uso y el almacenamiento apropia dos. Tenga en cuenta que si las instrucciones especficas de uso que figuran en la etiqueta de un Estndar de Referencia USP difieren de las incluidas en el Captulo <11>, prevalecern las instrucciones de la etiqueta. Consulte las actualizaciones progresivas de la informacin sobre Estndares de Referencia proporcionadas en los Suplementos USPNF y en los Anuncios de Revisin Provisional USPNF, que se publican en la revista bimensual de la USP: Pharmacopeial Forum.

Adecuacin para su uso Los usuarios deben asegurarse de que los Estndares de Referencia que estn utilizando correspondan a un lote oficial. Tambin deben determinar la adecuacin de los Estndares de Referencia para las aplicaciones y usos no incluidos en la USPNF.

Septiembreoctubre 2006

Edicin de Distribuidores Catlogo de Estndares de Referencia USP Oficiales

23

USO DE LOS ESTNDARES DE REFERENCIA USP

Almacenamiento Asegrese de que los Estndares de Referencia USP sean guardados de acuerdo a las instrucciones especificadas en la etiqueta, en sus envases originales cerrados, lejos del calor y la humedad y protegidos de la luz. Pesos Asegrese de que las substancias del Estndar de Referencia sean pesadas con exactitudtomando en cuenta los errores relativamente grandes que pueden asociarse con el peso de masas pequeascuando se dan instrucciones para la preparacin de una solucin o preparacin estndar para una determinacin cuantitativa. Consulte la USP 29NF 24 Captulos Generales <41> Pesos y Balanzas y <31> Equipo volumtrico y los Avisos Generales de la USPNF, para obtener informacin sobre el uso adecuado de los Estndares de Referencia USP. Secado Utilice un recipiente limpio y seco, y no el envase original, como recipiente de secado cuando sea necesario secar un Estndar de Referencia USP antes de usarlo. Asegrese de no secar una muestra repetidamente a temperaturas superiores a los 25C. Siga todos los requisitos de secado especial especificados en la etiqueta del Estndar de Referencia o en las secciones especficas de las monografas USP o NF (tenga en cuenta que cualquier instruccin especfica en la etiqueta o en la monografa prevalece sobre las instrucciones habituales de los Procedimientos que figuran en Pruebas y Anlisis en Avisos Generales de la USPNF). Siga el Mtodo I de la USPNF Captulo General <921> Determinacin de agua cuando se requiera de una determinacin titrimtrica de agua al utilizar un Estndar de Referencia. Los mtodos instrumentales o microanalticos son aceptables para este fin. Cuando se utilicen cantidades tpicas, los usuarios deben titular unos 50 mg del Estndar de Referencia con un cudruple del reactivo. Unidad del Producto Los Estndares de Referencia USP deben ser pedidos en unidades enteras. Observe que una unidad puede incluir varios envases individuales. Sin Devoluciones ni Cambios Los Estndares de Referencia USP no pueden ser devueltos ni son reembolsables. REQUISITOS DE LA DEA PARA PEDIDOS ENVIADOS FUERA DE ESTADOS UNIDOS Para facilitar el procesamiento correcto y eficiente del pedido, comunquese con Julie Smith al +1-301-816-8164 o enve un correo electrnico a [email protected]. Sustancias Qumicas de la Lista: Lista de Estndares de Referencia categorizados por la DEA como Sustancias Qumicas de la Lista
No. de catlogo Descripcin del producto
1202005 1236007 1240004 1241506 1241550 1430000 1533909 1534005 1581005 1581504 Mesilato de dihidroergotamina (250 mg) Sulfato de efedrina (200 mg) Maleato de ergonovina (100 mg) Tartrato de ergotamina (150 mg) Ergotaminina (100 mg) Maleato de metilergonovina (50 mg) Bitartrato de fenilpropanolamina (100 mg) Clorhidrato de fenilpropanolamina (250 mg) Clorhidrato de pseudoefedrina (125 mg) Sulfato de pseudoefedrina (200 mg)

Sustancias Qumicas de la Lista: Una copia del permiso de importacin, si est controlada en el pas al que se la exporta. Programas DEA I, II, III, IV, y V: Permiso de importacin original o carta de No Objecin (en Ingls o acompaada de su traduccin al Ingls) con una validez de por lo menos 60 das a partir de la fecha de su recepcin por parte del Servicio al Cliente de la USP. Una declaracin del Importador de no-reexportacin y de su uso exclusivo con fines mdicos o cientficos (en Ingls o acompaada de su traduccin al Ingls). Informacin general: Cargos Agregue US$ 25 a todos los precios unitarios de las Sustancias Controladas y Sustancias Qumicas de la Lista enviadas fuera de Estados Unidos. El cargo de expedicin para todas las Substancias Controladas por la DEA enviadas fuera de Estados Unidos es de US$ 255 por pedido. Los pedidos de sustancias controladas a ser enviadas fuera de Estados Unidos deben incluir El pago completo o la Orden de Compra para clientes con las condiciones netas aprobadas por la USP. Instrucciones Especiales para Permisos de Importacin de Mxico. Puede requerir un tiempo adicional obtener un certificado de la Embajada de Mxico. El Cliente asume la responsabilidad de los cargos exigidos por la Embajada de Mxico para el o los certificado/s. Comunquese con Julie Smith para informarse sobre el monto del cargo, ya que el precio est sujeto a cambios sin previo aviso. USP no puede despachar sustancias controladas fuera de Estados Unidos sin la autorizacin correspondiente de la DEA.

24

Edicin del Distribuidor Catlogo de Estndares de Referencia USP Oficiales

Septiembreoctubre 2006

USO DE LOS ESTNDARES DE REFERENCIA USP

Columna 1 (Nmero de catlogo): Nmero de catlogo asignado actualmente a cada Estndar de Referencia y Sustancia Autntica. Incluya este nmero en sus rdenes. Columna 2 (Descripcin): La descripcin del producto, tal cual se lo designa en la USPNF, en la etiqueta del producto, o en el Programa de Control de la Administracin para Control de Drogas, segn corresponda. La cantidad de material por envase figura despus del nombre entre parntesis (todos los materiales se encuentran en envases individuales, a menos que se especifique lo contrario). Columna 3 (Lote Actual): Designacin del lote actual de cada artculo oficial distribuido a la fecha de este catlogo. Si el lote actual est en blanco, el artculo no est disponible para distribucin. Columna 4 (Valores de Pureza): Los valores de pureza tal como figuran en la etiqueta del Estndar de Referencia o la Sustancia Autntica. Las interpretaciones del cdigo para las asignaciones de pureza son las siguientes: Columna 5 (Cdigo de Cambios): Cdigos que identifican los cambios realizados en el estado o en la informacin de los Estndares de Referencia de la USP desde la edicin Julio-Agosto 2006 del catlogo oficial. Las interpretaciones del cdigo son las siguientes:

Cdigo de de cambios 1 2 3 4 5 6 7 8 9

Interpretacin
Nuevo Estndar de Referencia Lote nuevo Cambio en el tamao del envase o en la descripcin Correccin de error tipogrfico Nuevo nmero de catlogo a utilizar en todos los pedidos El lote previo ya no es oficial; utilice slo el lote actual La fecha de uso vlida del lote previo ha sido prorrogada Cambios en el nmero de catlogo y/o en el nombre; consulte la seccin de referencia

Discontinuado

Cdigo de base (ai) (dr) (an) (fb) (ig)

Interpretacin como es seco anhidro base libre encendido

Columna 6 (Lotes Recientes/Fecha de Uso Vlida): Designaciones de lotes que ya no estn disponibles para distribucin. El mes y ao indicados entre parntesis indican la fecha (el ltimo da del mes) hasta el cual el lote fue vlido como Estndar de Referencia USP oficial. (por ejemplo, F-1 (06/00) significa que el lote F-1 ya no se distribuye, pero se lo consider oficial hasta el 30 de junio de 2000). Columna 7 (nmero CAS)*: El nmero CAS (Chemical Abstracts Number), cuando est disponible para Estndares de Referencia de la USP y Sustancias Autnticas. En el caso de mezclas se indica el nmero CAS del analito de inters.

* Se proporcionan los nmeros CAS con fines informativos exclusivamente, y su listado en el Catlogo de Estndares de Referencia USP no indica la designacin oficial de algn nmero CAS para una sal, ismero, estado de hidratacin, u otra forma qumica de algn Estndar de Referencia o Sustancia Autntica.

September-Oktober 2006

Ausgabe fr Vertriebsunternehmen Offizieller USP Referenz-Standards Katalog

25

WIE MAN DIE PRODUKTLISTE LIEST

Offizielle Referenz-Standards USP Referenz-Standards werden fr Pharmakope Assays und Tests gem den Verfahren, die in der offiziellen Standardspublikation, dem Formulierungsbuch der United States PharmacopeiaNational Formulary (USPNF) beschrieben sind, verlangt. Die USP Referenz-Standards helfen, die Einhaltung der offiziellen Qualittsanforderungen gem USPNF, welche von der FDA verlangt werden, zu berprfen. Die Referenz-Standards werden auch bei vielen anderen Anwendungen verwendet, einschlielich bei Messungen, die erforderlich sind, um exakte reproduzierbare Ergebnisse bei den modernen chromatographischen und spektrophotometrischen Methoden zu erzielen. Strenge Tests und Qualittskontrolle USP Referenz-Standards werden wegen ihrer hohen Reinheit, ihren kritischen Merkmalen und ihrer Eignung fr den bestimmten Zweck ausgewhlt. Auer wenn ein USP Referenz-Standard eine spezifische Wirksamkeit oder einen Gehalt festlegt, wird der USP Referenz-Standard als 100.0% rein fr USP-Zwecke, fr die er zur Verfgung gestellt ist, angesehen. Als Dienst fr unsere Kunden werden beschriftete Reinheitsangaben fr Referenz-Standards und authentische Substanzen, welche nach dem 1. Januar 2004 in diesem Katalog aufgefhrt sind, angegeben. Auf Seite 27 finden Sie Erklrungen darber, wie diese Werte berechnet werden. Heterogene Substanzen von natrlichem Ursprung werden ntigenfalls auch als Referenz-Standards bezeichnet. Gewhnlich sind dies die Gegenstcke von internationalen Standards. USP Referenz-Standards werden durch ein Verfahren von strengen Tests, Bewertung und Qualittskontrolle etabliert. Sie werden in drei oder mehreren LaboratorienUSP, FDA, und akademischen und Industrie-Laboratorienberall in den Vereinigten Staaten unabhngig getestet. Die Referenz-Standards werden unter der Autoritt des berwachungsausschusses von USP auf Empfehlung des USP Referenz-Standards Expertenkomitees, welches die Auswahl und die Eignung jeder Charge genehmigt, herausgegeben. Referenz-Standards Kategorien USP bietet mehr als 1.900 Referenz-Standards fr Arzneimittel, Arzneistofftrger und Nahrungsergnzungsmittel an. Auf den Seiten 3492 dieses Katalogs finden Sie eine komplette Liste der verfgbaren USP- und NF-Referenz-Standards mit Informationen, die bis Juni 2006 aktualisiert sind. Die Liste umfasst Referenz-Standards, welche von den gegenwrtigen offiziellen Ausgaben von USPNF gefordert werden. Referenz-Standards, die nicht in den gegenwrtigen USPNF gefordert werden, fr die jedoch ausreichend Nachfrage besteht. Referenz-Standards, welche in der gegenwrtigen Ausgabe des Food Chemicals Codex (FCC) spezifiziert sind. Authentische Substanzen (AS)stark gereinigte Proben von Chemikalien, einschlielich Substanzen, die missbruchlich verwendet werden und solche, die von analytischen, klinischen, pharmazeutischen und Forschungslaboratorien gefordert werden. Der Vertrieb von kontrollierten Substanzen unterliegt den Verordnungen und Lizenzvorschriften der Drogenbekmpfungsbehrde (Drug Enforcement AdministrationDEA) des U.S. Justizministeriums. USP arbeitet auch mit der Weltgesundheitsorganisation (WHO) bei deren Programm, internationale biologische Standards und chemische Referenzmaterialien fr Antibiotika, biologische, und chemotherapeutische Wirkstoffe zu schaffen, zusammen. Einige USP Referenz-Standards sind bezglich entsprechender internationaler Standards standardisiert. Richtige Anwendung von USP Referenz-Standards USP Referenz-Standards werden hauptschlich fr Qualittskontrollen bei der Durchfhrung von Assays und Tests, die in den USPNF beschrieben sind, zur Verfgung gestellt. Weder Referenz-Standards noch authentische Substanzen sind fr die Verwendung als Arzneimittel, Nahrungsergnzungsmittel, oder in medizinischen Gerten bestimmt. Um dem vorgesehenen Zweck dienlich sein zu knnen, muss jeder USP Referenz-Standard entsprechend gelagert, behandelt, und verwendet werden. Anwender der USP Referenz-Standards sollten sich auf das Allgemeine Kapitel <11> in der USPNF beziehen: Eintragung und Wegweiser in der USPNF Nehmen Sie Bezug auf die Liste der Revisionen, Ergnzungen, und Streichungen von einzelnen USP Referenz-Standards in USP 29NF 24. Einzelne USP- oder NF-Monographien spezifizieren die USP Referenz-Standard(s), welche fr Assay- und Testverfahren bentigt werden. Kapitel <11> der USP 29NF 24 Allgemeine Tests USP Referenz-Standards stellt zustzliche Informationen und Instruktionen fr die richtige Anwendung und Lagerung zur Verfgung. Beachten Sie, dass, falls spezifische Instruktionen fr die Anwendung auf dem Etikett eines USP Referenz-Standards von den Instruktionen in Kapitel <11> abweichen, die Instruktionen auf dem Etikett zu befolgen sind. Ziehen Sie die kumulativen Aktualisierungen der Referenz-Standards Informationen zu Rate, welche in den USPNF Ergnzungen und auch in den USPNF InterimRevisionsankndigungen zur Verfgung gestellt werden. Diese werden im zweimonatlich erscheinenden USP Journal, Pharmacopeial Forum, verffentlicht. Eignung fr die Verwendung Die Anwender mssen sicherstellen, dass die ReferenzStandards, die sie verwenden aus einer offiziellen Charge stammen. Anwender mssen die Eignung des Referenz-Standards fr Anwendungen und Verwendung, die nicht in der USPNF stehen, feststellen.

26

Ausgabe fr Vertriebsunternehmen Offizieller USP Referenz-Standards Katalog

September-Oktober 2006

VERWENDUNG VON USP REFERENZ-STANDARDS

Lagerung Stellen Sie sicher, dass die USP Referenz-Standards in ihren originalen mit Stopfen versehenen Flschchen aufbewahrt werden. Entsprechend den Anweisungen auf dem Etikett sollen sie vor Hitze, Feuchtigkeit, und Licht geschtzt gelagert werden. Wiegen Stellen Sie sicher, dass Referenz-Standardsubstanzen exakt gewogen werden. Dabei soll man daran denken, dass beim Wiegen von kleinen Massen relative groe Fehler auftreten knnen, wenn es darum geht, eine Standardlsung fr eine quantitative Bestimmung herzustellen. Siehe USP 29NF 24 Allgemeine Kapitel <41> Gewichte, Waagen und <31> Volumetrische Gerte, sowie Allgemeine Hinweise in USPNF zur Information bezglich der richtigen Verwendung von USP Referenz-Standards. Trocknen Verwenden Sie saubere und trockene Gefe und nicht den Originalbehlter, da das Trocknen des Gefes erforderlich ist, wo ein USP Referenz-Standard vor der Verwendung getrocknet werden muss. Stellen Sie sicher, dass eine Probe nicht wiederholt bei Temperaturen von ber von 25 C getrocknet wird. Befolgen Sie jede besondere Trocknungsanweisung, welche auf dem Referenz-Standardetikett oder in den spezifischen Abschnitten der USP oder NF Monographie angegeben ist (beachten Sie, dass jede spezifische Instruktion auf dem Etikett oder in der Monographie die gewhnliche Instruktion in den Verfahren unter Tests und Assays in den Allgemeinen Notizen von USPNF auer Kraft setzt). Folgen Sie der Methode I unter USPNF Allgemeines Kapitel <921> Wasserbestimmungen, wo die titrimetrische Bestimmung von Wasser zu der Zeit gefordert wird, wo ein Referenz-Standard verwendet werden soll. Instrumentelle oder mikroanalytische Methoden sind fr diesen Zweck akzeptabel. Wenn Sie typische Mengen verwenden, mssen die Anwender ca. 50 mg des Referenz-Standards mit einer vierfachen Verdnnung des Reagens titrieren. Produkteinheit USP Referenz-Standards mssen in ganzen Einheiten bestellt werden. Bitte beachten Sie, dass eine Einheit mehrere einzelne Behlter umfassen kann. Keine Rckgabe oder Umtausch USP Referenz-Standards drfen nicht zwecks Vergtung zurckgesandt oder umgetauscht werden. DEA ANFORDERUNGEN FR BESTELLUNGEN ZUM VERSAND AUSSERHALB DER VEREINIGTEN STAATEN Um eine effiziente und korrekte Bestellung zu erleichtern, kontaktieren Sie bitte Julie Smith unter +1-301-816-8164 oder per email [email protected]. Listenchemikalien: Liste der Referenz-Standards, welche von der DEA als Listenchemikalien kategorisiert wurden.
Katalognummer 1202005 1236007 1240004 1241506 1241550 1430000 1533909 1534005 1581005 1581504 Produktbeschreibung Dihydroergotamin-Mesylat (250 mg) Ephedrinsulfat (200 mg) Ergonovinmaleat (100 mg) Ergotamintartrat (150 mg) Ergotaminin (100 mg) Methylergonovinmaleat (50 mg) Phenylpropanolaminbitartrat (100 mg) Phenylpropanolamin-Hydrochlorid (250 mg) Pseudoephedrin-Hydrochlorid (125 mg) Pseudoephedrinsulfat (200 mg)

Listenchemikalien: Eine Kopie der Importgenehmigung, wenn die Substanz im Land, in welches sie exportiert werden soll, reguliert wird. DEA Aufstellung I, II, III, IV, und V: Original Importgenehmigung oder Unbedenklichkeitserklrung (in Englisch oder begleitet durch die englische bersetzung) wenigstens 60 Tage gltig vom Empfangsdatum durch USP. Eine Besttigung vom Importeur, dass kein Re-Export beabsichtigt ist und die Verwendung ausschlielich medizinischen oder wissenschaftlichen Zwecken dient (in Englisch oder begleitet von einer englischen bersetzung). Allgemeine Informationen Gebhren Addieren Sie zu allen Einzelpreisen 25,00 US$ fr alle DEA kontrollierten Substanzen und Listenchemikalien, die nach auerhalb der Vereinigten Staaten versandt werden. Die Versandkosten fr alle durch DEA kontrollierten Substanzen, die nach auerhalb der Vereinigten Staaten verschickt werden, betragen 255,00 US$ pro Bestellung. Die Bestellung fr kontrollierte Substanzen, die nach auerhalb der Vereinigten Staaten versandt werden sollen, muss Folgendes enthalten: Volle Bezahlung oder Bestellung von Kunden mit durch USP genehmigten Netto-Bedingungen. Besondere Instruktionen fr Importgenehmigung von Mexiko. Zustzliche Zeit kann erforderlich sein, um ein Zertifikat von der mexikanischen Botschaft zu erhalten. Der Kunde hat fr die Gebhr, welche von der Botschaft von Mexiko fr die Zertifikate berechnet wird, aufzukommen. Bitte kontaktieren Sie Julie Smith bezglich der Gebhr, da der Preis ohne Ankndigung gendert werden kann. USP kann kontrollierte Substanzen nicht nach auerhalb der Vereinigten Staaten verschicken, ohne dass eine Autorisierung von der DEA vorliegt.

September-Oktober 2006

Ausgabe fr Vertriebsunternehmen Offizieller USP Referenz-Standards Katalog

27

WIE MAN DIE PRODUKTLISTE LIEST

Spalte 1 (Katalognummer): Katalognummer, die gegenwrtig jedem Referenz-Standard und jeder authentischen Substanz zugeordnet ist. Bitte setzen Sie diese Nummer in Ihre Bestellungen ein. Spalte 2 (Beschreibung): Produktbeschreibung, wie sie im USPNF, auf dem Produktetikett und/oder im DEA Kontrollplan, soweit zutreffend, angegeben wurde. Die Menge an Material pro Behlter folgt dem Namen in Klammern (alle Substanzen sind in einzelnen Behltern, wenn nicht anders angegeben). Spalte 3 (Laufende Charge): Die laufende Chargenbezeichnung von jedem offiziellen Artikel, der ab Datum dieses Katalogs verkauft wird. Wenn die laufende Chargenbezeichnung leer ist, wird dieser Artikel nicht verkauft. Spalte 4 (Reinheitsangaben): Zugeordnete Reinheitsangaben, wie sie auf dem Etikett des Referenz-Standards oder der authentischen Substanz erscheinen. Die Code-Bedeutungen auf der Basis der Reinheitszuordnungen sind wie folgt: Spalte 5 (Code-nderung): Codes, welche jede nderung im Status oder in der Information der USP Referenz-Standards seit Juli-August 2006 im offiziellen Katalog identifizieren. Die Code-Bedeutungen sind wie folgt:

nderung Code 1 2 3 4 5 6 7 8

Bedeutung Neuer Referenz-Standard Neue Charge nderung der Packungsgre oder Beschreibung Tippfehlerkorrektur Neue Katalognummerbei allen Bestellungen verwenden Vorige Charge ist nicht lnger offiziell, nur laufende Charge verwenden Gltiges Verwendungsdatum der vorigen Charge ist verlngert nderung an Katalognummer und/oder Namen siehe Querverweis Sektion Auslaufmaterial

Basis Code (ai) (dr) (an) (fb) (ig)

Bedeutung as is getrocknet wasserfrei freie Base erhitzt

Spalte 6 (Vorige Charge/Gltiges Verwendungsdatum): Chargenbezeichnungen von neuen Chargen, die nicht lnger verkauft werden. Monat und Jahr in Klammern zeigen das Datum an (letzter Tag des Monats), bis zu welchem die Charge als offizieller USP Referenz-Standard gltig war (z.B. F-1 (06/00) bedeutet, dass Charge F-1 nicht lnger verkauft wird, aber dass sie bis zum 30. Juni 2000 offiziell war). Spalte 7 (CAS Nummer)*: Chemical Abstracts Service Nummer, falls verfgbar, fr USP Referenz-Standards und authentische Substanzen. Im Falle von Mischungen wird typischerweise die CAS Nummer des Analyts von Interesse angegeben.

* CAS Nummern werden nur aus Informationsgrnden angegeben, und ihre Angabe im USP Referenz-Standards Katalog ist keine offizielle Zuordnung einer CAS Nummer zu einem Salz, Isomer, Hydratationszustand oder einer anderen chemischen Form irgendeines spezifischen Referenz-Standards oder einer authentischen Substanz.

28

dition du distributeur Catalogue officiel des normes de rfrence USP

Septembre-octobre 2006

UTILISATION DES NORMES DE RFRENCE USP

Normes de rfrence officielles Lutilisation des normes de rfrence USP est exige pour les essais et tests pharmaceutiques dans la publication des normes officielles intitule United States PharmacopeiaNational Formulary (USPNF). Les normes de rfrence USP aident assurer la conformit aux exigences excutoires officielles de la FDA amricaine dans lUSPNF. Les normes de rfrence se prtent aussi plusieurs autres applications, y compris les mesures exiges pour obtenir des rsultats prcis et reproductibles pour les mthodes chromatographiques et spectrophotomtriques. Essai et contrle de la qualit rigoureux Les normes de rfrence USP sont slectionnes pour leur haut degr de puret, leurs caractristiques essentielles, et leur compatibilit avec lutilisation prvue par USP. moins quune tiquette dune norme de rfrence USP ne mentionne une puissance ou une teneur spcifique, la norme de rfrence USP suppose une substance pure 100.0 % aux fins prvues par USP. Pour mieux servir notre clientle, les valeurs de puret tiquetes pour les normes de rfrence et les substances authentiques mises aprs le 1er janvier 2004 sont listes dans ce catalogue. Voir la page 30 pour une explication de la mthode de calcul de ces valeurs. Les substances htrognes, dorigine naturelle, sont aussi dsignes au besoin normes de rfrence . Ces dernires sont gnralement des substances homologues de normes internationales. Les normes de rfrence USP ont t tablies selon un processus rigoureux dessai, dvaluation et de contrle de la qualit. Elles sont testes de manire indpendante dans trois laboratoires ou plus : USP, FDA, ainsi que dans des laboratoires acadmiques et industriels travers les tats-Unis. Les normes de rfrence sont mises sous lautorit du conseil dadministration dUSP, sur la recommandation du comit dexperts en matire de normes de rfrence dUSP qui approuve le choix et ladquation de chaque lot. Catgories de normes de rfrence USP offre plus de 1 900 normes de rfrence pour des produits pharmaceutiques, des excipients, et des complments alimentaires. Aux pages 3492 de ce catalogue, vous trouverez la liste complte des normes de rfrence USP et NF, dont linformation a t mise jour en juin 2006. La liste comprend les normes de rfrence exiges par ldition courante officielle dUSPNF ; les normes de rfrence non exiges par ldition courante dUSPNF mais dont la demande continue de justifier la publication ; les normes de rfrence spcifies dans ldition courante du Codex des produits chimiques alimentaires (FCC) ; les substances authentiques (SA) : des chantillons hautement purifis de produits chimiques, y compris des substances donnant lieu des abus, exiges par les laboratoires analytiques, cliniques, pharmaceutiques, et de recherche. La distribution des substances rglementes est soumise aux rglements et provisions de brevet de la Drug Enforcement Administration (DEA) du dpartement de la justice amricain. USP collabore galement avec lOrganisation mondiale de la sant llaboration de son programme dtablissement des normes biologiques et des substances chimiques de rfrence internationales pour des antibiotiques, des produits biologiques, et des agents chimiothrapeutiques. Certaines normes de rfrence USP ont t normalises pour correspondre aux normes internationales. Utilisation adquate des normes de rfrence USP Les normes de rfrence USP sont fournies principalement pour tre utilises au cours des preuves de contrle de la qualit lors des essais et tests dcrits dans lUSPNF. Les normes de rfrence et les substances authentiques ne sont pas destines tre utilises comme mdicaments, complments alimentaires, ou comme matriel mdical. Afin de servir aux fins prvues, chaque norme de rfrence doit tre entrepose, manipule et utilise adquatement. Les utilisateurs de normes de rfrence USP doivent se reporter au chapitre gnral <11> de lUSPNF : Liste et instructions de lUSPNF Reportez-vous la liste des rvisions, ajouts et suppressions de normes de rfrence USP individuelles dans lUSP 29NF 24. Les monographies individuelles USP ou NF spcifient les normes USP exiges pour les procdures dessai et de test. Le Test gnral de lUSP 29NF 24 du chapitre <11> des normes de rfrence USP procure de linformation supplmentaire ainsi que des instructions dutilisation et dentreposage. Veuillez noter que dans le cas o des instructions spcifiques apparaissant sur ltiquette dune norme de rfrence diffrent des instructions contenues dans le chapitre <11>, les instructions sur ltiquette prvalent. Consultez les mises jour cumulatives des normes de rfrence fournies dans les supplments USPNF de mme que les avis de rvision intrimaires USPNF qui apparaissent dans le journal bimensuel dUSP, le Pharmacopeial Forum.

Adquation dutilisation Les utilisateurs doivent sassurer que les normes de rfrence quils utilisent proviennent dun lot officiel. Les utilisateurs doivent dterminer ladquation des normes de rfrence pour des applications et des utilisations qui ne figurent pas dans lUSPNF.

Septembre-octobre 2006

dition du distributeur Catalogue officiel des normes de rfrence USP

29

UTILISATION DES NORMES DE RFRENCE USP

Entreposage Assurez-vous que les normes de rfrence USP sont entreposes dans leurs contenants dorigine bouchs, conformment aux instructions qui figurent sur ltiquette, labri de la chaleur, de lhumidit et de la lumire. Pesage Assurez-vous que les substances des normes de rfrence sont peses avec prcision, en tenant compte des marges derreur potentiellement leves associes au pesage de faibles masses, dans le cas o une solution de rfrence ou une prparation de rfrence est prpare pour un dosage quantitatif. Voir les chapitres gnraux dUSP 29NF 24 <41> Poids et balances et <31> Dispositifs volumtriques, ainsi que les Avis gnraux dUSPNF, pour de linformation concernant lutilisation adquate des normes de rfrence USP. Schage Utilisez un fluidiseur propre et sec (non le contenant original) comme fluidiseur de schage lorsquune norme de rfrence USP doit tre sche avant usage. Assurez-vous de ne pas scher un spcimen de manire rpte des tempratures dpassant 25 degrs Celsius. Suivez toute exigence de schage spciale indique sur ltiquette de la norme de rfrence ou dans les sections spcifiques des monographies USP ou NF (notez que toute instruction spcifique figurant sur ltiquette ou dans la monographie prvaut sur les instructions habituelles des procdures sous la rubrique Tests et essais des Avis gnraux dUSPNF. Suivez la mthode I du chapitre gnral dUSPNF <921> Dtermination de leau quand un dosage titrimtrique de leauest exig lors de lutilisation dune norme de rfrence. Les mthodes instrumentales ou micro-analytiques sont acceptables cette fin. Lors de lutilisation de quantits typiques, les utilisateurs doivent titrer environ 50 mg de la norme de rfrence avec quatre parts de ractif. Unit de produit Les normes de rfrence USP doivent tre commandes par units compltes. Veuillez noter quune unit peut comprendre plusieurs contenants individuels. Aucun retour darticle ni change Les normes de rfrence USP ne peuvent pas tre retournes contre remboursement ni changes. EXIGENCES DE LA DEA POUR LES COMMANDES EXPDIES HORS DES TATS-UNIS Afin que vos commandes soient traites avec efficacit et exactitude, veuillez contacter Julie Smith au +1-301-816-8164 ou encore, veuillez envoyer un courriel [email protected]. Liste des produits chimiques : Liste des normes de rfrence classes par la DEA comme liste de produits chimiques
No de catalogue Description du produit
1202005 1236007 1240004 1241506 1241550 1430000 1533909 1534005 1581005 1581504 Msylate de dihydroergotamine (250 mg) Sulfate dphdrine (200 mg) Malate dergonovine (100 mg) Tartrate dergotamine (150 mg) Ergotaminine (100 mg) Malate de mthylergonovine (50 mg) Bitartrate de phnylpropanolamine (100 mg) Hydrochlorure de phnylpropanolamine (250 mg) Hydrochlorure de pseudophdrine (125 mg) Sulfate de pseudophdrine (200 mg)

Liste des produits chimiques : Une copie du permis dimportation si la substance est rglemente dans le pays o elle est exporte. Feuilles I, II, III, IV, et V de la DEA : Permis dimportation original ou lettre de non objection (en anglais ou accompagne dune traduction en anglais) valide pendant au moins 60 jours partir de la date de rception par le Service la clientle dUSP. Une dclaration de non-rexportation et dutilisation rserve uniquement des fins mdicales et scientifiques de la part de limportateur (en anglais ou accompagne dune traduction en anglais). Renseignements gnraux : Frais Ajoutez 25,00 $ US tous les prix unitaires pour toutes les substances rglementes par la DEA et pour la liste des produits chimiques expdis hors des tats-Unis. Les frais dexpdition pour toutes les substances rglementes par la DEA envoyes hors des tats-Unis sont de 255,00 $ US par commande. Les commandes de substances rglementes qui doivent tre expdies hors des tats-Unis doivent comprendre un paiement complet ou un bon de commande pour les clients dont les conditions de paiement ont t approuves par USP. Des instructions spciales pour les permis dimportation du Mexique. Un dlai supplmentaire peut savrer ncessaire dans le but dobtenir un certificat de lambassade du Mexique. Le client doit assumer les frais chargs par lambassade du Mexique pour les certificats. Veuillez contacter Julie Smith pour les frais, car ceux-ci peuvent tre modifis sans pravis. USP ne peut expdier des substances rglementes hors des tats-Unis sans avoir obtenu au pralable une autorisation de la DEA.

30

dition du distributeur Catalogue officiel des normes de rfrence USP

Septembre-octobre 2006

UTILISATION DES NORMES DE RFRENCE USP

Colonne 1 (Numro de catalogue) : Numro de catalogue actuellement assign chaque norme de rfrence et substance authentique. Veuillez inclure ce numro dans vos commandes. Colonne 2 (Description) : La description du produit tel que dsign dans lUSPNF, ltiquette du produit, ou la feuille de contrle de la Drug Enforcement Administration, selon le cas. La quantit de substance par contenant suit le nom entre parenthses (toutes les substances sont contenues dans des rcipients simples moins dindication contraire). Colonne 3 (Lot courant) : La dsignation de lot courante de chaque article officiel distribu en date de ce catalogue. Si le lot courant est vierge, larticle nest pas distribu. Colonne 4 (Valeurs de puret) : La valeur de puret assigne telle quelle apparat sur ltiquette de la norme de rfrence ou de la substance authentique. Interprtations des codes dterminant la dsignation de puret : Colonne 5 (Code de changement) : Les codes de changement qui identifient toute modification au statut de la norme de rfrence ou toute information sy rapportant depuis le catalogue officiel de Juillet-aot 2006. Interprtations des codes : Code de changement 1 2 3 4 5 6 7 8 9

Interprtation
Nouvelle norme de rfrence Nouveau lot Changement dans la taille du paquet ou la description Correction derreur typographique Nouveau numro de catalogue : utiliser pour toutes les commandes Le lot prcdent nest plus officiel, nutiliser que le lot courant Date d'utilisation valide du lot prcdent reporte Changement du numro de catalogue et/ou du nom voir la rubrique de rfrence croise Discontinu

Base de code (ai) (dr) (an) (fb) (ig)

Interprtation tel quel sch anhydre base libre enflamm

Colonne 6 (Lot prcdent/date dutilisation valide) : Dsignations de lot pour les lots rcents qui ne sont plus distribus. Le mois et lanne entre parenthses indiquent la date (dernier jour du mois) jusqu laquelle le lot tait valide comme norme de rfrence USP officielle (p. ex. : F-1 (06/00) signifie que le lot F-1 nest plus distribu mais quil tait considr officiel jusquau 30 juin 2000). Colonne 7 (Numro CAS)* : Numro CAS (Chemical Abstracts Service), lorsquil est disponible, des normes de rfrence et substances authentiques. En cas de mlanges, le numro CAS de la substance analyser est gnralement list.

* Les numros CAS ne sont fournis qu titre de renseignement, et leur prsence dans le catalogue des normes de rfrence USP nindique pas une dsignation officielle de nimporte quel numro CAS un sel, un isomre, un tat dhydratation, ou toute autre forme chimique de nimporte quelle norme de rfrence ou substance authentique.

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

31

New Lots in Distribution

Cat. No. 1021204 1048652 Curr. Lot. F0F099 F0F149 Purity Value/Conc. 0.99 mg/mg (ai) 0.99 mg/mg (ai) Change Code* 1 1 Previous Lot/Valid Use Date CAS No. [123-30-8] n/f

Description 4-Aminophenol (100 mg) Benazepril Related Compound D (15 mg) (3-(1ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine1-acetic acid monohydrochloride) Citalopram Hydrobromide (200 mg) Citalopram Related Compound D (15 mg) (1-(4uorophenyl)-1-(3-(methylamino)propyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrochloride) Fluvastatin Sodium (350 mg) Hexacosanol (100 mg) Ibuprofen Related Compound C (0.2 mL/ampule; 3 ampules) (4-isobutylacetophenone) Mecamylamine Related Compound A (10 mg) (N,1,7,7-tetramethyl bicyclo [2.2.1] heptan-2-amine hydrochloride) Naratriptan Resolution Mixture (20 mg) Nefazodone Hydrochloride (200 mg) Deacetylnorgestimate (25 mg) ((E)- and (Z)-17deacetyl norgestimate mixture) Norgestimate Related Compound A (25 mg) (Levonorgestrel Acetate) Oxandrolone Related Compound B CIII (20 mg) (17 beta-hydroxy-17 alpha-methyl-4-oxa-5 alphaandrosta-3-one) Pamidronate Disodium (100 mg) Ramipril Related Compound B (20 mg) (Ramipril Isopropylester) Ritonavir Related Compounds Mixture (50 mg) Saccharin Sodium (100 mg) Vancomycin B with Monodechlorovancomycin (350 mg) Acetylcholine Chloride (200 mg) Alprostadil (25 mg) Amlodipine Besylate (350 mg) Baclofen Related Compound A (50 mg) (4-(4Chlorophenyl)-2-pyrrolidinone) Bethanechol Chloride (200 mg)

1134233 1134277

F0F157 F0F170

0.998 mg/mg (ai)

1 1

[59729-32-7] n/f

1285931 1305303 1335541 1376017

F0F015 F0F131 F0F011 F0F003

0.997 mg/mg (ai) 0.98 mg/mg (ai) 1.00 mg/mg (ai)

1 1 1 1

[93957-55-2] [506-52-5] [38861-78-8] [22321-23-9]

1457491 1457902 1471958 1471925 1482025

F0E346 F0F122 F0F089 F0F109 F0F136 0.999 mg/mg (ai)

1 1 1 1 1

[82752-99-6] [53016-31-2] [13732-69-9] [4424-45-7]

1492801 1598323 1604814 1607040 1709018 1008501 1016000 1029501 1048222 1071009

F0F096 F0F151 F0F058 F0F006 F0F138 H0F091 H1F110 G0F133 I0F047 H0E304

0.758 mg/mg (ai)

1 1 1 1

[109552-15-0] [295328-72-2] [155213-67-5] [6155-57-3] n/f G (03/07) H (06/07) F0D167 (06/07) H1C289 (06/07) H (11/04) G1D088 (05/07) G (03/05) F-3 (07/01) H (05/07) G-2 (03/03) G-1 (08/02) H0C175 (06/07) G (07/04) F (09/00) F-1 (06/07) F (11/99) H0C207 (05/07) G (05/03) H0C089 (05/07) G0B225 (12/03) F (10/03) [60-31-1] [745-65-3] [111470-99-6] n/f [590-63-6]

0.81 mg/mg (an) 1.000 mg/mg (dr) 0.991 mg/mg (ai) 0.997 mg/mg (an) 1.00 mg/mg (ai) 0.998 mg/mg (dr)

1 2 2 2,3 2 2

1078507

Bupivacaine Hydrochloride (1 g)

H1E255

0.945 mg/mg (ai)

[14252-80-3]

1097975

Cefotetan (500 mg)

I0E277

985 ug/mg (an)

[69712-56-7]

1098300 1134030 1134404

Cellulose Acetate (125 mg) Ciclopirox Olamine (125 mg) Clavam-2-carboxylate Potassium (4 ug)

G0E015 I0F067 H0C089 0.999 mg/mg (ai)

2 2 2,3

[9004-35-7] [41621-49-2] n/f

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

32 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

New Lots in Distribution

Cat. No. 1140327 Curr. Lot. G3F034 Purity Value/Conc. Change Code* 2 Previous Lot/Valid Use Date G2B110 (05/07) G-1 (01/04) G (02/99) G1C273 (06/07) G (12/04) F (05/07) F0B284 (03/07) G-1 (05/07) H (06/07) G-1 (01/99) O (05/07) I0A016 (05/07) H (01/04) F0D262 (06/07) F0C374 (04/07) I0B184 (06/07) H-1 (11/02) F2C132 (06/07) F-1 (02/05) F (11/99) F0B244 (05/07) I1C045 (05/07) I (11/04) H (09/01) G (10/99) F-1 (06/07) F (09/00) G (03/07) F0C201 (05/07) I1D108 (05/07) I (01/06) I0C146 (06/07) H (07/04) G (05/07) F0C226 (06/07) CAS No. n/f

Description Clonazepam Related Compound A (25 mg) (3Amino-4-(2-chlorophenyl)-6-nitrocarbostyril) Crospovidone (200 mg) Cyclosporine Resolution Mixture (25 mg) Desogestrel Related Compound B (15 mg) (3Hydroxy-desogestrel) Dichlorphenamide (200 mg) Dipyridamole (200 mg) Epinephrine Bitartrate (200 mg) Ethylparaben (200 mg) Fluconazole (200 mg) Fludarabine Phosphate (300 mg) Fluorometholone (200 mg) Fluoxetine Hydrochloride (200 mg)

1150706 1158650 1173257 1188006 1220506 1237000 1267000 1271700 1272204 1278007 1279804

G2E126 F1F134 G0F144 G2C046 H1F120 P0E320 I1F039 G0F102 G0E247 J0F140 G0F085 1.00 mg/mg (ai) 0.993 mg/mg (an) 0.996 mg/mg (ai) 0.999 mg/mg (ai) 0.998 mg/mg (dr) 0.998 mg/mg (ai) 0.96 mg/mg (ai)

2 2 2 2 2 2 2 2 2 2 2

[9003-39-8] [108027-45-8] (U) n/f [120-97-8] [58-32-2] [51-42-3] [120-47-8] [86386-73-4] [75607-67-9] [426-13-1] [59333-67-4]

1294808 1368609

Glutamine (100 mg) Lisinopril (300 mg)

G0F037 J0F043

1.00 mg/mg (ai) 1.000 mg/mg (an)

2 2

[56-85-9] [83915-83-7]

1376505 1377508 1392454 1414003 1437009 1447002 1478629

Mechlorethamine Hydrochloride (100 mg) (FOR U.S. SALE ONLY) Meclocycline Sulfosalicylate (300 mg) Meropenem (300 mg) Methotrexate (500 mg) Methylprednisolone Hemisuccinate (200 mg) Morphine Monohydrate CII (50 mg) (AS) Ondansetron Related Compound D (30 mg) (1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one) Promethazine Hydrochloride (500 mg) Propoxyphene Related Compound A (50 mg) (alpha-d-4-dimethylamino-1,2-diphenyl-3-methyl-2butanol Hydrochloride) Sumatriptan Succinate Related Compound A (15 mg) ([3-[2-(dimethylamino)ethyl]-2-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1H-indol5-yl]-N-methylmethanesulfonamide, succinate salt) Torsemide (200 mg) L-Valine (200 mg) Vincristine Sulfate (50 mg)

G0E271 H0F087 G0F100 J0D109 I1F076 G1F125 G0F153 1.00 mg/mg (ai) 678 ug/mg (an) 0.998 mg/mg (an) 0.999 mg/mg (an) 0.998 mg/mg (ai)

2 2 2 2 2 2 2,3

[55-86-7] [73816-42-9] [119478-56-7] [59-05-2] [2921-57-5] [6009-81-0] n/f

1570009 1575206

L0F056 H0F117

0.998 mg/mg (dr) 0.99 mg/mg (ai)

2 2

K (06/07) J-1 (10/00) G6D124 (04/07) G-5 (01/06) F0C221 (01/07)

[58-33-3] n/f

1642212

G0F113

0.92 mg/mg (ai)

n/f

1672304 1708503 1714007

G0E293 G0F115 P0F092

0.996 mg/mg (ai) 1.00 mg/mg (dr) 0.996 mg/mg (dr)

2 2 2,3

F0B090 (05/07) F-2 (05/07) F-1 (05/02) O0B062 (06/07) N (01/03) M (04/99)

[56211-40-6] [72-18-4] [2068-78-2]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

33

New Lots in Distribution

Cat. No. 1714506 1716002 Curr. Lot. F2E197 W0F126 Purity Value/Conc. 0.994 mg/mg (an) Change Code* 2 2,3 Previous Lot/Valid Use Date F1E133 (05/07) F0C243 (08/05) V0C258 (12/05) U (04/04) CAS No. [125317-39-7] [127-47-9]

Description Vinorelbine Tartrate (200 mg) Vitamin A (10 ampules containing vitamin A acetate in peanut oil)

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

34 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1000601 1001003 1001502 1002505 1003009 Curr. Lot. F-1 G0D300 F-2 F0C136 J2C423 0.996 mg/mg (dr) J-1 (04/06) J (05/02) I (05/99) L (06/04) K (02/00) 0.997 mg/mg (dr) 99.9% (ai) G-1 (06/99) F (03/03) 0.997 mg/mg (ai) 1.000 mg/mg (dr) 2 G (03/07) H (01/04) F (05/04) F-1 (01/07) F (05/02) 0.998 mg/mg (ai) J (02/06) F (10/05) F-1 (05/02) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. [34381-68-5] [152-72-7] [3598-37-6] [55589-62-3] [103-90-2]

Description Acebutolol Hydrochloride (125 mg) Acenocoumarol (200 mg) Acepromazine Maleate (250 mg) Acesulfame Potassium (200 mg) Acetaminophen (400 mg)

1004001 1005004 1005706 1006007 1006506 1006801 1007000 1008501 1009005 1009901 1009923 1011007 1011018

Acetanilide Melting Point Standard (500 mg) (Approximately 114 degrees) Acetazolamide (2 g) Glacial Acetic Acid (1.5 mL/ampule; 3 ampules) (AS) Acetohexamide (250 mg) Acetohydroxamic Acid (200 mg) Acetone (1.5 mL/ampule; 3 ampules) Acetophenazine Maleate (200 mg) Acetylcholine Chloride (200 mg) Acetylcysteine (200 mg) Acetyltributyl Citrate (500 mg) Acetyltriethyl Citrate (500 mg) Acitretin (200 mg) A c i t r e t i n R e l a te d C o m p o u n d A ( 2 0 m g ) ((2Z,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid) Acitretin Related Compound B (20 mg) (ethyl (allE)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate) Acyclovir (300 mg) Acyclovir Related Compound A (50 mg) (AS) (2[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl acetate) Ademetionine Disulfate Tosylate (500 mg) Adenine (200 mg) Adenosine (200 mg) Adipic Acid (100 mg) Agigenin (25 mg) Agnuside (25 mg) L-Alanine (200 mg) Albendazole (200 mg) Albuterol (200 mg) Albuterol Sulfate (200 mg) Alclometasone Dipropionate (300 mg) Alcohol (1.2 mL/ampule; 5 ampules) Dehydrated Alcohol (1.2 mL/ampule; 5 ampules) Alcohol DeterminationAcetonitrile (5 mL/ampule; 5 ampules)

M0A029 J1E041 F0D002 H F-1 F0D028 F-1 H0F091 H1B169 G0C120 G0E085 F0E266 F0E264

[103-84-4] [59-66-5] [64-19-7] [968-81-0] [546-88-3] [67-64-1] [5714-00-1] [60-31-1] [616-91-1] [77-90-7] [77-89-4] [55079-83-9] [69427-46-9]

1011029

F0E265

[54350-48-0]

1012065 1012076

J0C149 F0F010

I (06/04)

[59277-89-3] n/f

1012134 1012101 1012123 1012190 1012145 1012203 1012509 1012553 1012600 1012633 1012757 1012768 1012772 1012699

F0D073 G2D279 G0C295 F0D318 F F0D397 G0E002 H0E240 I J H F0D030 F0D031 F0C419 2% v/v (ai) 0.88 mg/mg (ai) 1.00 mg/mg (ai) 0.996 mg/mg (dr) F-2 (08/06) F-1 (04/01) G (10/06) F-1 (01/00) H (12/00) I (04/00) G (01/00) 1.000 mg/mg (dr) G-1 (12/05) G (06/00) F1B058 (01/05) F (04/03)

[97540-22-2] [73-24-5] [58-61-7] [124-04-9] n/f [11027-63-7] [56-41-7] [54965-21-8] [18559-94-9] [51022-70-9] [66734-13-2] [64-17-5] [64-17-5] n/f

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

35

USP Reference Standards and Authentic Substances

Cat. No. 1012688 1012780 1012906 1012939 1012950 1013002 1013024 1013057 1014005 1015008 1016000 1017105 1017502 1017364 1018505 1019202 1019417 1019508 1019701 1019712 Curr. Lot. F0C399 G0D288 F0B016 F0C169 F J0C186 G F F H1C133 H1F110 F F2B120 F0D342 H1D207 H0D346 F0C152 J0E226 H F0E287 0.981 mg/mg (an) I (10/06) H (08/00) 55.3 % (ai) 0.998 mg/mg (ai) 0.995 mg/mg (ai) H (02/06) G (04/01) G0B260 (06/06) F-1 (03/04) F-1 (01/04) 0.991 mg/mg (ai) 2 H (06/05) H (06/07) I-1 (01/05) I (07/02) F-3 (05/02) F-2 (04/99) Purity Value/Conc. 1.96% v/v (ai) 0.834 mg/mg (ai) F0B315 (02/06) Change Code* Previous Lot/Valid Use Date CAS No. n/f [121268-17-5] [70879-28-6] [97-59-6] [556-27-4] [315-30-0] n/f n/f [561-78-4] [28981-97-7] [745-65-3] [645-05-6] [21645-51-2] [17927-65-0] [665-66-7] [51022-69-6] [112901-68-5] [37517-28-5] [17440-83-4] [1458-01-1]

Description Alcohol DeterminationAlcohol (5 mL/ampule; 5 ampules) Alendronate Sodium (200 mg) Alfentanil Hydrochloride CII (500 mg) Allantoin (200 mg) Alliin (25 mg) Allopurinol (250 mg) Allopurinol Related Compound A (50 mg) (3Amino-4-carboxamidopyrazole Hemisulfate) S-Allyl-L-Cysteine (25 mg) Alphaprodine Hydrochloride CII (250 mg) Alprazolam CIV (200 mg) Alprostadil (25 mg) Altretamine (500 mg) Dried Aluminum Hydroxide Gel (200 mg) Aluminum Sulfate (2 g) (AS) Amantadine Hydrochloride (200 mg) Amcinonide (200 mg) Amifostine Disulde (25 mg) Amikacin (300 mg) Amiloride Hydrochloride (500 mg) Amiloride Related Compound A (30 mg) (AS) (Methyl 3,5-diamino-6-chloropyrazine-2-carboxylate) Aminobenzoate Potassium (200 mg) Aminobenzoate Sodium (200 mg) Aminobenzoic Acid (200 mg) (p-aminobenzoic acid) Aminobutanol (500 mg) Aminocaproic Acid (200 mg) 2-Amino-5-chlorobenzophenone (25 mg) Aminoglutethimide (200 mg) m-Aminoglutethimide (100 mg) Aminohippuric Acid (200 mg) 2-[3-Amino-5-(n-methylacetamido)-2,4,6-triiodobenzamido]-2-deoxy-d-glucose (25 mg) Aminopentamide Sulfate (200 mg) 4-Aminophenol (100 mg) m-Aminophenol (300 mg) Aminosalicylic Acid (125 mg) 3-Amino-2,4,6-triiodobenzoic Acid (50 mg) 5-Amino-2,4,6-triiodo-N-methylisophthalamic Acid (50 mg) Amiodarone Hydrochloride (200 mg) Amitraz (200 mg) Amitriptyline Hydrochloride (200 mg)

1019756 1019767 1019803 1020008 1021000 1022808 1025205 1025307 1025351 1025806 1025908 1021204 1026004 1026401 1026605 1027007 1027302 1028000 1029002

F-1 F H1C083 G-1 G0D101 I F G F-1 F F0B273 F0F099 F F-1 G F-1 F0D257 F0C042 J0A004 0.995 mg/mg (ai) 0.99 mg/mg (ai) 1 0.997 mg/mg (dr)

F (06/01) H (10/04) G (10/00) G (06/99) F-4 (09/05) H-1 (01/03) F (05/01)

[138-84-1] [55-06-6] [150-13-0] [96-20-8] [60-32-2] [719-59-5] [125-84-8] n/f [61-78-9] n/f [60-46-8] [123-30-8] [591-27-5]

F (03/99)

[65-49-6] [3119-15-1] [2280-89-9] [19774-82-4] [33089-61-1]

I (03/03)

[549-18-8]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

36 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1029501 1029909 1029910 1029942 1029953 1029986 1030001 1031004 1031401 1031503 1032007 1033000 1033203 1033407 1034002 1034308 1034320 1034341 Curr. Lot. G0F133 F-1 F2C082 F0D102 F0C134 F0D104 F-2 H0B238 G1D375 J0C043 J3C246 1009 ug/mg (dr) 1.000 mg/mg (dr) G-1 (04/03) G (03/07) F-1 (04/02) I (07/04) J-2 (01/05) J-1 (07/02) J-1 (05/07) J (12/01) G-1 G1D147 G0C317 G F F-1 F (03/00) 0.991 mg/mg (dr) G (10/99) G (08/05) F-1 (04/05) F (04/02) 100.0 % (ai) 33.3% NH3 (ai) Purity Value/Conc. 0.997 mg/mg (an) Change Code* 2,3 Previous Lot/Valid Use Date F0D167 (06/07) F (06/01) F-1 (06/05) F (05/00) CAS No. [111470-99-6] [33434-24-1] [33434-24-1] [8000-73-5] [12125-02-9] [7783-28-0] [57-43-2] [6398-98-7] [14028-44-5] [61336-70-7] [1397-89-3] [69-53-4] [69-52-3] [7177-48-2] [121-25-5] [60719-84-8] [62749-46-6] n/f

Description Amlodipine Besylate (350 mg) Ammonio Methacrylate Copolymer Type A (100 mg) Ammonio Methacrylate Copolymer Type B (100 mg) Ammonium Carbonate (2 g) (AS) Ammonium Chloride (200 mg) Ammonium Phosphate Dibasic (1 g) (AS) Amobarbital CII (200 mg) Amodiaquine Hydrochloride (500 mg) Amoxapine (200 mg) Amoxicillin (200 mg) Amphotericin B (125 mg) Ampicillin (200 mg) Ampicillin Sodium (125 mg) Ampicillin Trihydrate (200 mg) Amprolium (200 mg) Amrinone (500 mg) Amrinone Related Compound A (100 mg) (5carboxamide[3,4-bipyridin]-6(1H)-one) Amrinone Related Compound B (100 mg) (N-(1,6dihydro-6-oxo-(3,4-bipyridine)-5-yl)-2-hydroxypropanamide) Amrinone Related Compound C (50 mg) (1,6dihydro-6-oxo-(3,4-bipyridine)-5-carbonitrile) Anecortave Acetate (200 mg) Anecortave Acetate Related Compound A (20 mg) (9(11)-dehydrocortisol) Anileridine Hydrochloride CII (250 mg) 3-Anilino-2-(3,4,5-trimethoxybenzyl) acrylonitrile (25 mg) (AS) Antazoline Phosphate (200 mg) Anthralin (200 mg) Antipyrine (200 mg) Apigenin-7-glucoside (30 mg) Apomorphine Hydrochloride (250 mg) Apraclonidine Hydrochloride (100 mg) Aprobarbital CIII (200 mg) (AS) DISCONTINUED L-Arabinitol (500 mg) L-Arginine (200 mg) Arginine Hydrochloride (125 mg) Arsanilic Acid (25 mg) Ascorbic Acid (1 g) (Vitamin C) Ascorbyl Palmitate (2 g) (AS) Asparagine Anhydrous (200 mg) Asparagine Monohydrate (200 mg)

1034363 1034909 1034910 1036008 1036507 1038003 1039006 1040005 1040708 1041008 1041609 1042000 1042102 1042500 1042601 1042703 1043003 1043105 1043502 1043513

F-1 F0E298 F0E299 F G2D383 H I0B221 G F H H0B112 F0E311 1.00 mg/mg (an) 0.997 mg/mg (ai)

F (05/00)

n/f [7753-60-8] [10184-70-0] [126-12-5]

G-1 (04/06) G-1 (04/02) H (11/02) F-4 (09/01) G (01/03) G (06/03) F-1 (02/07) G-1 (06/07) G (09/00)

[30078-48-9] [154-68-7] [1143-38-0] [60-80-0] n/f [41372-20-7] [73218-79-8] [77-02-1] [7643-75-6] [74-79-3] [1119-34-2] [98-50-0] [50-81-7] [137-66-6] [70-47-3] [5794-13-8]

G0B060 F Q0B012 F0D326 F0E013 F0E012 0.988 mg/mg (ai) 1.00 mg/mg (dr) 1.00 mg/mg (ai)

F-1 (05/03) P (04/03)

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

37

USP Reference Standards and Authentic Substances

Cat. No. 1043706 1043750 1043728 1043819 1044006 1044301 1044403 Curr. Lot. H1B125 F0C137 I0D208 F0B087 H F I0F032 0.999 mg/mg (dr) H1C320 (04/07) H (01/05) G (08/01) G-1 (11/02) 0.99 mg/mg (ai) H (11/05) G-1 (10/99) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date H (05/03) CAS No. [22839-47-0] [106372-55-8] [5262-10-2] [6899-03-2] [50-78-2] [68844-77-9] [29122-68-7]

Description Aspartame (200 mg) Aspartame Acesulfame (200 mg) Aspartame Related Compound A (25 mg) (5Benzyl-3,6-dioxo-2-piperazineacetic Acid) Aspartic Acid (100 mg) Aspirin (500 mg) Astemizole (200 mg) Atenolol (200 mg)

1044651 1044662

Atovaquone (200 mg) Atovaquone Related Compound A (25 mg) (cis-2[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4naphthoquinone) Atracurium Besylate (100 mg) Atropine Sulfate (500 mg)

F0B190 F0B188

[95233-18-4] n/f

1044800 1045009

F0B143 M0B098 L-2 (04/03) L-1 (06/02) L (10/00) 0.996 mg/mg (dr) G0B280 (09/06) F (09/03) G (10/03) F (12/01) G (05/06) F-1 (02/02) F (02/99) F-1 (04/04) F (06/00) G-1 (02/00) G (11/04) F (06/00)

[64228-81-5] [5908-99-6]

1045337 1045508 1045600

Avobenzone (500 mg) Aurothioglucose (100 mg) Azaerythromycin A (100 mg) (9-Deoxo-9a-aza-9ahomoerythromycin A) Azaperone (200 mg) Azatadine Maleate (200 mg) Azathioprine (200 mg) Azithromycin (100 mg) Azlocillin Sodium (200 mg) Azo-aminoglutethimide (100 mg) Aztreonam (200 mg) Aztreonam E-Isomer (50 mg) Open Ring Aztreonam (25 mg) Bacampicillin Hydrochloride (200 mg) Bacitracin (1 g) (Susceptibility disk standard) Bacitracin Zinc (200 mg)

G1E109 H0B224 G1D368

[70356-09-1] [12192-57-3] [76801-85-9]

1045756 1045803 1046001 1046056 1046103 1046147 1046205 1046307 1046409 1047300 1047503 1048007

F G0B300 H H0C212 F F G0C077 F1D056 G0D071 G0B053 G1C254 N1E200 75.1 USP Bacitracin Units/mg (dr) F-1 (03/04) F (04/05) F (12/04) F (11/02) G (07/04) N0A024 (12/06) M-1 (11/02) M (02/00) 2 H1C289 (06/07) H (11/04) K (02/06) J (12/00) F0C250 (03/06)

[1649-18-9] [3978-86-7] [446-86-6] [117772-70-0] [37091-65-9] n/f [78110-38-0] n/f [87500-74-1] [37661-08-8] [1405-87-4] [1405-89-6]

1048200 1048222 1048506 1048619 1048620

Baclofen (500 mg) Baclofen Related Compound A (50 mg) (4-(4Chlorophenyl)-2-pyrrolidinone) Beclomethasone Dipropionate (200 mg) Benazepril Hydrochloride (125 mg) Benazepril Related Compound A (15 mg) ((3R)-3[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1acetic acid, monohydrochloride)

I I0F047 L0D312 G0E079 F0C252 1.00 mg/mg (ai) 0.992 mg/mg (dr) 0.996 mg/mg (dr)

[1134-47-0] n/f [5534-09-8] [86541-74-4] n/f

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

38 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1048630 Curr. Lot. F0C256 Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. n/f

Description Benazepril Related Compound B (15 mg) ((3S)-3[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1acetic acid, monohydrochloride) Benazepril Related Compound C (50 mg) ((3S)-3[[(1S)-1-carboxy-3-phenylpropyl]amino-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine]-1-acetic acid) Benazepril Related Compound D (15 mg) (3-(1ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine1-acetic acid monohydrochloride) Bendroumethiazide (200 mg) Benoxinate Hydrochloride (200 mg) Benzalkonium Chloride (5 mL of approx. 10% aqueous solution) Benzethonium Chloride (500 mg) Benzocaine (500 mg) Benzoic Acid (300 mg)

1048641

F0C425

1.00 mg/mg (ai)

[86541-78-8]

1048652

F0F149

0.99 mg/mg (ai)

n/f

1049000 1050009 1051001 1051500 1054000 1055002

H0C402 F-2 L0D209 F0E104 J0C130 G0D223

0.994 mg/mg (ai) Approx. 10% (w/v)

G-1 (06/05) F-1 (10/99) K0B151 (10/06) J (06/03) I (12/04)

[73-48-3] [5987-82-6] [8001-54-5] [121-54-0] [94-09-7] [65-85-0]

1.000 mg/mg (dr)

F6B173 (02/07) F-5 (03/04) F-4 (07/01) H (01/03) G (01/04) F-1 (11/01) F (09/00)

1056005 1056504

Benzonatate (1 g) 1,4-Benzoquinone (200 mg)

I0B003 G1B145

[104-31-4] [106-51-4]

1057507 1059003 1060002 1061005 1061901 1062008 1064003 1065006 1065210 1065618 1065709 1066009 1067001 1067307 1067704 1068004

Benzothiadiazine Related Compound A (100 mg) (4-Amino-6-chloro-1,3-benzenedisulfonamide) Benzphetamine Hydrochloride CIII (200 mg) (AS) Benzthiazide (200 mg) Benztropine Mesylate (200 mg) Benzyl Alcohol (500 mg/ampule) Benzyl Benzoate (5 g) 1-Benzyl-3-methyl-5-aminopyrazole Hydrochloride (25 mg) Bephenium Hydroxynaphthoate (500 mg) Berberine Chloride (50 mg) Betahistine Hydrochloride (200 mg) Betaine Hydrochloride (200 mg) Betamethasone (200 mg) Betamethasone Acetate (500 mg) Betamethasone Benzoate (200 mg) Betamethasone Dipropionate (125 mg) Betamethasone Sodium Phosphate (500 mg)

I0F027 F2C272 F I0C038 G0B306 J0C060 F-1 F F0E185 F0C105 F-1 K2C204 J0B079 F-1 K0C229 K0C358

1.00 mg/mg (dr)

H0B069 (02/07) G-4 (03/03) F-1 (10/05) H (09/04) F0B106 (10/03) I (05/04)

[121-30-2] [5411-22-3] [91-33-8] [132-17-2] [100-51-6] [120-51-4] n/f [3818-50-6]

0.81 mg/mg (ai) F (11/02) K-1 (10/04) K (11/02) I (08/03) J (04/04) I (03/99) 0.993 mg/mg (an) J0B043 (06/05) I-1 (02/03) I (01/01) J (07/05) I (05/00) F-1 (06/00) 0.998 mg/mg (dr) 2 G1D088 (05/07) G (03/05) F-3 (07/01)

[633-65-8] [5579-84-0] [590-46-5] [378-44-9] [987-24-6] [22298-29-9] [5593-20-4] [151-73-5]

1069007 1069903 1070006 1071009

Betamethasone Valerate (200 mg) Betaxolol Hydrochloride (200 mg) Betazole Hydrochloride (200 mg) Bethanechol Chloride (200 mg)

K0C330 G H H0E304

0.997 mg/mg (ai)

[2152-44-5] [63659-19-8] [138-92-1] [590-63-6]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

39

USP Reference Standards and Authentic Substances

Cat. No. 1071202 1071213 Curr. Lot. F0E321 F0E322 Purity Value/Conc. 0.999 mg/mg (ai) Change Code* Previous Lot/Valid Use Date CAS No. [90357-06-5] n/f

Description Bicalutamide (200 mg) Bicalutamide Related Compound A (25 mg) (N-[4cyano-3-(triuoromethyl)phenyl]-3-[(4-uoro-phenyl)sulnyl]-2-hydroxy-2-methyl-propanamide) Bile Salts (10 g) Positive Bioreaction (3 strips; 10 cm x 1 cm) Biotin (200 mg) Biperiden (200 mg) Biperiden Hydrochloride (200 mg) Bisacodyl (125 mg) 2,5-Bis(D-arabino-1,2,3,4-tetrahydroxybutyl)pyrazine (25 mg) Bis(2-ethylhexyl)maleate (250 mg) p-Bis(di-n-propyl)carbamylbenzenesulfonamide (50 mg) Bismuth Citrate (100 mg) Bismuth Subcarbonate (1 g) (AS) Bismuth Subgallate (2 g) (AS) Bismuth Subnitrate (1.5 g) (AS) Bismuth Subsalicylate (100 mg) Bisoprolol Fumarate (200 mg) Powdered Black Cohosh Extract (1.5 g) Bleomycin Sulfate (15 mg) Boric Acid (1 g) (AS) Bretylium Tosylate (200 mg) Brinzolamide (200 mg) Brinzolamide Related Compound A (50 mg) ((S)-()-4-ethylamino-2,3-dihydro-2-(3-methoxypropyl)4H-thieno-[3,2,e]-thiazine-6-sulfonamide-1,1-dioxide) Brinzolamide Related Compound B (50 mg) ((R)-4amino-2,3-dihydro-2-(3-methoxypropyl)-4H-thieno[3,2,e]-thiazine-6-sulfonamide-1,1-dioxide ethanedioate) Bromazepam CIV (100 mg) (AS) Bromocriptine Mesylate (150 mg) Bromodiphenhydramine Hydrochloride (200 mg) 8-Bromotheophylline (400 mg) Brompheniramine Maleate (125 mg) Budesonide (200 mg) Bumetanide (250 mg) Bumetanide Related Compound A (10 mg) (3Amino-4-phenoxy-5-sulfamoylbenzoic Acid) Bumetanide Related Compound B (25 mg) (3Nitro-4-phenoxy-5-sulfamoylbenzoic Acid)

1071304 1071439 1071508 1072001 1073004 1074007 1074700 1075203 1075509 1075531 1075600 1075622 1075644 1075553 1075757 1076206 1076308 1076341 1076352 1076363 1076374

I0C003 F0D014 I0D114 F2B080 G0E182 I1B162 F F-2 F F F0D324 F0D323 F0D388 F1C394 G0D316 F0D086 J0B213 F0D036 F-1 F0C034 F0C033 100.0% (dr) 0.997 mg/mg (dr) 98.4% (dr) 54.2% Bi2O3 (dr) 81.7% Bi2O3 (dr) 1.000 mg/mg (ai) 0.993 mg/mg (ai)

H-1 (05/04) H (05/99) H1B019 (11/05) H (04/03) F-1 (02/04) F-3 (08/06) F-2 (06/99) I (01/04) H-1 (02/99)

[145-42-6] n/f [58-85-5] [514-65-8] [1235-82-1] [603-50-9] n/f

F-1 (01/01)

[142-16-5] n/f [813-93-4] [5892-10-4] [22650-86-8] [1304-85-4]

F (08/05) F0B038 (08/05) I (01/04)

[14882-18-9] [104344-23-2] [84776-26-1] [9041-93-4] [10043-35-3] [61-75-6] [138890-62-7] n/f

1076385

F0C035

n/f

1076465 1076501 1077005 1077708 1078008 1078201 1078303 1078325 1078336

F0F064 I1C197 F-1 G I1A036 F0E302 I0C111 G0F031 F-2 0.99 mg/mg (ai) 0.997 mg/mg (ai) H0B030 (05/04) G (03/03) F-2 (03/07) F-1 (05/00) F-1 (01/03) F (07/02) I (01/03) H-1 (04/99) I (09/04)

[1812-30-2] [22260-51-1] [1808-12-4] [10381-75-6] [980-71-2] [51333-22-3] [28395-03-1] n/f [28328-53-2]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

40 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1078507 Curr. Lot. H1E255 Purity Value/Conc. 0.945 mg/mg (ai) Change Code* 2 Previous Lot/Valid Use Date H (05/07) G-2 (03/03) G-1 (08/02) F-1 (03/06) F (02/99) F (04/04) CAS No. [14252-80-3]

Description Bupivacaine Hydrochloride (1 g)

1078700 1078711

Buprenorphine Hydrochloride CIII (50 mg) Buprenorphine Related Compound A CII (50 mg) (21-[3-(1-propenyl)]-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine) Bupropion Hydrochloride (200 mg) Bupropion Hydrochloride Related Compound A (15 mg) (2-(tert-butylamino)-4-chloropropiophenone hydrochloride) Bupropion Hydrochloride Related Compound B (15 mg) (2-(tert-butylamino)-3-bromopropiophenone hydrochloride) Bupropion Hydrochloride Related Compound C (40 mg) (1-(3-chlorophenyl)-2-hydroxy-1-propanone) Bupropion Hydrochloride Related Compound F (30 mg) (1-(3-chlorophenyl)-1-hydroxy-2-propanone) Buspirone Hydrochloride (200 mg) Butabarbital CIII (200 mg) Butacaine Sulfate (600 mg) Butalbital CIII (200 mg)

G0E026 F1C076

0.995 mg/mg (ai)

[53152-21-9] n/f

1078733 1078744

G0E048 F0E082

0.998 mg/mg (ai)

F0C123 (02/06)

[31677-93-7] n/f

1078755

F0E011

n/f

1078766

F0D293

n/f

1078799

F0E076

n/f

1078802 1079000 1080000 1081002

H0B301 H0C007 F H0C054

G (05/05) G (03/04) G2B077 (07/04) G-2 (06/03) G (05/02) 1.000 mg/mg (dr) F (01/07) F (03/03) I (06/00) >99.0% (ai)

[33386-08-2] [125-40-6] [149-15-5] [77-26-9]

1081501 1082300 1082504 1082708 1082800 1082901 1083008 1083100

Butamben (200 mg) Butoconazole Nitrate (200 mg) Butorphanol Tartrate CIV (500 mg) Butylated Hydroxytoluene (500 mg) (AS) Monotertiary-butyl-p-benzoquinone (100 mg) (FCC) Butyl 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate (25 mg) 2-tert-Butyl-4-hydroxyanisole (200 mg) 3-tert-Butyl-4-hydroxyanisole (200 mg)

G0F059 F1B097 J F0D122 F F-1 L1E348 L0E259

[94-25-7] [64872-77-1] [58786-99-5] [128-37-0] [3602-55-9] n/f

0.996 mg/mg (ai) 0.997 mg/mg (ai)

L0C028 (03/07) K (09/03) K0C239(02/07) J (03/05) I-1 (09/01) H-1 (03/04) H (09/01)

[88-32-4] [121-00-6]

1084000 1085003 1086006 1086108 1086301 1086312 1086334 1086356 1086403

Butylparaben (200 mg) Caffeine (200 mg) Caffeine Melting Point Standard (1 g) (Approximately 236 degrees) Calcifediol (75 mg) Calcitriol (10 mg) Calcitriol Solution (5 mL) Calcium Acetate (1 g) (AS) Calcium Ascorbate (200 mg) Calcium Carbonate (1 g) (AS)

I0C139 J1D241 K0D372 G1E064 F0E062 F0D330 F0D156 F-1 F0D099 99.1% (dr) 0.996 mg/mg (ai) (as monohydrate) 0.993 mg/mg (ai) 0.974 ug/mL 100.0% (an) 0.998 mg/mg (ai)

[94-26-8] [58-08-2] [58-08-2] [63283-36-3] [32222-06-3] n/f [62-54-4]

J (02/06) I (06/02) J0B204 (11/06) I (03/04) G (07/06)

F (08/01)

[5743-28-2] [471-34-1]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

41

USP Reference Standards and Authentic Substances

Cat. No. 1086436 1086800 1086855 1086888 1086902 1086935 1087009 1087031 1087202 1087359 1087406 1087508 1087701 1088001 1089004 1090003 1091006 1091040 1091505 1091108 Curr. Lot. F0D153 F-1 F0D168 F0D227 G0B138 F0E142 O0C331 F0D394 F F0D255 F0D236 F0F030 F0D123 F F-2 F-2 (05/02) G F0D378 F0C312 G2D136 0.985 mg/mg (dr) G-1 (07/05) G (03/02) F-1 (06/00) F (03/99) G (01/04) 1.000 mg/mg (dr) 0.999 mg/mg (ai) G (07/06) J (11/06) I-1 (02/00) F (06/01) 9.8% CaO (ai) 100.0% (dr) 0.990 mg/mg (ai) 98.6% (dr) 0.990 mg/mg (dr) 37.2 % Ca (ai) N-1 (06/05) N (06/00) F-1 (01/04) F (11/01) 98.1% (ai) Purity Value/Conc. 101.9% (ai) F (09/00) Change Code* Previous Lot/Valid Use Date CAS No. [10035-04-8] [29039-00-7] [1305-62-0] [63690-56-2] [110638-68-1] [5743-49-7] [137-08-6] [12167-74-7] [5793-89-5] [1592-23-0] [10101-41-4] [464-49-3] [8006-44-8] [1403-17-4] [13956-29-1] [521-35-7] [1405-37-4] [124-07-2] n/f [404-86-4]

Description Calcium Chloride (1 g) (AS) Calcium Gluceptate (200 mg) Calcium Hydroxide (1 g) (AS) Calcium Lactate (1 g) Calcium Lactobionate (200 mg) Calcium Levulinate (1 g) (AS) Calcium Pantothenate (200 mg) (Vitamin B5) Tribasic Calcium Phosphate (1 g) (AS) Calcium Saccharate (200 mg) Calcium Stearate (2 g) (AS) Calcium Sulfate (1 g) (AS) Camphor (1 g) Candelilla Wax (250 mg) Candicidin (200 mg) Cannabidiol CI (25 mg) (AS) Cannabinol CI (25 mg) (AS) Capreomycin Sulfate (250 mg) Caprylic Acid (300 mg) Caprylocaproyl Polyoxylglycerides (200 mg) Capsaicin (100 mg)

1091200 1091221 1092009 1093001 1093205 1093500 1094004 1095506 1095517 1096000 1096407 1096509 1096531 1096553 1096600 1096699 1096757 1096779 1096804

Captopril (200 mg) Captopril Disulde (100 mg) Carbachol (200 mg) Carbamazepine (100 mg) Carbarsone (200 mg) Carbenicillin Indanyl Sodium (300 mg) Carbenicillin Monosodium Monohydrate (200 mg) Carbidopa (400 mg) Carbidopa Related Compound A (50 mg) (3-OMethylcarbidopa) Carbinoxamine Maleate (200 mg) Carboplatin (100 mg) Carboprost Tromethamine (25 mg) Carboxymethylcellulose Calcium (1.5 g) (AS) Carboxymethylcellulose Sodium (1.5 g) Carisoprodol (1 g) Carprofen (200 mg) (AS) Carteolol Hydrochloride (200 mg) Casticin (25 mg) Cathinone Hydrochloride CI (50 mg) (alpha-Aminopropiophenone Hydrochloride)

H G1B066 G1E010 K0E209 F G G-2 I H0B121 H H0C240 F-1 F0D336 F0D357 G F0D335 F-1 F0D358 I 0.99 mg/mg (ai) F (11/00) F-2 (05/02) H (10/99) G (04/03) G-1 (11/02) G (07/04) F (03/00) F (02/01)

[62571-86-2] [64806-05-9] [51-83-2] [298-46-4] [121-59-5] [26605-69-6] n/f [38821-49-7] n/f [3505-38-2] [41575-94-4] [58551-69-2] [9050-04-8] [9004-32-4] [78-44-4] [53716-49-7] [51781-21-6] [479-91-4] [76333-53-4]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

42 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1096906 Curr. Lot. I0E145 Purity Value/Conc. 0.994 mg/mg HPLC (an) 1.000 mg/mg UV (an) Change Code* Previous Lot/Valid Use Date H (11/06) CAS No. [70356-03-5]

Description Cefaclor (400 mg)

1096917 1097104 1097308 1097400 1097501 1097603 1097636 1097647 1097658 1097771 1097782 1097750 1097705 1097807 1097909 1097975

Cefaclor, Delta-3-Isomer (30 mg) Cefadroxil (125 mg) Cefamandole Lithium (200 mg) Cefamandole Nafate (200 mg) Cefamandole Sodium (250 mg) Cefazolin (400 mg) Cefepime Hydrochloride (500 mg) Cefepime Hydrochloride System Suitability (25 mg) Cexime (500 mg) Cefmenoxime Hydrochloride (350 mg) Cefmetazole (200 mg) Cefonicid Sodium (1 g) Cefoperazone Dihydrate (200 mg) Ceforanide (200 mg) Cefotaxime Sodium (250 mg) Cefotetan (500 mg)

G I1B319 H H F L0C345 G0D116 F0C095 F F G0E260 H0D105 H F-1 J0C189 I0E277 901 ug/mg (ai) 985 ug/mg (an) 2 0.988 mg/mg (ai) 887 ug/mg (an) 860 ug/mg (an) 935 ug/mg (ai)

F-1 (02/00) I (01/05) H (04/99)

n/f [66592-87-8] n/f [42540-40-9] [30034-03-8]

K (04/05) J (06/00) F0C063 (06/05)

[25953-19-9] [123171-59-5] n/f [79350-37-1] [75738-58-8]

F-1 (09/06) F (04/02) G (06/05) G (12/99) F (07/00) I (11/04) H0C175 (06/07) G (07/04) F (09/00) F (01/03) I (05/06) H (05/00)

[56796-20-4] [61270-78-8] [62893-19-0] [60925-61-3] [64485-93-4] [69712-56-7]

1098005 1098107 1098118 1098027 1098049

Cefotiam Hydrochloride (325 mg) Cefoxitin (500 mg) Cefpiramide (300 mg) Cefpodoxime Proxetil (350 mg) Cefprozil (E)-Isomer (50 mg)

G0B050 J0E038 F0C203 F0C192 G0D341 736 ug/mg (an) 872 ug/mg (ai) 0.992 mg/mg (an)

[66309-69-1] [35607-66-0] [70797-11-4] [87239-81-4]

F2C284 (08/05) F-1 (10/04) F (05/01) G0C037(06/06) F (12/03) G (06/06) F (03/00) G (12/99)

[92676-86-3]

1098050 1098129 1098130 1098173 1098184 1098195

Cefprozil (Z)-Isomer (200 mg) Ceftazidime, Delta-3-Isomer (15 mg) Ceftazidime Pentahydrate (300 mg) Ceftizoxime (350 mg) Ceftriaxone Sodium (350 mg) Ceftriaxone Sodium E-Isomer (25 mg)

H0E054 H0E106 H I0E262 G1D265 I0C190

927 ug/mg (ai)

[121412-77-9] n/f [78439-06-2] [68401-81-0] [104376-79-6] n/f

0.999 mg/mg (an) 925 ug/mg (an)

H (12/06) G0B264 (03/06) F (08/03) H (07/04) G (08/01) F-1 (02/00) G-1 (05/00) F-1 (05/02) H0B160 (09/06) G (03/03) 2 F-1 (06/07) F (11/99)

1098209 1098220 1098231 1098322 1098300

Cefuroxime Sodium (200 mg) Cefuroxime Axetil (500 mg) Cefuroxime Axetil Delta-3-Isomers (15 mg) Cellaburate (350 mg) (Cellulose Acetate Butyrate) Cellulose Acetate (125 mg)

H G H1E186 F0D220 G0E015

[56238-63-2] [64544-07-6] n/f [9004-36-8] [9004-35-7]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

43

USP Reference Standards and Authentic Substances

Cat. No. 1098355 1098388 1098402 1098708 1099008 1102000 1102408 1102500 1102805 1103003 1103105 1104006 Curr. Lot. Purity Value/Conc. Change Code* Previous Lot/Valid Use Date F-1 (05/07) F (03/99) F0D362 F0D364 G-1 J0D296 I F I-1 (06/07) I (07/02) J I1E065 F0B241 J0D299 1.000 mg/mg (an) I (10/05) H-1 (06/01) H (08/99) F-1 (02/99) N (10/04) M (03/00) I (04/00) I (07/06) H (03/99) 996 ug/mg (an) I-2 (10/05) I-1 (03/00) CAS No. [9004-38-0] [9004-34-6] [9004-34-6] n/f [23325-78-2] [58-71-9] [97468-37-6] [24356-60-3] [58456-86-3] [36653-82-4] [540-10-3] [6004-24-6]

Description Cellulose Acetate Phthalate (125 mg) Microcrystalline Cellulose (1 g) (AS) Powdered Cellulose (1 g) (AS) Cephaeline Hydrobromide (200 mg) Cephalexin (400 mg) Cephalothin Sodium (200 mg) Cephapirin Benzathine (100 mg) Cephapirin Sodium (200 mg) Cephradine (200 mg) Cetyl Alcohol (100 mg) Cetyl Palmitate (50 mg) Cetylpyridinium Chloride (500 mg)

1105009 1106001 1107004 1107300 1107401 1107503 1109000 1110009 1110020

Powdered Chaste Tree Extract (1.5 g) Chlorambucil (125 mg) (FOR U.S. SALE ONLY) Chloramphenicol (200 mg) Chloramphenicol Palmitate (200 mg) Chloramphenicol Palmitate Nonpolymorph A (200 mg) Chloramphenicol Palmitate Polymorph A (100 mg) Chlordiazepoxide CIV (200 mg) Chlordiazepoxide Hydrochloride CIV (200 mg) Chlordiazepoxide Related Compound A (25 mg) (7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one 4-Oxide) Chlorhexidine (200 mg) Chlorhexidine Acetate (500 mg) Chlorhexidine Related Compounds (50 mg) Chlorobutanol (200 mg) Chlorogenic Acid (50 mg) beta-Chlorogenin (20 mg) Parachlorophenol (500 mg) Chloroprocaine Hydrochloride (200 mg) Chloroquine Phosphate (500 mg) Chlorothiazide (200 mg)

F0C406 G N1C074 G-1 F-1 G1D219 I0B063 G-4 G G (10/05) F (08/99) H-1 (03/03)

[91722-47-3] [305-03-3] [56-75-7] [530-43-8] [530-43-8] [530-43-8] [58-25-3] [438-41-5] [963-39-3]

1111001 1111103 1111307 1112503 1115545 1115556 1496802 1117008 1118000 1121005

F0C306 G0E008 F0D017 G1D301 F0C420 F F0E061 G0B285 I H1E231 0.992 mg/mg HPLC (dr) 1.000 mg/mg UV (dr) 0.99 mg/mg (ai) F-3 (01/04) F-2 (03/99) H (10/99) H0B161 (11/06) G (04/03) 0.97 mg/mg (ai) G (09/05) F-3 (12/01) 0.996 mg/mg (an) F0C281 (02/06)

[55-56-1] [56-95-1] n/f [6001-64-5] [327-97-9] n/f [106-48-9] [3858-89-7] [50-63-5] [58-94-6]

1122008 1122700 1122722 1123000

Chlorotrianisene (1 g) Chloroxylenol (125 mg) Chloroxylenol Related Compound A (25 mg) (2chloro-3,5-dimethylphenol) Chlorpheniramine Maleate (125 mg)

F F2C259 G0C275 M0B020 F-1 (07/04) F (10/99) F-1 (07/04) L-1 (06/03)

[569-57-3] [88-04-0] [5538-41-0] [113-92-8]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

44 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1123102 Curr. Lot. G0B259 Purity Value/Conc. Change Code* Previous Lot/Valid Use Date F (06/03) CAS No. [113-92-8]

Description Chlorpheniramine Maleate Extended-Release Tablets (Drug Release Calibrator, Single Unit) (60 Tablets) Chlorphenoxamine Hydrochloride (200 mg) Chlorpromazine Hydrochloride (200 mg) Chlorpropamide (200 mg) Chlorprothixene (200 mg) Chlortetracycline Hydrochloride (200 mg) Chlorthalidone (200 mg) Chlorthalidone Related Compound A (15 mg) (4Chloro-3-sulfamoyl-2-benzophenone Carboxylic Acid) Chlorzoxazone (500 mg) Chlorzoxazone Related Compound A (50 mg) (2Amino-4-chlorophenol) Cholecalciferol (30 mg/ampule; 5 ampules) (Vitamin D3) Delta-4,6-cholestadienol (30 mg) Cholesteryl Caprylate (200 mg) Cholestyramine Resin (500 mg) Cholic Acid (2 g) (AS) Choline Bitartrate (200 mg) Choline Chloride (200 mg) Chondroitin Sulfate Sodium (300 mg) Chromium Picolinate (100 mg) Chymotrypsin (300 mg) Ciclopirox (50 mg) Ciclopirox Olamine (125 mg) Ciclopirox Related Compound A (25 mg) (3-Cyclohexyl-4,5-dihydro-5-methyl-5-isoxazolyl acetic acid) Ciclopirox Related Compound B (25 mg) (6-Cyclohexyl-4-methyl-2-pyrone) Cilastatin Ammonium Salt (100 mg) Cimetidine (200 mg) Cimetidine Hydrochloride (200 mg) Cinoxacin (200 mg) Ciprooxacin (200 mg) Ciprooxacin Ethylenediamine Analog (25 mg) Ciprooxacin Hydrochloride (400 mg) Ciprooxacin Related Compound A (25 mg) (AS) (7-Chloro-1-cyclopropyl-4-oxo-6-(piperazin-1-yl)1,4-dihydroquinoline-3-carboxylic acid hydrochloride salt) Cisplatin (100 mg)

1124003 1125006 1126009 1127001 1129007 1130006 1119309

F-1 J H F-1 K0C185 I0C255 I0E270 0.99 mg/mg (ai) 1008 ug/mg (ai) J-1 (12/04) J (02/02) H-1 (11/04) H (07/99) H0D251 (12/06) G0C376 (09/05) F-3 (07/04) H (07/01) G (11/00) L (10/03) K (09/99) I (04/99)

[562-09-4] [69-09-0] [94-20-2] [113-59-7] [64-72-2] [77-36-1] n/f

1130505 1130527 1131009 1131803 1132001 1133004 1133503 1133536 1133547 1133570 1133638 1134007 1134018 1134030 1134029

I G-1 M0B157 F F I F3B159 F0C057 F0C058 G0E236 F I F0E086 I0F067 F0E087 0.999 mg/mg (ai) 1.00 mg/mg (ai) 2 1.00 mg/mg (dr)

[95-25-0] [95-85-2] [67-97-0] [14214-69-8] [1182-42-9] [11041-12-6]

F-2 (01/03)

[81-25-4] [87-67-2] [67-48-1]

F0B256 (09/06) H (06/01) H0C207 (05/07) G (05/03)

[39455-18-0] [14639-25-9] [9004-07-3] [29342-05-0] [41621-49-2] n/f

1134040 1134051 1134062 1134073 1134109 1134313 1134324 1134335 1134346

F0E088 G0C334 I1C081 F F H0E306 J0A030 I0C265 F0E333

0.99 mg/mg (ai) 945 ug/mg (ai) F-1 (05/05) F (07/00) I (05/04)

[14818-35-0] n/f [51481-61-9] [70059-30-2] [28657-80-9]

0.998 mg/mg (ai)

G-1 (02/07) G (05/01) I (01/03) H-1 (02/99) H (02/05) G (04/00)

[85721-33-1] n/f [86393-32-0] n/f

1134357

G (03/01)

[15663-27-1]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

45

USP Reference Standards and Authentic Substances

Cat. No. 1134233 1134277 Curr. Lot. F0F157 F0F170 Purity Value/Conc. 0.998 mg/mg (ai) Change Code* 1 1 Previous Lot/Valid Use Date CAS No. [59729-32-7] n/f

Description Citalopram Hydrobromide (200 mg) Citalopram Related Compound D (15 mg) (1-(4uorophenyl)-1-(3-(methylamino)propyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrochloride) Citric Acid (200 mg)

1134368

F2E269

1.000 mg/mg (dr)

F1B092 (07/06) F-1 (01/04) F (07/02) F4B183 (03/06) F-3 (01/04) F-2 (09/01) G (04/07) F (04/01) 2,3 H0C089 (05/07) G0B225 (12/03) F (10/03) I (02/05) H (09/02) I (09/06) H (10/00) G (03/05)

[77-92-9]

1134379

Clarithromycin (75 mg)

G0D356

977 ug/mg (ai)

[81103-11-9]

1134390 1134380 1134404

Clarithromycin Identity (100 mg) Clarithromycin Related Compound A (50 mg) (6,11-di-O-methylerythromycin A) Clavam-2-carboxylate Potassium (4 ug)

F0E141 G1E310 H0C089

[81103-11-9] n/f n/f

1134426 1134506 1135000 1135021 1136002

Clavulanate Lithium (200 mg) Clemastine Fumarate (250 mg) Clidinium Bromide (2 g) Clidinium Bromide Related Compound A (250 mg) (3-Hydroxy-1-methylquinuclindinium Bromide) Clindamycin Hydrochloride (200 mg)

I1C270 J0C090 H0B115 I H0E044

0.952 mg/mg (ai) 0.998 mg/mg (ai)

n/f [14976-57-9] [3485-62-9] [76201-95-1]

867 ug/mg (ai)

G4A017 (07/06) G-3 (07/03) G-2 (05/99) F-2 (11/05) H-3 (04/04) H-2 (07/03) H-1 (02/99)

[58207-19-5]

1137005 1138008

Clindamycin Palmitate Hydrochloride (500 mg) Clindamycin Phosphate (125 mg)

G0D334 I0C165

586 ug/mg (an)

[25507-04-4] [24729-96-2]

1138201 1138405 1138427

Clioquinol (500 mg) Clobetasol Propionate (200 mg) Clobetasol Propionate Related Compound A (50 mg) (9-alpha-uoro-11-beta-hydroxy-16-betamethyl-3-oxo-androsta-1,4-diene-17(R)-spiro-2-[4chloro-5-ethylfuran-3(2H)-one]) Clocortolone Pivalate (200 mg) Clofazimine (200 mg) Clobrate (1 g) Clomiphene Citrate (500 mg)

N0E020 F2C309 F2C417

0.992 mg/mg (dr) 980 ug/mg (ai)

M (03/06) L-1 (01/03) F-1 (03/05) F (10/01) F-1 (12/05) F (01/03)

[130-26-7] [25122-46-7] n/f

1138507 1138904 1139000 1140000

G F1C392 I I0E164 0.995 mg/mg (an) (HPLC) 1.000 mg/mg (an) (UV) 100.00% F (03/07) H (04/01) H (05/06) G-1 (10/99)

[34097-16-0] [2030-63-9] [637-07-0] [50-41-9]

1140101

Clomiphene Related Compound A (100 mg) ((E,Z)-2-[4-(1,2-diphenylethenyl)phenoxy]-N,Ndiethylethanamine Hydrochloride) Clomipramine Hydrochloride (200 mg) Clonazepam CIV (200 mg)

F1B206

F (09/03)

n/f

1140247 1140305

F0C075 H0E003 0.999 mg/mg (ai) G1B175 (04/06) G (01/04) F-2 (01/00)

[17321-77-6] [1622-61-3]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

46 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1140327 Curr. Lot. G3F034 Purity Value/Conc. Change Code* 2 Previous Lot/Valid Use Date G2B110 (05/07) G-1 (01/04) G (02/99) G (04/01) CAS No. n/f

Description Clonazepam Related Compound A (25 mg) (3Amino-4-(2-chlorophenyl)-6-nitrocarbostyril) Clonazepam Related Compound B (25 mg) (2Amino-2-chloro-5-nitrobenzophenone) Clonazepam Related Compound C (25 mg) (2Bromo-2-(2-chlorobenzoyl)-4-nitroacetanilide) Clonidine (200 mg) Clonidine Hydrochloride (200 mg) Clonidine Related Compound A (25 mg) (Acetylclonidine) Clonidine Related Compound B (25 mg) (2-[(E)2,6-Dichlorophenylimino]-1-(1-{2-[(E)-2,6-dichlorophenylimino]-imidazolidin-1-yl}-ethyl)-imidazolidine) Clopidogrel Bisulfate (125 mg) Clopidogrel Related Compound A (20 mg) ((S)-(ochlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine5(4H)-acetic acid, hydrochloride) Clopidogrel Related Compound B (20 mg) (Methyl(+/-)-(o-chlorophenyl)-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-acetate, hydrochloride) Clopidogrel Related Compound C (20 mg) (methyl (-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2c]pyridine-5(4H)-acetate, hydrogen sulfate) Clorazepate Dipotassium CIV (125 mg) Clorsulon (200 mg) Clotrimazole (200 mg) Clotrimazole Related Compound A (25 mg) ((ochlorophenyl)diphenylmethanol) Cloxacillin Benzathine (200 mg) Cloxacillin Sodium (200 mg) Clozapine (100 mg) Cocaine Hydrochloride CII (250 mg) Cod Liver Oil (1 g) Codeine N-Oxide CI (50 mg) Codeine Phosphate CII (100 mg)

1140338 1140349 1140393 1140407 1140418 1140429

H F0C340 F0C401 H0D106 F0C373 F0C403 0.99 mg/mg (ai) 1.000 mg/mg (dr)

[2011-66-7] n/f [4205-90-7]

G (05/05)

[4205-91-8] [54707-71-0] n/f

1140430 1140586

F0E115 F0E117

0.995 mg/mg (ai) 1.18 mg/mg (bisulfate salt equivalent) (ai) 1.11 mg/mg (bisulfate salt equivalent) (ai) 0.99 mg/mg (ai)

[120202-66-6] [144750-42-5]

1140597

F0E119

[144750-52-7]

1140600

F0E118

[120202-71-3]

1140509 1140702 1141002 1141024

G0B027 F1B084 K0C282 I1D166 0.99 mg/mg (ai)

F-1 (06/03) F (12/99) F (01/04) J (02/05) I (05/99) I (11/05) H (10/01) G-1 (02/99) F (03/02) K (01/04) 1.000 mg/mg (dr) F0C032 (11/05) H-2 (01/04) H-1 (02/99) F-1 (11/02) I-1 (10/04) I (09/02) H-1 (01/00) H-1 (01/02) I (05/02) 0.420 mg/mg (dr) H (09/05) G (09/99)

[57109-90-7] [60200-06-8] [23593-75-1] [66774-02-5]

1141909 1142005 1142107 1143008 1145207 1143802 1144000

F-1 L0B086 G0D315 I0B074 F0D400 G0A034 J0C200

[23736-58-5] [7081-44-9] [5786-21-0] [53-21-4] [8001-69-2] [3688-65-1] [41444-62-6]

1145003 1146006 1146505 1147009 1148001 1148500 1148806 1149004 1150003 1150207

Codeine Sulfate CII (250 mg) Colchicine (300 mg) Colestipol Hydrochloride (200 mg) Colistimethate Sodium (200 mg) Colistin Sulfate (200 mg) Copovidone (100 mg) Corn Oil (1 g) (AS) Corticotropin (5.6 Units/vial; 5 vials) Cortisone Acetate (150 mg) Cottonseed Oil (1 g) (AS)

H-2 J F-1 H1D234 G-1 F0C194 F0D181 M I F0D173

[6854-40-6] [64-86-8] [37296-80-3] [8068-28-8] [1264-72-8] [2586-89-9] [8001-30-7]

L (06/99)

[9002-60-2] [50-04-4] [8001-29-4]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

47

USP Reference Standards and Authentic Substances

Cat. No. 1150353 1150502 1150513 Curr. Lot. F J1E187 F0E045 1.000 mg/mg (an) J (11/06) I (06/00) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. [60-27-5] [15826-37-6] [16150-44-0]

Description Creatinine (100 mg) Cromolyn Sodium (500 mg) Cromolyn Sodium Related Compound A (25 mg) (1,3-Bis-(2-acetyl-3-hydroxyphenoxy)-2-propanol) (AS) Crospovidone (200 mg) Crotamiton (200 mg) Cyanocobalamin (1.5 g of mixture with mannitol; 10.7 mcg/mg of mixture) (Vitamin B12) Cyclacillin (200 mg) Cyclandelate (200 mg) Cyclizine Hydrochloride (200 mg) Cyclobenzaprine Hydrochloride (200 mg) Alpha Cyclodextrin (50 mg) Beta Cyclodextrin (250 mg) Cyclomethicone 4 (200 mg) Cyclomethicone 5 (200 mg) Cyclomethicone 6 (200 mg) Cyclopentolate Hydrochloride (300 mg) Cyclophosphamide (500 mg) (FOR U.S. SALE ONLY) 2-Cyclopropylmethylamino-5-chlorobenzophenone (50 mg) Cycloserine (200 mg) Cyclosporine (50 mg) Cyclosporine Resolution Mixture (25 mg) Cyclothiazide (200 mg) Cyproheptadine Hydrochloride (500 mg) L-Cysteine Hydrochloride (200 mg) Cytarabine (250 mg) Cytosine (100 mg) Dacarbazine (125 mg) Dacarbazine Related Compound A (50 mg) (5aminoimidazole-4-carboxamide Hydrochloride) Dacarbazine Related Compound B (50 mg) (2azahypoxanthine) Dactinomycin (50 mg) Danazol (200 mg) Dapsone (125 mg) Daunorubicin Hydrochloride (200 mg) Decamethonium Bromide (250 mg) Deferoxamine Mesylate (500 mg) Dehydroacetic Acid (200 mg)

1150706 1151006 1152009 1152508 1152701 1154004 1154503 1154558 1154569 1154707 1154809 1154900 1156000 1157002 1157501 1158005 1158504 1158650 1159008 1161000 1161509 1162002 1162148 1162308 1162320 1162330 1162400 1162501 1164008 1164700 1165000 1166003 1166309

G2E126 H-1 N G F0C384 H0D321 G0A013 F-1 G F-2 G0D052 F2B024 I0C424 J1B200 F G H-1 F1F134 F-1 G H G-2 F0E284 H H0C052 G0C325 I H H0D260 L0B307 F I F 0.998 mg/mg (dr) 1.00 mg/mg (dr) 0.999 mg/mg (dr) 1.000 mg/mg (dr)

G1C273 (06/07) G (12/04) H (07/00) M-3 (08/99)

[9003-39-8] [483-63-6] [68-19-9] [3485-14-1] [456-59-7]

G (10/05) F-3 (07/03) F (10/00) F-1 (12/02) F-1 (06/02) F-2 (07/05) F-1 (09/99) F-1 (03/03) H (03/05) G (04/00) J (02/05)

[303-25-3] [6202-23-9] [10016-20-3] [7585-39-9] [69430-24-6] [69430-24-6] [69430-24-6] [5870-29-1] [6055-19-2] n/f [68-41-7]

H (11/02) G-2 (03/00) 2 F (05/07)

[59865-13-3] [108027-45-8] (U) [2259-96-3] [41354-29-4] [7048-04-6] [147-94-4] [71-30-7] [4342-03-4] [72-40-2] [63907-29-9] [50-76-0]

F-4 (11/02) G (05/00) G-1 (07/00) G (01/99) G (03/04) F (03/00) F-1 (03/05) F (12/01) G (10/00) G-3 (02/06) G-2 (08/99) K (11/03) J (08/00)

[17230-88-5] [80-08-0] [23541-50-6] [541-22-0] [138-14-7] [520-45-6]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

48 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1166400 1166502 1169001 1170000 1046089 1171003 1171251 1171706 1171900 1171910 1172006 1173009 1173235 1173246 Curr. Lot. F F-1 F H1C036 F0E068 I1F025 F0E006 J0C143 F0C187 F0C031 I0E283 H-1 G0C390 F0B279 F0B282 (11/04) 1.000 mg/mg (dr) H-1 (11/06) H (10/99) 1.00 mg/mg (ai) I (07/05) H (08/00) 0.92 mg/mg (ai) 1.000 mg/mg (dr) I0B129 (03/07) H (09/02) H (08/04)G-1 (08/01) F (03/04) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. n/f [81-23-2] [56-94-0] [64-73-3] n/f [86398-53-0] [154-17-6] [23515-45-9] [57041-67-5] n/f [58-28-6] [17598-65-1] [54024-22-5] n/f

Description Dehydrocarteolol Hydrochloride (100 mg) Dehydrocholic Acid (200 mg) Demecarium Bromide (250 mg) Demeclocycline Hydrochloride (200 mg) N-Demethylazithromycin (15 mg) Denatonium Benzoate (200 mg) 2-Deoxy-D-Glucose (100 mg) (AS) Desacetyl Diltiazem Hydrochloride (50 mg) Desurane (0.5 mL) Desurane Related Compound A (0.1 mL) (bis(1,2,2,2-tetrauoroethyl) ether) Desipramine Hydrochloride (125 mg) Deslanoside (100 mg) Desogestrel (50 mg) Desogestrel Related Compound A (15 mg) (13Ethyl-11-methylene-18, 19-dinor-5alpha, 17alphapreg-3-en-20-yl-17-ol, desogestrel delta-3 isomer) Desogestrel Related Compound B (15 mg) (3Hydroxy-desogestrel) Desogestrel Related Compound C (25 mg) (3Keto-desogestrel) Desosaminylazithromycin (15 mg) Desoximetasone (200 mg) Desoxycorticosterone Acetate (200 mg) Desoxycorticosterone Pivalate (125 mg) Dexamethasone (125 mg) Dexamethasone Acetate (200 mg) Dexamethasone Phosphate (200 mg)

1173257 1173268 1046078 1173508 1174001 1175004 1176007 1176506 1177000

G0F144 F0B281 F0E067 H0B036 J0C014 H0C276 J H0E339 K0E275

0.96 mg/mg (ai)

F0B284 (03/07)

n/f [54048-10-1]

0.99 mg/mg (ai) G (01/04) I (01/04) H (05/00) G (01/04) 0.996 mg/mg (dr) 0.996 mg/mg (dr) G (12/06) F-1 (06/99) J1B070 (01/07) J (08/03) I (03/00) I (03/03) 0.999 mg/mg (ai) G1A025 (11/05) G (12/02) I (08/04) H (02/02)

n/f [382-67-2] [56-47-3] [808-48-0] [50-02-2] [1177-87-3] [312-93-6]

1178002 1179005 1179504 1179628 1179708 1179741 1179854 1179865 1179876 1179720 1179887 1179763 1179898 1179650

Dexbrompheniramine Maleate (200 mg) Dexchlorpheniramine Maleate (300 mg) Dexpanthenol (500 mg) Dextran 1 (50 mg) Dextran 40 (50 mg) Dextran 70 (50 mg) Dextran 4 Calibration (100 mg) Dextran 10 Calibration (100 mg) Dextran 40 Calibration (100 mg) Dextran 40 System Suitability (200 mg) Dextran 70 Calibration (100 mg) Dextran 70 System Suitability (200 mg) Dextran 250 Calibration (100 mg) Dextran T-10 (200 mg)

J H0D199 J0C293 F0D297 F0C247 F0C260 F0C002 F0C010 F0C011 F0B181 F0C013 F0B182 F0C039 F0D238 1.000 mg/mg (dr)

[2391-03-9] [2438-32-6] [81-13-0] [9004-54-0] [9004-54-0] [9004-54-0] [9004-54-0] [9004-54-0] [9004-54-0] [9004-54-0] [9004-54-0] [9004-54-0] [9004-54-0] [9004-54-0]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

49

USP Reference Standards and Authentic Substances

Cat. No. 1179800 1180004 Curr. Lot. F0B242 I0C311 1.000 mg/mg (dr) H (05/05) G (08/03) F-6 (12/99) G (06/00) I (07/03) 0.999 mg/mg (dr) J-1 (04/07) J (11/02) I (08/99) G (01/02) I-1 (10/99) G (04/06) H (02/00) 0.999 mg/mg (ai) I (02/06) H (12/01) H-1 (11/02) H (04/00) I (12/04) H (04/01) G (12/03) H-2 (01/03) 99.2% (ai) 0.99 mg/mg (ai) 2 G-1 (05/07) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. [9004-54-0] [51-63-8]

Description Dextran Vo Marker (100 mg) Dextroamphetamine Sulfate CII (500 mg)

1180503 1181007 1181302

Dextromethorphan (2 g) Dextromethorphan Hydrobromide (500 mg) Dextrose (500 mg)

H J0B167 J2E294

[125-71-3] [6700-34-1] [50-99-7]

1181506 1182000 1183002 1184005 1184027 1185008 1185020 1023403 1186000 1187003 1187080 1187091 1187207 1187954 1188006 1188301 1188800 1188811 1189009 1190008 1191000 1192003 1192808 1193006 1193301 1193505 1194009 1195001 1197007 1197302 1197506 1198000

Diacetylated Monoglycerides (200 mg) Diacetyluorescein (200 mg) Diacetylmorphine Hydrochloride CI (25 mg) (AS) (Heroin Hydrochloride) Diatrizoic Acid (100 mg) Diatrizoic Acid Related Compound A (50 mg) (5Acetamido-3-amino-2,4,6-triiodobenzoic Acid) Diazepam CIV (100 mg) Diazepam Related Compound A (25 mg) (2Methyl-amino-5-chlorobenzophenone) Diazepam Related Compound B (25 mg) (3Amino-6-chloro-1-methyl-4-phenylcarbostyril) Diazoxide (200 mg) Dibucaine Hydrochloride (200 mg) Dibutyl Phthalate (200 mg) Dibutyl Sebacate (1 mL) (AS) Dichloralphenazone CIV (200 mg) 2,4-Dichlorophenol (100 mg) Dichlorphenamide (200 mg) Dichlorvos (150 mg) (2,2-dichlorovinyl dimethyl phosphate) (AS) Diclofenac Sodium (200 mg) Diclofenac Related Compound A (50 mg) (N-(2,6dichlorophenyl)indolin-2-one) Dicloxacillin Sodium (500 mg) Dicumarol (200 mg) Dicyclomine Hydrochloride (125 mg) Dienestrol (125 mg) Diethanolamine (3 mL) Diethylcarbamazine Citrate (200 mg) Diethylene Glycol Monoethyl Ether (0.5 mL/ampule) Diethyl Phthalate (200 mg) Diethylpropion Hydrochloride CIV (200 mg) Diethylstilbestrol (200 mg) Diethyltoluamide (3 g) Diorasone Diacetate (200 mg) Diunisal (200 mg) Digitalis (3 g)

G H J H0E084 I I1C364 I I1C102 G1C017 I F0D125 F0D128 F0B010 F0E113 G2C046 F0D141 H0B150 I0D337 J0C182 G H I F0D118 G-1 G0C159 G H K5B291 H1D076 G G F 0.981 mg/mg (an) K-4 (05/04) H (11/06) F-1 (03/00) F0B095 (09/06) F-1 (03/00) G (03/99) 1.00 mg/mg (ai) G-1 (03/04) G (05/01) H (06/06) G (05/02) I0B142 (09/04) H (05/03)

[68990-54-5] [596-09-8] [1502-95-0] [50978-11-5] [1713-07-1] [439-14-5] [1022-13-5] [5220-02-0] [364-98-7] [61-12-1] [84-74-2] [109-43-3] [480-30-8] [120-83-2] [120-97-8] [62-73-7] [15307-79-6] [15362-40-0] [13412-64-1] [66-76-2] [67-92-5] [84-17-3] [111-42-2] [1642-54-2] [111-90-0] [84-66-2] [134-80-5] [56-53-1] [134-62-3] [33564-31-7] [22494-42-4] [8031-42-3]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

50 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1199002 1200000 1200600 1200804 1201002 1202005 1203008 1204000 1204102 1204805 1205003 1206006 1208001 1210105 1211006 Curr. Lot. M O0B096 G0C071 I0D205 I0C277 J0B085 J J0D250 F F0C026 I J0B055 G F H0D273 0.999 mg/mg (ai) G0C198 (10/06) F-3 (07/04) F-2 (05/02) I (06/03) 0.996 mg/mg (ai) I (06/05) 0.997 mg/mg (dr) N-1 (04/03) F-1 (12/03) F (01/00) H (09/05) G (03/01) H (07/04) I (03/03) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. [71-63-6] [20830-75-5] [19408-84-5] [5965-13-9] [6639-99-2] [6190-39-2] [5490-27-7] [67-96-9] [96-26-4] [3736-81-0] [33286-22-5] [523-87-5] [2773-92-4] [41992-23-8] [67-68-5]

Description Digitoxin (200 mg) Digoxin (250 mg) Dihydrocapsaicin (25 mg) Dihydrocodeine Bitartrate CII (200 mg) 17alpha-Dihydroequilin (50 mg) Dihydroergotamine Mesylate (250 mg) (List Chemical) Dihydrostreptomycin Sulfate (200 mg) Dihydrotachysterol (30 mg/ampule; 4 ampules) Dihydroxyacetone (250 mg) Diloxanide Furoate (200 mg) Diltiazem Hydrochloride (200 mg) Dimenhydrinate (100 mg) Dimethisoquin Hydrochloride (2 g) N-(3-Dimethylamino-propyl)-2-aza-8,8-diethyl-8germaspiro [4:5]decane-1,3-dione (AS) Dimethyl Sulfoxide (3 g)

1213001 1213103 1214004 1217909 1218005 1219008 1220302 1220506 1220700 1221000 1222002 1222501 1223005 1224008 1224507 1224700 1224802 1224904 1224959 1224960

Dinoprost Tromethamine (50 mg) Dinoprostone (50 mg) Dioxybenzone (150 mg) Diphenhydramine Citrate (125 mg) Diphenhydramine Hydrochloride (200 mg) Diphenoxylate Hydrochloride CII (200 mg) Dipivefrin Hydrochloride (200 mg) Dipyridamole (200 mg) Dirithromycin (200 mg) Disodium Guanylate (300 mg) (FCC) Disodium Inosinate (500 mg) (FCC) Disopyramide Phosphate (200 mg) 2,4-Disulfamyl-5-triuoromethylaniline (125 mg) Disulram (200 mg) Dobutamine Hydrochloride (600 mg) Docusate Calcium (500 mg) Docusate Sodium (500 mg) Docusate Potassium (100 mg) Dolasetron Mesylate (200 mg) Dolasetron Mesylate Related Compound A (25 mg) (Hexahydro-8-hydroxy-2,6-methano-2Hquinolizin-3(4H)-one hydrochloride) Dopamine Hydrochloride (200 mg) Dorzolamide Hydrochloride (200 mg)

F F0C030 F1B277 H1C350 J0B013 I1D339 I H1F120 F F-1 F H-1 G F-3 H-1 H0B044 K0D134 F-1 F0C319 F0C321 0.988mg/mg (an) F-2 (07/02) H (01/00) G-1 (07/02) J (09/05) I-1 (05/02) F (11/99) H (03/02) 0.998 mg/mg (dr) 2 0.998 mg/mg (dr) 1.000 mg/mg (dr) F (10/03) H0B128 (08/06) G (04/03) I (07/03) I (08/06) H (03/02) H (06/99) H (06/07) G-1 (01/99)

[38562-01-5] [363-24-6] [131-53-3] [88637-37-0] [147-24-0] [3810-80-8] [64019-93-8] [58-32-2] [62013-04-1] [5550-12-9] [4691-65-0] [22059-60-5] [654-62-6] [97-77-8] [49745-95-1] [128-49-4] [577-11-7] [7491-09-0] [115956-13-3] n/f

1225204 1225281

G G0E278 0.998 mg/mg (ai)

F-5 (05/02) F0C040 (11/06)

[62-31-7] [130693-82-2]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

51

USP Reference Standards and Authentic Substances

Cat. No. 1225292 Curr. Lot. G0E029 Purity Value/Conc. Change Code* Previous Lot/Valid Use Date F0C068 (12/05) CAS No. n/f

Description Dorzolamide Hydrochloride Related Compound A (20 mg) ((4R,6R)-4-(ethylamino)-5,6-dihydro-6methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide7,7-dioxide, monohydrochloride) Doxapram Hydrochloride (200 mg) Doxazosin Mesylate (200 mg) Doxepin Hydrochloride (500 mg) Doxorubicin Hydrochloride (50 mg) Doxycycline Hyclate (200 mg)

1225000 1225419 1225500 1225703 1226003

F4C053 G0E173 I K J0E174 859 ug/mg (ai) (chromatographic) 864 ug/mg (ai) (spectroscopic) 0.997 mg/mg (ai)

F-3 (07/04) F0C079 (08/06) J (06/02) I (09/06) H (01/00)

[7081-53-0] [77883-43-3] [1229-29-4] [25316-40-9] [24390-14-5]

1227006 1229001 1230000 1231003 1231502 1231728 1231706 1231808 1232006 1233009 1233508 1234001 1234704 1234668 1234680 1234806 1235004 1235274

Doxylamine Succinate (300 mg) Droperidol (250 mg) Dyclonine Hydrochloride (200 mg) Dydrogesterone (200 mg) Dyphylline (200 mg) Powdered Echinacea Purpurea Extract (1 g) Powdered Echinacea Angustifolia Extract (1 g) Econazole Nitrate (200 mg) Edetate Calcium Disodium (200 mg) Edetate Disodium (200 mg) Edetic Acid (200 mg) Edrophonium Chloride (200 mg) Powdered Eleuthero Extract (1.5 g) Eleutheroside B (15 mg) (Syringin) Eleutheroside E (15 mg) (Syringaresinol diglucoside) Emedastine Difumarate (100 mg) Emetine Hydrochloride (300 mg) Enalaprilat (300 mg)

I0B266 I0C029 G I0B114 G-2 F0D018 F0D019 G1C346 H0B272 I0D405 F-1 H F0C291 F0E056 F0E057 F0C059 H0B201 J0C268 95% (ai) 98% (ai) 1.00 mg/mg (ai)

H (01/04) H-1 (01/05) H (04/99) H (01/04) G-1 (11/02)

[562-10-7] [548-73-2] [536-43-6] [152-62-5] [479-18-5] [90028-20-9] [84696-11-7]

G (07/05) G-3 (11/04) G-2 (11/99) H (06/06) G-2 (04/02) G (08/99)

[68797-31-9] [23411-34-9] [6381-92-6] [60-00-4] [116-38-1] [84696-12-5] [118-34-3] [96038-87-8] [87233-62-3]

G (05/03) I (11/04) H (03/01) G (08/99) 0.992 mg/mg (ai) J (05/05) I (06/01) G2B274 (06/06) G-1 (12/03) G (06/99) G (02/01) H-1 (11/02) I-1 (12/03) I (06/00) 1.00 mg/mg (dr) 0.998 mg/mg (ai) 2 G (08/06) F-1 (06/00) O (05/07) F (12/06) I (11/04) H-1 (05/00)

[316-42-7] [84680-54-6]

1235300 1235503

Enalapril Maleate (200 mg) Endotoxin (10,000 USP Endotoxin Units)

J1C267 G3E069

[76095-16-4] n/f

1235809 1235900 1236007 1236506 1236801 1237000 1237509 1238002

Enurane (1 mL) Enrooxacin (200 mg) (AS) Ephedrine Sulfate (200 mg) (List Chemical) 4-Epianhydrotetracycline Hydrochloride (50 mg) Epilactose (200 mg) Epinephrine Bitartrate (200 mg) Epitetracycline Hydrochloride (200 mg) (AS) Equilin (25 mg)

G-1 F0E094 H-2 J0C041 H0E049 P0E320 G0E261 I1B290

[13838-16-9] [93106-60-6] [134-72-5] [4465-65-0] [50468-56-9] [51-42-3] [23313-80-6] [474-86-2]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

52 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1239005 1239504 1240004 1241007 1241506 1241550 1241903 1242000 Curr. Lot. P0B275 I N H I0B174 G0B177 F0E313 M1E251 96.7% Erythromycin A 978 ug/mg (ai) (microbial) M (02/07) L (08/99) G (11/04) F-1 (09/01) F (05/01) F-2 (01/03) F-1 (02/02) F (02/99) F-1 (06/04) F (09/99) G (01/03) G-1 (06/01) G (07/03) H (01/02) G-1 (05/03) 0.999 mg/mg (an) 0.999 mg/mg (an) L0C337 (03/07) K1B007 (07/05) K (04/03) G-1 (01/06) G (02/00) 0.996 mg/mg (ai) L (04/06) K (05/02) I-1 (06/01) K (07/03) J-1 (07/00) I (12/03) H (09/01) G (08/02) P1B193 (11/04) P0B052 (01/04) P (03/03) O (08/99) 0.99 mg/mg (ai) F0B252 (04/07) G (03/03) H (01/04) F-1 (06/04) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date O (02/04) N (12/99) H-1 (01/00) M-1 (07/02) CAS No. [50-14-6] [8067-24-1] [129-51-1] [57-87-4] [379-79-3] [639-81-6] [149-32-6] [114-07-8]

Description Ergocalciferol (30 mg/ampule; 5 ampules) (Vitamin D2) Ergoloid Mesylates (300 mg) Ergonovine Maleate (100 mg) (List Chemical) Ergosterol (50 mg) Ergotamine Tartrate (150 mg) (List Chemical) Ergotaminine (100 mg) (List Chemical) Erythritol (200 mg) Erythromycin (250 mg)

1242010

Erythromycin B (150 mg)

G1C080

[527-75-3]

1242021

Erythromycin C (50 mg)

F-3

n/f

1242032 1243002 1245008 1246000 1247003 1248006 1249009 1249202 1250008

Erythromycin Related Compound N (50 mg) (NDemethylerythromycin A) Erythromycin Estolate (200 mg) Erythromycin Ethylsuccinate (200 mg) Erythromycin Gluceptate (200 mg) Erythromycin Lactobionate (200 mg) Erythromycin Stearate (200 mg) Erythrosine Sodium (100 mg) Escin (350 mg) Estradiol (500 mg)

F2A023 H H H H-1 H0B187 F F0F088 M0E309

n/f [3521-62-8] [1264-62-6] [23067-13-2] [3847-29-8] [643-22-1] [49746-10-3] [11072-93-8] [50-28-2]

1251000 1252003 1254009 1254508 1255001 1255500 1256004 1257007 1258305 1260001

Estradiol Benzoate (250 mg) (AS) Estradiol Cypionate (200 mg) Estradiol Valerate (100 mg) Estriol (100 mg) Estrone (200 mg) Estropipate (500 mg) Ethacrynic Acid (200 mg) Ethambutol Hydrochloride (200 mg) Ethchlorvynol CIV (0.7 ml) Ethinyl Estradiol (150 mg)

H0C332 G-1 L1D286 J K1B099 J0B262 F H F0B011 Q0C162

[50-50-0] [313-06-4] [979-32-8] [50-27-1] [53-16-7] [7280-37-7] [58-54-8] [1070-11-7] [113-18-8] [57-63-6]

1260012 1261004 1262801 1262823 1263000

Ethinyl Estradiol Related Compound A (20 mg) (6Keto-ethinyl estradiol) Ethionamide (200 mg) Ethopabate (125 mg) Ethopabate Related Compound A (25 mg) (Methyl4-acetamido-2-hydroxybenzoate) Ethopropazine Hydrochloride (300 mg)

G0E301 H0B148 F F G

n/f [536-33-4] [59-06-3] n/f [1094-08-2]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

53

USP Reference Standards and Authentic Substances

Cat. No. 1264002 1264501 1265005 1265504 1266008 1266507 1267000 1267500 1268003 1268502 1268513 1268604 1268706 1268728 Curr. Lot. H F F H-1 H F I1F039 F2B134 I0A033 G F0E227 G G F-1 1.00 mg/mg (an) F-1 (05/99) F (10/01) F (05/02) 2 I0A016 (05/07) H (01/04) F-1 (04/04) H-1 (01/03) H (04/01) F-2 (02/03) H (06/99) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date G-2 (11/01) G-1 (05/99) CAS No. [77-67-8] [86-35-1] [452-35-7] [9004-57-3] [4940-11-8] [3198-07-0] [120-47-8] [121-32-4] [297-76-7] [7414-83-7] [13517-23-2] [2809-21-4] [41340-25-4] [109518-50-5]

Description Ethosuximide (125 mg) Ethotoin (200 mg) Ethoxzolamide (200 mg) Ethylcellulose (1 g) Ethyl Maltol (1 g) (FCC) Ethylnorepinephrine Hydrochloride (200 mg) Ethylparaben (200 mg) Ethyl Vanillin (200 mg) Ethynodiol Diacetate (200 mg) Etidronate Disodium (200 mg) Etidronate Disodium Related Compound A (300 mg) (Sodium phosphite dibasic pentahydrate) Etidronic Acid Monohydrate (1 g) Etodolac (400 mg) Etodolac Related Compound A (25 mg) ((+/-)-8ethyl-1-methyl-1,3,4,9-tetrahydropyrano [3,4-b]-indole-1-acetic acid) Etoposide (300 mg) Etoposide Resolution Mixture (30 mg) Eugenol (500 mg) (AS) Famotidine (125 mg)

1268808 1268852 1268965 1269200

H0C315 F0B209 F0D303 I0E063 0.997 mg/mg (dr)

G (11/04)

[33419-42-0] [33419-42-0] [97-53-0]

H-1 (06/06) H (11/02) G (03/99) F-1 (04/05) F (09/02)

[76824-35-6]

1269389 1269390

Felodipine (200 mg) Felodipine Related Compound A (100 mg) (ethyl methyl 4-(2,3-dichlorophenyl)-2,6-dimethylpyridine3,5-dicarboxylate) Fenbendazole (100 mg) Fenbendazole Related Compound A (30 mg) (Methyl (1H-benzimidazole-2-yl)carbamate) Fenbendazole Related Compound B (30 mg) (Methyl [5(6)-chlorobenzimidazole-2-yl]carbamate) Fenoldopam Mesylate (200 mg) Fenoldopam Related Compound A (20 mg) (NMethyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol hydrochloride) Fenoldopam Related Compound B (20 mg) (1H-3Benzazapine-7,8-diol, 2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-, methanesulfonate) Fenoprofen Calcium (500 mg) Fenoprofen Sodium (500 mg) Ferrous Sulfate (1.5 g) (AS) Fentanyl Citrate CII (100 mg)

G0D065 F0B207

0.999 mg/mg (ai)

[72509-76-3] [96302-71-7]

1269403 1269414 1269425 1269458 1269469

F F0D009 F0D008 F0C125 F0C124 0.99 mg/mg (ai) 0.99 mg/mg (ai)

[43210-67-9] [10605-21-7] n/f [67227-57-0] n/f

1269470

F0C126

n/f

1269505 1269550 1270355 1270005

G-1 G F0D196 K0C264 101.0% (ai) J2B227 (11/04) J-1 (09/03) J (05/02) I (06/00) 0.996 mg/mg (ai) F0D244 (02/07) F-1 (05/02)

[53746-45-5] [66424-46-2] [7782-63-0] [990-73-8]

1270377

Fexofenadine Hydrochloride (200 mg)

F1E289

[138452-21-8]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

54 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1270388 Curr. Lot. F0D245 Purity Value/Conc. 0.99 mg/mg (ai) Change Code* Previous Lot/Valid Use Date CAS No. n/f

Description Fexofenadine Related Compound A (25 mg) (4-[1oxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-alpha,alpha-dimethyl benzeneacetic acid) Fexofenadine Related Compound B (25 mg) (3-[1hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-alpha,alpha-dimethyl benzeneacetic acid hydrochloride) Fexofenadine Related Compound C (15 mg) ((+)4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-isopropylbenzene) (AS) Finasteride (200 mg) Flecainide Acetate (200 mg) Flecainide Related Compound A (75 mg) (3-[2,5bis(2,2,2-triuoroethoxy)phenyl]-1,5,6,7,8,8a-hexahydroimidazo-[1,5a]pyridine Hydrochloride) Floxuridine (250 mg) Fluconazole (200 mg) Fluconazole Related Compound A (10 mg) (2-[2uoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H1,2,4-triazol-1-yl)-propan-2-ol) Fluconazole Related Compound B (10 mg) (2-(4uorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-propan2-ol) Fluconazole Related Compound C (10 mg) (1,1(1,3-phenylene)di(1H-1,2,4-triazole)) Flucytosine (200 mg) Fludarabine Phosphate (300 mg) Fludeoxyglucose (100 mg) Fludeoxyglucose Related Compound A (15 mg) (4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane) Fludrocortisone Acetate (250 mg) Flumazenil (200 mg) Flumazenil Related Compound A (20 mg) (8uoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazol[1,5-alpha][1,4]benzodiazepine-3-carboxylic acid) Flumazenil Related Compound B (20 mg) (Ethyl 8hydroxy-5,6-dihydro-5-methyl-6-oxo-4H-imidazol[1,5-alpha][1,4]benzodiazepine-3-carboxylate) Flumethasone Pivalate (200 mg) Flunisolide (200 mg) Flunixin Meglumine (300 mg)

1270399

F0D246

n/f

1270446

F0E291

n/f

1270402 1270800 1270821

F1E139 F2A022 F

0.997 mg/mg (ai)

F (07/06) F-1 (02/05) F (06/03)

[98319-26-7] [54143-56-5] n/f

1271008 1271700 1271711

F-2 G0F102 F0D080 1.00 mg/mg (ai) 0.95 mg/mg (ai) 2

F-1 (08/01) F0D262 (06/07)

[50-91-9] [86386-73-4] n/f

1271722

F0D081

0.92 mg/mg (ai)

[81886-51-3]

1271733 1272000 1272204 1272907 1272918

F0D082 G0E151 G0E247 F0E100 F0D119

0.98 mg/mg (ai) 1.000 mg/mg (dr) 0.993 mg/mg (an) 1.00 mg/mg (ai) 2 F (06/05) F0C374 (04/07)

n/f [2022-85-7] [75607-67-9] [29702-43-0] [23978-09-8]

1273003 1273808 1273819

H F0C305 F0E147

G (08/01)

[514-36-3] [78755-81-4] n/f

1273820

F0E148

n/f

1274006 1274505 1274607

I I H0E241 1.000 mg/mg (dr)

H (01/02) H (01/01) G (11/06) F-1 (04/02) F (09/99) J (03/06) I (11/99) F-1 (02/03) I (08/04) H (04/99) F (06/05)

[2002-29-1] [77326-96-6] [42461-84-7]

1275009 1276001 1277004 1277252 1277274

Fluocinolone Acetonide (100 mg) Fluocinonide (100 mg) Fluorescein (200 mg) Fluoride Dentifrice: Sodium Fluoride/Silica (4.5 oz) Fluoride Dentifrice: Sodium Fluoride/Sodium Bicarbonate Powder (4 oz)

J1E014 I G0B171 J0C294 G0D270

0.993 mg/mg (dr)

[67-73-2] [356-12-7] [2321-07-5] n/f n/f

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

55

USP Reference Standards and Authentic Substances

Cat. No. 1277300 1277354 1277401 1277423 1277456 1278007 1278109 1278302 1279000 1279804 Curr. Lot. G G G-1 F-1 H0B105 J0F140 F H0C140 H2D190 G0F085 1.000 mg/mg (dr) 0.999 mg/mg (ai) 2 G (01/05) F-1 (12/99) H-1 (09/05) H (01/02) F2C132 (06/07) F-1 (02/05) F (11/99) G (06/04) F-1 (05/01) F (06/00) approx. 2 mg/mL (ai) F3C085 (05/05) F-2 (06/04) F-1 (09/02) F (09/00) 0.996 mg/mg (ai) 2 G (08/99) F (07/99) G (11/02) I0B184 (06/07) H-1 (11/02) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. n/f n/f n/f n/f n/f [426-13-1] [3801-06-7] [86393-33-1] [51-21-8] [59333-67-4]

Description Fluoride Dentifrice: Sodium MonouorophosphateCalcium Carbonate (4.6 oz) Fluoride Dentifrice: Sodium Monouorophosphate/ Dicalcium Phosphate (4.6 oz) Fluoride Dentifrice: Sodium Monouorophosphate (1000 ppm)/Silica (5.25 oz) Fluoride Dentifrice: Sodium Monouorophosphate (1500 ppm)/Silica (5.25 oz) Fluoride Dentifrice: Stannous Fluoride-Silica (4 oz) Fluorometholone (200 mg) Fluorometholone Acetate (200 mg) Fluoroquinolonic Acid (50 mg) Fluorouracil (250 mg) Fluoxetine Hydrochloride (200 mg)

1279815

Fluoxetine Related Compound A (15 mg) (Nmethyl-3-phenyl-3-[(alpha,alpha,alpha-(triuoro-mtolyl)oxy]propylamine Hydrochloride) Fluoxetine Related Compound B (5 mL of a 0.01N HCl solution, approx. 2 mg/mL) (N-methyl-3-phenylpropylamine) Fluoxetine Related Compound C (15 mg) (NMethyl-N-[3-phenyl-3-(4-triuoromethyl-phenoxy)propyl]-succinamic acid) Fluoxymesterone CIII (200 mg) Fluphenazine Decanoate Dihydrochloride (500 mg) Fluphenazine Enanthate Dihydrochloride (125 mg) Fluphenazine Hydrochloride (125 mg) Flurandrenolide (100 mg) Flurazepam Hydrochloride CIV (200 mg) Flurazepam Related Compound C (50 mg) (5chloro-2-(2-diethylaminoethylamino)-2-uorobenzophenone Hydrochloride) Flurazepam Related Compound F (50 mg) (7chloro-5-(2-uorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one) Flurbiprofen (200 mg) Flurbiprofen Related Compound A (100 mg) (2-(4Biphenylyl)propionic Acid) Flurbiprofen Sodium (200 mg) Flutamide (200 mg) o-Flutamide (50 mg) Fluticasone Propionate (100 mg) Fluticasone Propionate Resolution Mixture (25 mg)

H0C131

n/f

1279826

G0D023

[23580-89-4]

1279837

F0C352

n/f

1280009 1280803 1281001 1282004 1284000 1285002 1285308

G-2 G H H I0B245 J0C365 I0D361 0.996 mg/mg (ai) 1.00 mg/mg (ai)

G-1 (04/00) F-1 (10/01) G (02/99) H (09/03) I (09/03) H-1 (40/06)

[76-43-7] n/f [3105-68-8] [146-56-5] [1524-88-5] [1172-18-5] n/f

1285603

I0C092

H (01/04)

[2886-65-9]

1285750 1285760 1285807 1285851 1285862 1285873 1285884

H0D349 H F H0B278 F-1 F0F036 F0E123

0.994 mg/mg (ai)

G (01/06) G (03/01)

[5104-49-4] n/f [56767-76-1]

G (11/04) F-1 (06/00) F (01/00) 0.989 mg/mg (ai)

[13311-84-7] n/f [80474-14-2] n/f

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

56 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1285895 Curr. Lot. F0E122 Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. n/f

Description Fluticasone Propionate System Suitability Mixture (25 mg) (Fluticasone Propionate and Fluticasone Propionate Related Compounds B, C and D) Fluvastatin Sodium (350 mg) Fluvastatin Related Compound B (15 mg) ([R*,S*E]-(+/-)-7-[3-(4-uorophenyl)-1-methylethyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid 1,1, dimethylethyl ester) Fluvastatin for System Suitability (25 mg) (Fluvastatin sodium and uvastatin sodium anti-isomer ([R*,R*-E]-(+/-)-7-[3-(4-Fluorophenyl)-1-(methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt)) Fluvoxamine Maleate (200 mg) Folic Acid (500 mg) (Vitamin M or Vitamin Bc) Folic Acid Related Compound A (50 mg) (Calcium Formyltetrahydrofolate) Formononetin (50 mg) 10-Formylfolic Acid (25 mg) Fosphenytoin Sodium (250 mg) Fructose (125 mg)

1285931 1285964

F0F015 F0F017

0.997 mg/mg (ai)

[93957-55-2] [129332-29-2]

1285942

F0F016

n/f

1285909 1286005 1286027 1286060 1286300 1286366 1286504

F0E016 P I0B176 F0C196 F2B226 G0E124 I3E340

0.996 mg/mg (dr) O (07/00) H-1 (04/04) H (01/00) F-1 (01/04) 0.999 mg/mg (an) 0.999 mg/mg (ai) F0C156 (07/06) I-2 (04/07) I-1 (11/02) I (08/99) G-1 (03/07) G (04/02) G-1 (01/01) J (10/03) I (08/02) 0.99 mg/mg (ai) 0.999 mg/mg (ai) 1.00mg/mg (ai) 0.99 mg/mg (ai) H (08/04) G-3 (03/01) F (03/06) F1D263 (07/06) F (10/05)

[61718-82-9] [59-30-3] [1492-18-8] [485-72-3] [134-05-4] [92134-98-0] [57-48-7]

1286606 1286708 1286800 1287008 1287020 1287030 1287303 1287325 1287369 1287507 1287518

L-Fucose (200 mg) (AS) Fumaric Acid (200 mg) Furazolidone (200 mg) Furosemide (125 mg) Furosemide Related Compound A (50 mg) (2Chloro-4-N-furfurylamino-5-sulfamoylbenzoic Acid) Furosemide Related Compound B (100 mg) (4Chloro-5-sulfamoylanthranilic Acid) Gabapentin (250 mg) Gabapentin Related Compound A (50 mg) (3,3pentamethylene-5-butyrolactam) Gabapentin Related Compound E (25 mg) (Carboxymethyl-cyclohexanecarboxylic acid) Gadodiamide (500 mg) Gadodiamide Related Compound A (50 mg) (gadolinium sodium diethylenetriamine pentaacetic acid monomethylamide) Gadodiamide Related Compound B (50 mg) (gadolinium disodium diethylenetriamine pentaacetic acid) Gadopentetate Monomeglumine (500 mg) Gadoteridol (500 mg) Gadoteridol Related Compound A (50 mg) (10-(2hydroxypropyl)-1,4,7,10-tetraazacyclododecane1,4,7-triacetic acid) Gadoteridol Related Compound B (50 mg) (1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, monogadolinium salt)

F0E007 H0E328 G-2 J1B131 J J0E326 G0E005 G0E125 F0E190 F F 1.00 mg/mg (ai)

[2438-80-4] [110-17-8] [67-45-8] [54-31-9] n/f [3086-91-7] [60142-96-3] [64744-50-9] n/f [131410-48-5] n/f

1287529

n/f

1287609 1287631 1287642

F1F094 F F0A002

0.998 mg/mg (an)

F (12/06)

[92923-57-4] [120066-54-8] [120041-08-9]

1287653

F0B198

[112188-16-6]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

57

USP Reference Standards and Authentic Substances

Cat. No. 1287664 Curr. Lot. F0B199 Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. [220182-19-4]

Description Gadoteridol Related Compound C (50 mg) (1,4,7,10-Tetraaza-11-oxo-bicyclo[8.2.2]tetradecane-4,7-diacetic acid) Gadoversetamide (200 mg) Gadoversetamide Related Compound A (200 mg) (Hydrogen[8,11,14-tris(carboxymethyl)-6-oxo-2oxa-5,8,11,14-tetraazahexadecan-16-oato(4-)]gadolinium) Galactitol (500 mg) Galactose (200 mg) Gallamine Triethiodide (200 mg) Ganciclovir (200 mg) Ganciclovir Related Compound A (15 mg) ((RS)-2Amino-9-(2,3-dihydroxy-propoxymethyl)-1,9-dihydro-purin-6-one) Gemcitabine Hydrochloride (200 mg) Gembrozil (200 mg) Gembrozil Related Compound A (20 mg) (2,2dimethyl-5-[2,5-dimethyl-4-(propene-1-yl)phenoxy]valeric acid) Gentamicin Sulfate (200 mg)

1287675 1287686

F0C172 F0C173

[131069-91-5] n/f

1287711 1287700 1288000 1288306 1288317

F0D376 F-4 F F0C287 F0C288

0.99 mg/mg (ai) F-3 (05/01)

[608-66-2] [59-23-4] [65-29-2] [82410-32-0] n/f

1288463 1288500 1288510

F0D037 H G0D369

0.997 mg/mg (ai) 0.99 mg/mg (ai) F0C101 (10/05)

[122111-03-9] [25812-30-0] n/f

1289003

M0D314

697 ug/mg (dr)

L0C279 (08/04) K (12/04) J-1 (04/00) F (08/06) F (04/01)

[1405-41-0]

1290002 1291005 1291504 1291708 1292008 1292303 1292314 1292325 1292336 1292347 1292507 1292609

Gentian Violet (650 mg) Gibberellic Acid (200 mg) (FCC) Powdered Ginger (500 mg) Powdered Asian Ginseng Extract (1.5 g) Gitoxin (50 mg) Glimepiride (200 mg) Glimepiride Related Compound A (20 mg) (glimepiride cis-isomer) Glimepiride Related Compound B (20 mg) (glimepiride sulfonamide) Glimepiride Related Compound C (20 mg) (Glimepiride urethane) Glimepiride Related Compound D (20 mg) (Glimepiride-3-isomer) Glipizide (125 mg) Glipizide Related Compound A (25 mg) (N-{2-[(4aminosulfonyl)phenyl]ethyl}-5-methyl-pyrazinecarboxamide) Glucosamine Hydrochloride (200 mg) Glutamic Acid (200 mg) Glutamine (100 mg) gamma-Glutamyl-S-allyl-L-cysteine (25 mg) Glutethimide CII (500 mg) Glyburide (200 mg) Glyburide Related Compound A (25 mg) (5-chloro2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide)

G0E112 G F F0B289 G F0E228 F0E232 F0E233 F0E234 F0E235 G1C174

1.000 mg/mg (an)

[548-62-9] [77-06-5] n/f [50647-08-0]

F-3 (07/00) 0.994 mg/mg (ai)

[4562-36-1] [93479-79-1] n/f [119018-29-0] [119018-30-3] n/f

G (07/04) G-1 (06/07) G (04/99)

[29094-61-9] n/f

1294207 1294976 1294808 1294848 1295006 1295505 1295516

F0C363 F0C069 G0F037 F F G1C347 F0E224 0.990 mg/mg (dr) G (04/06) F-2 (11/02) 1.00 mg/mg (ai) 2 F0B244 (05/07)

[66-84-2] [56-86-0] [56-85-9] n/f [77-21-4] [10238-21-8] [16673-34-0]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

58 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1295607 Curr. Lot. H1E032 Purity Value/Conc. 1.00 mg/mg (ai) Change Code* Previous Lot/Valid Use Date H0C073 (03/07) G1A001 (04/04) G (12/02) F (04/99) F-2 (03/03) 0.999 mg/mg (dr) F-3 (05/06) F-2 (02/00) G (05/04) G (07/00) H-1 (07/02) 992 ug/mg (ai) I (03/07) H-1 (09/02) I0C138 (10/04) H (08/03) J (04/00) 0.993 mg/mg (dr) I (11/05) H (09/02) F-1 (06/00) F (06/07) G-1 G0B123 F1C224 F I K0C362 H-1 (05/02) J (12/04) F-1 (02/03) F (11/99) F (12/04) CAS No. [56-81-5]

Description Glycerin (2 mL)

1295709 1295800 1296009 1295888 1297001 1298004 1299007 1299200 1300004 1301007 1301404 1301608 1301801 1302000 1302101 1302305 1302509 1303002 1303013

Glyceryl Behenate (200 mg) Glycine (200 mg) Glycopyrrolate (200 mg) Glycyrrhizic Acid (25 mg) Human Chorionic Gonadotropin (1 vial, 5,760 USP Units per package) Gramicidin (200 mg) Griseofulvin (200 mg) Griseofulvin Permeability Diameter (2 g) Guaiacol (1 g) Guaifenesin (200 mg) Guanabenz Acetate (200 mg) Guanadrel Sulfate (200 mg) Guanethidine Monosulfate (200 mg) Guanethidine Sulfate (500 mg) Guanfacine Hydrochloride (125 mg) Halazepam CIV (200 mg) (AS) Halcinonide (300 mg) Haloperidol (200 mg) Haloperidol Related Compound A (15 mg) (4,4Bis[(4-p-chlorophenyl)-4-hydroxy-piperidino]-butyrophenone) Haloprogin (200 mg) Halothane (1 mL) Heparin Sodium (10 x 1 mL) Hexachlorophene (500 mg) Hexacosanol (100 mg) 2E, 4E-Hexadienoic Acid Isobutylamide (25 mg) Hexobarbital CIII (500 mg) Hexylcaine Hydrochloride (1 g) Hexylene Glycol (125 mg) Hexylresorcinol (200 mg) L-Histidine (200 mg) Histamine Dihydrochloride (250 mg) Homatropine Hydrobromide (200 mg) Homatropine Methylbromide (250 mg) Homopolymer Polypropylene (3 Strips) Homosalate (500 mg)

F3B113 G0E099 H0B304 F0C006 H I I1D406 J0C380 K I1C098 G F-1

[18641-57-1] [56-40-6] [596-51-0] [1405-86-3] [9002-61-3] [1405-97-6] [126-07-8] [126-07-8] [90-05-1] [93-14-1] [23256-50-0] [22195-34-2] [645-43-2] [60-02-6] [29110-48-3] [23092-17-3] [3093-35-4] [52-86-8] [67987-08-0]

1303308 1303501 1304005 1305008 1305303 1305507 1307003 1308006 1308200 1308307 1308505 1309009 1310008 1311000 1311306 1311408

F G0D068 K-5 I F0F131 F0C353 F F-1 G F G0A018 M0C280 H2C049 J F0C096 H0D322 0.994 mg/mg (ai) G0D072 (09/06) F0B102 (04/05) F-2 (01/03) F-1 (04/00) L (07/04) H-1(02/05) H (08/02) I-1 (06/01) F-2 (04/02) F-1 (04/99) 0.98 mg/mg (ai) 1.00 mg/mg (ai) 1 F-1 (03/05) K-4 (08/03) K-3 (02/99) H-2 (01/01)

[777-11-7] [151-67-7] [9041-08-1] [70-30-4] [506-52-5] [82240-09-3] [56-29-1] [532-76-3] [107-41-5] [136-77-6] [71-00-1] [56-92-8] [51-56-9] [80-49-9] [9003-07-0] [118-56-9]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

59

USP Reference Standards and Authentic Substances

Cat. No. 1313006 1313210 1314009 1315001 Curr. Lot. K1E183 F0E204 I L0E176 0.997 mg/mg (dr) Purity Value/Conc. 0.998 mg/mg (dr) 0.99 mg/mg (ai) H (05/02) K0C217 (11/06) J0A026 (01/05) I-1 (12/02) I (07/02) H-2 (11/99) Change Code* Previous Lot/Valid Use Date K (10/06) J-1 (09/02) CAS No. [304-20-1] [118-08-1] [58-93-5] [34195-34-1]

Description Hydralazine Hydrochloride (200 mg) Hydrastine (10 mg) Hydrochlorothiazide (200 mg) Hydrocodone Bitartrate CII (250 mg)

1315012

Hydrocodone Bitartrate Related Compound A CII (70 mg) (Morphinan-6-one, 4-hydroxy-3-methoxy17-methyl) Hydrocortisone (200 mg) Hydrocortisone Acetate (200 mg) Hydrocortisone Butyrate (200 mg) Hydrocortisone Cypionate (200 mg) Hydrocortisone Hemisuccinate (200 mg)

F0C214

[847-86-9]

1316004 1317007 1317302 1318000 1319002

M1C110 K H F I0D343 0.998 mg/mg (dr)

M (10/04) L (09/00) J (10/99)

[50-23-7] [50-03-3] [13609-67-1] [508-99-6]

H (03/06) G-3 (03/02) G-2 (08/99) F (07/02) I (01/05) H-2 (03/01) G-1 (10/04) G (11/01) F-4 (02/99) F (06/01) I (05/04)

[83784-20-7]

1320001 1321004 1322007 1323000 1324002

Hydrocortisone Phosphate Triethylamine (200 mg) Hydrocortisone Valerate (200 mg) Hydroumethiazide (200 mg) Hydromorphone Hydrochloride CII (50 mg) Hydroquinone (500 mg)

F-1 F-1 F-2 J0C372 H0C249

n/f [57524-89-7] [135-09-1] [71-68-1] [123-31-9]

1325005 1327000 1329006 1329709 1329800 1332000 1333003 1333058 1334006 1335009

Hydroxyamphetamine Hydrobromide (200 mg) Hydroxychloroquine Sulfate (200 mg) Hydroxyprogesterone Caproate (200 mg) Hydroxypropyl Betadex (200 mg) Hydroxypropyl Cellulose (200 mg) Hydroxyurea (200 mg) Hydroxyzine Hydrochloride (500 mg) Hydroxyzine Related Compound A (25 mg) (pChlorobenzhydrylpiperazine) Hydroxyzine Pamoate (500 mg) Hyoscyamine Sulfate (125 mg)

G J0B297 H F0B295 F-1 H J0F024 H1E248 H0C016 H0C193 0.999 mg/mg (dr)

[306-21-8] [747-36-4] [630-56-8] [128446-35-5] [9004-64-2]

G (01/00) I0C385 (03/07) H (05/05) H (09/06) G-1 (07/03) G2A007 (09/04) G-1 (08/02) G (10/99)

[127-07-1] [2192-20-3] [303-26-4] [10246-75-0] [6835-16-1]

1335010 1335202 1330005 1335279 1335304 1335508

Hyoscyamine Related Compound A (10 mg) (Norhyoscyamine Sulfate) Hyperoside (50 mg) Hypromellose (250 mg) (Hydroxypropyl Methylcellulose) Hypromellose Acetate Succinate (100 mg) Hypromellose Phthalate (100 mg) Ibuprofen (750 mg)

F0E250 F H0C387 F0D275 F-1 J1E043 0.999 mg/mg (ai) F (12/00) J (08/06) I (06/02) G-1 (11/04) G (02/02)

[537-29-1] [482-36-0] [9004-65-3] [71138-97-1] [9050-31-1] [15687-27-1]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

60 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1335541 1335701 Curr. Lot. F0F011 I0D309 Purity Value/Conc. 1.00 mg/mg (ai) 955 ug/mg (ai) Change Code* 1 H0C061 (11/05) G (11/03) F (06/00) H (07/04) 1.000 mg/mg (an) G (03/06) F-1 (11/00) F (02/99) G1B132 (10/06) G (01/04) G (10/99) H (11/04) 0.929 mg/mg (ai) G1C296 (05/06) G (01/05) F (01/01) H (09/01) 0.998 mg/mg (dr) H (07/06) G (07/02) Previous Lot/Valid Use Date CAS No. [38861-78-8] [57852-57-0]

Description Ibuprofen Related Compound C (0.2 mL/ampule; 3 ampules) (4-isobutylacetophenone) Idarubicin Hydrochloride (50 mg)

1336001 1336205

Idoxuridine (250 mg) Ifosfamide (500 mg)

H1B230 G1C371

[54-42-2] [3778-73-2]

1336500 1336806 1337004 1337809

Imidazole (200 mg) Imidurea (200 mg) Iminodibenzyl (25 mg) Imipenem Monohydrate (100 mg)

G2E031 H I0C253 H0E040

1.00 mg/mg (ai)

[288-32-4] [39236-46-9] [494-19-9] [74431-23-5]

1338007 1338801 1338812

Imipramine Hydrochloride (200 mg) Indapamide (250 mg) Indapamide Related Compound A (50 mg) (4Chloro-N-(2-methyl-indol-1-yl)-3-sulfamoylbenzamide) (AS) Indigotindisulfonate Sodium (500 mg) Indinavir (100 mg) Indinavir System Suitability (100 mg) Indocyanine Green (200 mg) Indomethacin (200 mg) Insulin (100 mg) Insulin Human (100 mg)

I H1E103 F0E052

[113-52-0] [26807-65-8] [63968-75-2]

1339000 1339178 1339189 1340009 1341001 1342004 1342106

H1B153 F0D308 F0D352 I0B045 J0B165 H I0C383 26.6 USP Insulin Human Units/mg (ai) 172 USP Insulin Lispro Units/vial 0.971 mg/mg (ai)

H (06/03)

[860-22-0] [180683-37-8] [180683-37-8]

H (09/01) I (01/04) H (05/99) H1A031 (07/05) H (11/02) G (04/00)

[3599-32-4] [53-86-1] [9004-10-8] [11061-68-0]

1342321 1342208 1342300 1342503 1343007 1343517 1343540

Insulin Lispro (5.97 mg) Insulin (Beef) (100 mg) Insulin (Pork) (100 mg) Iocetamic Acid (200 mg) Iodipamide (200 mg) Iodixanol (200 mg) Iodixanol Related Compound C (25 mg) (5-Acetyl[3-[[3,5-bis[[(2,3-dihydroxypropyl)amino]carbonyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N-bis-(2,3-dihydroxypropyl)-2,4,6-triiodo1,3-benzenedicarboxamide) Iodixanol Related Compound D (50 mg) (5-[Acetyl(2-hydroxy-3-methylpropyl)amino]-N,N-bis(2,3dihydroxypropyl)2,4,6-triiodo-1,3-benzenedicarboxamide) Iodixanol Related Compound E (25 mg) (5-[[3-[[3[[(2,3-Dihydoxypropyl)amino]carbonyl]-5-[[amino]carbonyl]-2,4,6-triiodophenyl](acetylimino)]-2-hydroxypropyl]-(acetylimino)]-N,N-bis(2,3-dihydoxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) o-Iodohippuric Acid (100 mg)

F0E140 F F F G F0B240 F0B236

[133107-64-9] [11070-73-8] [12584-58-6] [16034-77-8] [606-17-7] [92339-11-2] n/f

1343550

F0B231

[89797-00-2]

1343561

F0B229

n/f

1344305

[147-58-0]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

61

USP Reference Standards and Authentic Substances

Cat. No. 1344509 1344600 1344622 Curr. Lot. I0D285 F-1 F-1 Purity Value/Conc. Change Code* Previous Lot/Valid Use Date H (07/06) G (07/02) F (01/99) F (10/01) CAS No. [83-73-8] [66108-95-0] n/f

Description Iodoquinol (100 mg) Iohexol (100 mg) Iohexol Related Compound A (100 mg) (5-(acetylamino)-N,N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) Iohexol Related Compound B (50 mg) (5-aminoN,N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) Iohexol Related Compound C (100 mg) (N,Nbis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide) Iopamidol (200 mg) Iopamidol Related Compound A (50 mg) (N,N-Bis(1,3-dihydroxy-2-propyl)-5-amino-2,4,6-triiodoisophthalamide) Iopamidol Related Compound B (100 mg) (5Glycolamido-N,N-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodoisophthalamide) Iopromide (400 mg) Iopromide Related Compound A (50 mg) (5-Amino-N,N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-Nmethyl-1,3-benzenedicarboxamide) Iopromide Related Compound B (50 mg) (5-(Acetylamino)-N,N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-1,3-benzenedicarboxamide) Iothalamic Acid (200 mg) Ioversol (200 mg) Ioversol Related Compound A (50 mg) (5-AminoN,N-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide) Ioversol Related Compound B (50 mg) (N,Nbis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)carbonyl)methoxy]-2,4,6-triiodoisophthalamide) Ioxaglic Acid (100 mg) Ioxilan (400 mg) Ioxilan Related Compound A (100 mg) (5-amino2,4,6-triiodo-3 N-(2-hydroxyethyl)carbamoyl benzoic acid) Ipodate Calcium (200 mg) Ipodate Sodium (200 mg) Isoamyl Methoxycinnamate (750 mg/ampule) Isocarboxazid (200 mg) Isoetharine Hydrochloride (250 mg) Isoupredone Acetate (200 mg) Isourane (1 mL) Isourane Related Compound A (0.1 mL) (1Chloro-2,2,2-triuoroethyl chlorodiuoromethyl ether) Isourane Related Compound B (0.1 mL) (2,2,2Triuoroethyldiuoromethyl ether) L-Isoleucine (200 mg)

1344644

F-1

F (01/04)

[76801-93-9]

1344666

F-1

F (09/03)

n/f

1344702 1344724

G G

[60166-93-0] [60166-98-5]

1344735

n/f

1344804 1344826

F F

[73334-07-3] n/f

1344837

n/f

1345002 1345104 1345115

G F F

[2276-90-6] [87771-40-2] [76801-93-9]

1345126

n/f

1345159 1345206 1345228

F F F

[59017-64-0] [107793-72-6] [22871-58-5]

1346005 1347008 1347755 1348000 1348500 1348907 1349003 1349014

F-1 F-1 F0B017 F-1 F-2 F0C109 H1C199 F0C232

F (06/06)

[1151-11-7] [1221-56-3] [71617-10-2] [59-63-2] [2576-92-3] [338-98-7]

H (12/04)

[26675-46-7] n/f

1349025 1349502

F0C233 F-2 F-1 (09/02)

n/f [73-32-5]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

62 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1349604 1349626 Curr. Lot. G0D311 F0E263 Purity Value/Conc. 0.97 mg/mg (ai) 0.511 mg/mg 1,6GPS; 0.453 mg/mg 1,1-GPM (ai) Change Code* Previous Lot/Valid Use Date F1B107 (11/05) F (01/03) CAS No. [3344-12-5] [64519-82-0]

Description Isomalathion (50 mg) Isomalt (200 mg)

1349659 1349706 1350002 1350308 1350400 1350603 1351005 1352008 1353000 1353500 1354003 1354207 1354218

Isometheptene Mucate (200 mg) Isoniazid (200 mg) Isopropamide Iodide (200 mg) Isopropyl Alcohol (1.5 mL/ampule; 3 ampules) (AS) Isopropyl Myristate (500 mg) Isopropyl Palmitate (500 mg) Isoproterenol Hydrochloride (125 mg) Isosorbide (75% solution, 1 g) Diluted Isosorbide Dinitrate (500 mg of 25% mixture with mannitol) Isotretinoin (200 mg) Isoxsuprine Hydrochloride (200 mg) Isradipine (200 mg) Isradipine Related Compound A (25 mg) (Isopropyl methyl 4-(4-benzofurazanyl)-2,6-dimethyl-3,5-pyridinedicarboxylate) Ivermectin (200 mg) Kanamycin Sulfate (200 mg) Powdered Kava Extract (1 g) Kawain (200 mg) Ketamine Hydrochloride CIII (250 mg) Ketamine Related Compound A (50 mg) (1-[(2Chlorophenyl)(methylimino)methyl]cylcopentanol) Ketoconazole (200 mg)

F H F-2 F0D261 J0D247 I K I I2E153 I1E066 F-3 H0E252 F1D243 0.995 mg/mg (dr) G0B054 (01/07) F (05/03) F (02/06) 25.1 % (ai) 0.998 mg/mg (ai) H-2 (10/00) I-1 (08/06) I (10/99) I (08/06) H (10/00) 99.9% (ai) I1C183 (06/06) I (01/05) H (10/99)

[7492-31-1] [54-85-3] [71-81-8] [67-63-0] [110-27-0] [142-91-6] [51-30-9] [652-67-5] [87-33-2] [4759-48-2] [579-56-6] [75695-93-1] n/f

1354309 1355006 1355709 1355753 1356009 1356020 1356508

G0D408 J F0C161 F0C160 H0E091 F0C118 G4B179

0.906 mg/mg (ai)

F0B196 (02/06) I (06/99)

[70288-86-7] [25389-94-0] n/f [500-64-1]

0.998 mg/mg (ai)

G-2 (06/06) G-1 (07/00)

[1867-66-9] [6740-87-0]

G-3 (01/04) G-2 (06/01) G-1 (01/99) G (07/04) F-2 (05/99) G (11/05)

[65277-42-1]

1356632 1356643

Ketoprofen (200 mg) Ketoprofen Related Compound A (25 mg) (alphaMethyl-3-(4-methylbenzoyl) benzeneacetic acid) (AS) Ketorolac Tromethamine (200 mg) Labetalol Hydrochloride (200 mg)

H0B216 H0E028

[22071-15-4] [107257-20-5]

1356665 1356654

G1E331 G1F090

1.000 mg/mg (dr) 0.998 mg/mg (dr)

G (04/07) F-2 (04/99) G (02/07) F-2 (01/02) F-1 (03/01)

[74103-07-4] [32780-64-6]

1356698 1356734 1356676 1356687

Lactase (200 mg) Lactic Acid (1.5 mL/ampule; 3 ampules) (AS) Anhydrous Lactose (100 mg) Lactitol (500 mg)

F0D032 F0D027 G1C004 G0E254

105,000 USP units/g (ai) 88.5% (ai) G (12/04) F (06/01) 0.997 mg/mg (an) F0B005 (09/06)

[9031-11-2] [50-21-5] [63-42-3] [81025-04-9]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

63

USP Reference Standards and Authentic Substances

Cat. No. 1356701 1356803 1356836 1356847 1356880 1356905 1356916 1356927 Curr. Lot. H0C151 H F0C361 F0D024 F G0C421 G0D307 F0B311 1.00 mg/mg (ai) 0.995 mg/mg (ai) F (11/04) F0B310 (10/05) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date G-1 (07/05) G (08/02) G-1 (08/00) CAS No. [5989-81-1] [4618-18-2] [134678-17-4] [134678-17-4] [8006-54-0] [8027-33-6] [103577-45-3] n/f

Description Lactose Monohydrate (500 mg) Lactulose (1 g) Lamivudine (200 mg) Lamivudine Resolution Mixture A (10 mg) Lanolin (20 g) Lanolin Alcohols (5 g) Lansoprazole (150 mg) Lansoprazole Related Compound A (25 mg) (2[[[3-methyl-4-(2,2,2-triouroethoxy)-2-pyridyl]methyl]sulfonyl]benzimidazole) Lauroyl Polyoxylglycerides (500 mg) Letrozole (200 mg) Letrozole Related Compound A (25 mg) (4,4-(1H1,3,4-triazol-1-ylmethylene)dibenzonitrile) L-Leucine (200 mg) Leucovorin Calcium (500 mg)

1356950 1356971 1356982 1357001 1358004

F1E144 F0B170 G0D298 H0B237 K0F033 0.998 mg/mg (an)

F0D020 (08/06) F0B168 (10/05) G-1 (04/04) G (08/00) J2B219 (04/07) J-1 (07/04) J (05/02) F-1 (05/04) 98% (ai) 0.999 mg/mg (dr) F(08/05) G (04/06) F-2 (06/03) F-1 (12/00) F (08/01)

n/f [112809-51-5] n/f [61-90-5] [1492-18-8]

1358503 1359302 1359506 1359801 1359903 1359925

Leuprolide Acetate (200 mg) Levamisole Hydrochloride (125 mg) Levmetamfetamine CII (75 mg) Levobunolol Hydrochloride (200 mg) Levocarnitine (400 mg) Levocarnitine Related Compound A (100 mg) (3carboxy-N,N,N-trimethyl-2-propen-1-aminium chloride) Levodopa (200 mg) Levodopa Related Compound A (50 mg) (3-(3,4,6Trihydroxyphenyl)-alanine) Levodopa Related Compound B (50 mg) (3-Methoxytyrosine) Levonordefrin (200 mg) Levopropoxyphene Napsylate (300 mg) Levorphanol Tartrate CII (500 mg) Levothyroxine (500 mg) Lidocaine (250 mg) Lincomycin Hydrochloride (200 mg) Lindane (200 mg) Linoleoyl Polyoxylglycerides (100 mg) Liothyronine (250 mg)

F0C430 F2C122 F1C113 H0E047 G0B197 F-1

0.907 mg/mg (an,fb)

[74381-53-6] [16595-80-5] [33817-09-3] [27912-14-7] [541-15-1] [6538-82-5]

1361009 1361010 1420006 1362500 1363004 1364007 1365000 1366002 1367005 1367504 1367708 1368008

I K I0C300 F-1 G I0D138 L0D226 L H2B130 F-2 F0C283 M0D338 0.993 mg/mg (dr) 1.000 mg/mg (an) 0.994 mg/mg (dr)

H (09/00) J (01/03) I (06/00) H (07/04)

[59-92-7] [27244-64-0]

[829-74-3] [55557-30-7] H (07/05) G (03/01) K (12/06) J (10/00) H-1 (01/04) [5985-38-6] [51-48-9] [137-58-6] [7179-49-9] [58-89-9] n/f L1C262 (12/05) L (08/04) K (08/01) 2 I1C045 (05/07) I (11/04) H (09/01) G (10/99) [6893-02-3]

1368609

Lisinopril (300 mg)

J0F043

1.000 mg/mg (an)

[83915-83-7]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

64 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1369000 1370000 1370203 1370225 1370270 1370280 Curr. Lot. G0B031 H0C202 F F G0D344 F0D229 0.999 mg/mg (ai) F0C414 (12/05) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date F-2 (01/03) F-1 (01/01) G-2 (09/04) G-1 (02/03) CAS No. [554-13-2] [34552-83-5] [121961-22-6] n/f [79794-75-5] [100643-71-8]

Description Lithium Carbonate (300 mg) Loperamide Hydrochloride (200 mg) Loracarbef (200 mg) Loracarbef L-Isomer (25 mg) Loratadine (200 mg) Loratadine Related Compound A (15 mg) (8Chloro-6,11-dihydro-11(4-piperidinylidene)-5Hbenzo[5,6]cyclohepta[1,2-b] pyridine) Loratadine Related Compound B (15 mg) (8Chloro-6,11-dihydro-11(N-methyl-4-piperidinylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine) Lorazepam CIV (200 mg)

1370291

F0D230

n/f

1370305

I1D404

0.998 mg/mg (ai)

I0C048 (06/06) H0B023 (06/04) F-1 (06/01)

[846-49-1]

1370327

Lorazepam Related Compound A (25 mg) (7Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-acetoxy2H-1,4-benzodiazepin-2-one) Lorazepam Related Compound B (25 mg) (2Amino-2,5-dichlorobenzophenone) Lorazepam Related Compound C (25 mg) (6Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxaldehyde) Lorazepam Related Compound D (25 mg) (6Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxylic Acid) Lorazepam Related Compound E (25 mg) (6Chloro-4-(o-chlorophenyl)-2-quinazoline Methanol) Losartan Potassium (250 mg) Lovastatin (125 mg) Lovastatin Related Compound A (10 mg) (dihydrolovastatin) Loxapine Succinate (125 mg)

[2848-96-6]

1370338 1370349

G H

F-2 (01/04) G (01/03) F-3 (01/02) F-2 (01/04)

[2958-36-3] n/f

1370350

G0A014

[54643-79-7]

1370360

H0D254

0.98 mg/mg (ai)

G (02/06) F-3 (07/02) F-2 (04/99) H1B067 (01/04) H (08/03) G0C326 (11/05) F0B235 (09/04)

n/f

1370462 1370600 1370611 1370702

F0D287 H2C012 H0D274 H0C094

0.998 mg/mg (ai)

[124750-99-8] [75330-75-5] n/f [27833-64-3]

0.998 mg/mg (dr)

G0B026 (11/05) F-2 (06/03) F-1 (07/01) F (03/99)

1370804 1370906 1371002 1371501 1372005 1373008 1286209 1374000 1374226 1374248 1374260

Lutein (1 mL) Lynestrenol (20 mg) Lysergic Acid Diethylamide Tartrate CI (10 mg) (AS) (LSD) L-Lysine Acetate (200 mg) L-Lysine Hydrochloride (200 mg) Mafenide Acetate (400 mg) Mafenide Related Compound A (50 mg) (4-Formylbenzenesulfonamide) Magaldrate (200 mg) Magnesium Carbonate (2 g) (AS) Magnesium Chloride (1 g) (AS) Magnesium Hydroxide (1 g) (AS)

F0D291 F0B314 I F1C027 I0E230 F1D216 G0C351 F-1 F0D256 F0D157 F0D158

0.056 mg/mg in corn oil (ai)

[127-40-2] [52-76-6] [50-37-3] F (11/04) [57282-49-2] [657-27-2] [13009-99-9] n/f [74978-16-8]

1.00 mg/mg (dr) 0.999 mg/mg (an) 1.00 mg/mg (dr)

H (03/07) G (07/00) F (07/05) F (08/05)

41.8% MgO (ai) 100.3% (ai) 98.5% (dr)

[546-93-0] [7791-18-6] [1309-42-8]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

65

USP Reference Standards and Authentic Substances

Cat. No. 1374292 1374306 1374340 Curr. Lot. F0E107 F2B081 F0D214 65% Stearate 29% Palmitate 4.8% Mg (ai) 99.8% (ig) 0.993 mg/mg (ai) F-1 (11/05) F (08/01) F-2 (12/00) F-1 (04/03) F-1 (12/99) F-1 (12/99) 0.947 mg/mg (ai) 0.996 mg/mg (an) Purity Value/Conc. 99.8% (ig) F-1 (01/04) Change Code* Previous Lot/Valid Use Date CAS No. [7757-87-1] [18917-95-8] [577-04-0]

Description Magnesium Phosphate (2 g) (AS) Magnesium Salicylate (200 mg) Magnesium Stearate (5 g) (AS)

1374361 1374408 1374500 1374601 1374907 1375003 1375025 1375058 1375069 1375070

Magnesium Sulfate (1 g) (AS) Malathion (500 mg) Maleic Acid (300 mg) Malic Acid (200 mg) Maltitol (200 mg) Maltol (4 g) (FCC) Maltose Monohydrate (500 mg) Mandelic Acid (500 mg) Mangafodipir Trisodium (200 mg) Mangafodipir Related Compound A (15 mg) (manganese (II) dipyridoxyl monophosphate sodium salt) Mangafodipir Related Compound B (15 mg) (manganese (II) dipyridoxyl diphosphate mono-overalkylated sodium salt) Mangafodipir Related Compound C (15 mg) (manganese (III) dipyridoxyl diphosphate sodium salt) Manganese Chloride (1 g) (AS) Manganese Sulfate (1 g) (AS) Mannitol (200 mg) Maprotiline Hydrochloride (200 mg) Mazindol CIV (350 mg) Mebendazole (200 mg) Mebrofenin (100 mg) Mecamylamine Hydrochloride (200 mg) Mecamylamine Related Compound A (10 mg) (N,1,7,7-tetramethyl bicyclo [2.2.1] heptan-2-amine hydrochloride) Mechlorethamine Hydrochloride (100 mg) (FOR U.S. SALE ONLY) Meclizine Hydrochloride (500 mg) Meclocycline Sulfosalicylate (300 mg) Meclofenamate Sodium (500 mg) Medroxyprogesterone Acetate (200 mg) Medroxyprogesterone Acetate Related Compound A (25 mg) (4,5-beta-Dihydromedroxyprogesterone acetate) Medrysone (500 mg) Mefenamic Acid (200 mg) Meoquine Hydrochloride (100 mg) Meoquine Related Compound A (20 mg) (threomeoquine) Megestrol Acetate (500 mg)

F0D160 G0D143 G G0B158 G G F0E035 F F0D272 F0D266

[10034-99-8] [121-75-5] [110-16-7] [6915-15-7] [585-88-6] [118-71-8] [6363-53-7] [90-64-2] [140678-14-4] n/f

1375080

F0D267

n/f

1375091 1375127 1375149 1375105 1375207 1375309 1375502 1375706 1376006 1376017

F0D283 F0D150 F0D151 I0B212 H H G1C195 F F-2 F0F003 1 99.6% (dr) 99.8% (ai) H (03/04) G (07/02) G (02/03) G (11/04)

n/f [13446-34-9] [10034-96-5] [69-65-8] [10347-81-6] [22232-71-9] [31431-39-7] [78266-06-5] [826-39-1] [22321-23-9]

1376505 1377009 1377508 1377803 1378001 1378012

G0E271 I-1 H0F087 H I0D013 F0C427 0.995 mg/mg (ai) 1.00 mg/mg (ai) 678 ug/mg (an)

F-1 (06/07) F (09/00) G (03/07) H-2 (09/05) H-1 (04/03)

[55-86-7] [31884-77-2]

[73816-42-9] [6385-02-0] [71-58-9] n/f

1379004 1379605 1379059 1379060 1379106

F G0C025 F0E165 F0E166 I H (05/00) F3A032 (08/04) F-2 (01/03)

[2668-66-8] [61-68-7] [51773-92-3] n/f [595-33-5]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

66 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1379140 1380105 1379254 1379265 Curr. Lot. F0D385 F0E027 F0D304 F0D305 Purity Value/Conc. 99.5% (dr) 0.999 mg/mg (dr) 0.993 mg/mg (ai) 1.00 mg/mg (ai) Change Code* Previous Lot/Valid Use Date CAS No. [6284-40-8] [73-31-4] [2919-66-6] n/f

Description Meglumine (500 mg) (AS) Melatonin (100 mg) (AS) Melengestrol Acetate (125 mg) Melengestrol Acetate Related Compound A (25 mg) (17-hydroxy-16-methylenepregna-4-ene3,20-dione 17-acetate) Melengestrol Acetate Related Compound B (25 mg) (6,16-dimethylene-17-hydroxypregna-4ene-3,20-dione 17-acetate) Meloxicam (400 mg) Meloxicam Related Compound A (25 mg) (4Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid ethyl ester 1,1-dioxide) Meloxicam Related Compound B (25 mg) (2Amino-5-methyl-thiazole) Meloxicam Related Compound C (30 mg) (Isopropyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3carboxylate-1,1-dioxide) Meloxicam Related Compound D (30 mg) (4Methoxy-2-methyl-(5-methyl-1,3-thiazol-2yl)-2H1,2-benzothiazine-3-carboxamide-1,1-dioxide) Melphalan Hydrochloride (100 mg) (FOR U.S. SALE ONLY) Melting Point Standards - See Cross Reference Section

1379276

F0D306

0.98 mg/mg (ai)

n/f

1379401 1379412

F0E158 F0E167

0.999 mg/mg (ai)

[71125-38-7] [24683-26-9]

1379423 1379434

F0E168 F0E159

1.00 mg/mg (ai) 0.99 mg/mg (ai)

[7305-71-7] n/f

1379445

F0E160

1.00 mg/mg (ai)

n/f

1379300

H0B296

0.975 mg/mg (ai)

G (01/05)

[3223-07-2]

1381006 1381709 1381742 1382009 1383001 1385007 1386000 1387002 1388005 1389008 1390007 1391000 1392002

Menadione (200 mg) (Vitamin K3) Menthol (250 mg) Menthyl Anthranilate (500 mg/ampule) Mepenzolate Bromide (200 mg) Meperidine Hydrochloride CII (200 mg) Mephenytoin (250 mg) Mephobarbital CIV (250 mg) Mepivacaine Hydrochloride (200 mg) Meprednisone (200 mg) Meprobamate CIV (200 mg) Meprylcaine Hydrochloride (200 mg) 3-Mercapto-2-methylpropanoic Acid 1,2-Diphenylethylamine Salt (75 mg) Mercaptopurine (500 mg)

H-3 I0B049 F0B103 F I G G H G-1 F G I2C263

H-2 (02/00) H (04/03)

[58-27-5] [2216-51-5] [134-09-8] [76-90-4]

H-1 (12/99) F (01/01) G-4 (02/99) G (03/07) G (03/02)

[50-13-5] [50-12-4] [115-38-8] [1722-62-9] [1247-42-3] [57-53-4] [956-03-6] n/f

I-1 (10/04) I (07/02) H (12/99) 0.998 mg/mg (an) 2 F0C201 (05/07) G1B001 (06/05) G (01/03) F-1 (03/00) I-1 (12/04) J (07/04) I-1 (09/99)

[6112-76-1]

1392454 1392705

Meropenem (300 mg) Mesalamine (200 mg)

G0F100 H0C341

[119478-56-7] [89-57-6]

1393005 1394008 1395500 1396003 1396309

Mesoridazine Besylate (250 mg) Mestranol (200 mg) Metaproterenol Sulfate (200 mg) Metaraminol Bitartrate (200 mg) Metformin Hydrochloride (200 mg)

J0C117 K0C065 F-3 F-3 H0E136 1.00 mg/mg (ai)

[32672-69-8] [72-33-3] [5874-97-5] [33402-03-8]

G0D271 (07/06) F0C209 (08/05)

[1115-70-4]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

67

USP Reference Standards and Authentic Substances

Cat. No. 1396310 1396331 1396342 1396364 1396400 1396502 1396604 1397006 1398009 1399001 1401001 1402004 1404000 1405002 1406005 1407008 1408000 1409003 1409502 1409604 1410002 Curr. Lot. F0C210 F0F019 F0E343 F0D222 G0B140 G0B141 G1B088 I0C348 I0B163 I F-1 F-1 F-1 F-2 H0B239 F-1 G H0C047 F G0C304 J0C333 F-2 (01/05) F-1 (11/00) I1B186 (11/04) I (03/03) H (03/00) F (02/01) 1.00 mg/mg (ai) G (08/06) F-2 (11/99) H-1 (03/04) 1.000 mg/mg (an) 0.999 mg/mg (an) 2 F-2 (08/05) I1D108 (05/07) I (01/06) F-1 (05/99) G (05/04) F-1 (07/99) G-1 (05/04) 903 ug/mg (ai) 100.0% (dr) F-2 (04/03) F-2 (04/03) G (08/03) H (10/05) G (04/01) H-1 (08/03) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. [461-58-5] [1674-62-0] [1985-46-2] [62-51-1] n/f n/f n/f [3963-95-9] [1095-90-5] [51-57-0] [53-46-3] [33032-12-1] [72-44-6] [50-11-3] [554-57-4] [1982-37-2] [1229-35-2] [100-97-0] [5714-73-8] [587-23-5] [7246-14-2]

Description Metformin Related Compound A (50 mg) (1-Cyanoguanidine) Metformin Related Compound B (25 mg) (1Methylbiguanide hydrochloride) Metformin Related Compound C (25 mg) (N,NDimethyl-[1,3,5]triazine-2,4,6-triamine) Methacholine Chloride (500 mg) (AS) Methacrylic Acid Copolymer Type A (200 mg) Methacrylic Acid Copolymer Type B (200 mg) Methacrylic Acid Copolymer Type C (100 mg) Methacycline Hydrochloride (200 mg) Methadone Hydrochloride CII (200 mg) Methamphetamine Hydrochloride CII (125 mg) Methantheline Bromide (200 mg) Methapyrilene Fumarate (200 mg) Methaqualone CI (500 mg) Metharbital CIII (200 mg) Methazolamide (500 mg) Methdilazine (200 mg) Methdilazine Hydrochloride (200 mg) Methenamine (500 mg) Methenamine Hippurate (200 mg) Methenamine Mandelate (200 mg) Methicillin Sodium (500 mg) (AS)

1411005 1411504 1412008 1413000 1414003 1415006 1416009 1417001 1418004 1419007 1421009 1422001 1424007 1424018

Methimazole (200 mg) L-Methionine (200 mg) Methocarbamol (200 mg) Methohexital CIV (500 mg) Methotrexate (500 mg) Methotrimeprazine (125 mg) Methoxamine Hydrochloride (200 mg) Methoxsalen (500 mg) Methoxyurane (1 mL) Methoxyphenamine Hydrochloride (250 mg) Methscopolamine Bromide (200 mg) Methsuximide (500 mg) Methyclothiazide (200 mg) Methyclothiazide Related Compound A (100 mg) (4-amino-6-chloro-N-3-methyl-m-benzenedisulfonamide) Methyl Alcohol (3 x 1.5 mL) Methylbenzethonium Chloride (500 mg) Methyl Benzylidene Camphor (200 mg) Methyl Caprate (300 mg)

G G1D398 H2B029 G0D252 J0D109 F-2 F H G F G1D004 F-2 G G 0.999 mg/mg (dr)

[60-56-0] [63-68-3] [532-03-6] [18652-93-2] [59-05-2] [60-99-1] [61-16-5] [298-81-7] [76-38-0] [5588-10-3]

G (02/05) F-1 (08/99) F-2 (12/00)

[155-41-9] [77-41-8] [135-07-9] n/f

1424109 1424211 1424222 1424233

F0D015 F0E101 F0B118 G0D087

0.999 mg/mg (ai)

[67-56-1] [25155-18-4] [36861-47-9] F (04/06) [110-42-9]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

68 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1424244 1424255 1424506 1425000 1426002 1427005 1428008 Curr. Lot. F G0D064 G0B222 F I1E059 G-2 H0D163 1.000 mg/mg (dr) (Colorimetric) 0. 90 mg /mg (d r) (TLC) G (08/05) 0.999 mg/mg (an) I (02/06) 1.00 mg/mg (ai) F (07/05) F-2 (05/03) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. [106-70-7] [111-11-5] [9004-67-5] [15589-00-1] [41372-08-1] [2508-79-4] [7220-79-3]

Description Methyl Caproate (300 mg) Methyl Caprylate (300 mg) Methylcellulose (1 g) (AS) 4-Methyl-2,5-dimethoxyamphetamine Hydrochloride CI (25 mg) (AS) (STP) Methyldopa (500 mg) Methyldopate Hydrochloride (200 mg) Methylene Blue (250 mg)

1429000 1430000 1430305 1430327 1430349 1430509 1431002 1431501 1431556 1431603 1431625 1432005 1433008 1434011 1434022

Methylenedioxy-3,4-amphetamine Hydrochloride CI (25 mg) (AS) (MDA) Methylergonovine Maleate (50 mg) (List Chemical) Methyl Laurate (500 mg) Methyl Linoleate (5 x 50 mg) Methyl Linolenate (5 x 50 mg) 3-O-Methylmethyldopa (50 mg) Methyl 5-methyl-3-isoxazolecarboxylate (25 mg) Methyl Myristate (300 mg) Methyl Oleate (500 mg) Methyl Palmitate (300 mg) Methyl Palmitoleate (300 mg) Methylparaben (125 mg) Methylphenidate Hydrochloride CII (125 mg) Methylphenidate Hydrochloride Erythro Isomer Solution CII (0.5 mL) Methylphenidate Related Compound A (50 mg) (alpha-Phenyl-2-piperidineacetic Acid Hydrochloride) Methylprednisolone (200 mg) Methylprednisolone Acetate (200 mg) Methylprednisolone Hemisuccinate (200 mg) Methyl Salicylate (2 mL) (AS) Methyl Stearate (300 mg) Methyltestosterone CIII (200 mg) Methysergide Maleate (350 mg) Metoclopramide Hydrochloride (500 mg) Metocurine Iodide (300 mg) Metolazone (200 mg) Metoprolol Fumarate (200 mg) Metoprolol Related Compound A (20 mg) ((+/-)1(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]-propan-2-ol)

F-1 J G0C356 G0D107 G-1 F-1 G0C357 G0C148 G0E329 F K0C382 I1C241 F0C368 G 0.5 mg/mL (ai) F-2 (10/99) 0.999 mg/mg (dr) J-1 (10/05) J (03/03)) I (04/05) H (05/01) 1.00 mg/mg (ai) 0.998 mg/mg (ai) F (01/01) F (03/05) F (04/04) F(02/07) 0.998 mg/mg (ai) 0.99 mg/mg (ai) I (05/02) F (03/05) F (07/06) F (09/06)

[6292-91-7] [57432-61-8] [111-82-0] [112-63-0] [301-00-8] n/f n/f [124-10-7] [112-62-9] [112-39-0] n/f [99-76-3] [298-59-9] n/f n/f

1435003 1436006 1437009 1437450 1437508 1438001 1440003 1440808 1441006 1441200 1441287 1441232

I0E170 H0D148 I1F076 F0D070 G0E290 J1E324 H1F038 H0D121 G G0B246 F F0C343

0.995 mg/mg (dr) 0.995 mg/mg (ai) 0.998 mg/mg (ai) 99.1 % (ai) 1.0 mg/mg (ai) 0.996 mg/mg (dr) 0.997 mg/mg (dr) 0.999 mg/mg (an) 2

H (07/06) G-2 (05/05) G-1 (02/00) I0C146 (06/07) H (07/04) F (11/06) J (02/07) I (11/01) H (12/06) G (06/05) F-2 (06/99) F-1 (05/03)

[83-43-2] [53-36-1] [2921-57-5] [119-36-8] [112-61-8] [58-18-4] [129-49-7] [54143-57-6] [7601-55-0] [17560-51-9] [119637-66-0] n/f

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

69

USP Reference Standards and Authentic Substances

Cat. No. 1441243 Curr. Lot. G0E189 Purity Value/Conc. Change Code* Previous Lot/Valid Use Date F0C377 (03/07) CAS No. n/f

Description Metoprolol Related Compound B (50 mg) ((+/-)1chloro-2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propane) Metoprolol Related Compound C (20 mg) ((+/-)4[2-Hydroxy-3-(1-methylethyl)aminopropoxy]benzaldehyde) Metoprolol Related Compound D (50 mg) ((+/)N,N-bis-[2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl](1-methylethyl)amine hydrochloride) Metoprolol Succinate (200 mg) Metoprolol Tartrate (200 mg) Metrizamide (500 mg) Metronidazole (100 mg) Metyrapone (200 mg) Metyrosine (200 mg) Mexiletine Hydrochloride (200 mg) Mezlocillin Sodium (350 mg) Miconazole (200 mg) Miconazole Nitrate (200 mg) Powdered Milk Thistle Extract (250 mg) Milrinone (500 mg) Milrinone Related Compound A (50 mg) (1,6Dihydro-2-methyl-6-oxo(3,4-bipyridine)-5-carboxamide) Minocycline Hydrochloride (200 mg) Minoxidil (125 mg) Mirtazapine (350 mg) Mitomycin (50 mg) Mitotane (500 mg) Mitoxantrone Hydrochloride (400 mg) Mitoxantrone System Suitability Mixture (0.3 mg) Modanil CIV (200 mg) Molindone Hydrochloride (500 mg) Mometasone Furoate (200 mg)

1441254

F0C344

n/f

1441265

G0E188

F0C378 (12/06)

n/f

1441298 1441301 1441505 1442009 1443001 1443205 1443250 1443307 1443409 1443500 1443850 1443908 1443919

F0C415 H1B059 F J0C316 H F F3E098 G G-1 J0D011 F0B321 H0F083 F0C051

0.998 mg/mg (ai) H (01/04) G-1 (11/99) 1.000 mg/mg (dr) I (07/05) G (06/01) 0.999 mg/mg (dr) F-2 (02/06) F-1 (09/02) G (07/02) 0.997 mg/mg (dr) I (06/06) H (06/99) G0D340 (04/07) F0C050 (09/05)

[98418-47-4] [56392-17-7] [31112-62-6] [443-48-1] [54-36-4] [672-87-7] [5370-01-4] [59798-30-0] [22916-47-8] [22832-87-7] [84604-20-6]

0.999 mg/mg (an)

[78415-72-2] [80047-24-1]

1444004 1444208 1444279 1444707 1445007 1445200 1445211 1445404 1445459 1445470

I0C178 H1C168 F0D155 K G0C044 I0D174 F0D010 F0D351 F H0E009 0.998 mg/mg (dr) 0.997 mg/mg (ai) 0.990 mg/mg (an) 0.999 mg/mg (an)

H-3 (04/04) H-2 (07/02) H (03/04) G (05/99) J (07/01) F (07/04) H (05/05) G (03/01)

[13614-98-7] [38304-91-5] [61337-67-5] [50-07-7] [53-19-0] [70476-82-3] n/f [68693-11-8] [15622-65-8]

G0B073 (01/07) F-1 (04/03) F (02/01)

[83919-23-7]

1445481 1445506 1445925 1445801 1446000 1446600 1446804 1446906 1446950

Monensin Sodium (200 mg) Monobenzone (200 mg) Monoethanolamine (1 mL) Mono- and Di-acetylated Monoglycerides (200 mg) Monoglycerides (125 mg) Monosodium Glutamate (1 g) (AS) Monostearyl Maleate (100 mg) Morantel Tartrate (100 mg) Moricizine Hydrochloride (250 mg)

F0B293 F F0D149 F H1D232 F0D387 G F0D295 F1D057 0.997 mg/mg (ai) 0.999 mg/mg (an) F (03/05) 0.963 mg/mg (ai) 99.7% (ai) F-2 (04/00) H (11/05)

[22373-78-0] [103-16-2] [141-43-5] [68990-54-5] [68990-53-4] [6106-04-3] [2424-62-6] [26155-31-7] [29560-58-5]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

70 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1447002 1448005 Curr. Lot. G1F125 N0E161 0.999 mg/mg (an) Purity Value/Conc. Change Code* 2 Previous Lot/Valid Use Date G (05/07) M0D016 (09/06) L0B056 (04/05) K (06/03) J-1 (07/00) F-1 (12/04) F (03/02) 926 ug/mg (ai) G (03/05) F (02/01) F (02/02) CAS No. [6009-81-0] [6211-15-0]

Description Morphine Monohydrate CII (50 mg) (AS) Morphine Sulfate CII (500 mg)

1448504 1448901 1448923 1448990 1449008 1449518 1449530 1449700 1450007 1450404 1451000 1452002 1453005

Moxalactam Disodium (500 mg) Mupirocin (50 mg) Mupirocin Lithium (100 mg) Myristic Acid (200 mg) Myristyl Alcohol (1 g) Nabumetone (200 mg) Nabumetone Related Compound A (15 mg) (1-(6Methoxy-2-naphthyl)-but-1-en-3-one) Nadolol (200 mg) Nafcillin Sodium (200 mg) Naftine Hydrochloride (200 mg) Nalidixic Acid (200 mg) Nalorphine Hydrochloride CIII (250 mg) Naloxone (125 mg)

F-1 F2C158 H0C176 F0E120 G F0C072 F0D165 G0C308 H F G I M0D085 0.999 mg/mg (dr) L0B124 (09/06) K-1 (12/02) K (07/01) G1B039 (03/04) G (02/03) 0.995 mg/mg (ai) F-3 (04/05) F-2 (04/02)

[64953-12-4] [12650-69-0] [73346-79-9] [544-63-8] [112-72-1] [42924-53-8] n/f [42200-33-9] [7177-50-6] [65473-14-5] [389-08-2] [57-29-4] [465-65-6]

1453504 1453526 1454008 1455000 1456003 1457006 1457301 1457403 1457469 1457491 1457505 1457902 1458009

Naltrexone (200 mg) Naltrexone Related Compound A CII (30 mg) (N(3-butenyl)-noroxymorphone Hydrochloride) Nandrolone CIII (50 mg) Nandrolone Decanoate CIII (250 mg) Nandrolone Phenpropionate CIII (250 mg) Naphazoline Hydrochloride (200 mg) Naproxen (200 mg) Naproxen Sodium (200 mg) Naratriptan Hydrochloride (125 mg) Naratriptan Resolution Mixture (20 mg) Natamycin (200 mg) Nefazodone Hydrochloride (200 mg) Neomycin Sulfate (200 mg)

H0C150 F F4D144 J0D218 H L0E207 I-1 J0C379 F0C360 F0E346 J0D180 F0F122 L3E135 0.917 mg/mg (ai) 0.999 mg/mg (ai) 782 ug/mg (dr) 1 0.999 mg/mg (dr) 0.998 mg/mg (ai) 1 0.989 mg/mg (dr) 1.00 mg/mg (ai) 0.999 mg/mg (dr)

[16590-41-3] n/f

F-3 (04/05) I (06/06) K (02/07) I (03/03) H-1 (01/01) I (07/05)

[434-22-0] [360-70-3] [62-90-8] [550-99-2] [22204-53-1] [26159-34-2] [143388-64-1] -

I (06/05) H (11/99) L-2 (01/07) L-1 (09/01) L (02/99) H (07/00)

[7681-93-8] [82752-99-6] [1405-10-3]

1459001 1460000 1460204 1460215

Neostigmine Bromide (200 mg) Neostigmine Methylsulfate (200 mg) Neotame (200 mg) Neotame Related Compound A (15 mg) (N-[N(3,3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine) Netilmicin Sulfate (500 mg) Nevirapine Anhydrous (100 mg)

G I F0F044 F0F045 0.954 mg/mg (ai) 1.00 mg/mg (ai)

[114-80-7] [51-60-5] [165450-17-9] n/f

1460500 1460703

I0C388 F0D159

653 ug/mg (dr) 0.997 mg/mg (ai)

H (01/05) G (05/02)

[56391-57-2] [129618-40-2]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

71

USP Reference Standards and Authentic Substances

Cat. No. 1460714 1460725 Curr. Lot. F0D034 F0D035 Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. n/f n/f

Description Nevirapine Hemihydrate (100 mg) Nevirapine Related Compound A (15 mg) (5,11Dihydro-6H-11-ethyl-4-methyl-dipyrido[3,2-b2,3e][1,4]diazepin-6-one) Nevirapine Related Compound B (15 mg) (5,11Dihydro-4-methyl-6H-dipyrido[3,2-b:2,3-e][1,4]diazepin-6-one) Niacin (200 mg) Niacinamide (500 mg) (Vitamin B3) Nicotine Bitartrate Dihydrate (500 mg) Nifedipine (125 mg) Nifedipine Nitrophenylpyridine Analog (25 mg) Nifedipine Nitrosophenylpyridine Analog (25 mg) Nitrofurantoin (500 mg) Nitrofurantoin Related Compound A (25 mg) (N(Aminocarbonyl)-N-[([5-nitro-2-furanyl]-methylene)amino]-glycine) Nitrofurazone (200 mg) Nitrofurfural Diacetate (100 mg) Nitrofurazone Related Compound A (500 mg) (5Nitro-2-furfuraldazine) Diluted Nitroglycerin (5 ampules, approx. 200 mg of a 0.948% solution in propylene glycol each) Nizatidine (200 mg) Nonoxynol 9 (0.5 mL) Nonoxynol 10 (200 mg) Nordazepam CIV (50 mg) (7-Chloro-1,3-dihydro-5phenyl-2H-1,4-benzodiazepin-2-one) Norepinephrine Bitartrate (125 mg) Norethindrone (200 mg)

1460736

F0D033

n/f

1461003 1462006 1463304 1463508 1463600 1463701 1464001 1021703

I0E295 N0E024 G1C070 K0D401 K K J F2E037

0.998 mg/mg (ai) 0.999 mg/mg (dr)

H2C121 (02/07) H-1 (01/05) M-1 (04/06) M (02/01) G (05/05) F (05/99)

[59-67-6] [98-92-0] [6019-06-3] [21829-25-4] n/f n/f [67-20-9] n/f

0.998 mg/mg (ai)

J0B243 (03/06) I-1 (04/04) J (04/01) J (07/02) I-1 (11/02)

0.98 mg/mg (ai)

F-1 (08/06)

1465004 1465503 1466007 1466506 1467804 1467950 1468002 1468400 1468501 1469005

I0E149 G0D066 H0B100 G G H-1 F H1B035 I0C381 K0C307

0.995 mg/mg (ai) 0.99 mg/mg (ai)

H-1 (11/06) H (09/01) F-1 (12/04) G (07/03)

[59-87-0] [92-55-7] n/f [55-63-0]

F-1 (06/00) H (03/02) H (03/03) G (03/00) H (04/05) 0.998 mg/mg (ai) J1B065 (09/05) J-1 (05/03) J (07/02) I-1 (03/01) J0B072 (09/06) I (04/03) H (06/99) H (12/06) G (04/01) 1 1 I (07/04) H (05/99) H (11/04)

[76963-41-2] [26027-38-3] [26027-38-3] [1088-11-5] [69815-49-2] [68-22-4]

1470004

Norethindrone Acetate (100 mg)

J1E102

0.997mg/mg (dr)

[51-98-9]

1471007 1471506 1471914 1471958 1471925 1472000 1473002 1473206

Norethynodrel (200 mg) Noroxacin (200 mg) Norgestimate (200 mg) Deacetylnorgestimate (25 mg) ((E)- and (Z)-17deacetyl norgestimate mixture) Norgestimate Related Compound A (25 mg) (Levonorgestrel Acetate) Norgestrel (125 mg) Noroxymorphone Hydrochloride CII (50 mg) Norphenylephrine Hydrochloride (25 mg)

G H1D317 F0C086 F0F089 F0F109 J0C269 H1C177 F0E205 0.995 mg/mg (dr)

[68-23-5] [70458-96-7] [35189-28-7] [53016-31-2] [13732-69-9] [6533-00-2] n/f [15308-34-6]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

72 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1474005 1474504 1475008 1476000 1477003 1477900 1477943 1477411 1477502 1477808 1478108 1478119 Curr. Lot. I1D054 G H0D327 F-2 O0D177 H0D213 G0D278 G0C211 G H0D059 G0E180 F0E276 0.999 mg/mg (ai) 5751 Nystatin units/ mg (dr) 0.987 mg/mg (ai) 0.995 mg/mg (ai) N1B004 (09/05) N (01/03) G0C024 (09/05) F0B032 (12/03) F0B091 (12/05) F0B104 (05/04) F-2 (07/00) G (03/06) F-1 (07/99) F-2 (07/06) F-1 (08/02) 1012 ug/mg (dr) G-2 (05/05) Purity Value/Conc. 1.000 mg/mg (dr) Change Code* Previous Lot/Valid Use Date I (05/05) H (04/00) CAS No. [894-71-3] [128-62-1] [303-81-1] [849-55-8] [1400-61-9] [5466-77-3] [118-60-5] [6197-30-4] [9002-93-1] [5333-42-6] [82419-36-1] [82419-52-1]

Description Nortriptyline Hydrochloride (200 mg) Noscapine (500 mg) Novobiocin (200 mg) Nylidrin Hydrochloride (200 mg) Nystatin (200 mg) Octinoxate (500 mg) (Octyl Methoxycinnamate) Octisalate (400 mg) (Octyl Salicylate) Octocrylene (500 mg) Octoxynol 9 (200 mg) Octyldodecanol (200 mg) Ooxacin (200 mg) Ooxacin Related Compound A (25 mg) ((RS)-9uoro-2,3-dihydro-3-methyl-7-oxo-10-(piperazin-1yl)-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid) Oleic Acid (1 g) Oleoyl Polyoxylglycerides (100 mg) Olive Oil (1 g) (AS) Omeprazole (200 mg)

1478130 1478152 1478254 1478505

F0E001 F0C313 F0D175 H1B211 H (05/04) G-1 (04/02) G (09/01)

[112-80-1] n/f [8001-25-0] [73590-58-6]

1478516 1478571 1478582 1478593

Omeprazole Related Compound A (15 mg) (Omeprazole Sulfone) (AS) Ondansetron (300 mg) Ondansetron Hydrochloride (300 mg) Ondansetron Related Compound A (50 mg) (3[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl4H-carbazol-4-one hydrochloride) Ondansetron Related Compound C (50 mg) (1,2,3,9-Tetrahydro-9-methyl-4H-carbazol-4-one) Ondansetron Related Compound D (30 mg) (1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one) Ondansetron Resolution Mixture (50 mg) Orphenadrine Citrate (200 mg) Orphenadrine Related Compound A (50 mg) ((RS)-N,N-dimethyl-2-[(3-methylphenyl)-phenylmethoxy]ethanamine citrate) (AS) Oxacillin Sodium (200 mg) Oxandrolone CIII (50 mg) Oxandrolone Related Compound B CIII (20 mg) (17 beta-hydroxy-17 alpha-methyl-4-oxa-5 alphaandrosta-3-one) Oxaprozin (200 mg) Oxazepam CIV (200 mg) Oxfendazole (200 mg)

F0D363 F0E281 G0D154 F0C191 0.999 mg/mg (an) 0.993 mg/mg (an) F0C222 (05/05)

[88546-55-8] [99614-02-5] [103639-04-9] [119812-29-2]

1478618 1478629

F0C251 G0F153 1.00 mg/mg (ai) 2,3 F0C226 (06/07)

[27397-31-1] n/f

1478630 1479009 1479010

F0D242 G F0F042 F-4 (05/02)

n/f [4682-36-4] n/f

1481000 1482003 1482025

J H0E223 F0F136 0.994 mg/mg (ai) 1

I (03/02) G0B220 (08/06) F-4 (07/03)

[7240-38-2] [53-39-4] [4424-45-7]

1482207 1483006 1483301

F0C115 H0D259 F0C128 1.000 mg/mg (dr) G-1 (08/05) G (12/00)

[21256-18-8] [604-75-1] [53716-50-0]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

73

USP Reference Standards and Authentic Substances

Cat. No. 1483505 1484009 1485001 1485103 1485114 1485125 1485136 Curr. Lot. I0C344 G H0B263 H0E080 H0E169 F0D061 F0D062 0.998 mg/mg (dr) 1.00 mg/mg (dr) G (11/03) F-2 (12/99) G-1 (05/06) G (11/02) G (07/06) F-2 (01/00) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date H (02/05) CAS No. [6452-73-9] [4499-40-5] [131-57-7] [1508-65-2] [4335-77-7] [10399-13-0] n/f

Description Oxprenolol Hydrochloride (200 mg) Oxtriphylline (500 mg) Oxybenzone (150 mg) Oxybutynin Chloride (200 mg) Oxybutynin Related Compound A (100 mg) (Phenylcyclohexylglycolic Acid) Oxybutynin Related Compound B (20 mg) (Cyclohexyl mandelic acid methyl ester) Oxybutynin Related Compound C (20 mg) (4(Ethylmethylamino)but-2-ynyl(+/-)-2-cyclohexyl-2hydroxy-2-phenylacetate hydrochloride) Oxycodone CII (200 mg)

1485191

J0F026

0.999 mg/mg (dr)

I1D206 (03/07) I0B046 (08/05) H (01/03) G-1 (01/01) I (03/05) G (10/03) G (03/03) F (07/02)

[76-42-6]

1486004 1487007 1488000 1490103 1491004 1491015 1491300 1491332 1491343 1491354 1491503 1492040 1492007 1492801 1493000 1494057

Oxymetazoline Hydrochloride (200 mg) Oxymetholone CIII (200 mg) Oxymorphone CII (500 mg) Oxyquinoline Sulfate (200 mg) Oxytetracycline (200 mg) Oxytetracycline Hydrochloride (200 mg) (AS) Oxytocin (5 vials, 46 USP units per vial) Paclitaxel (200 mg) Paclitaxel Related Compound A (20 mg) (Cephalomannine) Paclitaxel Related Compound B (20 mg) (10Deacetyl-7-epipaclitaxel) Padimate O (300 mg) Palm Oil (1 g) (AS) Palmitic Acid (500 mg) Pamidronate Disodium (100 mg) Pamoic Acid (250 mg) Pancreatin Amylase and Protease (2 g)

J0C206 G1B247 H0B214 F-1 J0C084 F0E258 F G0E018 F0C179 G0E019 H0B154 F0D179 K0F048 F0F096 G-4 I1E218 174 USP Units of amylase activity/mg 124 USP Units of protease activity/mg 21.2 USP Units of Lipase Activity/mg (ai) 0.99 mg/mg (an) 0.758 mg/mg (ai) 1 0.98 mg/mg (ai) 0.989 mg/mg (ai) 913 ug/mg (ai)

[2315-02-8] [434-07-1] [76-41-5] [134-31-6] [6153-64-6] [2058-46-0] [50-56-6]

I-1 (10/04)

F0C180 (04/06)

[33069-62-4] [71610-00-9]

F0C181 (03/06) G (04/03) J0D329(01/07) I (12/05) G-3 (01/03) I (09/06) H (10/00)

nf [21245-02-3] [8002-75-3] [57-10-3] [109552-15-0] [130-85-8] [8049-47-6]

1494079

Pancreatin Lipase (2 g)

I1E327

I (05/06) H-1 (03/01)

[8049-47-6]

1494217 1494501 1494807 1495005

Pancuronium Bromide (200 mg) Panthenol, Racemic (200 mg) Pantolactone (500 mg) Papain (1 g)

F0D377 G

[15500-66-0] F-1 (02/00) F (06/07) 6 I0C389 (07/06) H (06/04) G (12/01) [16485-10-2] [599-04-2] [9001-73-4]

1496008 1497000 1498003 1498706

Papaverine Hydrochloride (200 mg) Paramethadione (500 mg) Paramethasone Acetate (200 mg) Parbendazole (200 mg)

H G G F F-1 (05/01)

[61-25-6] [115-67-3] [1597-82-6] [14255-87-9]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

74 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1499006 1500003 1500218 1500230 Curr. Lot. F-1 G G0D003 G0D137 0.972 mg/mg (ai) 0.92 mg/mg (ai) F-3 (01/01) F0B288 (09/04) F0B189 (10/05) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. [306-07-0] [1263-89-4] [110429-35-1] n/f

Description Pargyline Hydrochloride (200 mg) Paromomycin Sulfate (125 mg) Paroxetine Hydrochloride (350 mg) Paroxetine Related Compound B (10 mg) (trans-4phenyl-3-[(3,4-methylenedioxy)phenoxymethyl]piperidine hydrochloride) Paroxetine Related Compound C (15 mg) ((+)trans-Paroxetine hydrochloride) Paroxetine Related Compound D (10 mg) (AS) (cis-Paroxetine hydrochloride) Paroxetine Related Compound E Mixture (25 mg) (1-Methyl-4-(p-uorophenyl)-1,2,3,6-tetrahydropyridine in Paroxetine Hydrochloride Matrix) Paroxetine Related Compound F (10 mg) (trans(-)1-Methyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4uorophenyl)piperidine) Paroxetine Related Compound G (0.4 mg) ((+/)trans-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4uorophenyl-4-phenyl)piperidine hydrochloride) Paroxetine System Suitability Mixture A (50 mg) Parthenolide (25 mg) Particle Count Set (2 blanks and 2 suspensions) Peanut Oil (1 g) (AS) Penbutolol Sulfate (200 mg) Penicillamine (200 mg) Penicillamine Disulde (100 mg) Penicillin G Benzathine (200 mg) Penicillin G Potassium (200 mg)

1500240 1500251 1500262

G0D053 G0E096 F1F028

0.96 mg/mg (ai)

F0B192 (05/05) F0C228 (12/06)

[130855-30-0] n/f n/f

0.86 ng/mg (ai)

F0D225 (11/06)

1500273

F0D237

1.00 mg/mg (ai)

n/f

1500284

G0E121

0.4 mg in ~1.5 mg povidone

F0D110 (12/06)

n/f

1500353 1500400 1500502 1500557 1500808 1501006 1501108 1502009 1502508

F0E150 F J0D067 F0D171 F H1B164 H J1D164 J0C349 89.3%/1595 USP Penicillin G units/mg (ai) H (01/04) G (07/00) J (04/06) I (07/05) H (02/99) F-1 (08/04) F (03/99) L-3 (08/06) L-2 (09/01) F (08/05) G-1 (06/04) G (06/00) 0.998 mg/mg (dr) H (01/05) G-1 (11/00) F (09/01) 0.997 mg/mg (ai) H3C144 (12/04) H-2 (07/04) H-1 (08/02) F0B202 (12/05) F (04/04) F (07/04) 0.998 mg/mg (dr) J0B249 (04/07) I (10/03) G (07/02) I (12/05) H (09/02)

n/f [20554-84-1] n/f [8002-03-7] [38363-32-5] [52-67-5] [20902-45-8] [41372-02-5] [113-98-4]

1502552 1502701 1504489 1504503 1505007 1505506 1507002

Penicillin G Procaine (200 mg) Penicillin G Sodium (150 mg) Penicillin V (200 mg) Penicillin V Potassium (200 mg) Pentazocine CIV (500 mg) Pentetic Acid (100 mg) Pentobarbital CII (200 mg)

G0C271 L4C366 F1C318 H0C213 I0C418 F-1 I0D359

[6130-64-9] [69-57-8] [87-08-1] [132-98-9] [359-83-1] [67-43-6] [76-74-4]

1508901 1510007 1510801 1510845 1510867 1511000 1511203 1512002

Pentoxifylline (200 mg) Pepsin (5 g) Perubron (0.5 mL) Pergolide Mesylate (200 mg) Pergolide Sulfoxide (50 mg) Perphenazine (200 mg) Perphenazine Sulfoxide (100 mg) Phenacemide (250 mg)

F1D350 F-2 G0C103 F1C225 F0B014 K0F018 G-1 F

0.999 mg/mg (dr)

[6493-05-6] [9001-75-6] [423-55-2] [66104-23-2] [72822-01-6] [58-39-9] [10078-25-8] [63-98-9]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

75

USP Reference Standards and Authentic Substances

Cat. No. 1513005 1514008 1515000 1516003 1516502 1517006 1517301 1517607 1520000 1522006 1522301 1523009 1524001 1524806 1524908 1525004 1525707 1526007 1526200 1528002 1528501 1529005 1530004 1530503 1530809 1531007 1533002 1533250 1533308 1533851 1533909 1534005 1534402 1534413 Curr. Lot. H-1 H3A009 H0C426 G1B025 G G F F G F F1C342 F-2 J F0F029 F-3 F-2 F0D231 G F0D069 G H0B309 F I H F J0A008 K1C290 F0D395 F F F J F0E127 F0E128 I (02/02) I-1 (02/03) K (03/05) J (02/99) G (02/02) 0.998 mg/mg (ai) F-1 (03/01) G (08/03) 0.994 mg/mg (dr) 0.999 mg/mg (ai) F (08/04) 0.998 mg/mg (dr) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date H (09/00) H-2 (02/03) H-1 (06/01) G-4 (12/04) G (12/02) F (01/01) F-1 (04/02) CAS No. [62-44-2] [62-44-2] [136-40-3] [956-90-1] [50-58-8] [156-51-4] n/f n/f [834-28-6] [83-12-5] [132-20-7] [1707-14-8] [50-06-6] [108-95-2] [77-09-8] [143-74-8] [92-84-2] [63-92-3] [122-99-6] [86-34-0] [1197-21-3] [73-05-2] [65-28-1] [63-91-2] [27503-81-7] [50-33-9] [61-76-7] [60-12-8] [89-24-7] n/f [67244-90-0] [154-41-6] [1176-08-5] n/f

Description Phenacetin (500 mg) Phenacetin Melting Point Standard (500 mg) (Approximately 135 degrees) Phenazopyridine Hydrochloride (200 mg) Phencyclidine Hydrochloride CII (25 mg) (AS) Phendimetrazine Tartrate CIII (350 mg) Phenelzine Sulfate (200 mg) D-Phenethicillin Potassium (200 mg) L-Phenethicillin Potassium (200 mg) Phenformin Hydrochloride (200 mg) Phenindione (250 mg) Pheniramine Maleate (100 mg) Phenmetrazine Hydrochloride CII (200 mg) Phenobarbital CIV (200 mg) Phenol (500 mg) Phenolphthalein (250 mg) Phenolsulfonphthalein (100 mg) Phenothiazine (500 mg) (AS) Phenoxybenzamine Hydrochloride (250 mg) Phenoxyethanol (500 mg) (2-Phenoxyethanol) Phensuximide (500 mg) Phentermine Hydrochloride CIV (200 mg) Phentolamine Hydrochloride (300 mg) Phentolamine Mesylate (200 mg) L-Phenylalanine (200 mg) Phenylbenzimidazole Sulfonic Acid (200 mg) Phenylbutazone (250 mg) Phenylephrine Hydrochloride (125 mg) Phenylethyl Alcohol (1 mL) 5-Phenylhydantoin (100 mg) Phenylpropanediol (100 mg) Phenylpropanolamine Bitartrate (100 mg) (List Chemical) Phenylpropanolamine Hydrochloride (250 mg) (List Chemical) Phenyltoloxamine Citrate (100 mg) Phenyltoloxamine Related Compound A (50 mg) (2-(2-benzylphenoxy)ethylmethylamine hydrochloride) Phenytoin (200 mg)

1535008

J0E090

0.999 mg/mg (ai)

I2B233 (05/06) I-1 (03/04) I (04/01) H (02/07) G (05/99)

[57-41-0]

1535507 1535019 1535020

Phenytoin Sodium (200 mg) Phenytoin Related Compound A (50 mg) (2,2Diphenylglycine) Phenytoin Related Compound B (50 mg) (alpha((aminocarbonyl)amino)-alpha-phenyl benzeneacetic acid) Phosphated Riboavin (100 mg)

H1E335 F0C155 F0C157

1.000 mg/mg (dr) (UV)

[630-93-3] [3060-50-2] [6802-95-5]

1535700

G1B286

G (07/04)

[6184-17-4]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

76 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1535802 1537003 1538006 1538505 1538902 1539009 1539508 1539701 1541000 1541500 1541703 1541805 1541907 1542003 1543006 1544508 1545205 1545409 1545500 1546106 1546300 1546707 1546809 Curr. Lot. F0D026 H-1 N0B303 F I0D055 I1E138 G I0B210 F H F F F F F H1D038 H F1D233 F-2 F0C009 H0C020 G1D115 H0E114 G-5 (05/04) G-4 (06/01) G (06/05) F-1 (04/01) G1B166 (10/06) G (06/04) F-2 (12/99) 0.998 mg/mg (ai) H (07/05) G (01/99) G (04/00) F (05/06) F-1 (09/00) H-1 (12/04) 0.998 mg/mg (dr) 0.991 mg/mg (dr) H (09/05) I (11/06) Purity Value/Conc. 86.8% (ai) H (06/00) M-1 (07/04) M (09/01) Change Code* Previous Lot/Valid Use Date CAS No. [7664-38-2] [57-64-7] [84-80-0] [92-13-7] [54-71-7] [148-72-1] [2062-78-4] [13523-86-9] [3819-00-9] [66258-76-2] [142-88-1] [144-29-6] [142-64-3] [14538-56-8] [129-77-1] [36322-90-4] [18378-89-7] n/f n/f [9003-11-6] [9016-00-6] [9002-88-4] [9002-88-4]

Description Phosphoric Acid (1.5 mL/ampule; 3 ampules) (AS) Physostigmine Salicylate (200 mg) Phytonadione (500 mg) (Vitamin K1) Pilocarpine (300 mg) Pilocarpine Hydrochloride (200 mg) Pilocarpine Nitrate (200 mg) Pimozide (200 mg) Pindolol (200 mg) Piperacetazine (250 mg) Piperacillin (500 mg) Piperazine Adipate (200 mg) Piperazine Citrate (200 mg) Piperazine Dihydrochloride (200 mg) Piperazine Phosphate (200 mg) Piperidolate Hydrochloride (200 mg) Piroxicam (200 mg) Plicamycin (50 mg) Polacrilex Resin (100 mg) Polacrilin Potassium (200 mg) Poloxalene (500 mg) Polydimethylsiloxane (500 mg) Polyethylene, High Density (3 strips) Low-Density Polyethylene (3 strips)

1546401 1546423 1546445 1546467 1546489 1546503 1546525 1546547 1546569 1546580 1546605 1546627 1546649 1546650 1546660 1546853 1546900 1546922 1546966 1547007 1547200

Polyethylene Glycol 200 (1 g) Polyethylene Glycol 300 (1 g) Polyethylene Glycol 400 (1 g) Polyethylene Glycol 600 (1 g) Polyethylene Glycol 1000 (1 g) Polyethylene Glycol 1500 (1 g) Polyethylene Glycol 3000 (1 g) Polyethylene Glycol 3350 (1 g) Polyethylene Glycol 4000 (1 g) Polyethylene Glycol 6000 (1 g) Polyethylene Glycol 8000 (1 g) Polyethylene Glycol 10000 (1 g) Polyethylene Glycol 12000 (1 g) Polyethylene Glycol 20000 (1 g) Polyethylene Glycol 35000 (1 g) Polyethylene Oxide (100 mg) Polyethylene Terephthalate (PET) (3 Strips) Polyethylene Terephthalate G (PETG) (3 Strips) Polyisobutylene (1 g) Polymyxin B Sulfate (200 mg) Polyoxyl 35 Castor Oil (1 g)

F0E316 F0E336 F0E344 F0E345 F0F008 F0F009 F0F013 F0F012 F0F040 F0F041 F0F050 F0F051 F0F052 F0F053 F0F054 F-1 F F F0E108 K F0E116 J-1 (09/99)

[25322-68-3] [25322-68-3] [25322-68-3] [25322-68-3] [25322-68-3] [25322-68-3] [25322-68-3] [25322-68-3] [25322-68-3] [25322-68-3] [25322-68-3] [25322-68-3] [25322-68-3] [25322-68-3] [25322-68-3] [25322-68-3] [25038-59-9] [25640-14-6] [9003-27-4] [1405-20-5] [61791-12-6]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

77

USP Reference Standards and Authentic Substances

Cat. No. 1547801 1372402 1547903 1547404 1547346 1372606 1547368 1547925 1547936 1547947 1547969 1548000 1549807 1548101 1548134 1549840 1548167 1548190 1548225 1550001 1551004 1548280 1548349 1551128 1551139 1551140 1548407 1551150 Curr. Lot. F0C292 F0E253 F-2 F F0D353 F0D354 F0D355 F0D130 F0D204 F0D131 F0D132 F-1 F0E083 F0D161 F0D074 F0D384 F0D075 F0D127 F0D201 H0C064 J0B292 F0D078 F0D325 F0D281 F0D313 F0D380 F0D264 I0B283 100.0% (dr) 100.0% (ai) 99.7% (dr) 100.0% (dr) 99.8% (an) 99.6% (dr) H0B119 (04/04) G-1 (04/03) G (02/01) 0.84 mg/mg (dr) H0B149 (12/04) G-1 (01/03) G (07/99) F (11/01) G-1 (03/01) G (08/99) 0.998 mg/mg (dr) I (10/05) H (11/02) F-1 (11/02) F-3 (07/02) F-2 (09/00) 99.7% (dr) 0.999 mg/mg (an) 99.9% (dr) 99.9% (dr( 99.8% (dr) 100.0% (dr) 100.0% (dr) G (06/04) I-1 (07/03) I (11/00) F-1 (05/00) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. [9004-95-9] [9002-92-0] [9004-99-3] [9004-99-3] [9005-00-9] [9005-00-9] [9005-00-9] [9005-64-5] [9005-66-7] [9005-67-8] [9005-65-6] [346-18-9] [127-08-2] [582-25-2] [298-14-6] [868-14-4] [584-08-7] [7447-40-7] [6100-05-6] [299-27-4] [78247-49-1] [7681-11-0] [7757-79-1] [7758-11-4] [7778-77-0] [6381-59-5] [24634-61-5] [76578-81-9]

Description Polyoxyl 20 Cetostearyl Ether (100 mg) Polyoxyl Lauryl Ether (500 mg) Polyoxyl 40 Stearate (200 mg) Polyoxyl 50 Stearate (200 mg) Polyoxyl 2 Stearyl Ether (1 g) (AS) Polyoxyl 10 Stearyl Ether (1 g) Polyoxyl 20 Stearyl Ether (1 g) (AS) Polysorbate 20 (2 g) (AS) Polysorbate 40 (2 g) (AS) Polysorbate 60 (2 g) (AS) Polysorbate 80 (2 g) (AS) Polythiazide (200 mg) Potassium Acetate (500 mg) (AS) Potassium Benzoate (1 g) (AS) Potassium Bicarbonate (1 g) (AS) Potassium Bitartrate (3 g) (AS) Potassium Carbonate (1 g) (AS) Potassium Chloride (1 g) (AS) Potassium Citrate (1 g) (AS) Potassium Gluconate (200 mg) Potassium Guaiacolsulfonate (500 mg) Potassium Iodide (1 g) (AS) Potassium Nitrate (5 g) (AS) Dibasic Potassium Phosphate (5 g) (AS) Monobasic Potassium Phosphate (5 g) (AS) Potassium Sodium Tartrate (2 g) (AS) Potassium Sorbate (1 g) (AS) Potassium Sucrose Octasulfate (300 mg)

1551300

Potassium Trichloroammineplatinate (20 mg)

I0D022

[13820-91-2]

1551503 1553000 1554002 1554501 1554603 1554658

Povidone (100 mg) Pralidoxime Chloride (200 mg) Pramoxine Hydrochloride (500 mg) Prazepam CIV (500 mg) Praziquantel (200 mg) Praziquantel Related Compound A (50 mg) (2benzoyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino [2,1a]isoquinolin-4-one) Praziquantel Related Compound B (50 mg) (2(cyclohexylcarbonyl)-2,3,6,7-tetrahydro-4H-pyrazino [2,1-alpha]isoquinolin-4-one) Praziquantel Related Compound C (50 mg) (2-(Nformylhexahydrohippuroyl)-1,2,3,4-tetrahydroisoquinolin-1-one)

F-1 G-2 I1D197 G0C066 G F-1

[9003-39-8] [51-15-0] [637-58-1] [2955-38-6] [55268-74-1] n/f

1554669

G0E039

0.98 mg/mg (dr)

F-2 (12/05) F-1 (06/00) F-1 (06/00)

n/f

1554670

F-2

n/f

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

78 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1554705 1555005 1556008 1556507 1557000 1558003 1559006 Curr. Lot. H0B254 N0D212 J 1.000 mg/mg (dr) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date G-1 (02/05) G (02/01) M (02/06) L-1 (04/02) I-1 (02/02) H-1 (05/07) H (02/99) F0E300 F N0E330 0.990 mg/mg (ai) (HPLC) 0.997 mg/mg (ai) (Spectrophotometric) M0D211 (03/07) L1B251 (11/05) L (11/04) K-1 (01/02) K (02/00) N (06/04) M (09/02) L (11/00) F-2 (03/04) 1.00 mg/mg (ai) CAS No. [19237-84-4] [50-24-8] [52-21-1] [2920-86-7] [125-02-0] [7681-14-3] [53-03-2]

Description Prazosin Hydrochloride (500 mg) Prednisolone (200 mg) Prednisolone Acetate (200 mg) Prednisolone Hemisuccinate (125 mg) Prednisolone Sodium Phosphate (100 mg) Prednisolone Tebutate (200 mg) Prednisone (250 mg)

1559505

Prednisone Tablets (Dissolution Calibrator, Disintegrating) (30 tablets) Prilocaine (200 mg) Prilocaine Hydrochloride (200 mg) Prilocaine Related Compound A (100 mg) (otoluidine hydrochloride) Prilocaine Related Compound B (50 mg) ((RS)-N(4-methylphenyl)-2-(propylamino)propanamide) Primaquine Phosphate (200 mg) Primidone (200 mg) Probenecid (200 mg) Probucol (200 mg) Probucol Related Compound A (25 mg) (2,2,6,6tetra-tert-butyldiphenoquinone) Probucol Related Compound B (25 mg) (4,4dithio-bis(2,6-di-tert-butylphenol)) Probucol Related Compound C (25 mg) (4-[(3,5-ditert-butyl-2-hydroxyphenylthio)isopropylidenethio]2,6-di-tert-butylphenol) Procainamide Hydrochloride (200 mg) Procaine Hydrochloride (200 mg) Procarbazine Hydrochloride (200 mg) Prochlorperazine Maleate (200 mg) Procyclidine Hydrochloride (200 mg) Progesterone (200 mg)

O0C056

[53-03-2]

1560990 1561008 1561019 1561020 1561507 1562000 1563003 1563309 1563320 1563331 1563342

F0E073 F3B215 F0E074 F0E075 F-1 H0D399 I0A011 G F-2 F-2 F-2 1.000 mg/mg (dr) G (07/06) F-6 (04/99) H-1 (03/03) F-1 (01/02) F-1 (11/04) F-1 (08/03) F-1 (05/00)

[721-50-6] [1786-81-8] [636-21-5] n/f [63-45-6] [125-33-7] [57-66-9] [23288-49-5] n/f n/f n/f

1563502 1564006 1565009 1566001 1567004 1568007

H1B117 I0E089 F H-1 G I0D373 0.998 mg/mg (ai) 0.998 mg/mg (dr)

H (04/03) H (12/06)

[614-39-1] [51-05-8] [366-70-1] [84-02-6] [1508-76-5]

H6C088(03/06) H-5 (11/04) H-4 (07/02) F-2 (09/05) F-1 (01/02) G (10/03) 2 K (06/07) J-1 (10/00) G (12/04) F-1 (01/01) H (11/02) F-1 (12/03)

[57-83-0]

1568506 1569000 1570009 1570304 1570508 1329505

L-Proline (200 mg) Promazine Hydrochloride (200 mg) Promethazine Hydrochloride (500 mg) Propafenone Hydrochloride (200 mg) Propantheline Bromide (200 mg) Propantheline Bromide Related Compound A (50 mg) (9-Hydroxypropantheline bromide)

G0D146 H0B261 L0F056 G1C184 I0A019 G0B258

1.00 mg/mg (dr)

[147-85-3] [53-60-1] [58-33-3] [34183-22-7] [50-34-0] n/f

0.998 mg/mg (dr)

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

79

USP Reference Standards and Authentic Substances

Cat. No. 1571001 1572208 1572503 1572536 1572547 1572558 1572525 Curr. Lot. G F0D029 F0D379 F0E060 F0D239 F0D240 F0D193 99.8 % w/w (ai) 0.999 mg/mg (ai) 1.00 mg/mg (ai) 0.99 mg/mg (ai) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. [5875-06-9] [79-09-4] [2078-54-8] n/f n/f n/f n/f

Description Proparacaine Hydrochloride (200 mg) Propionic Acid (1.5 mL/ampule; 3 ampules) (AS) Propofol (200 mg) Propofol Related Compound A (25 mg) (3,3-5,5Tetraisopropyldiphenol) Propofol Related Compound B (50 mg) (2,6diisopropylbenzoquinone) Propofol Related Compound C (50 mg) (2,6diisopropylphenyl isopropylether) Propofol Resolution Mixture (100 mg) (Propofol, 2,6-diisopropylphenyl isopropylether, and 2-isopropyl-6-n-propylphenol) Propoxycaine Hydrochloride (200 mg) Propoxyphene Hydrochloride CII (1 g) Propoxyphene Napsylate CII (1 g) Propoxyphene Related Compound A (50 mg) (alpha-d-4-dimethylamino-1,2-diphenyl-3-methyl-2butanol Hydrochloride) Propoxyphene Related Compound B (50 mg) (alpha-d-2-Acetoxy-4-dimethylamino-1,2-diphenyl3-methylbutane) Propranolol Hydrochloride (200 mg) Propylene Carbonate (200 mg) Propylene Glycol (1 mL) Propyl Gallate (200 mg) Propylparaben (200 mg) Propylthiouracil (200 mg) Prostaglandin A1 (25 mg) Prostaglandin B1 (25 mg) ((13E,15S)-15-Hydroxy9-oxoprosta-8(12),13-dien-1-oic Acid) Protriptyline Hydrochloride (200 mg) Pseudoephedrine Hydrochloride (125 mg) (List Chemical) Pseudoephedrine Sulfate (200 mg) (List Chemical) Pyrantel Pamoate (1 g) Pyrazinamide (200 mg) Pyridostigmine Bromide (200 mg) Pyridoxine Hydrochloride (200 mg) (Vitamin B6) Pyrilamine Maleate (200 mg) Pyrimethamine (200 mg) Pyrvinium Pamoate (500 mg) Quazepam CIV (200 mg) Quazepam Related Compound A (30 mg) (7Chloro-1-(2,2,2-triuoroethyl)-5-(2-uorophenyl)1,3-dihydro-2H-1,4-benzodiazepine-2-one) Quercetin (500 mg)

1573007 1574000 1575002 1575206

F L0C285 H1C323 H0F117 0.993 mg/mg (an) 0.99 mg/mg (ai) 2 K (09/04) H (05/05) G6D124 (04/07) G-5 (01/06) G-3 (05/05)

[550-83-4] [1639-60-7] [26570-10-5] n/f

1008002

H0D012

0.94 mg/mg (ai)

n/f

1576005 1576504 1576708 1576800 1577008 1578000 1578500 1578554 1580002 1581005 1581504

I0C170 F I0C022 G2D203 J0D402 G H0B108 F0E022 G0E034 J1B203 H0E285 0.999 mg/mg (dr) 1.00 mg/mg (ai) 0.999 mg/mg (dr) 1.000 mg/mg (dr) 1.000 mg/mg (ai)

H-1 (12/04) H (09/01) H (03/04) G (02/99) G-1 (10/05) G (01/03) I (08/06) H (02/00) F-1 (01/00) G (04/03)

[318-98-9] [108-32-7] [57-55-6] [121-79-9] [94-13-3] [51-52-5] [14152-28-4] [13345-51-2]

F-1 (12/05) J (01/04) I (05/02) G1C135 (04/07) G (06/04) F-2 (05/02) H-1 (04/00) F-2 (02/00)

[1225-55-4] [345-78-8] [7460-12-0]

1584003 1585006 1586009 1587001 1588004 1589007 1592001 1592205 1592227

I G I0C324 P I0B276 H G F F 0.999 mg/mg (dr)

[22204-24-6] [98-96-4] [101-26-8] [58-56-0] [59-33-6] [58-14-0] [3546-41-6] [36735-22-5] n/f

H (01/05) O-1 (04/00) H (12/03) G (07/02)

1592409

G0D407

1.000 mg/mg (an)

F0B015

[6151-25-3]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

80 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1593004 1593412 Curr. Lot. F-1 F0C114 Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. [6151-30-0] [103733-49-9]

Description Quinacrine Hydrochloride (200 mg) Quinapril Related Compound A (50 mg) (Ethyl[3S[2(R*),3a,11a beta]]-1,3,4,6,11,11a-hexahydro-3methyl-1,4-dioxo-alpha-(2-phenylethyl)-2H-pyrazino[1,2-b]isoquinoline-2-acetate) Quinapril Related Compound B (50 mg) (3-Isoquinolinecarboxylic acid, 2-[2-[(1-carboxy-3-phenylpropyl)amino]-1-oxopropyl]-1,2,3,4-tetrahydro-,[3S[2[R*(R*)],3R*]]-) Quinethazone (1.5 g) Quinic Acid (200 mg) Quinidine Gluconate (200 mg) Quinidine Sulfate (500 mg) Quinine Hydrochloride Dihydrate (1 g) Quinine Sulfate (500 mg)

1593423

F0C116

[82768-85-2]

1594007 1594506 1595000 1595509 1596807 1597005

G F H1A028 H-1 F0C108 I0E071 0.984 mg/mg (an) (HPLC) 1.000 mg/mg (an) (Spectrophotometric) H (06/06) H (04/03) H (12/99)

[73-49-4] [77-95-2] [7054-25-3] [6591-63-5] [6119-47-7] [6119-70-6]

1597504 1598008 1598303 1598314

Quininone (50 mg) 3-Quinuclidinyl Benzilate (25 mg) (FOR U.S. SALE ONLY) Ramipril (200 mg) R a m i p r i l R e l a t e d Co m p o u n d A ( 2 0 m g ) ((2S,3aS,6aS)-1-[(S)2-[[(S)1-(methoxycarbonyl)-3phenylpropyl]amino]-1-oxopropyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid) Ramipril Related Compound B (20 mg) (Ramipril Isopropylester) Ramipril Related Compound C (20 mg) (Hexahydroramipril Hydrochloride) Ramipril Related Compound D (20 mg) (Ramipril Diketopiperazine) Ranitidine Hydrochloride (200 mg) Ranitidine Related Compound A (50 mg) (5-[[(2aminoethyl)thio]methyl]-N,N-dimethyl-2-furanmethanamine hemifumarate) Ranitidine Related Compound B (50 mg) (N,Nbis[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-2-nitro-1,1-ethenediamine) Ranitidine Related Compound C (50 mg) (N-[2[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]sulnyl]ethyl]-N-methyl-2-nitro-1,1-ethenediamine) Ranitidine Resolution Mixture (20 mg) Rauwola Serpentina (15 g) Powdered Red Clover Extract (500 mg) Repaglinide (200 mg) Repaglinide Related Compound A (50 mg) ((S)-3Methyl-1-[2-(1-piperidinyl)phenyl]butylamine, Nacetyl-L-glutamate salt) Repaglinide Related Compound B (50 mg) (3Ethoxy-4-ethoxycarbonyl-phenylacetic acid)

H0B034 H G0D345 F0C100 0.998 mg/mg (ai)

G-1 (03/04) G (11/01) F0C099 (11/05)

[84-31-1] [6581-06-2] [87333-19-5] [91224-69-0]

1598323 1598338 1598347 1598405 1598507

F0F151 F0E157 F0E036 H0B268 H1B137

[295328-72-2] n/f n/f G (01/04) H (01/04) G (01/01) G (03/06) F-4 (04/02) I (01/04) H (05/01) [66357-59-3] [91224-69-0]

1598609

G1D347

[72126-78-4]

1598700

I1B136

[73851-70-4]

1598450 1599000 1599500 1600813 1600824

F0E323 G F0C188 G0D276 F0B267 0.999 mg/mg (ai) F0B265 (02/06)

n/f [8063-17-0] n/f [135062-02-1] n/f

1600835

F0B269

[99469-99-5]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

81

USP Reference Standards and Authentic Substances

Cat. No. 1600846 Curr. Lot. F0B271 Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. [107362-12-9]

Description Repaglinide Related Compound C (25 mg) ((S)-2Ethoxy-4-[2-[[2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]-2-oxoethyl] benzoic acid) Reserpine (200 mg) Residual Solvents Mixture - Class 1 (1.2 mL/ ampule; 3 ampules) Residual Solvent Class 1 - Benzene (1.2 mL/ ampule; 3 ampules) Residual Solvent Class 1 - Carbon Tetrachloride (1.2 mL/ampule; 3 ampules) Residual Solvent Class 1 - 1,2-Dichloroethane (1.2 mL/ampule; 3 ampules) Residual Solvent Class 1 - 1,1-Dichloroethene (1.2 mL/ampule; 3 ampules) Residual Solvent Class 1 - 1,1,1-Trichloroethane (1.2 mL/ampule; 3 ampules) Residual Solvents Class 2 - Mixture A (1.2 mL/ ampule; 3 ampules) Residual Solvents Class 2 - Mixture B (1.2 mL/ ampule; 3 ampules) Residual Solvent Class 2 - Mixture C (1.2 mL/ ampule; 3 ampules) Residual Solvent Class 2 - Acetonitrile (1.2 mL/ ampule; 3 ampules) Residual Solvent Class 2 - Chlorobenzene (1.2 mL/ampule; 3 ampules) Residual Solvent Class 2 - Chloroform (1.2 mL/ ampule; 3 ampules) Residual Solvent Class 2 - Cyclohexane (1.2 mL/ ampule; 3 ampules) Residual Solvent Class 2 - 1,2-Dichloroethene (1.2 mL/ampule; 3 ampules) Residual Solvent Class 2 - 1,2-Dimethoxyethane (1.2 mL/ampule; 3 ampules) Residual Solvent Class 2 - N,N-Dimethylacetamide (1.2 mL/ampule; 3 ampules) Residual Solvent Class 2 - N,N-Dimethylformamide (1.2 mL/ampule; 3 ampules) Residual Solvent Class 2 - 1,4-Dioxane (1.2 mL/ ampule; 3 ampules) Residual Solvent Class 2 - 2-Ethoxyethanol (1.2 mL/ampule; 3 ampules) Residual Solvent Class 2 - Ethylene Glycol (1.2 mL/ampule; 3 ampules) Residual Solvent Class 2 - Formamide (1.2 mL/ ampule; 3 ampules) Residual Solvent Class 2 - Hexane (1.2 mL/ ampule; 3 ampules) Residual Solvent Class 2 - Methanol (1.2 mL/ ampule; 3 ampules) Residual Solvent Class 2 - 2-Methoxyethanol (1.2 mL/ampule; 3 ampules)

1601000 1601102 1601146 1601168 1601180 1601204 1601226 1601281 1601292 1601306 1601340 1601361 1601383 1601408 1601420 1601463 1601485 1601500 1601521 1601543 1601565 1601587 1601601 1601623 1601645

O0C106 F0C407 F0C408 F0C409 F0C412 F0C411 F0C410 F0D051 F0D248 F0D182 F0D049 F0D048 F0D186 F0D047 F0D040 F0D185 F0D169 F0D189 F0D050 F0D195 F0D191 F0D188 F0D268 F0D045 F0D194 2.00 mg/mL (ai) 1.81 mg/mL (ai) 0.293 mg/mL (ai) 18.0 mg/mL (ai) 9.2 mg/mL (ai) 0.479 mg/mL (ai) 5.44 mg/mL (ai) 4.42 mg/mL (ai) 1.89 mg/mL (ai) 0.80 mg/mL (ai) 3.07 mg/mL (ai) 1.10 mg/mL (ai) 0.256 mg/mL (ai) 14.8 mg/mL (ai) 0.253 mg/mL (ai) 10.1 mg/mL (ai) 19.7 mg/mL (ai) 25.1 mg/mL (ai) 37.9 mg/mL (ai) 49.1 mg/mL (ai)

N (06/03)

[50-55-5] n/f n/f n/f n/f n/f n/f n/f n/f n/f n/f n/f n/f n/f n/f n/f n/f n/f n/f n/f n/f n/f n/f n/f n/f

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

82 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1601667 1601689 1601441 1601703 1601725 1601747 1601769 1601770 1601780 1601805 1601827 1601849 1602003 1602706 1603006 1603800 1604009 1604202 1604508 1604600 1604701 1604803 1604814 1605500 1605512 1605523 Curr. Lot. F0D202 F0D044 F0D046 F0D183 F0D210 F0D215 F0D187 F0D043 F0D228 F0D042 F0D221 F0D041 I0D135 H1C335 N0C021 G0B040 J H F0C266 F G-1 F0F049 F0F058 F0E334 F0E315 F0E318 0.943 mg/mg (ai) 1.00 mg/mg (ai) 0.992 mg/mg (ai) 1 Purity Value/Conc. 0.248 mg/mL (ai) 5.46 mg/mL (ai) 2.90 mg/mL (ai) 2.63 mg/mL (ai) 0.248 mg/mL (ai) 0.99 mg/mL (ai) 0.80 mg/mL (ai) 3.49 mg/mL (ai) 0.493 mg/mL (ai) 4.39 mg/mL (ai) 0.391 mg/mL (ai) 10.7 mg/mL (ai) 0.998 mg/mg (ai) H-1 (10/05) H (04/01) H (03/05) G (08/01) M-1 (09/04) M (11/00) F (11/02) I (09/00) G (12/01) Change Code* Previous Lot/Valid Use Date CAS No. n/f n/f n/f n/f n/f n/f n/f n/f n/g n/f n/f n/f [108-46-3] [36791-04-5] [83-88-5] [72559-06-9] [13292-46-1] [13983-13-6] [1501-84-4] [49697-38-3] [23239-51-2] [155213-67-5] [155213-67-5] [132112-35-7] [21436-98-6] [112773-90-7]

Description Residual Solvent Class 2 - Methylbutylketone (1.2 mL/ampule; 3 ampules) Residual Solvent Class 2 - Methylcyclohexane (1.2 mL/ampule; 3 ampules) Residual Solvent Class 2 - Methylene Chloride (1.2 mL/ampule; 3 ampules) Residual Solvent Class 2 - N-Methylpyrrolidone (1.2 mL/ampule; 3 ampules) Residual Solvent Class 2 - Nitromethane (1.2 mL/ ampule; 3 ampules) Residual Solvent Class 2 - Pyridine (1.2 mL/ ampule; 3 ampules) Residual Solvent Class 2 - Sulfolane (1.2 mL/ ampule; 3 ampules) Residual Solvent Class 2 - Tetrahydrofuran (1.2 mL/ampule; 3 ampules) Residual Solvent Class 2 - Tetralin (1.2 mL/ ampule; 3 ampules) Residual Solvent Class 2 - Toluene (1.2 mL/ ampule; 3 ampules) Residual Solvent Class 2 - Trichloroethylene (1.2 mL/ampule; 3 ampules) Residual Solvent Class 2 - Xylenes (1.2 mL/ ampule; 3 ampules) Resorcinol (200 mg) Ribavirin (200 mg) Riboavin (500 mg) (Vitamin B2) Rifabutin (50 mg) Rifampin (300 mg) Rifampin Quinone (50 mg) Rimantadine Hydrochloride (300 mg) Rimexolone (100 mg) Ritodrine Hydrochloride (200 mg) Ritonavir (200 mg) Ritonavir Related Compounds Mixture (50 mg) Ropivacaine Hydrochloride (200 mg) Ropivacaine Related Compound A (25 mg) (2,6dimethylaniline hydrochloride) Ropivacaine Related Compound B (50 mg) ((R)(+)-1-Propylpiperidine-2-carboxylic acid (2,6-dimethylphenyl)-amide hydrochloride monohydrate) Roxarsone (200 mg) Rutin (100 mg) Saccharin (200 mg) Saccharin Sodium (100 mg) Salicylamide (200 mg)

1606208 1606503 1607007 1607040 1608000

F G0C355 G4C375 F0F006 F-4 1 F-3 (05/03) F (09/05) G-3 (03/06) G-2 (12/01)

[121-19-7] [153-18-4] [81-07-2] [6155-57-3] [65-45-2]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

83

USP Reference Standards and Authentic Substances

Cat. No. 1609002 Curr. Lot. J3C400 Purity Value/Conc. 0.994 mg/mg (ai) Change Code* Previous Lot/Valid Use Date J2B147 (01/06) J-1 (10/03) J (10/02) I (07/99) CAS No. [69-72-7]

Description Salicylic Acid (125 mg)

1609013 1609501

Salicylic Acid Related Compound A (100 mg) (4hydroxybenzoic acid) Salicylic Acid Tablets (Dissolution Calibrator, Nondisintegrating) (30 tablets) Salsalate (125 mg) Saquinavir Mesylate (200 mg) Saquinavir Related Compound A (25 mg) (N-tertbutyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)[[N-(2-quinolylcarbonyl)-D-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide) Scopolamine Hydrobromide (250 mg) Scopoletin (20 mg) Secobarbital CII (200 mg) Selegiline Hydrochloride (200 mg) Selenomethionine (100 mg) Sennosides (250 mg) L-Serine (200 mg) Sesame Oil (1 mL/ampule; 2 ampules) (AS) Sesame Oil Related Compound A (6 mg/vial; 3 vials) (1,2-dilinoleoyl-3-oleoyl-rac-glycerol) Sesame Oil Related Compound B (6 mg/vial; 3 vials) (1,2-dilinoleoyl-3-palmitoyl-rac-glycerol, PLL) Sevourane (1 mL) Sevourane Related Compound A (0.2 mL) (1,1,3,3,3-Pentauoroisopropenyl uoromethyl ether) Sevourane Related Compound B (0.2 mL) (1,1,1,3,3,3-hexauoro-2-methoxypropane) Sevourane Related Compound C (0.2 mL) (1,1,1,3,3,3-hexauoro-2-propanol) Silver Sulfadiazine (200 mg) Silybin (50 mg) Silydianin (20 mg) Simethicone (50 g) Simvastatin (200 mg)

F0F108 Q0D200

0.99 mg/mg (ai) P0C404 (10/06) O (01/06) N (02/02)

[99-96-7] [69-72-7]

1609807 1609829 1609831

G F0B008 F0B009

[552-94-3] [149845-06-7] n/f

1610001 1610090 1611004 1611900 1611955 1612007 1612506 1612404 1612415 1612426

J0B051 F0C329 H G F0B006 H1B223 G F0E134 F0E131 F0E132

I-1 (01/03)

[6533-68-2] [92-61-5] [76-73-3] [14611-52-0] [1464-42-2]

H (04/04) F-3 (11/00)

[81-27-6] (A) [128-57-4] (B) [56-45-1] [8008-74-0] [2190-21-8] [64550-34-1]

1612540 1612550

F0C219 F0C261

[28523-86-6] [58109-34-5]

1612572 1612594 1612608 1612630 1612641 1612652 1612700

F0D140 F0D142 I G0D392 F H0D084 I0D382

1.00 mg/mg (ai) 1.00 mg/mg (ai) H (04/01) 0.94 mg/mg (ai) 5.3% SiO2 (ai) 0.994 mg/mg (ai) F (01/06) G (11/04) F (07/00) H1B093 (02/06) H (07/03) G (02/02) F-1 (05/99) H (04/04) G (10/00) 0.98 mg/mg (an) 99.8% (dr) G-1 (03/05) 99.7% (dr)

[13171-18-1] [920-66-1] [22199-08-2] [22888-70-6] [29782-68-1] [8050-81-5] [79902-63-9]

1612801 1612947 1613407 1613509 1613564 1613655

Sisomicin Sulfate (500 mg) Beta-Sitosterol (300 mg) Sodium Acetate (1 g) (AS) Sodium Ascorbate (200 mg) Sodium Benzoate (1 g) Sodium Bicarbonate (3 g) (AS)

I0C238 F0D217 F0D083 G2C067 F0E025 F0D235

[53179-09-2] [83-46-5] [127-09-3] [134-03-2] [532-32-1] [144-55-8]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

84 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1613600 1613757 1613804 1613859 1614002 1614308 Curr. Lot. F F0D100 F0D269 F0D172 I0E033 J0E249 100.0% (dr) 100.0% (ai) 100.0% (an) 1.000 mg/mg (ai) 1.000 mg/mg (dr) H-1 (03/06) H (05/01) I0C299 (12/06) H (04/05) G (06/00) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. [156-54-7] [497-19-8] [7647-14-5] [6132-04-3] [7681-49-4] [867-56-1]

Description Sodium Butyrate (25 mg) Sodium Carbonate Anhydrous (1 g) (AS) Sodium Chloride (1 g) (AS) Sodium Citrate (1 g) (AS) Sodium Fluoride (1 g) Sodium Lactate (200 mg)

1614363 1614396 1614454 1614501 1614603 1614669 1614670 1614705 1614807 1615107 1615708 1615956 1616008 1617000 1617408 1617419

Sodium Lauryl Sulfate (1 g) (AS) Sodium Metabisulte (1 g) (AS) Sodium Nitrite (1 g) (AS) Sodium Nitroprusside (500 mg) Sodium Propionate (200 mg) Sodium Starch Glycolate Type A (400 mg) Sodium Starch Glycolate Type B (400 mg) Sodium Stearyl Fumarate (200 mg) Sodium Sulfate Anhydrous (1 g) (AS) Sodium Thiosulfate (1 g) (AS) Somatropin (8.63 USP Somatropin Units/vial) Sorbic Acid (1 g) (AS) 1,4-Sorbitan (200 mg) Sorbitol (125 mg) Sotalol Hydrochloride (300 mg) Sotalol Related Compound A (50 mg) (N-[4-[[(1Methylethyl)amino]acetyl]phenyl]methanesulfonamide monohydrochloride) Sotalol Related Compound B (50 mg) (N-(4-Formylphenyl)methanesulfonamide) Sotalol Related Compound C (50 mg) (N-[4-[2-[(1Methylethyl)amino]ethyl]phenyl]methanesulfonamide hydrochloride) Spectinomycin Hydrochloride (200 mg) Spironolactone (125 mg) Spironolactone Related Compound A (100 mg) (Canrenone (3-Oxo-17-alpha-pregna-4,6-diene-21, 17-carbolactone)) (AS) Squalane (500 mg) Stanozolol CIII (200 mg) Stavudine (250 mg) Stavudine System Suitability Mixture (20 mg) Stearic Acid (500 mg) Stearoyl Polyoxyglycerides (100 mg) Stearyl Alcohol (125 mg) Streptomycin Sulfate (200 mg) Succinylcholine Chloride (500 mg) Succinylmonocholine Chloride (150 mg)

F0D381 F0D111 F0D117 H F-1 G0E221 F0E222 G F0D112 F0D178 F0E191 F0D129 I0A003 H1B139 G0E198 F0C235 0.997 mg/mg (ai) 99.4% (ai) H (04/03) G (02/00) H (01/04) F0C234 (09/06) 99.8% (dr) 100.2% (an) F-2 (05/01) 98.6% (ai) 99.6% (dr) G (11/99) F (03/02) F0C087 (11/06)

[151-21-3] [7681-57-4] [7632-00-0] [13755-38-9] [6700-17-0] [9063-38-1] [9063-38-1] [4070-80-8] [7757-82-6] [10102-17-7] [12629-01-5] [110-44-1] [27299-12-3] [50-70-4] [959-24-0] n/f

1617420 1617430

F0C236 F0C237

n/f n/f

1618003 1619006 1619017

G0C310 J-1 F0E184

650 ug/mg (ai)

F-2 (01/05)

[22189-32-8] [52-01-7] [976-71-6]

1619505 1620005 1620209 1620220 1621008 1621507 1622000 1623003 1623502 1623604

G-1 F-3 F0E050 F0E051 J1D360 F0C286 H2B217 J0B195 H1E325 G 0.995 mg/mg (an) H-1 (12/04) H (09/99) I (04/03) H (12/06) F-1 (02/01) J (02/06) I (10/01) 0.997 mg/mg (ai) F-2 (02/01)

[111-01-3] [10418-03-8] [3056-17-5] n/f [57-11-4] n/f [112-92-5] [3810-74-0] [71-27-2] n/f

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

85

USP Reference Standards and Authentic Substances

Cat. No. 1623626 1623637 Curr. Lot. G1E317 H1C223 Purity Value/Conc. 0.998 mg/mg (ai) Change Code* Previous Lot/Valid Use Date G0B028 (02/07) F (04/03) H0B002 (11/04) G-1 (03/03) G (05/99) 1.000 mg/mg (dr) H0B208 (09/06) G (05/03) F-1 (04/02) F (09/99) G (05/05) F-1 (05/00) F (05/02) G-1 (11/06) I (09/04) H (08/01) I (03/04) 0.998 mg/mg (ai) F4C298 (09/05) F-3 (11/04) F-2 (03/99) F-2 (10/05) F-1 (07/02) H (12/04) F-2 (01/03) I (04/02) 0.98 mg/mg (ai) H (01/06) G (11/01) N (01/04) J-1 (03/04) J (09/99) F-2 (09/00) H (07/04) J (11/06) I (07/00) 0.96 mg/mg (ai) 1.000 mg/mg (dr) G-2 (02/07) G-1 (06/99) G (08/00) 0.992 mg/mg (ai) G (03/05) I-1 (06/99) F (02/07) H F0E314 F0F074 F0C220 1.00 mg/mg (an) G-1 (12/01) CAS No. [56038-13-2] [57-50-1]

Description Sucralose (400 mg) Sucrose (100 mg)

1623648

Sufentanil Citrate CII (25 mg)

H1E105

[60561-17-3]

1623670 1623681 1623706 1623808 1624006 1624505 1625009 1626001

Sulbactam (250 mg) Sulconazole Nitrate (200 mg) Sulfabenzamide (200 mg) Sulfacetamide (300 mg) Sulfacetamide Sodium (500 mg) Sulfachlorpyridazine (200 mg) Sulfadiazine (200 mg) Sulfadimethoxine (200 mg)

H0C396 F-1 G G-2 I1B318 F J G0D249

0.976 mg/mg (ai)

[68373-14-8] [61318-91-0] [127-71-9] [144-80-9] [6209-17-2] [80-32-0] [68-35-9] [122-11-2]

1626500 1628007 1629000 1630009 1631001 1631500 1632004 1633007 1633506 1634000 1635002 1635206 1635228 1636005 1636504 1637008 1638000 1639003 1640002 1642008 1642019 1642100 1642154

Sulfadoxine (200 mg) Sulfamerazine (500 mg) Sulfamethazine (1 g) Sulfamethizole (200 mg) Sulfamethoxazole (200 mg) Sulfamethoxazole N4-glucoside (25 mg) Sulfanilamide (5 g) Sulfanilamide Melting Point Standard (500 mg) (Approximately 165 degrees) Sulfanilic Acid (200 mg) Sulfapyridine (200 mg) Sulfapyridine Melting Point Standard (1 g) (Approximately 191 degrees) Sulfaquinoxaline (200 mg) Sulfaquinoxaline Related Compound A (25 mg) (N1,N2-diquinoxalin-2-ylsulfanilamide) Sulfasalazine (125 mg) Sulfathiazole (350 mg) Sulnpyrazone (200 mg) Sulsoxazole (200 mg) Sulsoxazole Acetyl (200 mg) Sulsoxazole Diolamine (500 mg) DISCONTINUED Sulindac (200 mg) Sulindac Related Compound A (20 mg) (transsulindac) Sulisobenzone (500 mg) Sumatriptan (50 mg)

F3C336 H1C171 G-3 F-3 I-1 H1D290 O0B047 K0B133 G I0B298 J1E042 F0A005 F0E093 G3F035 H H0C416 J H-1

0.999 mg/mg (ai)

[2447-57-6] [127-79-7] [57-68-1] [144-82-1] [723-46-6] n/f [63-74-1] [63-74-1] [121-57-3] [144-83-2] [144-83-2] [59-40-5] n/f [599-79-1] [72-14-0] [57-96-5] [127-69-5] [80-74-0] [4299-60-9] [38194-50-2] [53933-60-1] [4065-45-6] [103628-46-2]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

86 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1642201 1642212 Curr. Lot. F1E256 G0F113 Purity Value/Conc. 0.989 mg/mg (ai) 0.92 mg/mg (ai) 2 Change Code* Previous Lot/Valid Use Date F0C231 (10/06) F0C221 (01/07) CAS No. [103628-48-4] n/f

Description Sumatriptan Succinate (200 mg) Sumatriptan Succinate Related Compound A (15 mg) ([3-[2-(dimethylamino)ethyl]-2-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1H-indol5-yl]-N-methylmethanesulfonamide, succinate salt) Sumatriptan Succinate Related Compound C (50 mg) ([3-[2-(dimethylamino)ethyl]-1-(hydroxymethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide succinate salt) Sumatriptan Succinate Related Impurities (25 mg) Suprofen (200 mg) Tacrine Hydrochloride (500 mg) Tagatose (200 mg) Talbutal CIII (250 mg) Tamoxifen Citrate (200 mg)

1642223

F0C230

n/f

1642256 1642507 1642700 1642904 1643000 1643306

F0E046 F F0C119 F0E017 F I0D294 0.994 mg/mg (ai) H (10/05) G-2 (09/01) G-1 (05/00) 0.996 mg/mg (dr)

n/f [40828-46-4] [1684-40-8] [87-81-0] [115-44-6] [54965-24-1]

1643328 1643340 1643361 1643408 1643452 1643463

Tannic Acid (2 g) (AS) Tartaric Acid (1 g) (AS) Taurine (100 mg) Temazepam CIV (200 mg) Terazosin Hydrochloride (200 mg) Terazosin Related Compound A (50 mg) (1-(4Amino-6,7-dimethoxy-2-quinazolinyl)piperazine dihydrochloride) Terazosin Related Compound B (50 mg) (1-(4hydroxy-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine) Terazosin Related Compound C (25 mg) (1,4bis(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine dihydrochloride) Terbutaline Sulfate (125 mg) Terbutaline Related Compound A (50 mg) (tertbutylamino-3,5-dihydroxyacetophenone sulfate) Terconazole (200 mg)

F0D292 F0D176 F0C104 H0C205 F0C244 F0C245 G (06/04) F (12/99) 100.0% (dr)

[1401-55-4] [87-69-4] [107-35-7] [846-50-4] [70024-40-7] n/f

1643474

F0C218

n/f

1643485

F0C257

n/f

1643500 1643510 1643703

H F0D289 H0E229

G (04/99)

[23031-32-5] n/f

G3C322 (09/06) G-2 (08/05) G-1(04/01) G (03/99) G (12/99)

[67915-31-5]

1643805 1643907

Terfenadine (200 mg) Terfenadine Related Compound A (100 mg) (1-[4(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-butanone) Terfenadine Related Compound B (50 mg) (Terfenadine-N-oxide) Terpin Hydrate (750 mg) Testolactone CIII (125 mg) Testosterone CIII (125 mg) Testosterone Cypionate CIII (200 mg) Testosterone Enanthate CIII (200 mg) Testosterone Propionate CIII (200 mg)

H G

[50679-08-8] n/f

1643929 1644003 1645006 1646009 1647001 1648004 1649007

F H0C395 F-1 I1B253 H0D162 K0D253 L1C005 1.000 mg/mg (ai) 0.998 mg/mg (ai) I (08/04) G-1 (03/05) G (08/01) J (07/06) L (08/04) K-1 (11/01) 0.999 mg/mg (an) G (06/06)

n/f [2451-01-6] [968-93-4] [58-22-0] [58-20-8] [315-37-7] [57-85-2]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

87

USP Reference Standards and Authentic Substances

Cat. No. 1650006 1651009 1652001 1652500 1653004 1655000 1656002 1656308 1657005 1658008 1659000 1660000 1661002 1662504 1663008 1663700 1664000 1665003 1666006 1667100 1667202 1667213 1667280 1667235 Curr. Lot. J L0C216 G1A015 F0C107 J0B180 G0A027 O F G F-1 H1B205 F-1 I1D198 H H G0E175 I G H F G F0D391 F0E178 F0E179 0.998 mg/mg (an) F-3 (12/00) G-1 (05/00) 1075 USP Thiostrepton Units/mg (dr) F1B022 (10/06) F (11/02) H (01/99) 1.000mg/mg (dr) I (09/05) H (09/04) G (12/99) F-1 (09/00) I (01/04) F-1 (04/03) F (04/01) N (11/02) M-1 (04/99) 976 ug/mg (ai) K (12/04) G (03/03) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. [136-47-0] [64-75-5] [522-48-5] [50-35-1] [58-55-9] [148-79-8] [67-03-8] [77-27-0] [52239-63-1] [1179-69-7] [54-64-8] [154-42-7] [76-75-5] [50-52-2] [130-61-0] [1393-48-2] [52-24-4] [3313-26-6] [3313-27-7] [553-08-2] [72-19-5] [89-83-8] [145821-59-6] n/f

Description Tetracaine Hydrochloride (200 mg) Tetracycline Hydrochloride (200 mg) Tetrahydrozoline Hydrochloride (200 mg) Thalidomide (200 mg) Theophylline (200 mg) Thiabendazole (100 mg) Thiamine Hydrochloride (500 mg) (Vitamin B1 Hydrochloride) Thiamylal CIII (200 mg) Thiethylperazine Malate (200 mg) Thiethylperazine Maleate (200 mg) Thimerosal (500 mg) Thioguanine (200 mg) Thiopental CIII (250 mg) Thioridazine (200 mg) Thioridazine Hydrochloride (200 mg) Thiostrepton (200 mg) Thiotepa (500 mg) Thiothixene (250 mg) (E)-Thiothixene (100 mg) Thonzonium Bromide (200 mg) L-Threonine (200 mg) Thymol (500 mg) Tiagabine Hydrochloride (300 mg) Racemic Tiagabine Hydrochloride Mixture (25 mg) ((S)-(+),(R)-(-)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid, hydrochloride) Tiagabine Related Compound A (15 mg) ((R)-ethyl 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylate, hydrochloride) Tiamulin (100 mg) Tiamulin Fumarate (250 mg) Tiamulin Related Compound A (50 mg) (Tosyl pleuromutilin) Ticarcillin Monosodium Monohydrate (200 mg) Tiletamine Hydrochloride (200 mg) Tilmicosin (400 mg) Timolol Maleate (200 mg) Tinidazole (200 mg) Tinidazole Related Compound A (100 mg) (2methyl-5-nitroimidazole) Tinidazole Related Compound B (20 mg) (1-(2ethyl-sulfonylethyl)-2-methyl-4-nitroimidazole) Tioconazole (200 mg) Tioconazole Related Compound A (25 mg) (1-[2,4Dichloro-beta-[(3-thenyl)-oxy]phenethyl]imidazole Hydrochloride)

1667224

F0E177

n/f

1667355 1667290 1667337 1667304 1667359 1667370 1667406 1667520 1667530 1667541 1667439 1667450

F0E219 F0C327 F0C328 H F0C019 F0D393 G-1 F0C093 F0C091 F0E274 H H0F095 0.95 mg/mg (ai) 1.00 mg/mg (ai) G (04/02) G (02/07) 830 ug/mg cis (an) 126 ug/mg trans (an) G-1 (03/99)

[55297-95-5] [55297-96-6] n/f [74682-62-5] [14176-50-2] [108050-54-0] [26921-17-5] [19387-91-8] [696-23-1] [25459-12-5] [65899-73-2] n/f

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

88 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1667461 Curr. Lot. G Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. n/f

Description Tioconazole Related Compound B (25 mg) (1-[2,4Dichloro-beta-[(2,5-dichloro-3-thenyl)oxy]phenethyl]imidazole Hydrochloride) Tioconazole Related Compound C (25 mg) (1-[2,4Dichloro-beta-[(5-bromo-2-chloro-3-thenyl)-oxy]phenethyl]imidazole Hydrochloride) Titanium Dioxide (1 g) (AS) Tobramycin (350 mg) Tocainide Hydrochloride (125 mg) Alpha Tocopherol (250 mg) (Vitamin E Alcohol) Alpha Tocopheryl Acetate (250 mg) (Vitamin E Acetate) Alpha Tocopheryl Acid Succinate (250 mg) (Vitamin E Succinate) Tolazamide (200 mg) Tolazoline Hydrochloride (300 mg) Tolbutamide (200 mg) Tolcapone (200 mg) Tolcapone Related Compound A (25 mg) (4methyl-3,4-dihydroxybenzophenone) Tolcapone Related Compound B (25 mg) (4hydroxy-3-methoxy-4-methyl-5-nitrobenzophenone) Tolmetin Sodium (500 mg) Tolnaftate (200 mg) Toluenesulfonamides, ortho and para (200 mg of each supplied in a set) DISCONTINUED o-Toluenesulfonamide (200 mg) p-Toluenesulfonamide (200 mg) Torsemide (200 mg) Torsemide Related Compound A (75 mg) (4-[(3methylphenyl)amino]-3-pyridinesulfonamide) Torsemide Related Compound B (75 mg) (N-[(nbutylamino)carbonyl]-4-[(3-methylphenyl)amino]-3pyridinesulfonamide) Torsemide Related Compound C (75 mg) (N[(ethylamino)carbonyl]-4-[(3-methylphenyl)amino]3-pyridinesulfonamide) Transplatin (25 mg) Trazodone Hydrochloride (200 mg) Trenbolone CIII (50 mg) Trenbolone Acetate CIII (200 mg) Tretinoin (30 mg/vial; 5 vials)

1667472

n/f

1667585 1667508 1667552 1667600 1667701 1667803

F0D079 L0E077 F-1 M K G0D077

99.6% (dr) 970 ug/mg (an) K0B248 (07/06) J (08/03) F (04/99) L-1 (01/00) J (06/99) 0.995 mg/mg GC 0.978 mg/mg HPLC (ai) F-5 (05/05) F-4 (01/02) G-1 (06/00) H (06/00) 0.999 mg/mg (ai)

[13463-67-7] [32986-56-4] [35891-93-1] [10191-41-0] [7695-91-2] [4345-03-3]

1668001 1669004 1670003 1670207 1670218 1670229

G-2 F I F0D280 F0D282 F0D284

[1156-19-0] [59-97-2] [64-77-7] [134308-13-7] n/f n/f

1670502 1671006 1672009 1672010 1672020 1672304 1672315 1672326

I0B064 J0C405 1.000 mg/mg (dr)

H (09/03) I (02/05) F-4 (07/06) F-3 (11/99)

[64490-92-2] [2398-96-1] [88-19-7] (o) [70-55-3] (p) [88-19-7] [70-55-3]

F0E163 F0E162 G0E293 F0B071 F0B083

1.00 mg/mg (ai) 1.00 mg/mg (ai) 0.996 mg/mg (ai) 2 F0B090 (05/07)

[56211-40-6] n/f n/f

1672337

F0B078

n/f

1672803 1673500 1673806 1673828 1674004

H0B287 G0F069 F0D389 F0D390 J0D145 0.998 mg/mg (dr) 0.99 mg/mg (ai) 0.999 mg/mg (ai) 0.996 mg/mg (ai)

G (03/04) F-2 (04/07)

[14913-33-8] [25332-39-2] [10161-33-8] [10161-34-9]

I2B185 (01/06) I-1 (01/04) I (01/02) H (06/01) G-1 (02/05) G (06/01) J (03/99)

[302-79-4]

1675007 1676000 1677002 1678005

Triacetin (1 g) Triamcinolone (250 mg) Triamcinolone Acetonide (500 mg) Triamcinolone Diacetate (200 mg)

H0C413 H-1 K G

[102-76-1] [124-94-7] [76-25-5] [67-78-7]

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

89

USP Reference Standards and Authentic Substances

Cat. No. 1679008 1680007 1680506 1680608 1680801 1681000 1682206 1682217 1683005 1683504 1683606 1685000 1685500 1686003 1686309 1686310 1687006 1689001 1690000 1692006 1692505 1693009 1694001 1695004 1696007 1696109 1696200 1696958 1697000 1698002 1699005 1700002 1700501 1702008 1703805 1703850 1704003 1704502 1705006 1705301 Curr. Lot. G I H0B041 G0C227 F H G0D001 F0E292 F-1 F2B257 G0C393 H0A010 F F-2 F G0E004 J F-3 G H-2 J0B228 H0C278 H-1 (06/02) I (01/04) G (04/04) G (02/07) F (02/03) J I G G F0D120 F-1 G H0E307 I0E055 G2E237 K-1 F0C008 F0D333 I0E111 F K0C141 G0E154 1.00 mg/mg (ai) 0.999 mg/mg (ai) J (05/05) F0B191 (04/06) H (07/06) G (02/00) 0.99 mg/mg (ai) 3250 USP Trypsin Units/mg (dr) F-3 (07/99) G-1 (01/07) G (02/99) H (01/06) G (12/99) G-1 (12/06) G (09/00) H-1 (02/02) F-1 (02/02) F-1 (10/99) 1.00 mg/mg (ai) F (02/06) I (07/01) F-2 (08/01) F-1 (03/04) F-1 (09/03) F (08/96) F-1 (10/05) F (03/02) G (03/03) 0.997 mg/mg (ai) F0B135 (05/05) G-1 (03/03) F (01/05) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. [5611-51-8] [396-01-0] [28911-01-5] [77-94-1] [52-68-6] [133-67-5] [3380-34-5] n/f [4310-35-4] [38260-01-4] [77-93-0] [440-17-5] n/f [1098-60-8] [70-00-8] [14599-46-3] [52-49-3] [4330-99-8] [127-48-0] [554-92-7] [738-70-5] [3902-71-4] [6138-56-3] [154-69-8] [6138-79-0] n/f n/f [102-71-6] [2751-09-9] [77-86-1] [1508-75-4] [9002-07-7] [73-22-3] [6989-98-6] [1401-69-0] [1405-54-5] [25301-02-4] [7246-21-1] [60-18-4] [303-98-0]

Description Triamcinolone Hexacetonide (125 mg) Triamterene (200 mg) Triazolam CIV (200 mg) Tributyl Citrate (500 mg) Trichlorfon (200 mg) Trichlormethiazide (200 mg) Triclosan (200 mg) Triclosan Related Compounds Mixture A (1.2 mL/ ampule; 3 ampules) Tridihexethyl Chloride (200 mg) Trientine Hydrochloride (125 mg) Triethyl Citrate (500 mg) Triuoperazine Hydrochloride (200 mg) 2-[N-(2,2,2-Triuoro-ethyl)amino-5]-chlorobenzophenone (25 mg) Triupromazine Hydrochloride (200 mg) Triuridine (200 mg) Triuridine Related Compound A (20 mg) (5Carboxy-2-deoxyuridine) Trihexyphenidyl Hydrochloride (200 mg) Trimeprazine Tartrate (200 mg) Trimethadione (200 mg) Trimethobenzamide Hydrochloride (500 mg) Trimethoprim (300 mg) Trioxsalen (200 mg) Tripelennamine Citrate (200 mg) DISCONTINUED Tripelennamine Hydrochloride (200 mg) Triprolidine Hydrochloride (500 mg) Triprolidine Hydrochloride Z-Isomer (100 mg) Trisalicylic Acid (100 mg) Trolamine (3 mL) Troleandomycin (250 mg) Tromethamine (125 mg) Tropicamide (200 mg) Trypsin Crystallized (300 mg) L-Tryptophan (200 mg) Tubocurarine Chloride (250 mg) Tylosin (250 mg) Tylosin Tartrate (100 mg) Tyloxapol (600 mg) Tyropanoate Sodium (500 mg) L-Tyrosine (500 mg) Ubidecarenone (200 mg)

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

90 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1705323 1705312 1705505 1705800 1706009 1706698 1706701 1707806 1707908 1708503 1708707 Curr. Lot. F0E210 F0B194 G2C018 G F F0D331 H0E110 G H0D126 G0F115 L0E030 1.00 mg/mg (ai) 1.00 mg/mg (dr) 0.998 mg/mg (ai) 2 1.00 mg/mg (ai) 0.999 mg/mg (dr) G0D374 (11/06) F0C078 (12/05) F-1 (11/01) F (09/99) G0B146 (05/05) F (01/04) F-2 (05/07) F-1 (05/02) K0D224 (04/07) J1B127 (08/05) J (01/04) I-1 (11/00) F2C386 (02/06) F1B156 (05/05) F (01/03) G-1 (11/04) G (01/02) F-1 (06/99) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. [303-97-9] [303-98-0] [112-38-9] [3083-77-0] [66-75-1] [57-13-6] [58069-82-2] [128-13-2] [3569-10-6] [72-18-4] [99-66-1]

Description Ubidecarenone Related Compound A (15 mg) (Coenzyme Q9) Ubidecarenone for System Suitability (25 mg) Undecylenic Acid (200 mg) Uracil Arabinoside (50 mg) Uracil Mustard (500 mg) (FOR U.S. SALE ONLY) Urea (200 mg) Urea C 13 (100 mg) Ursodiol (125 mg) Valerenic Acid (15 mg) L-Valine (200 mg) Valproic Acid (500 mg)

1708729

Valproic Acid Related Compound A (0.25 mL) (diallylacetic acid) Valproic Acid Related Compound B (50 mg) ((2RS)-2-(1-methylethyl)pentanoic acid) (AS) Valsartan (350 mg) Valsartan Related Compound A (10 mg) ((R)-NValeryl-N-([2-(1H-tetrazole-5-yl)-biphen-4-yl]methyl)-valine) Valsartan Related Compound C (10 mg) ((S)-NValeryl-N-([2-(1-H-tetrazole-5-yl)biphenyl-4-yl]methyl)valine benzyl ester) Vancomycin Hydrochloride (4 vials, each vial contains 100,500 mcg of vancomycin activity) Vancomycin B with Monodechlorovancomycin (350 mg) Vanillin (200 mg) Vanillin Melting Point Standard (1 g) (Approximately 82 degrees) Vecuronium Bromide (50 mg) Vecuronium Bromide Related Compound A (25 mg) (3alpha, 17beta-diacetyl-oxy-2beta, 16beta-bispiperidinyl-5alpha-androstan) Verapamil Hydrochloride (200 mg) Verapamil Related Compound A (50 mg) (3,4Dimethoxy-alpha-[3-(methylamino)propyl]-alpha(1-methylethyl)-benzeneacetonitrile monoHydrochloride)

G0C398

[99-67-2]

1708718 1708762 1708773

F0E201 G0F065 F1E272 0.997 mg/mg (an) 0.96 mg/mg (ai) F0C147 (03/07) F0C215 (10/06)

[62391-99-5] [137862-53-4] n/f

1708795

F1D025

0.99 mg/mg (ai)

F0C208 (09/05)

n/f

1709007 1709018 1710006 1711009

L1D039 F0F138 J0A021 J1C303 0.81 mg/mg (an) 1

L (07/05) K (08/01)

[1404-93-9] n/f

I (03/05) H (04/99) J (06/05) I-1 (03/03) I (11/00)

[121-33-5] [121-33-5]

1711155 1711166

F0C367 F0B178

[50700-72-6] n/f

1711202 1711304

G1E095 H

0.999 mg/mg (dr)

G (08/06) F-4 (06/00) G (01/01)

[152-11-4] n/f

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

91

USP Reference Standards and Authentic Substances

Cat. No. 1711406 Curr. Lot. G Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. [1794-55-4]

Description Verapamil Related Compound B (50 mg) (alpha[2-[[2-(3,4-dimethoxyphenyl)-ethyl]methylamino]ethyl]-3,4-dimethoxy-alpha-(1-methylethyl)-benzeneacetonitrile monoHydrochloride) Verapamil Related Compound D (50 mg) (5,5-[[2(3,4)dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)-2-(1-methylethyl)pentanenitrile] hydrochloride) Verteporn (200 mg) Verteporn Related Compound A (50 mg) ((+/-)18Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)4a,8,14,19-tetramethyl-23H,25H-benzo[b]prophine-9,13-dipropanoic acid) Vidarabine (200 mg) Vinblastine Sulfate (50 mg) Vincristine Sulfate (50 mg)

1711428

F0E342

[190850-50-1]

1711461 1711472

F0C166 F0C167

[129497-78-5] n/f

1711508 1713004 1714007

G-2 M0B308 P0F092

939 ug/mg (ai)

G-1 (09/05) L (12/04) K (05/99)

[24356-66-9] [143-67-9] [2068-78-2]

0.996 mg/mg (dr)

2,3

O0B062 (06/07) N (01/03) M (04/99) F1E133 (05/07) F0C243 (08/05)

1714506 1714528 1715000 1716002 1717504 1717708 1719000 1719102 1720000 1720203 1720407 1720429 1720600 1721002 1722005 1724000 1724306 1724317 1724500 1724521 1724532 1724656 1724667

Vinorelbine Tartrate (200 mg) Vinorelbine Related Compound A (25 mg) (4-ODeacetylvinorelbine tartrate) Viomycin Sulfate (200 mg) Vitamin A (10 ampules containing vitamin A acetate in peanut oil) Vitamin D Assay System Suitability (1.5 g) Vitexin (30 mg) Warfarin (200 mg) Warfarin Related Compound A (50 mg) (3-(ohydroxyphenyl)-5-phenyl-2-cyclohexen-1-one) Xanthanoic Acid (100 mg) Xanthone (100 mg) Xylazine (200 mg) Xylazine Hydrochloride (200 mg) Xylitol (1 g) Xylometazoline Hydrochloride (125 mg) Xylose (1 g) Yohimbine Hydrochloride (200 mg) Zalcitabine (200 mg) Zalcitabine Related Compound A (50 mg) (2,3Didehydro-2,3-dideoxycytidine) Zidovudine (400 mg) Zidovudine Related Compound B (25 mg) (3chloro-3-deoxythymidine) Zidovudine Related Compound C (100 mg) (thymine) Zileuton (150 mg) Zileuton Related Compound A (50 mg) (N-(1Benzo[b]thien-2-ylethyl) urea)

F2E197 F0C242 F W0F126 F-1 F0C142 I0B305 H0E268 G-1 F-1 F1C001 F G0B037 I0B101 F F F F0B234 G1D319 G0B116 F-1 F0C062 F0B316

0.994 mg/mg (an)

[125317-39-7] n/f [37883-00-4]

2,3

V0C258 (12/05) U (04/04) F (08/06) H-2 (08/04) H-1 (11/01) G1B111 (02/07) G (01/04) G (12/00) F (02/05) F-3 (11/02) F-2 (05/00) H-1 (05/03)

[127-47-9] [67-97-0] [3681-93-4] [81-81-2] [37209-23-7] [82-07-5] [90-47-1] [7361-61-7] [23076-35-9] [87-99-0] [1218-35-5] [58-86-6] [65-19-0] [7481-89-2] [7481-88-1]

0.991 mg/mg (ai)

G (10/05) F (09/01) F-1 (03/03) F (06/01) F (09/01)

[30516-87-1] [25526-94-7] [65-71-4] [111406-87-2] n/f

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

92 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Reference Standards and Authentic Substances

Cat. No. 1724678 1724689 1724747 1724769 1724805 Curr. Lot. F0B313 F0B299 F0D170 F0D133 G0C023 99.7% (ig) 56.4% (ai) F-1 (03/04) F (05/02) Purity Value/Conc. Change Code* Previous Lot/Valid Use Date CAS No. n/f n/f [1314-13-2] [7446-20-2] [33754-49-3]

Description Zileuton Related Compound B (50 mg) (2-(Benzo[b]thien-2-oyl)benzo[b]thiophene) Zileuton Related Compound C (50 mg) (1-Benzo[b]thien-2-ylethanone) Zinc Oxide (2 g) (AS) Zinc Sulfate (1 g) (AS) Zolazepam Hydrochloride (500 mg)

*See Page 21 for Change Code Interpretation

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

93

Cross Reference List

Former Cat. No. 00200-6 1008002 1021703 02200-3 02250-2 1023403 02380-0 02420-2 02240-6 02460-0 02490-5 02610-6 02620-8 1042000 06300-0 07350-3 07480-1 07500-4 1076002 08650-5 11230-0 11310-9 11320-0 11330-2 11400-0 11500-2 11510-4 Former Description/Cross Reference 5-Acetamido-3-amino-2,4,6-triiodobenzoic Acid (50 mg) (Limit Test) alpha-d-2-Acetoxy-4-dimethylamino-1,2-diphenyl-3methylbutane N-(Aminocarbonyl)-N-[([5-nitro-2-furanyl]-methylene)-amino]-glycine (25 mg) 3-Amino-4-carboxamidopyrazole Hemisulfate (50 mg) (Limit Test) 4-Amino-6-chloro-1,3-benzenedisulfonamide (100 mg) (Limit Test) 3-Amino-6-chloro-1-methyl-4-phenylcarbostyril (25 mg) 2-Amino-2-chloro-5-nitrobenzophenone (25 mg) (Limit Test) 4-Amino-6-chloro-N-3-methyl-m-benzenedisulfonamide (100 mg) (Limit Test) 2-Amino-4-chlorophenol (50 mg) (Limit Test) 3-Amino-4-(2-chloro-phenyl)-6-nitrocarbostyril (25 mg) (Limit Test) 2-Amino-2,5-dichlorobenzophenone (25 mg) (Limit Test) 3-Amino-4-phenoxy-5-sulfamoylbenzoic Acid (25 mg) (Limit Test) alpha-Aminopropiophenone Hydrochloride (50 mg) (Limit Test) Aprobarbital CIII (200 mg) (AS) DISCONTINUED 5-Benzyl-3,6-dioxo-2-piperazineacetic Acid (250 mg) (Limit Test) 2-(4-Biphenylyl)propionic Acid (100 mg) (Limit Test) N,N-Bis-(1,3-dihydroxy-2-propyl)-5-amino-2,4,6-triiodoisophthalamide (50 mg) (Limit Test) 4,4-Bis[4-(p-chlorophenyl)-4-hydroxypiperidino]-butyrophenone (25 mg) (Limit Test) 4,4-Bis[1,2,3,6-tetrahydro-4-(2-oxo-1-benzimidazolinyl)-1pyridyl]butyrophenone (25 mg) DISCONTINUED Calcium Formyltetrahydrofolate (50 mg) (AS) (For Qualitiative Use Only) p-Chlorobenzhydrylpiperazine (25 mg) 6-Chloro-4-(o-chloro-phenyl)-2-quinazolinecarboxaldehyde (25 mg) (Limit Test) 6-Chloro-4-(o-chloro-phenyl)-2-quinazolinecarboxylic Acid (25 mg) (Limit Test) 6-Chloro-4-(o-chloro-phenyl)-2-quinazoline Methanol (25 mg) (Limit Test) 7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2one (50 mg) (Limit Test) 7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2one 4-oxide (25 mg) (Limit Test) 2-Chloro-4-N-furfuryl-amino-5-sulfamolybenzoic acid (50 mg) (Limit Test) Cat. No. 1184027 1008002 1021703 1013024 1057507 1023403 1140338 1424018 1130527 1140327 1370338 1078325 1096804 N/A 1043728 1285760 1344724 1303013 N/A 1286027 1333058 1370349 1370350 1370360 1468400 1110020 1287020 New Description Diatrizoic Acid Related Compound A (50 mg) (5-Acetamido-3-amino-2,4,6-triiodobenzoic Acid) Propoxyphene Related Compound B (50 mg) (alpha-d-2Acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane) Nitrofurantoin Related Compound A (25 mg) (N-(Aminocarbonyl)-N-[([5-nitro-2-furanyl]-methylene)-amino]-glycine) Allopurinol Related Compound A (50 mg) (3-Amino-4carboxamidopyrazole Hemisulfate) Benzothiadiazine Related Compound A (100 mg) (4-Amino-6-chloro-1,3-benzenedisulfonamide) Diazepam Related Compound B (25 mg) (3-Amino-6chloro-1-methyl-4-phenylcarbostyril) Clonazepam Related Compound B (25 mg) (2-Amino-2chloro-5-nitrobenzophenone) Methyclothiazide Related Compound A (100 mg) (4-Amino6-chloro-N-3-methyl-m-benzenedisulfonamide) Chlorzoxazone Related Compound A (25 mg) ( 2-Amino-4chlorophenol) Clonazepam Related Compound A (25 mg) (3-Amino-4-(2chlorophenyl)-6-nitrocarbostyril) Lorazepam Related Compound B (25 mg) (2-Amino-2,5dichlorobenzophenone) Bumetanide Related Compound A (25 mg) (3-Amino-4phenoxy-5-sulfamoylbenzoic Acid) Cathinone Hydrochloride CI (50 mg) (alpha-Aminopropiophenone Hydrochloride) DISCONTINUED, Last Lot/Valid Use Date: F-1 (02/07) Aspartame Related Compound A (75 mg) (5-Benzyl-3,6dioxo-2-piperazineacetic Acid) Flurbiprofen Related Compound A (100 mg) (2-(4-Biphenylyl)propionic Acid) Iopamidol Related Compound A (50 mg) (N,N-Bis-(1,3dihydroxy-2-propyl)-5-amino-2,4,6-triiodoisophthalamide) Haloperidol Related Compound A (25 mg) (4,4-Bis[4-pchlorophenyl)-4-hydroxypiperidino]-butyrophenone DISCONTINUED, Last Lot/Valid Use Date: G (05/03) Folic Acid Related Compound A (50 mg) (Calcium Formyltetrahydrofolate) Hydroxyzine Related Compound A (25 mg) (p-Chlorobenzhydrylpiperazine) Lorazepam Related Compound C (25 mg) (6-Chloro-4-(ochlorophenyl)-2-quinazolinecarboxaldehyde) Lorazepam Related Compound D (25 mg) (6-Chloro-4-(ochlorophenyl)-2-quinazolinecarboxylic Acid) Lorazepam Related Compound E (25 mg) (6-Chloro-4-(ochlorophenyl)-2-quinazoline Methanol) Nordazepam CIV (50 mg) (7-Chloro-1,3-dihydro-5-phenyl2H-1,4-benzodiazepin-2-one) Chlordiazepoxide Related Compound A (25 mg) (7-Chloro1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one 4-oxide) Furosemide Related Compound A (50 mg) (2-Chloro-4-Nfurfurylamino-5-sulfamoylbenzoic Acid)

94 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

Cross Reference List

Former Cat. No. 11550-1 11650-4 11670-8 11900-3 1119309 1153001 15870-8 21000-3 Former Description/Cross Reference 2-Chloro-3,5-dimethyl-phenol (50 mg) (Limit Test) (o-Chlorophenyl)diphenyl-methanol (25 mg) (Limit Test) 4-(4-Chlorophenyl)-2-pyrrolidinone (75 mg) (Limit Test) 4-Chloro-5-sulfamoylanthranilic Acid (100 mg) (Limit Test) 4-Chloro-3-sulfamoyl-2-benzophenone Carboxylic Acid (100 mg) Cyclizine (1 g) DISCONTINUED Cyclosporine U (25 mg) DISCONTINUED alpha-d-4-Dimethylamino-1,2-diphenyl-3-methyl-2-butanol Hydrochloride (125 mg) (Limit Test) Diphemanil Methylsulfate (500 mg) DISCONTINUED Etoposide Related Compound A (25 mg) (4-Demethylepipodophyllotoxin 9-[4,6-O-(R)-ethylidene-alpha-D-glucopyranoside) DISCONTINUED Evans Blue (200 mg) Fluoride Dentifrice: Sodium Fluoride-Calcium Pyrophosphate (high beta-phase) (180 g) DISCONTINUED 4-Formylbenzenesulfonamide (50 mg) Glucagon (25 mg, 0.95 U/mg) DISCONTINUED Hyaluronidase (500 mg) DISCONTINUED 3-Hydroxy-1-methylquinuclidinium Bromide (250 mg) (Limit Test) 9-Hydroxypropantheline Bromide (50 mg) Hydroxypropyl Methylcellulose (250 mg) Hydroxypropyl Methylcellulose Phthalate (100 mg) Levallorphan Tartrate (200 mg) DISCONTINUED Levo-alpha-acetylmethadol Hydrochloride CII (25 mg) (AS) DISCONTINUED Melting Point Standard - Acetanilide (500 mg; approximately 114 degrees) Melting Point Standard - Caffeine (1 g; approximately 236 degrees) Melting Point Standard - Phenacetin (500 mg; approximately 135 degrees) Melting Point Standard - Sulfanilamide (1 g; approximately 165 degrees) Melting Point Standard - Sulfapyridine (2 g; approximately 191 degrees) Melting Point Standard - Vanillin (1 g; approximately 82 degrees) 1384004 1420006 42420-0 Mephentermine Sulfate (250 mg) DISCONTINUED 3-Methoxytyrosine (50 mg) 2-Methylamino-5-chlorobenzophenone (25 mg) (Limit Test) Cat. No. 1122722 1141024 1048222 1287030 1119309 N/A 1158650 1575206 New Description Chloroxylenol Related Compound A (50 mg) (2-Chloro-3,5dimethyl-phenol) Clotrimazole Related Compound A (25 mg) ((o-Chlorophenyl)diphenyl-methanol ) Baclofen Related Compound A (50 mg) (4-(4-Chlorophenyl)-2-pyrrolidinone) Furosemide Related Compound B (100 mg) (4-Chloro-5sulfamoylanthranilic Acid) Chlorthalidone Related Compound A (25 mg) (4-Chloro-3sulfamoyl-2-benzophenone Carboxylic Acid) DISCONTINUED, Last Lot/Valid Use Date: F (04/04) Cyclosporine Resolution Mixture (25 mg) (Replaces Cat. No. 15870-8 Cyclosporine U (25 mg)) Propoxyphene Related Compound A (50 mg) (alpha-d-4Dimethylamino-1,2-diphenyl-3-methyl-2-butanol Hydrochloride) DISCONTINUED, Last Lot/Valid Use Date: H(03/06) Etoposide Resolution Mixture (30 mg)

1216000 1268820

N/A 1268852

1269006 1277208 1286209 1294003 1312003 32720-4 1329505 1330005 33010-7 1359007 1362001

N/A N/A 1286209 N/A N/A 1135021 1329505 1330005 1335304 N/A N/A 1004001 1086006 1514008 1633007 1635002 1711009 N/A 1420006 1185020

DISCONTINUED, Last Lot/Valid Use Date: G (04/04) DISCONTINUED, Last Lot/Valid Use Date: F (01/04) Mafenide Related Compound A (50 mg) (4-Formylbenzenesulfonamide) DISCONTINUED, Last Lot/Valid Use Date: H (01/05) DISCONTINUED, Last Lot/Valid Use Date: H (06/05) Clidinium Bromide Related Compound A (250 mg) (3Hydroxy-1-methylquinuclindinium Bromide) Propantheline Bromide Related Compound A (50 mg) (9Hydroxypropantheline bromide) Hypromellose (250 mg) (Hydroxypropyl Methylcellulose) Hypromellose Phthalate (100 mg) DISCONTINUED, Last Lot/Valid Use Date: G-1 (09/04) DISCONTINUED, Last Lot/Valid Use Date: F-1 (08/03) Acetanilide Melting Point Standard (500 mg) (Approximately 114 degrees) Caffeine Melting Point Standard (1 g) (Approximately 236 degrees) Phenacetin Melting Point Standard (500 mg) (Approximately 135 degrees) Sulfanilamide Melting Point Standard (500 mg) (Approximately 165 degrees) Sulfapyridine Melting Point Standard (1 g) (Approximately 191 degrees) Vanillin Melting Point Standard (1 g) (Approximately 82 degrees) DISCONTINUED, Last Lot/Valid Use Date: F-1 (04/05) Levodopa Related Compound B (50 mg) (3-Methoxytyrosine) Diazepam Related Compound A (25 mg) (2-Methylamino5-chlorobenzophenone)

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

95

Cross Reference List

Former Cat. No. 42430-2 1434000 Former Description/Cross Reference 3-O-Methylcarbidopa (50 mg) Methylphenidate Hydrochloride Erythro Isomer CII (25 mg) DISCONTINUED; Last Lot/Valid Use Date: J0B294 (04/05); please order 1434011 Mitoxantrone Related Compound A Hydrochloride (30 mg) (8-amino-1,4-dihydroxy-5[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione Hydrochloride) DISCONTINUED; Please order 1445211 5-Nitro-2-furfuraldazine (500mg) 3-Nitro-4-phenoxy-5-sulfamoylbenzoic Acid (25 mg) (Limit Test) Octyl Methoxycinnamate (500 mg) Octyl Salicylate (400 mg) Oxamniquine (200 mg) DISCONTINUED Oxamniquine Related Compound A (25 mg) (1,2,3,4tetrahydro-2-isopropylaminomethyl-7-nitro-6-quinolinemethyl methanesulfonate) DISCONTINUED Oxamniquine Related Compound B (25 mg) (1,2,3,4tetrahydro-2-isopropylaminomethyl-5-nitro-6-quinolinemethanol) DISCONTINUED Oxyphenbutazone (1 g) DISCONTINUED Paroxetine Related Compound A (10 mg) (trans-4-(pmethoxyphenyl)-3-[(3,4-methylenedioxy)phenoxy]methylpiperidine Hydrochloride) DISCONTINUED Pancreatin (2 g) Cat. No. 1095517 1434011 New Description Carbidopa Related Compound A (50 mg) (3-O-Methylcarbidopa) Methylphenidate Hydrochloride Erythro Isomer Solution CII (0.5 mL) Mitoxantrone System Suitability Mixture (0.3 mg)

1445222

1445211

46600-7 46660-8 1477900 1477943 1481500 1481703

1466007 1078336 1477900 1477943 N/A N/A

Nitrofurazone Related Compound A (500mg) (5-Nitro-2furfuraldazine) Bumetanide Related Compound B (25 mg) (3-Nitro-4phenoxy-5-sulfamoylbenzoic Acid) Octinoxate (500 mg) (Octyl Methoxycinnamate) Octisalate (400 mg) (Octyl Salicylate) DISCONTINUED, Last Lot/Valid Use Date: F (10/05) DISCONTINUED, Last Lot/Valid Use Date: F (10/05)

1481805

N/A

DISCONTINUED, Last Lot/Valid Use Date: F (10/05)

1489002 1500229

N/A N/A

DISCONTINUED, Last Lot/Valid Use Date: H(12/05) DISCONTINUED, Last Lot/Valid Use Date: F1D058 (10/05)

49400-2

1494057 a n d / o r 1494079 N/A 1485114 1434022 1546707 N/A 1071304 N/A N/A N/A 1672010 and 1672020 1361010 N/A 1656002 1603006 1462006 1087009 1587001

Pancreatin Amylase and Protease (2 g) and/or Pancreatin Lipase (2 g) DISCONTINUED, Last Lot/Valid Use Date: F-1 (02/04) Oxybutynin Related Compound A (100 mg) (Phenylcyclohexylglycolic Acid) Methylphenidate Related Compound A (50 mg) (alphaPhenyl-2-piperidineacetic Acid Hydrochloride) Polyethylene, High Density (3 strips) DISCONTINUED, Last Lot/Valid Use Date: F (09/05) Bile Salts (10 g) (Sodium Taurocholate) DISCONTINUED, Last Lot/Valid Use Date: F (02/07) DISCONTINUED, Last Lot/Valid Use Date: F-1 (11/04) DISCONTINUED, Last Lot/Valid Use Date: F (10/04) o-Toluenesulfonamide (200 mg) and p-Toluensulfonamide (200 mg) Levodopa Related Compound A (50 mg) (3-(3,4,6-Trihydroxyphenyl)-alanine) DISCONTINUED, Last Lot/Valid Use Date: G (02/07) Thiamine Hydrochloride (500 mg) (Vitamin B1 Hydrochloride) Riboavin (500 mg) (Vitamin B2) Niacinamide (500 mg) (Vitamin B3) Calcium Pantothenate (200 mg) (Vitamin B5) Pyridoxine Hydrochloride (200 mg) (Vitamin B6)

1527000 53180-1 53350-1 54500-1 1576720 61500-5 1640002 1653106 1667279 1672009

Phenprocoumon (200 mg) DISCONTINUED Phenylcyclohexylglycolic Acid (100 mg) (Limit Test) alpha-Phenyl-2-piperidineacetic Acid Hydrochloride (50 mg) (Limit Test) Plastic, Negative Control Propylene Glycol Diacetate (250 mg) DISCONTINUED Sodium Taurocholate (20 g) Sulsoxazole Diolamine (500 mg) DISCONTINUED Theophylline Extended-Release Beads (Drug Release Calibrator, Multiple Unit) (20 g) DISCONTINUED Thromboplastin, Human Recombinant (set) (1 vial Thromboplastin and 1 vial Diluent) DISCONTINUED Toluenesulfonamides, ortho and para (200 mg of each supplied in a set) DISCONTINUED, Last Lot/Valid Use Date: F-4 (07/06) 3-(3,4,6-Trihydroxyphenyl)-alanine (50 mg) (Limit Test) Tripelennamine Citrate (200 mg) DISCONTINUED Vitamin B1 Hydrochloride Vitamin B2 Vitamin B3 Vitamin B5 Vitamin B6

68800-9 1694001

96 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

Cross Reference List

Former Cat. No. Former Description/Cross Reference Vitamin B12 Vitamim Bc Vitamin C Vitamin D2 Vitamin D3 Vitamin E Alcohol Vitamin E Acetate Vitamin E Acid Succinate Vitamin K1 Vitamin K3 Vitamin M Cat. No. 1152009 1286005 1043003 1239005 1131009 1667600 1667701 1667803 1538006 1381006 1286005 New Description Cyanocobalamin (1.5 g of mixture with mannitol; 10.7 mcg/ mg of mixture) (Vitamin B12) Folic Acid (500 mg) (Vitamin M or Vitamin Bc) Ascorbic Acid (1 g) (Vitamin C) Ergocalciferol (150 mg; 30 mg/ampule; 5 ampules) (Vitamin D2) Cholecalciferol (30 mg/ampul; 5 ampuls) (Vitamin D3) Alpha Tocopherol (250 mg) (Vitamin E Alcohol) Alpha Tocopheryl Acetate (250 mg) (Vitamin E Acetate) Alpha Tocopheryl Acid Succinate (250 mg) (Vitamin E Succinate) Phytonadione (500 mg) (Vitamin K1) Menadione (200 mg) (Vitamin K3) Folic Acid (500 mg) (Vitamin M or Vitamin Bc)

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

97

USP Authentic Substances

Cat. No. 1005706 1012076 1036507 1017364 1019712 1029942 1029986 1042000 1043105 1059003 1075600 1075622 1075644 1076341 1076465 1082708 1086334 1086403 1086436 1086855 1086935 1087031 1087359 1087406 1089004 1090003 1096531 1096699 1098388 1098402 1133503 1134346 1148806 1150207 1150513 1171251 1183002 1187091 1188301 1210105 1235900 1237509 1251000 1268965 1270355 1270446 1286606 Description Glacial Acetic Acid (1.5 mL/ampule; 3 ampules) (AS) Acyclovir Related Compound A (50 mg) (AS) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl acetate) 3-Anilino-2-(3,4,5-trimethoxybenzyl) acrylonitrile (25 mg) (AS) Aluminum Sulfate (2 g) (AS) Amiloride Related Compound A (30 mg) (AS) (Methyl 3,5-diamino-6-chloropyrazine-2-carboxylate) Ammonium Carbonate (2 g) (AS) Ammonium Phosphate Dibasic (1 g) (AS) Aprobarbital CIII (200 mg) (AS) Ascorbyl Palmitate (2 g) (AS) Benzphetamine Hydrochloride CIII (200 mg) (AS) Bismuth Subcarbonate (1 g) (AS) Bismuth Subgallate (2 g) (AS) Bismuth Subnitrate (1.5 g) (AS) Boric Acid (1 g) (AS) Bromazepam CIV (100 mg) (AS) Butylated Hydroxytoluene (500 mg) (AS) Calcium Acetate (1 g) (AS) Calcium Carbonate (1 g) (AS) Calcium Chloride (1 g) (AS) Calcium Hydroxide (1 g) (AS) Calcium Levulinate (1 g) (AS) Tribasic Calcium Phosphate (1 g) (AS) Calcium Stearate (2 g) (AS) Calcium Sulfate (1 g) (AS) Cannabidiol CI (25 mg) (AS) Cannabinol CI (25 mg) (AS) Carboxymethylcellulose Calcium (1.5 g) (AS) Carprofen (200 mg) (AS) Microcrystalline Cellulose (1 g) (AS) Powdered Cellulose (1 g) (AS) Cholic Acid (2 g) (AS) Ciprooxacin Related Compound A (25 mg) (AS) (7-Chloro-1-cyclopropyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3carboxylic acid hydrochloride salt) Corn Oil (1 g) (AS) Cottonseed Oil (1 g) (AS) Cromolyn Sodium Related Compound A (25 mg) (1,3-Bis-(2-acetyl-3-hydroxyphenoxy)-2-propanol) (AS) 2-Deoxy-D-Glucose (100 mg) (AS) Diacetylmorphine Hydrochloride CI (25 mg) (AS) (Heroin Hydrochloride) Dibutyl Sebacate (1 mL) (AS) Dichlorvos (150 mg) (2,2-dichlorovinyl dimethyl phosphate) (AS) N-(3-Dimethylamino-propyl)-2-aza-8,8-diethyl-8-germaspiro [4:5]decane-1,3-dione (AS) Enrooxacin (200 mg) (AS) Epitetracycline Hydrochloride (200 mg) (AS) Estradiol Benzoate (250 mg) (AS) Eugenol (500 mg) (AS) Ferrous Sulfate (1.5 g) (AS) Fexofenadine Related Compound C (15 mg) ((+)-4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-isopropylbenzene) (AS) L-Fucose (200 mg) (AS) F0D336 F0D335 F0D362 F0D364 F3B159 F0E333 F0D181 F0D173 F0E045 F0E006 J F0D128 F0D141 F F0E094 G0E261 H0C332 F0D303 F0D196 F0E291 F0E007 Curr. Lot F0D002 F0F010 G2D383 F0D342 F0E287 F0D102 F0D104 F-1 F0D326 F2C272 F0D324 F0D323 F0D388 F0D036 F0F064 F0D122 F0D156 F0D099 F0D153 F0D168 F0E142 F0D394 F0D255 F0D236 F-2

Note: Where the Current Lot is blank the item is not in distribution

98 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

USP Authentic Substances

Cat. No. 1302305 1338812 1350308 1356643 1356734 1371002 1374226 1374248 1374260 1374292 1374340 1374361 1375127 1375149 1379140 1381005 1396364 1410002 1424506 1425000 1429000 1437450 1446600 1447002 1478254 1478516 1479010 1491015 1492040 1500251 1500557 1516003 1525707 1535802 1547346 1372606 1547925 1547936 1547947 1547969 1549807 1548101 1548134 1549840 1548167 1548190 1548225 1548280 Description Halazepam CIV (200 mg) (AS) Indapamide Related Compound A (50 mg) (4-Chloro-N-(2-methyl-indol-1-yl)-3-sulfamoylbenzamide) (AS) Isopropyl Alcohol (1.5 mL/ampule; 3 ampules) (AS) Ketoprofen Related Compound A (25 mg) (alpha-Methyl-3-(4-methylbenzoyl) benzeneacetic acid) (AS) Lactic Acid (1.5 mL/ampule; 3 ampules) (AS) Lysergic Acid Diethylamide Tartrate CI (10 mg) (AS) (LSD) Magnesium Carbonate (2 g) (AS) Magnesium Chloride (1 g) (AS) Magnesium Hydroxide (1 g) (AS) Magnesium Phosphate (2 g) (AS) Magnesium Stearate (5 g) (AS) Magnesium Sulfate (1 g) (AS) Manganese Chloride (1 g) (AS) Manganese Sulfate (1 g) (AS) Meglumine (500 mg) (AS) Melatonin (100 mg) (AS) Methacholine Chloride (500 mg) (AS) Methicillin Sodium (500 mg) (AS) Methylcellulose (1 g) (AS) 4-Methyl-2,5-dimethoxyamphetamine Hydrochloride CI (25 mg) (AS) (STP) Methylenedioxy-3,4-amphetamine Hydrochloride CI (25 mg) (AS) (MDA) Methyl Salicylate (2 mL) (AS) Monosodium Glutamate (1 g) (AS) Morphine Monohydrate CII (50 mg) (AS) Olive Oil (1 g) (AS) Omeprazole Related Compound A (15 mg) (Omeprazole Sulfone) (AS) Orphenadrine Related Compound A (50 mg) ((RS)-N,N-dimethyl-2-[(3-methylphenyl)-phenylmethoxy]ethanamine citrate) (AS) Oxytetracycline Hydrochloride (200 mg) (AS) Palm Oil (1 g) (AS) Paroxetine Related Compound D (10 mg) (AS) (cis-Paroxetine hydrochloride) Peanut Oil (1 g) (AS) Phencyclidine Hydrochloride CII (25 mg) (AS) Phenothiazine (500 mg) (AS) Phosphoric Acid (1.5 mL/ampule; 3 ampules) (AS) Polyoxyl 2 Stearyl Ether (1 g) (AS) Polyoxyl 10 Stearyl Ether (1 g) Polysorbate 20 (2 g) (AS) Polysorbate 40 (2 g) (AS) Polysorbate 60 (2 g) (AS) Polysorbate 80 (2 g) (AS) Potassium Acetate (500 mg) (AS) Potassium Benzoate (1 g) (AS) Potassium Bicarbonate (1 g) (AS) Potassium Bitartrate (3 g) (AS) Potassium Carbonate (1 g) (AS) Potassium Chloride (1 g) (AS) Potassium Citrate (1 g) (AS) Potassium Iodide (1 g) (AS) Curr. Lot F1C224 F0E052 F0D261 H0E028 F0D027 I F0D256 F0D157 F0D158 F0E107 F0D214 F0D160 F0D150 F0D151 F0D385 F0E027 F0D222 J0C333 G0B222 F F-1 F0D070 F0D387 G1F125 F0D175 F0D363 F0F042 F0E258 F0D179 G0E096 F0D171 G1B025 F0D231 F0D026 F0D353 F0D354 F0D130 F0D204 F0D131 F0D132 F0E083 F0D161 F0D074 F0D384 F0D075 F0D127 F0D201 F0D078

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition Ofcial USP Reference Standards Catalog

99

USP Authentic Substances

Cat. No. 1548349 1551128 1551139 1551140 1548407 1572208 1612404 1613407 1613655 1613757 1613804 1613859 1614363 1614396 1614454 1614807 1615107 1615956 1619017 1643328 1643340 1667585 1708718 1724747 1724769 Description Potassium Nitrate (5 g) (AS) Dibasic Potassium Phosphate (5 g) (AS) Monobasic Potassium Phosphate (5 g) (AS) Potassium Sodium Tartrate (2 g) (AS) Potassium Sorbate (1 g) (AS) Propionic Acid (1.5 mL/ampule; 3 ampules) (AS) Sesame Oil (1 mL/ampule; 2 ampules) (AS) Sodium Acetate (1 g) (AS) Sodium Bicarbonate (3 g) (AS) Sodium Carbonate Anhydrous (1 g) (AS) Sodium Chloride (1 g) (AS) Sodium Citrate (1 g) (AS) Sodium Lauryl Sulfate (1 g) (AS) Sodium Metabisulte (1 g) (AS) Sodium Nitrite (1 g) (AS) Sodium Sulfate Anhydrous (1 g) (AS) Sodium Thiosulfate (1 g) (AS) Sorbic Acid (1 g) (AS) Spironolactone Related Compound A (100 mg) (Canrenone (3-Oxo-17-alpha-pregna-4,6-diene-21, 17-carbolactone)) (AS) Tannic Acid (2 g) (AS) Tartaric Acid (1 g) (AS) Titanium Dioxide (1 g) (AS) Valproic Acid Related Compound B (50 mg) ((2RS)-2-(1-methylethyl)pentanoic acid) (AS) Zinc Oxide (2 g) (AS) Zinc Sulfate (1 g) (AS) Curr. Lot F0D325 F0D281 F0D313 F0D380 F0D264 F0D029 F0E134 F0D083 F0D235 F0D100 F0D269 F0D172 F0D381 F0D111 F0D117 F0D112 F0D178 F0D129 F0E184 F0D292 F0D176 F0D079 F0E201 F0D170 F0D133

Note: Where the Current Lot is blank the item is not in distribution

100 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

Dietary Supplement Reference Standards Available from USP

Cat. No. 1012509 1021000 1042500 1042601 1043502 1043513 1161509 1294976 1294808 1295800 1308505 1349502 1357001 1359903 1359925 1371501 1372005 1411504 1530503 1568506 1612506 1667202 1700501 1705006 1708503 Description L-Alanine (200 mg) Aminocaproic Acid (200 mg) L-Arginine (200 mg) Arginine Hydrochloride (125 mg) Asparagine Anhydrous (200 mg) Asparagine Monohydrate (200 mg) L-Cysteine Hydrochloride (200 mg) Glutamic Acid (200 mg) Glutamine (100 mg) Glycine (200 mg) L-Histidine (200 mg) L-Isoleucine (200 mg) L-Leucine (200 mg) Levocarnitine (400 mg) Levocarnitine Related Compound A (100 mg) (3-carboxy-N,N,N-trimethyl-2-propen-1-aminium chloride) L-Lysine Acetate (200 mg) L-Lysine Hydrochloride (200 mg) L-Methionine (200 mg) L-Phenylalanine (200 mg) L-Proline (200 mg) L-Serine (200 mg) L-Threonine (200 mg) L-Tryptophan (200 mg) L-Tyrosine (500 mg) L-Valine (200 mg) G0B060 F0E013 F0E012 H F0C069 G0F037 G0E099 G0A018 F-2 H0B237 G0B197 F-1 F1C027 I0E230 G1D398 H G0D146 G G G2E237 K0C141 G0F115 Curr. Lot G0E002 G0D101

AMINO ACIDS

BOTANICALS
BLACK COHOSH 1076206 1091108 1200600 CHAMOMILE 1040708 1012203 1096779 1105009 1286060 1599500 1134368 1181302 1286504 1374601 1594506 1617000 1623637 Apigenin-7-Glucoside (30 mg) Agnuside (25 mg) Casticin (25 mg) Powdered Chaste Tree Extract (1.5 g) Formononetin (50 mg) Powdered Red Clover Extract (500 mg) Citric Acid (200 mg) Dextrose (500 mg) Fructose (125 mg) Malic Acid (200 mg) Quinic Acid (200 mg) Sorbitol (125 mg) Sucrose (100 mg) F F0D397 F0D358 F0C406 F0C196 F0C188 F2E269 J2E294 I3E340 G0B158 F H1B139 H1C223 CHASTE TREE Powdered Black Cohosh Extract (1.5 g) Capsaicin (100 mg) Dihydrocapsaicin (25 mg) F0D086 G2D136 G0C071 CAPSAICIN/CAPSICUM

RED CLOVER

CRANBERRY LIQUID

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition 101 Ofcial USP Reference Standards Catalog

Dietary Supplement Reference Standards Available from USP

Cat. No. ELEUTHERO 1234704 1234668 1234680 ECHINACEA 1115545 1231728 1231706 1305507 FEVERFEW 1500400 1606503 GARLIC 1012145 1012950 1115556 1294848 1411504 1013057 GINGER 1091108 1291504 GINKGO 1115545 1592409 1606503 1291708 1291708 1065210 1313210 1115545 1335202 1592409 1606503 1717708 1249202 KAVA 1355709 KAWAIN 1355753 LICORICE 1295888 Glycyrrhizic Acid (25 mg) F0C006 MILK THISTLE Kawain (200 mg) F0C160 Powdered Kava Extract (1 g) F0C161 Chlorogenic Acid (50 mg) Quercetin (500 mg) Rutin (100 mg) Powdered Asian Ginseng Extract (1.5 g) Powdered Asian Ginseng Extract (1.5 g) Berberine Chloride (50 mg) Hydrastine (10 mg) Chlorogenic Acid (50 mg) Hyperoside (50 mg) Quercetin (500 mg) Rutin (100 mg) Vitexin (30 mg) Escin (350 mg) F0C420 G0D407 G0C355 F0B289 F0B289 F0E185 F0E204 F0C420 F G0D407 G0C355 F0C142 F0F088 Capsaicin (100 mg) Powdered Ginger (500 mg) G2D136 F Agigenin (25 mg) Alliin (25 mg) beta-Chlorogenin (20 mg) gamma-Glutamyl-S-allyl-L-cysteine (25 mg) L-Methionine (200 mg) S-Allyl-L-Cysteine (25 mg) F F F F G1D398 F Parthenolide (25 mg) Rutin (100 mg) F G0C355 Chlorogenic Acid (50 mg) Powdered Echinacea Purpurea Extract (1 g) Powdered Echinacea Angustifolia Extract (1 g) 2E, 4E-Hexadienoic Acid Isobutylamide (25 mg) F0C420 F0D018 F0D019 F0C353 Powdered Eleuthero Extract (1.5 g) Eleutheroside B (15 mg) (Syringin) Eleutheroside E (15 mg) (Syringaresinol diglucoside) F0C291 F0E056 F0E057 Description Curr. Lot

GARLIC FLUID EXTRACT

AMERICAN GINSENG ASIAN GINSENG GOLDENSEAL

HAWTHORN LEAF WITH FLOWER

HORSE CHESTNUT

Note: Where the Current Lot is blank the item is not in distribution

102 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

Dietary Supplement Reference Standards Available from USP

Cat. No. 1443850 1612630 1612641 PYGEUM 1612947 1115545 1335202 1485001 1606503 1424233 1424244 1424255 1430305 1430327 1430349 1431501 1431556 1431603 1431625 1437508 1612947 1043819 1294976 1610090 1612947 VALERIAN 1707908 1133536 1133547 1133570 1133638 1150353 1294207 1381005 1611955 1705301 1705323 1705312 1043003 1071508 1086356 1087009 1131009 1131803 Valerenic Acid (15 mg) Choline Bitartrate (200 mg) Choline Chloride (200 mg) Chondroitin Sulfate Sodium (300 mg) Chromium Picolinate (100 mg) Creatinine (100 mg) Glucosamine Hydrochloride (200 mg) Melatonin (100 mg) (AS) Selenomethionine (100 mg) Ubidecarenone (200 mg) Ubidecarenone Related Compound A (15 mg) (Coenzyme Q9) Ubidecarenone for System Suitability (25 mg) Ascorbic Acid (1 g) (Vitamin C) Biotin (200 mg) Calcium Ascorbate (200 mg) Calcium Pantothenate (200 mg) (Vitamin B5) Cholecalciferol (30 mg/ampule; 5 ampules) (Vitamin D3) Delta-4,6-cholestadienol (30 mg) H0D126 F0C057 F0C058 G0E236 F F F0C363 F0E027 F0B006 G0E154 F0E210 F0B194 Q0B012 I0D114 F-1 O0C331 M0B157 F Beta-Sitosterol (300 mg) Chlorogenic Acid (50 mg) Hyperoside (50 mg) Oxybenzone (150 mg) Rutin (100 mg) Methyl Caprate (300 mg) Methyl Caproate (300 mg) Methyl Caprylate (300 mg) Methyl Laurate (500 mg) Methyl Linoleate (5 x 50 mg) Methyl Linolenate (5 x 50 mg) Methyl Myristate (300 mg) Methyl Oleate (500 mg) Methyl Palmitate (300 mg) Methyl Palmitoleate (300 mg) Methyl Stearate (300 mg) Beta-Sitosterol (300 mg) Aspartic Acid (100 mg) Glutamic Acid (200 mg) Scopoletin (20 mg) Beta-Sitosterol (300 mg) F0D217 F0C420 F H0B263 G0C355 G0D087 F G0D064 G0C356 G0D107 F G0C357 G0C148 G0E329 F G0E290 F0D217 F0B087 F0C069 F0C329 F0D217 ST. JOHN S WORT Description Powdered Milk Thistle Extract (250 mg) Silybin (50 mg) Silydianin (20 mg) Curr. Lot F0B321 G0D392 F

SAW PALMETTO

STINGING NETTLE

MISCELLANEOUS DIETARY SUPPLEMENTS

VITAMINS-MINERALS

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition 103 Ofcial USP Reference Standards Catalog

Dietary Supplement Reference Standards Available from USP

Cat. No. 1152009 1179504 1239005 1241007 1286005 1286027 1370804 1381006 1461003 1462006 1494501 1494807 1538006 1550001 1587001 1603006 1613509 1614002 1656002 1667600 1667701 1667803 1716002 1717504 Description Cyanocobalamin (1.5 g of mixture with mannitol; 10.7 mcg/mg of mixture) (Vitamin B12) Dexpanthenol (500 mg) Ergocalciferol (30 mg/ampule; 5 ampules) (Vitamin D2) Ergosterol (50 mg) Folic Acid (500 mg) (Vitamin M or Vitamin Bc) Folic Acid Related Compound A (50 mg) (Calcium Formyltetrahydrofolate) Lutein (1 mL) Menadione (200 mg) (Vitamin K3) Niacin (200 mg) Niacinamide (500 mg) (Vitamin B3) Panthenol, Racemic (200 mg) Pantolactone (500 mg) Phytonadione (500 mg) (Vitamin K1) Potassium Gluconate (200 mg) Pyridoxine Hydrochloride (200 mg) (Vitamin B6) Riboavin (500 mg) (Vitamin B2) Sodium Ascorbate (200 mg) Sodium Fluoride (1 g) Thiamine Hydrochloride (500 mg) (Vitamin B1 Hydrochloride) Alpha Tocopherol (250 mg) (Vitamin E Alcohol) Alpha Tocopheryl Acetate (250 mg) (Vitamin E Acetate) Alpha Tocopheryl Acid Succinate (250 mg) (Vitamin E Succinate) Vitamin A (10 ampules containing vitamin A acetate in peanut oil) Vitamin D Assay System Suitability (1.5 g) Curr. Lot N J0C293 P0B275 H P I0B176 F0D291 H-3 I0E295 N0E024 G F N0B303 H0C064 P N0C021 G2C067 I0E033 O M K G0D077 W0F126 F-1

Note: Where the Current Lot is blank the item is not in distribution

104 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

Controlled Substances Reference Standards Available from USP

Cat. No. 1012906 1014005 1015008 1030001 1036008 1059003 1076465 1078700 1078711 1079000 1081002 1082504 1089004 1090003 1096804 1109000 1110009 1140305 1140509 1143008 1143802 1144000 1145003 1180004 1183002 1185008 1187207 1194009 1200804 1219008 1258305 1270005 1280009 1285002 1295006 1302305 1307003 1315001 1315012 1323000 1356009 1359506 1364007 1370305 1371002 1375309 1383001 1386000 Description Alfentanil Hydrochloride CII (500 mg) Alphaprodine Hydrochloride CII (250 mg) Alprazolam CIV (200 mg) Amobarbital CII (200 mg) Anileridine Hydrochloride CII (250 mg) Benzphetamine Hydrochloride CIII (200 mg) (AS) Bromazepam CIV (100 mg) (AS) Buprenorphine Hydrochloride CIII (50 mg) Buprenorphine Related Compound A CII (50 mg) (21-[3-(1-propenyl)]-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14endo-ethano-6,7,8,14-tetrahydrooripavine) Butabarbital CIII (200 mg) Butalbital CIII (200 mg) Butorphanol Tartrate CIV (500 mg) Cannabidiol CI (25 mg) (AS) Cannabinol CI (25 mg) (AS) Cathinone Hydrochloride CI (50 mg) (alpha-Aminopropiophenone Hydrochloride) Chlordiazepoxide CIV (200 mg) Chlordiazepoxide Hydrochloride CIV (200 mg) Clonazepam CIV (200 mg) Clorazepate Dipotassium CIV (125 mg) Cocaine Hydrochloride CII (250 mg) Codeine N-Oxide CI (50 mg) Codeine Phosphate CII (100 mg) Codeine Sulfate CII (250 mg) Dextroamphetamine Sulfate CII (500 mg) Diacetylmorphine Hydrochloride (Heroin Hydrochloride) CI (25 mg) (AS) Diazepam CIV (100 mg) Dichloralphenazone CIV (200 mg) Diethylpropion Hydrochloride CIV (200 mg) Dihydrocodeine Bitartrate CII (200 mg) Diphenoxylate Hydrochloride CII (200 mg) Ethchlorvynol CIV (0.7 ml) Fentanyl Citrate CII (100 mg) Fluoxymesterone CIII (200 mg) Flurazepam Hydrochloride CIV (200 mg) Glutethimide CII (500 mg) Halazepam CIV (200 mg) (AS) Hexobarbital CIII (500 mg) Hydrocodone Bitartrate CII (250 mg) Hydrocodone Bitartrate Related Compound A CII (70 mg) (Morphinan-6-one, 4-hydroxy-3-methoxy-17-methyl) Hydromorphone Hydrochloride CII (50 mg) Ketamine Hydrochloride CIII (250 mg) Levmetamfetamine CII (75 mg) Levorphanol Tartrate CII (500 mg) Lorazepam CIV (200 mg) Lysergic Acid Diethylamide Tartrate (LSD) CI (10 mg) (AS) Mazindol CIV (350 mg) Meperidine Hydrochloride CII (200 mg) Mephobarbital CIV (250 mg) I I0B063 G-4 H0E003 G0B027 I0B074 G0A034 J0C200 H-2 I0C311 J I1C364 F0B010 H I0D205 I1D339 F0B011 K0C264 G-2 J0C365 F F1C224 F L0E176 F0C214 J0C372 H0E091 F1C113 I0D138 I1D404 I H I G Curr. Lot F0B016 F H1C133 F-2 F F2C272 F0F064 G0E026 F1C076 H0C007 H0C054 J F-2

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition 105 Ofcial USP Reference Standards Catalog

Controlled Substances Reference Standards Available from USP

Cat. No. 1389008 1398009 1399001 1404000 1405002 1413000 1425000 1429000 1433008 1434011 1438001 1445404 1447002 1448005 1452002 1453526 1454008 1455000 1456003 1468400 1473002 1482003 1482025 1483006 1485191 1487007 1488000 1505007 1507002 1516003 1516502 1523009 1524001 1528501 1554501 1574000 1575002 1592205 1611004 1620005 1623648 1643000 1643408 1645006 1646009 1647001 1648004 1649007 1656308 Description Meprobamate CIV (200 mg) Methadone Hydrochloride CII (200 mg) Methamphetamine Hydrochloride CII (125 mg) Methaqualone CI (500 mg) Metharbital CIII (200 mg) Methohexital CIV (500 mg) 4-Methyl-2,5-dimethoxyamphetamine Hydrochloride (STP) CI (25 mg) (AS) Methylenedioxy-3,4-amphetamine Hydrochloride (MDA) CI (25 mg) (AS) Methylphenidate Hydrochloride CII (125 mg) Methylphenidate Hydrochloride Erythro Isomer Solution CII (0.5 mL) Methyltestosterone CIII (200 mg) Modanil CIV (200 mg) Morphine Monohydrate CII (50 mg) (AS) Morphine Sulfate CII (500 mg) Nalorphine Hydrochloride CIII (250 mg) Naltrexone Related Compound A CII (30 mg) (N-(3-butenyl)-noroxymorphone hydrochloride) Nandrolone CIII (50 mg) Nandrolone Decanoate CIII (250 mg) Nandrolone Phenpropionate CIII (250 mg) Nordazepam CIV (50 mg) (7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one) Noroxymorphone Hydrochloride CII (50 mg) Oxandrolone CIII (50 mg) Oxandrolone Related Compound B CIII (20 mg) (17 beta-hydroxy-17 alpha-methyl-4-oxa-5 alpha-androsta-3-one) Oxazepam CIV (200 mg) Oxycodone CII (200 mg) Oxymetholone CIII (200 mg) Oxymorphone CII (500 mg) Pentazocine CIV (500 mg) Pentobarbital CII (200 mg) Phencyclidine Hydrochloride CII (25 mg) (AS) Phendimetrazine Tartrate CIII (350 mg) Phenmetrazine Hydrochloride CII (200 mg) Phenobarbital CIV (200 mg) Phentermine Hydrochloride CIV (200 mg) Prazepam CIV (500 mg) Propoxyphene Hydrochloride CII (1 g) Propoxyphene Napsylate CII (1 g) Quazepam CIV (200 mg) Secobarbital CII (200 mg) Stanozolol CIII (200 mg) Sufentanil Citrate CII (25 mg) Talbutal CIII (250 mg) Temazepam CIV (200 mg) Testolactone CIII (125 mg) Testosterone CIII (125 mg) Testosterone Cypionate CIII (200 mg) Testosterone Enanthate CIII (200 mg) Testosterone Propionate CIII (200 mg) Thiamylal CIII (200 mg) Curr. Lot G-1 I0B163 I F-1 F-2 G0D252 F F-1 I1C241 F0C368 J1E324 F0D351 G1F125 N0E161 I F F4D144 J0D218 H H1B035 H1C177 H0E223 F0F136 H0D259 J0F026 G1B247 H0B214 I0C418 I0D359 G1B025 G F-2 J H0B309 G0C066 L0C285 H1C323 F H F-3 H1E105 F H0C205 F-1 I1B253 H0D162 K0D253 L1C005 F

Note: Where the Current Lot is blank the item is not in distribution

106 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

Controlled Substances Reference Standards Available from USP

Cat. No. 1661002 1673806 1673828 1680506 Description Thiopental CIII (250 mg) Trenbolone CIII (50 mg) Trenbolone Acetate CIII (200 mg) Triazolam CIV (200 mg) Curr. Lot I1D198 F0D389 F0D390 H0B041

Note: Where the Current Lot is blank the item is not in distribution

SeptemberOctober 2006

Distributors Edition 107 Ofcial USP Reference Standards Catalog

AUTHORIZED USP DISTRIBUTORS

For the convenience of our customers outside the United States, USP has authorized distribution by the organizations or companies listed below. Customers who order through these distributors should obtain information on ordering, pricing, and shipping directly from the distributors. USP products distributed are listed in italics below each listing.
Wako Pure Chemical Industries, Ltd. 1-2, Doshomachi 3-Chome, Chuo-Ku Osaka, 540-8605 JAPAN Tel: 0120-052-099 Fax: 0120-052-806 E-mail: [email protected] www.wako-chem.co.jp Reference Standards KOREA Daejung Chemicals & Metals Co., Ltd. 1235-8 Jeongwang-dong, Shiheung-city Gyeonggi-do KOREA Tel: (+82)-31-488-8822 Fax: (+82)-31-488-8966 Reference Standards EXPORTER TO KOREA C&S Specialties, Inc. 121 Piermont Road Norwood, NJ 07648 USA Tel: 201-750-7740 Fax: 201-750-7742 Reference Standards FRANCE BEDI - Bureau detudes et de documentation industrielle 8, place de la Republique 75011 Paris FRANCE Tel: (+33) 1-47-00-62-63 Fax: (+33) 1-47-00-04-69 USPNF (Print or Electronic); Pharmacopeial Forum; USP Dictionary ` SOTAX Sarl 24, rue de Bale FR-68300 St-Louis FRANCE Tel: (+33) 03-89-70-08-46 Fax: (+33) 03-89-70-17-81 www.sotax.com E-mail: [email protected] Dissolution Calibrator Products GERMANY Deutscher Apotheker Verlag Postfach 10 10 61 D-70 009 Stuttgart GERMANY Tel: (+49) 711-2582-341 Fax: (+49) 711-2582-290 E-mail: [email protected] http://www.deutscher-apothekerverlag.de USPNF (Print and Electronic); Pharmacopeial Forum (Print and Electronic); USP Dictionary; Chromatographic Reagents SOTAX GmbH Wallbrunneck Wallbrunnstrasse 24 DE-79539 Lorrach GERMANY Tel: (+49) 07621-16-56-35 Fax: (+49) 07621-16-57-15 www.sotax.com E-mail: [email protected] Dissolution Calibrator Products ITALY Licosa S.P.A. Ufcio di Milano Via Bartolini, 29 20155 Milano ITALY Tel: (+39) (02) 39265083 Fax: (+39) (02) 39217304 E-mail: [email protected] USPNF (Print and Electronic); Pharmacopeial Forum; USP Dictionary Nova Chimica Via Galileo Galilei, 47 20092 Cinisello Balsamo (MI) ITALY Tel: (+39) (02) 66045392 Fax: (+39) (02) 66045394 E-mail: [email protected] http://www.novachimica.com Reference Standards SOTAX srl. Via Milazzo, 14 IT-24124 Bergamo ITALY Tel: (+39) 035-21-95-55 Fax: (+39) 035-21-36-43 E-mail: [email protected] www.sotax.com Dissolution Calibrator Products SPAIN / PORTUGAL CYMIT QUIMICA SL GuillemTell, 42 08006 Barcelona SPAIN Tel: (+34) 93-2412927 Fax: (+34) 93-4144979 E-mail: [email protected] Web: www.cymitquimica.com USPNF (Print); Spanish USPNF (Print); USP Pharmacists Pharmacopeia; Chromatographic Reagents; Pharmacopeial Forum; USP Dictionary SWEDEN Boktjanst Sverige AB PO Box 344 SE-541 31 Skovde SWEDEN Tel: (+46) 0500-419580 Fax: (+46) 0500-487387 www.botjanst.se E-mail: [email protected] USPNF (Print and Electronic); Pharmacopeial Forum (Print and Electronic); USP Dictionary; Chromatographic Reagents SWITZERLAND Deutscher Apotheker Verlag Postfach 10 10 61 D-70 009 Stuttgart GERMANY Tel: (+49) 711-2582-341 Fax: (+49) 711-2582-290 E-mail: [email protected] http://www.deutscher-apothekerverlag.de USPNF (Print and Electronic); Pharmacopeial Forum (Print and Electronic); USP Dictionary; Chromatographic Reagents SOTAX AG Binningerstrasse 106 CH-4123 Allschwil 1 SWITZERLAND Tel: (+41) 061-487-54-54 Fax: (+41) 061-482-13-31 www.sotax.com E-mail: [email protected] Dissolution Calibrator Products

ASIA
INDIA LGC Promochem India Private Ltd. P.O. Box 8061 No. 142, 3rd Floor, 5th Cross Rajamahal Villas Extension Bangalore 560 080 INDIA Tel: (+91) 80-23611256 or (+91) 80-23611257 Fax: (+91) 80-23613859 E-mail: [email protected] Reference Standards; USPNF Asian Edition (Print); Pharmacopeial Forum (Print and Electronic); USP Dictionary; Chromatographic Reagents LGC Promochem India Private Limited No. 408, B Wing, Galleria, Hiranandani Gardens, Powai Mumbai 400 076 INDIA Tel: (+91) 022-25700244, 25706044 Fax: (+91) 022-25703741 E-mail: [email protected] Reference Standards; USPNF Asian Edition (Print); Pharmacopeial Forum (Print and Electronic); USP Dictionary; Chromatographic Reagents LGC Promochem India Private Limited No. 7-1-213/B, 1st Floor, Opp. Govt Hospital, Ameerpet, Hyderabad 500 016 INDIA Tel: (+91) 040-23736378 Fax: (+91) 040-23736379 E-mail: [email protected] Reference Standards; USPNF Asian Edition (Print); Pharmacopeial Forum (Print and Electronic); USP Dictionary; Chromatographic Reagents JAPAN Maruzen International Co. 3-10 Nihombashi 2-Chome Chuo-ku,Tokyo l03 JAPAN Tel: (+91) 3-3275-8591 Fax: (+91) 3-3278-1937 USPNF (Print and Electronic); Pharmacopeial Forum; USP Dictionary; Chromatographic Reagents Society of Japanese Pharmacopeia Reference Standards Section, Osaka Branch 2-1-1 Izumimachi, Chuo-ku, Osaka 540-0019, JAPAN Tel: (+91) 6-6221-3444 Fax: (+91) 6-6943-1397 E-mail: [email protected] Reference Standards

EUROPE
AUSTRIA Deutscher Apotheker Verlag Postfach 10 10 61 D-70 009 Stuttgart GERMANY Tel: (+49) 711-2582-341 Fax: (+49) 711-2582-290 E-mail: [email protected] http://www.deutscher-apothekerverlag.de USPNF (Print and Electronic); Pharmacopeial Forum (Print and Electronic); USP Dictionary; Chromatographic Reagents UNITED KINGDOM SOTAX Ltd. 13 Station Road London N3 2SB UNITED KINGDOM Tel: (+44) 020-8349 6947 Fax: (+44) 020-8349 6948 www.sotax.com E-mail: [email protected] Dissolution Calibrator Products The Stationery Ofce (TSO) Freepost ANG4748 Norwich NR3 1YX UNITED KINGDOM Tel: (+44) 0870 600 5522 Fax: (+44) 0870 600 5533 www.tsoshop.co.uk E-mail: [email protected] USPNF (Print and Electronic); Pharmacopeial Forum (Print and Electronic); USP Dictionary; Chromatographic Reagents; USP Pharmacists Pharmacopeia

108 Distributors Edition Ofcial USP Reference Standards Catalog

SeptemberOctober 2006

AUTHORIZED USP DISTRIBUTORS

TURKEY Ekin Kimya Ticaret Limited Sirketi Bulgurlu Mahallesi Sarigazi Caddesi No: 29 Post code: 34696 Uskudar-Istanbul TURKEY Tel: (+90) 216-524-12-24 Fax: (+90) 216-524-12-80/81 Reference Standards; USPNF (Print or Electronic); Pharmacopeial Forum; USP Dictionary EXPORTER TO BRAZIL ITI International Trade Inc., 10767 SW 104 Street Miami, FL 33176 USA Tel: (305) 596-7740 Fax: (305) 596-6461 http://www.iitinternational.net E-mail: [email protected] Reference Standards; USPNF (Print or Electronic); Pharmacopeial Forum; USP Dictionary; Chromatographic Reagents; Pharmacists Pharmacopeia CHILE Merck S.A. Chile Francisco De Paula Taforo 1981 Codigo Postal 6842305 Casilla 48-D Santiago CHILE Tel: (56-2) 3400000 Fax: (56-2) 3400199 E-mail: [email protected] http://www.merck.cl Reference Standards; USPNF (Print or Electronic); Pharmacopeial Forum; USP Dictionary COLOMBIA Merck S.A. Carrera 65 No. 10-95 Bogota DC COLOMBIA Tel: (+57) 1-4254749 Fax: (+57) 1-4255407 E-mail: [email protected] http://www.merck.com.co Reference Standards; USPNF (Print or Electronic); Pharmacopeial Forum; USP Dictionary Kimia Trading Ltda. Calle 88 No. 34-50 Bogota DC COLOMBIA Phone: (+57) 1-6160089, (+57) 1-2568164 Fax: (+57) 1-6184448 E-mail: [email protected] or [email protected] Reference Standards; USPNF (Print or Electronic); USPNF Spanish; PF (Print or Electronic); USP Dictionary; Chromatographic Reagents; Pharmacists Pharmacopeia ECUADOR Merck Ecuador C.A. AV. Amazonas 4545 y Pereira Edif. Centro Financiero Piso 6 Quito ECUADOR Tel: (593) 2298-1677 Fax: (593) 2298-1644 E-mail: [email protected] http://www.merck.com.ec Reference Standards; USPNF (Print or Electronic); Pharmacopeial Forum; USP Dictionary MEXICO Asociacion Farmaceutica Mexicana, AC (AFM) Adolfo Prieto 1649-601 03100 Mexico, D.F. MEXICO Tel: (5255) 5524-5685 Fax: (5255) 5534-5098 USPNF (Print or Electronic); Pharmacopeial Forum Proveedora Quimico Farmaceutica, S.A. de C.V. Calle Jose Maria Morelos No. 164 Barrio del Nino Jesus Tlalpan D.F.C.P.14080 MEXICO Tel: (5255)-1315-1427 Fax: (5255) 5796-6649 E-mail: [email protected] [email protected] http://www.proquifa.com.mx Reference Standards; USPNF (Print or Electronic); Pharmacopeial Forum; USP Dictionary; Spanish USP-NF (Print); Chromatographic Reagents PERU Merck Peruana S.A. Peru AV. Los Frutales 220 Ate. Vitarte Casilla 4331 Lima 3 PERU Tel: (511) 618-7500 Fax: (511) 437-2955 E-mail: [email protected] http://www.merck.com.pe Reference Standards; USPNF (Print or Electronic); Pharmacopeial Forum; USP Dictionary URUGUAY Infodynamics S.R.L. Zorrilla 233 11300 Montevideo URUGUAY Tel: (+59) 82-7100499 Fax: (+59) 82-7100499 USPNF (Print or Electronic); Pharmacopeial Forum; USP Dictionary VENEZUELA Merck S.A. Calle Hans Neumann Edicio Corimyn Piso 3, Los Cortijos de Lourdes Caracas VENEZUELA Tel: (+58) 212-2351379 Fax: (+58) 212-2377632 E-mail: [email protected] http://www.merck.com.ve Reference Standards; USPNF (Print or Electronic); Pharmacopeial Forum; USP Dictionary EXPORTER TO CENTRAL AMERICA Pharma Scientic 2820 San Bernardo Suite 9 Laredo, TX 78045 Tel: (956) 729-8110 Fax: (956) 729-8112 E-mail: [email protected] Reference Standards; USPNF (Print or Electronic); Pharmacopeial Forum; USP Dictionary; Spanish USPNF (Print); Chromatographic Reagents EXPORTER TO LATIN AMERICA Farma International 9501 Old South Dixie Hwy. Miami, FL 33156 USA E-mail: [email protected] http://www.farmainternational.com Tel: 305-670-4416 Fax: 305-670-4417 Reference Standards; USPNF (Print or Electronic); Pharmacopeial Forum; USP Dictionary; Chromatographic Reagents

LATIN AMERICA
ARGENTINA Carpe Scheider y Cia, S.A. Godoy Cruz 2769, 5 Piso 1425 Buenos Aires ARGENTINA Tel: (+54) 11-477-60477 Fax: (+54) 11-477-59619 Reference Standards; USPNF (Print or Electronic); Pharmacopeial Forum; USP Dictionary; Chromatographic Reagents EUROLAB S.A. Paraguay 2452 5 Piso C1121ABN Buenos Aires ARGENTINA Tel: (+54) 11-4966-1818 Fax: (+54) 11-4966-1818 ext.105 www.eurolabsa.com.ar E-mail: [email protected] Reference Standards; USPNF (Print or Electronic); Pharmacopeial Forum (Print or Electronic); Chromatographic Reagents; Pharmacists Pharmacopeia; USAN Dictionary V.R. Publishing, LLC AV. Belgrano 3786 No 2 Posta Cod. 1210 Buenos Aires ARGENTINA Tel: (0054-11) 4931-4861 E-mail: [email protected] USPNF (Print); USPNF Spanish (Print) BRAZIL Ayalla Marketing e Representacoes Ltda. (Ricera American Corp. - Filial nos EUA) Av. Barao de Vallim, 142 - Campo Belo 04613-030 - Sao Paulo - SP BRAZIL Tel: (+55) 11-5561-7486 Fax: (+55) 11-5041-8434/5535-9606 E-mail: [email protected] Reference Standards; USPNF (Print or Electronic); Pharmacopeial Forum; USP Dictionary; Chromatographic Reagents LAS do Brasil, Ltda. Av. V-8 Qd. 22 Lt. 25 Papillon Park Ap. de Golania Goias - Brasil CEP; 74.952-560 CNPJ: 06.880.842/0001-61 Insc. Estadual: 10383862-7 Tel: (+55) 62-3094-5552 Fax: (+55) 62-3094-5553 E-mail: [email protected] Reference Standards; USPNF (Print or Electronic); Pharmacopeial Forum; USP Dictionary; Chromatographic Reagents; Pharmacists Pharmacopeia

MIDDLE EAST
ISRAEL Ophir Analytical Ltd. 6 Hamelacha St. Ent. 15 P. O. Box 11616 Park-Afek Rosh-Haayin ISRAEL E-mail: [email protected] Tel: (+972) 3-902-2277 Fax: (+972) 3-902-2488 Reference Standards

SOUTH AFRICA
Industrial Analytical (Pty) LTD Kyalami Business Park Industrial Analytical House 4 Indianapolis Road Kyalami, 1684, SOUTH AFRICA Tel: (+27) 11-466-4321 Fax: (+27) 11-466-4611 E-mail: [email protected] http://www.industrialanalytical.co.za Reference Standards; USPNF (Print or Electronic); Pharmacopeial Forum; USP Dictionary; Chromatographic Reagents

NORTH AMERICA
CANADA A&C American Chemicals Ltd. 3010 De Baene Street Montreal, Quebec H4S IL2 CANADA Tel: 514-336-1493 Fax: 514-336-1768 E-mail: [email protected] http://www.acamchem.com Reference Standards USA National Technical Information Service 5285 Port Royal Road Springeld, VA 22161 USA Tel: 703-605-6400 Fax: 703-605-6715 USPNF (Print or Electronic)

USP publications in online and CD formats provide the same quality content found in print, along with convenient bonus features that make accessing the information you need even easier!*

USPNF Online andCD

In addition to what is in the print edition, these formats offer you 4 A glossary of frequently asked questions 4 Extensive search features 4  onvenient quick search, bookmarking, printing, and copy-paste options C The online format also features My USPNF, which allows you to save frequent searches, bookmark important pages, and create a customized table of contents all in an organized, online format thats easy to access for future use.

USPNF electronic subscriptions available in online and CD formats

N E W!

Exclusive to USP 30NF 25 Online and CD: Viewable chemical structures for more than 300 impurities. These new structures are in addition to the more than 1,000 drug substance structures found in USPNF print. Electronic functions let you zoom in, zoom out, and print. Expect additional structures in 2007 as new monographs and Reference Standards are established.

Pharmacopeial Forum (PF) Online

Track, influence, and discuss the development of official USPNF standards through PF Online, USPs bimonthly electronic journal. It allows you to 4 Review and comment on proposed USPNF revisions 4 Prepare for future compliance through early notice of proposed changes 4  et information for current compliance through notice of official changes G
PF electronic subscription online only

Includes My PFa special feature that allows users to save searches, bookmark material and track the progression of changes.

It s Ea sy to Order
Visit www.usp.org or call 1-800-227-8772, +1-301-881-0666, or 00-800-4875-5555 (Europe only). Outside the U.S., contact your USP Authorized Distributor.

*AvailableinEnglishonly.

ISO 9001:2000 Certified

AAV6TD